
<html lang="en"     class="pb-page"  data-request-id="7b15a874-3fe5-4d18-b82d-2dae53005354"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00628;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis" /></meta><meta name="dc.Creator" content="Akanksha  Upadhyay" /></meta><meta name="dc.Creator" content="Pragya  Chandrakar" /></meta><meta name="dc.Creator" content="Sampa  Gupta" /></meta><meta name="dc.Creator" content="Naveen  Parmar" /></meta><meta name="dc.Creator" content="Sandeep Kumar  Singh" /></meta><meta name="dc.Creator" content="Mamunur  Rashid" /></meta><meta name="dc.Creator" content="Pragati  Kushwaha" /></meta><meta name="dc.Creator" content="Muhammad  Wahajuddin" /></meta><meta name="dc.Creator" content="Koneni V.  Sashidhara" /></meta><meta name="dc.Creator" content="Susanta  Kar" /></meta><meta name="dc.Description" content="In our efforts to identify novel chemical scaffolds for the development of antileishmanial agents, a series of quinoline–metronidazole hybrid compounds was synthesized and tested against the murine..." /></meta><meta name="Description" content="In our efforts to identify novel chemical scaffolds for the development of antileishmanial agents, a series of quinoline–metronidazole hybrid compounds was synthesized and tested against the murine..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 24, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00628" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00628" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00628" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00628" /></link>
        
    
    

<title>Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00628" /></meta><meta property="og:title" content="Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0010.jpeg" /></meta><meta property="og:description" content="In our efforts to identify novel chemical scaffolds for the development of antileishmanial agents, a series of quinoline–metronidazole hybrid compounds was synthesized and tested against the murine model of visceral leishmaniasis. Among all synthesized derivatives, 15b and 15i showed significant antileishmanial efficacy against both extracellular promastigote (IC50 9.54 and 5.42 μM, respectively) and intracellular amastigote (IC50 9.81 and 3.75 μM, respectively) forms of Leishmania donovani with negligible cytotoxicity toward the host (J774 macrophages, Vero cells). However, compound 15i effectively inhibited the parasite burden in the liver and spleen (&gt;80%) of infected BALB/c mice. Mechanistic studies revealed that 15i triggers oxidative stress which induces bioenergetic collapse and apoptosis of the parasite by decreasing ATP production and mitochondrial membrane potential. Structure–activity analyses and pharmacokinetic studies suggest 15i as a promising antileishmanial lead and emphasize the importance of quinoline–metronidazole series as a suitable platform for the future development of antileishmanial agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00628"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00628">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00628&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00628&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00628&amp;href=/doi/10.1021/acs.jmedchem.9b00628" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5655-5671</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00612" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jmv062i011_1288048" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Akanksha Upadhyay</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akanksha Upadhyay</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akanksha++Upadhyay">Akanksha Upadhyay</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pragya Chandrakar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pragya Chandrakar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Parasitology Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pragya++Chandrakar">Pragya Chandrakar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sampa Gupta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sampa Gupta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sampa++Gupta">Sampa Gupta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naveen Parmar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naveen Parmar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Parasitology Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naveen++Parmar">Naveen Parmar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandeep Kumar Singh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandeep Kumar Singh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandeep+Kumar++Singh">Sandeep Kumar Singh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mamunur Rashid</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mamunur Rashid</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mamunur++Rashid">Mamunur Rashid</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pragati Kushwaha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pragati Kushwaha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pragati++Kushwaha">Pragati Kushwaha</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Muhammad Wahajuddin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Muhammad Wahajuddin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Muhammad++Wahajuddin">Muhammad Wahajuddin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Koneni V. Sashidhara</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Koneni V. Sashidhara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#88e3fed7fbe9fbe0e1ece0e9fae9c8ebecfae1a6faedfba6e1e6"><span class="__cf_email__" data-cfemail="abc0ddf4d8cad8c3c2cfc3cad9caebc8cfd9c285d9ced885c2c5">[email protected]</span></a>. Phone: +91-522-2772450, ext. 4683/4684. Fax: +91-522-2771942/2771970 (K.V.S.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Koneni+V.++Sashidhara">Koneni V. Sashidhara</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Susanta Kar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susanta Kar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Parasitology Division, CSIR-Central Drug Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</div><div class="loa-info-affiliations-info">Academy of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e5969096848b91848e8497a58681978ccb978096cb8c8b"><span class="__cf_email__" data-cfemail="4a393f392b243e2b212b380a292e382364382f39642324">[email protected]</span></a>. Phone: +91-522-2772450, ext. 4495 (S.K.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susanta++Kar">Susanta Kar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9907-539X" title="Orcid link">http://orcid.org/0000-0002-9907-539X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00628&amp;href=/doi/10.1021%2Facs.jmedchem.9b00628" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5655–5671</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 24, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 April 2019</li><li><span class="item_label"><b>Published</b> online</span>24 May 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00628" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00628</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5655%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAkanksha%2BUpadhyay%252C%2BPragya%2BChandrakar%252C%2BSampa%2BGupta%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D11%26contentID%3Dacs.jmedchem.9b00628%26title%3DSynthesis%252C%2BBiological%2BEvaluation%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%252C%2Band%2BMechanism%2Bof%2BAction%2BStudies%2Bof%2BQuinoline%25E2%2580%2593Metronidazole%2BDerivatives%2BAgainst%2BExperimental%2BVisceral%2BLeishmaniasis%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5671%26publicationDate%3DJune%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00628"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1997</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00628" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Akanksha&quot;,&quot;last_name&quot;:&quot;Upadhyay&quot;},{&quot;first_name&quot;:&quot;Pragya&quot;,&quot;last_name&quot;:&quot;Chandrakar&quot;},{&quot;first_name&quot;:&quot;Sampa&quot;,&quot;last_name&quot;:&quot;Gupta&quot;},{&quot;first_name&quot;:&quot;Naveen&quot;,&quot;last_name&quot;:&quot;Parmar&quot;},{&quot;first_name&quot;:&quot;Sandeep&quot;,&quot;last_name&quot;:&quot;Kumar Singh&quot;},{&quot;first_name&quot;:&quot;Mamunur&quot;,&quot;last_name&quot;:&quot;Rashid&quot;},{&quot;first_name&quot;:&quot;Pragati&quot;,&quot;last_name&quot;:&quot;Kushwaha&quot;},{&quot;first_name&quot;:&quot;Muhammad&quot;,&quot;last_name&quot;:&quot;Wahajuddin&quot;},{&quot;first_name&quot;:&quot;Koneni&quot;,&quot;last_name&quot;:&quot;V. Sashidhara&quot;},{&quot;first_name&quot;:&quot;Susanta&quot;,&quot;last_name&quot;:&quot;Kar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5655-5671&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00628&quot;},&quot;abstract&quot;:&quot;In our efforts to identify novel chemical scaffolds for the development of antileishmanial agents, a series of quinoline–metronidazole hybrid compounds was synthesized and tested against the murine model of visceral leishmaniasis. Among all synthesized derivatives, 15b and 15i showed significant antileishmanial efficacy against both extracellular promastigote (IC50 9.54 and 5.42 μM, respectively) and intracellular amastigote (IC50 9.81 and 3.75 μM, respectively) forms of Leishmania donovani with negligible cytotoxicity toward the host (J774 macrophages, Vero cells). However, compound 15i effectively inhibited the parasite burden in the liver and spleen (&gt;80%) of infected BALB/c mice. Mechanistic studies revealed that 15i triggers oxidative stress which induces bioenergetic collapse and apoptosis of the parasite by decreasing ATP production and mitochondrial membrane potential. Structure–activity analyses and pharmacokinetic studies suggest 15i as a promising antileishmanial lead and emphasize the importance o&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00628&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00628" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00628&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00628" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00628&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00628" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00628&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00628&amp;href=/doi/10.1021/acs.jmedchem.9b00628" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00628" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00628" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00628%26sid%3Dliteratum%253Aachs%26pmid%3D31124675%26genre%3Darticle%26aulast%3DUpadhyay%26date%3D2019%26atitle%3DSynthesis%252C%2BBiological%2BEvaluation%252C%2BStructure%25E2%2580%2593Activity%2BRelationship%252C%2Band%2BMechanism%2Bof%2BAction%2BStudies%2Bof%2BQuinoline%25E2%2580%2593Metronidazole%2BDerivatives%2BAgainst%2BExperimental%2BVisceral%2BLeishmaniasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D11%26spage%3D5655%26epage%3D5671%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=290795" title="Quinolines">Quinolines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/jmcmar.2019.62.issue-11/20190613/jmcmar.2019.62.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In our efforts to identify novel chemical scaffolds for the development of antileishmanial agents, a series of quinoline–metronidazole hybrid compounds was synthesized and tested against the murine model of visceral leishmaniasis. Among all synthesized derivatives, <b>15b</b> and <b>15i</b> showed significant antileishmanial efficacy against both extracellular promastigote (IC<sub>50</sub> 9.54 and 5.42 μM, respectively) and intracellular amastigote (IC<sub>50</sub> 9.81 and 3.75 μM, respectively) forms of <i>Leishmania donovani</i> with negligible cytotoxicity toward the host (J774 macrophages, Vero cells). However, compound <b>15i</b> effectively inhibited the parasite burden in the liver and spleen (>80%) of infected BALB/c mice. Mechanistic studies revealed that <b>15i</b> triggers oxidative stress which induces bioenergetic collapse and apoptosis of the parasite by decreasing ATP production and mitochondrial membrane potential. Structure–activity analyses and pharmacokinetic studies suggest <b>15i</b> as a promising antileishmanial lead and emphasize the importance of quinoline–metronidazole series as a suitable platform for the future development of antileishmanial agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62415" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62415" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">World Health Organization (WHO) classifies leishmaniasis as one of the most neglected tropical human diseases of global health concern. Visceral leishmaniasis (VL) is a life-threatening disease caused by the obligate intracellular parasites <i>Leishmania donovani</i>, <i>Leishmania infantum</i> (syn. <i>Leishmania chagasi</i>).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> VLs is nearly always fatal, if not treated; as this disease confers detrimental effects on vital organs like the liver and spleen.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> According to the recent report of WHO, leishmaniasis is prevalent in approximately 90 countries that include areas of India, Nepal, Bangladesh, Sudan, South Sudan, Ethiopia, and Brazil. It is estimated that approximately 70 000 deaths and 1.5–2 million new cases occur every year because of leishmaniasis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Because of the lack of a potent vaccine, chemotherapy emerges as the only approach to cure different types of leishmanial infection. Pentavalent antimonial-based drugs such as sodium stibogluconate, meglumine antimoniate, and other chemotherapeutics like amphotericin B, paromomycin, and pentamidine are the mainstays of antileishmanial chemotherapy.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> However, these drug treatments entail high costs, involve prolonged administration, and even exhibit side-effects like nephrotoxicity, ototoxicity, hepatotoxicity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Additionally, the gradual increase in the resistance of parasite strains against antileishmanial drugs has limited their use for treatment in endemic areas.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Miltefosine is the only available oral drug for the first-line therapy of VL<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> as well as cutaneous leishmaniasis,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> yet its usage involves several drawbacks such as high price, potential fetotoxicity, and teratogenicity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In the search for more effective drugs against VL and other “neglected tropical diseases”, researchers have reassessed the therapeutic value of nitroheterocyclic compounds. In particular, nitro-containing imidazoles like nitroimidazo-oxazine and nitroimidazooxazole delamanid were shown to have effective antileishmanial efficacy.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> Moreover, the 5-nitroimidazole, fexinidazole is now in clinical trials while back-up nitroimidazoles, such as DNDI-VL-2098 are at an advanced stage of preclinical development for use in the treatment of VL.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Research suggests that reduction of the nitro group of nitroimidazoles in pathogens lead to the formation of reactive metabolic intermediates that covalently bind with DNA and trigger cell death. In <i>Leishmania</i>, nitroimidazoles are activated by a novel nitroreductase that results in the generation of reactive nitrogen species, including nitric oxides (NO) that are major effectors of these compounds. Because the des-nitro forms of these compounds were found to be inactive against <i>L. donovani</i>, this suggests that the nitrogroup plays a key role in the antileishmanial activity of this series.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Quinolines are an important structural motif found in numerous natural products that exhibit diverse biological activities.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17−20)</a> Quinoline derivatives have been found to be active against promastigotes of different <i>Leishmania</i> species. Compounds with antileishmanial activity such as sitamaquine and tafenoquine, both 8-aminoquinolines, have been extensively studied in recent decades.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> Different analogues of quinoline conjugated to sulfonamide, hydrazide, and hydrazine are known to exert antileishmanial activity by inducing depolarization of the mitochondrial membrane potential (MMP) in promastigotes.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In addition to these, quinoline derivatives exerted their effect by inducing reactive oxygen species (ROS) levels in promastigotes.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In view of the above considerations, herein, we introduced the nitroimidazole moieties at the second position of quinolines to generate a novel series of hybrids and checked its efficacy against dual life stages of the <i>L. donovani</i> parasite. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> shows the chemical structures of some representative drug leads that contain a quinoline or nitroimidazole in their molecular framework and forms the basis of our designed prototype hybrid. The concept of molecular hybridization was utilized to incorporate them in one molecular platform, in order to produce new hybrid architecture with better efficacy and less toxicity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Strategy for designing of quinoline–nitroimidazole hybrids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50775" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50775" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Our multistep synthetic route is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The synthesis of the proposed prototype was initiated by the tosylation of metronidazole (MET-OH) <b>9</b> with excess use of toluene sulphonyl chloride (<b>10</b>) in the presence of triethylamine in CH<sub>2</sub>Cl<sub>2</sub>(10 mL) at 0 °C, afforded the MET-OTs <b>11</b> in good yield.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Then, the MET-OTs <b>11</b> was treated with 3-hydroxyacetophenone <b>12a</b> and 4-hydroxyacetophenone <b>12b</b> in the presence of K<sub>2</sub>CO<sub>3</sub> in DMF at room temperature yielded the desired products <b>13a</b> and <b>13b</b>, respectively.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Further, these compounds were treated with various substituted 2-aminoarylketones in the presence of TFA at 120 °C for 3 h.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Under the present reaction conditions, <b>13a</b> or <b>13b</b> with various substituted 2-aminoarylketones <b>14</b> proceeded smoothly and furnished the corresponding products <b>15a–15m</b> in good to moderate yield.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Quinoline–Metronidazole Conjugates (<b>15a–15m</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Et<sub>3</sub>N, DCM, 0 °C, 5 h. (ii) K<sub>2</sub>CO<sub>3</sub>, DMF, 35–40 °C, 24 h (iii) TFA, 120 °C, 3 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vitro Antileishmanial Activity of Quinoline–Metronidazole Derivatives</h3><div class="NLM_p">To assess the antileishmanial potency of quinoline–metronidazole derivatives, inhibition of promastigotes and intracellular amastigotes of <i>L. donovani</i> was tested initially at two concentrations, that is, 25 and 50 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) for 48 h. To check these, we used luciferase expressing <i>L. donovani</i> parasite and cell viability of both promastigotes and intracellular amastigotes was assessed in terms of relative luciferase units. Based on preliminary screening, we found compounds <b>15b</b>, <b>15h</b>, and <b>15i</b> to be maximally active against the promastigote stage of the parasite with inhibition rates between 93 and 95% at 50 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Most of the compounds showed less to moderate activity against the intracellular amastigote form as well, with inhibition ranging from 23 to 67% at 50 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). From the aforementioned compounds, <b>15b</b> and <b>15i</b> were found to exhibit significant activity against amastigotes, with >93% parasite killing at 50 μM concentration (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). These quinoline–metronidazole hybrids displayed superior antileishmanial activity in comparison to their parent subunits (i.e., quinoline and metronidazole) which showed 83.6 and 68.1% antiamastigote killing, respectively, at 50 μM concentration.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Antileishmanial Efficacy of Compounds<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">promastigotes</th><th class="rowsep1 colsep0" colspan="2" align="center">intracellular amastigotes</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">s. no.</th><th class="colsep0 rowsep0" align="center">compound code</th><th class="colsep0 rowsep0" align="center">concentration (μM)</th><th class="colsep0 rowsep0" align="center">% inhibition</th><th class="colsep0 rowsep0" align="center">concentration (μM)</th><th class="colsep0 rowsep0" align="center">% inhibition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">63 ± 7.2</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">66.4 ± 7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">43 ± 5.9</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">31.2 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">94.7 ± 2.1</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">93.2 ± 3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">77.8 ± 8.2</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">75.2 ± 7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"><b>15c</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">58.2 ± 7.1</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">59.2 ± 9.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">41.2 ± 6</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">38.2 ± 6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"><b>15d</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">60.8 ± 8.8</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">65.3 ± 7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">30.2 ± 4.1</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">29.5 ± 6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><b>15e</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">NSI</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">10.4 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">NSI</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">NSI</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"><b>15f</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">26 ± 3.9</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">NSI</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">12.3 ± 4.6</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">NSI</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left"><b>15g</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">NSI</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">12.1 ± 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">NSI</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">NSI</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><b>15h</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">93.2 ± 4.4</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">67.7 ± 8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">78.2 ± 9.1</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">45.3 ± 5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left"><b>15i</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">94.4 ± 1.2</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">93.8 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">85.8 ± 6.4</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">83.2 ± 7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left"><b>15j</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">65.8 ± 7.2</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">64.4 ± 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">45.3 ± 5</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">34.2 ± 5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"><b>15k</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">63.9 ± 7.3</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">60.3 ± 7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">41.3 ± 5.2</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">33.8 ± 4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left"><b>15l</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">61.7 ± 7.7</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">27.2 ± 4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">38.2 ± 5.1</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">12.1 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"><b>15m</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">59.1 ± 6.4</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">63.6 ± 7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">34.4 ± 5.1</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">23.4 ± 4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"><b>metronidazole</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">62.2 ± 5.2</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">68.1 ± 5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">41.3 ± 3.8</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">31.2 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left"><b>quinoline</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">80.2 ± 5.2</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">83.6 ± 4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">42.4 ± 3.1</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">64.5 ± 3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left"><b>miltefosine</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">99.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">99.2 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">97.2 ± 0.7</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">98.3 ± 0.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Percentages of inhibition are expressed as mean ± standard deviation for each compound of three individual experiments (at least) performed in duplicates, NSI (no significant inhibition).</p></div></div></div><div class="NLM_p">The antileishmanial activity of most active compounds <b>15b</b> and <b>15i</b> was measured in time as well as dose-dependent fashion against <i>L. donovani</i> promastigotes and amastigotes by MTT and luciferase assay, respectively. Dose- and time-dependent inhibition against promastigotes were observed by both compounds <b>15b</b> and <b>15i</b>, where maximum inhibition was >93% as determined by luciferase and MTT assay (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B). In addition to these, half-maximal inhibition (IC<sub>50</sub>) concentrations of <b>15b</b> and <b>15i</b> against promastigotes were 9.54 ± 0.73 and 5.42 ± 0.45 μM as determined by luciferase assay. This was comparable with the antipromastigote IC<sub>50</sub> of both these compounds (9.4 ± 1.2 and 5.3 ± 0.65 μM for <b>15b</b> and <b>15i</b>, respectively) as determined by MTT assay. Similarly, different concentrations of <b>15b</b> and <b>15i</b> were found to successfully inhibit the intracellular multiplication of the parasite in a dose-dependent fashion in J774 macrophages, where maximum elimination of amastigotes was observed at a dose of 50 μM by both luciferase assays (>96%, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C) and Giemsa staining of intracellular amastigotes (>93%, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). Half-maximal inhibition concentrations (IC<sub>50</sub>) of <b>15b</b> and <b>15i</b> against intracellular amastigotes, were found to be 9.81 ± 2.05 and 3.75 ± 0.68 μM by luciferase assay and 9.09 ± 1.04 and 4.06 ± 0.70 μM by Giemsa staining, respectively, at 48 h, both of which are lesser than that of their parent subunits metronidazole, or quinoline (IC<sub>50</sub>: 28.4 and 11.6 μM, respectively). Moreover, they are either equivalent to, or lesser than the IC<sub>50</sub> of miltefosine (standard chemotherapeutic regimen for VLs, anti-amastigote IC<sub>50</sub>: 9.59 μM) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). Both these compounds were found to be noncytotoxic and exhibited a higher safety index (SI = CC<sub>50</sub>/IC<sub>50</sub>, of <b>15b</b> and <b>15i</b>, was observed as 12.6 and 17.6 in J774 cells, and 36.05 and 57.9 in Vero cells, respectively, as compared to miltefosine, SI = 5.8 and 5.3 in J774 macrophages and Vero cells, respectively). Both <b>15b</b> and <b>15i</b> showed much less toxicity toward J774 and Vero cells as >92% cells and >86% cells were viable up to 50 and 100 μM concentrations, respectively. Increasing the concentration of both <b>15b</b> and <b>15i</b> to 100 μM did not alter their activity against promastigotes and amastigotes significantly and was almost equivalent to the percentage inhibition observed at 50 μM. Thereby, the 50 μM concentration was taken as the MIC (maximum inhibitory concentration) for both <b>15b</b> and <b>15i</b>. The preliminary in vitro screening revealed that out of the synthesized derivatives, ten compounds exhibited better (58–95%) inhibition at 50 μM concentrations against promastigotes. Interestingly, the hybrids were more active against <i>L. donovani</i> as compared to the parental subunits alone, that is, quinoline and metronidazole. The unsubstituted quinoline analog <b>15h</b> displayed significant activity (93.2% inhibition) against promastigotes as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The presence of methyl substitution at R<sub>2</sub> of the quinoline ring enhances activity against promastigotes with lesser cytotoxicity when evaluated and compared to miltefosine as shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A (<b>15b</b> and <b>15i</b> having IC<sub>50</sub> = 9.54 ± 0.73 μM and IC<sub>50</sub> = 5.42 ± 0.45 μM, respectively). Further, these derivatives were tested for their activity against the intracellular amastigotes form. In this screening, again the compounds <b>15b</b> and <b>15i</b> possessing a methyl group at R<sub>2</sub> position exhibited robust activity against amastigotes with IC<sub>50</sub> = 9.81 ± 2.05 μM and IC<sub>50</sub> = 3.75 ± 0.68 μM, respectively, as compared to the standard drug miltefosine. However, the substitution at R<sub>1</sub> position of quinoline had no influence on biological activity. Thus, in terms of preliminary structure–activity relationship (SAR), the methyl substitution at the fourth position, that is, R<sub>2</sub> of the quinoline ring enhanced activity against both the promastigote and amastigote stages of the parasite. Also, both para and meta substitution of the phenyl ring attached to the quinoline ring with the nitroimidazole moiety were pivotal for optimum activity, which could be seen in the case of compounds <b>15b</b> and <b>15i</b>. A preliminary summary of SAR is schematically represented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. These results further led to the evaluation of in vitro pharmacokinetics stability of <b>15b</b> and <b>15i</b> before proceeding for the determination of antileishmanial efficacy against <i>L. donovani</i>-infected BALB/c mice.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Antileishmanial activity of <b>15b</b> and <b>15i</b> in in vitro. (A) Percentage inhibition of parasites was assessed by luciferase assay after treatment with <b>15b</b> and <b>15i</b> at different concentrations for 24 and 48 h. (B) Percent viability/survival of promastigotes was evaluated by MTT assay after treatment with varying concentrations of <b>15b</b> and <b>15i</b> for 48 h. (C,D) Macrophages were infected with a 1:8 (cell: promastigote) ratio, followed by treatment with different doses of compounds <b>15b</b> and <b>15i</b> for 48 h, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The percentage of amastigote inhibition was determined by luciferase assay (C) and the number of intra-macrophagic amastigotes was evaluated by Giemsa staining (D) as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (E,F) Vero cells and J774 macrophages were incubated at varying concentrations of <b>15b</b> and <b>15i</b> for 48 h and cell viability was checked by the MTT method. Data are represented as means ±SD of individual experiments (<i>n</i> = 3), which were done in replicate. Significance levels are represented as untreated vs <b>15b</b>, <b>15i-</b>treated groups with 25 and 50 μM doses, **<i>p</i> < 0.005, ***<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pictorial representation of SAR of quinoline–metronidazole hybrid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro Pharmacokinetic Study</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> In Vitro-Simulated Gastric Fluid and Simulated Intestinal Fluid Stability</h4><div class="NLM_p">The stability of <b>15b</b> and <b>15i</b> was assessed in simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, pH 6.5). Both these compounds were found to be stable in gastric fluid as 84.72 ± 2.62% of <b>15b</b> and 83.58 ± 0.77% of <b>15i</b> remained intact after 2 h of incubation with SGF (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vitro stability of compounds <b>15b</b> and <b>15i</b> in simulated gastric (A) and intestinal (B) fluids up to 2 h. In vitro stability of compounds <b>15b</b> and <b>15i</b> in rat plasma (C) and in RLMs (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">However, the percentage remaining in the intestinal fluid was found to be only 11.40 ± 0.35 and 43.56 ± 3.84% for <b>15b</b> and <b>15i</b>, respectively, as observed up to 2 h (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). These results demonstrated that compound <b>15i</b> was relatively more stable as compared to <b>15b</b> in the intestinal fluid.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> In Vitro Plasma Stability</h4><div class="NLM_p last">Evaluation of plasma stability of <b>15b</b> and <b>15i</b> in rat plasma is depicted in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C. The results demonstrate that the compounds were found to be stable as 68.16 ± 0.085% of <b>15b</b> and 88.50 ± 3.95% of <b>15i</b>, remained intact in rat plasma after 2 h incubation. The results also clearly indicated that compound <b>15i</b> was more stable in rat plasma as compared to <b>15b</b>.</div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> In Vitro Microsomal Stability</h4><div class="NLM_p last">In vitro microsomal stability indicates hepatic clearance (Cl) of drug from the liver. The result of microsomal stability of compound <b>15b</b> and <b>15i</b> using rat liver microsomes (RLM) is shown in (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). The compounds <b>15b</b> and <b>15i</b> were found to be intact as 72.77 ± 2.32 and 75.97 ± 0.63%, respectively, after 60 min incubation in RLM. The in vitro half-life (<i>t</i><sub>1/2</sub>) and related parameters of compound <b>15b</b> and <b>15i</b> were calculated by plotting the natural logarithm of the percentage compound remaining versus incubation time up to 60 min. The half-life values of <b>15b</b> and <b>15i</b> were found to be 2.18 ± 0.32 and 2.50 ± 0.27 h, respectively. Nevertheless, the intrinsic Cl values of compounds <b>15b</b> and <b>15i</b> were found to be 10.7 ± 1.56 and 9.3 ± 0.99 μL/min/mg, respectively. The abovementioned preclinical stability studies demonstrated that compound <b>15i</b> has higher stability under a different set of experimental conditions as compared to compound <b>15b</b>.</div></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> In Vivo Activity of Compound <b>15b</b> and <b>15i</b> Against <i>L. donovani</i>-Infected Mice</h4><div class="NLM_p"><i>L. donovani-</i>infected BALB/c mice (15 days) were administered with compounds <b>15b</b> and <b>15i</b> via intraperitoneal route (as described in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>), for five consecutive days with 12.5–200 mg/kg/day dose range and then sacrificed at 7th day after completion of treatment. The parasitic load was determined in the stamp smears obtained from spleen and liver. Both compounds <b>15b</b> and <b>15i</b> were observed to inhibit parasitic load in the organs of infected BALB/c mice in a dose-dependent fashion (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B). However, dose-dependent antileishmanial activity was different for both the compounds where <b>15i</b> exhibited better efficacy as compared to <b>15b</b>. Parasitic inhibition by compound <b>15i</b> in liver and spleen was observed to be >62% at 25 mg/kg (lower dose), whereas compound <b>15b</b> was able to eliminate >50% parasite from liver and spleen at 50 mg/kg dose. For <b>15i</b>, maximum inhibition of organ parasite burden was obtained at 50 mg/kg/day dose for 5 consecutive days, where we observed >80.3 and >82.3% inhibition in both splenic and liver parasitic load, respectively, at the 7th day of post-treatment. The inhibition observed was much higher when compared to their parent components (quinoline and metronidazole alone) administered for 5 consecutive days at the dose of 50 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C,D). We observed 36.6 and 40.8% inhibition of the parasitic load in spleen and liver, respectively, for metronidazole, and 55.2 and 58.2% inhibition of parasite burden in spleen and liver, respectively, for quinoline. Moreover, no significant increase in therapeutic efficacy of <b>15i</b> was observed upon increasing the dose to 100 mg/kg (inhibition in spleen and liver parasite burden was 81.7 and 82.5%, respectively) and 200 mg/kg (inhibition in spleen and liver parasite burden was 82.2 and 82.7%, respectively). However, maximum inhibition in liver and splenic parasitic load was found to be 54.14 and 55.5%, respectively, for <b>15b</b>, even at a higher dose of (200 mg/kg). Miltefosine used as standard reference drug showed >98% inhibition of parasite burden at a curative dose (25 mg/kg/day for 5 days) in both the spleen and liver of infected BALB/c mice. During the experimental time duration, all mice were found to be alive, healthy, and no marked reduction in weight was observed in any of the experimental groups. Additionally, in order to assess the in vivo safety index, the major serological markers of toxicity, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels were also checked in BALB/c mice of different experimental groups. On comparing ALT and AST levels in uninfected and <i>L. donovani-</i>infected BALB/c mice at 3rd and 5th week postinfection, we found a significant rise in the serum level of both serological markers ALT and AST in <i>L. donovani-</i>infected BALB/c mice, which were measured as 82 and 202 U/L, respectively, after 5th week of infection. On the other hand, levels in control BALB/c mice was measured as 31 and 97 U/L, respectively, at 5th week (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>E,F). Interestingly, treatment with <b>15i</b> in infected BALB/c mice clearly reduced the levels of both serological markers at every time period. Nevertheless, levels of both markers remained within the normal range (AST—54 to 298 U/L and ALT—17 to 77 U/L in control animal). These results suggested that <b>15i</b> did not induce any hepatotoxicity.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>15b</b> and <b>15i</b> treatment in controlling in vivo infection: 15 day-infected BALB/c mice were treated with different doses of <b>15b</b> and <b>15i</b> as indicated. Mice of different experimental groups (<i>n</i> = 5 mice per group), were killed for the determination of hepatic (A) and splenic (B) parasite burden by the stamp-smear method and represented as Leishman Donovan units (LDU). The in vivo safety index of <b>15b</b> and <b>15i</b> was determined by assessment of serological markers. (C,D) 15 day-infected BALB/c mice were treated with 50 mg/kg of quinoline, metronidazole, <b>15b</b>, <b>15i</b> and 25 mg/kg of miltefosine for 5 consecutive days. Mice of different experimental groups (<i>n</i> = 5 mice per group), were sacrificed at day 7 post-treatment for the determination of hepatic (C) and splenic (D) parasite burden by the stamp-smear method and represented as LDU. (E) AST and (F) ALT at various time points in infected and treated BALB/c mice. Data represent mean ± SD (<i>n</i> = 5 mice per group), representative of three independent experiments were performed in replicate. Significance is indicated for untreated vs <b>15b</b>, <b>15i-</b>treated groups with 50 mg/kg dose; *<i>p</i> < 0.05, **<i>p</i> < 0.005, ***p < 0.0006, ns = nonsignificant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Effect of <b>15i</b> on Host Immunomodulation As Well As Plasma Membrane Integrity/Programmed Cell Death of <i>L. donovani</i> Promastigotes</h3><div class="NLM_p">During infection, <i>L. donovani</i> creates a favorable environment by shifting the T-cell responses from healing Th1 to nonhealing Th2 mode that favors the persistence of the parasite inside the host. Thus, redirecting the immune response from Th2 to Th1 mode and boosting immune cells by stimulating Th1-mediated proinflammatory cytokine secretion is a rational approach in leishmanial chemotherapy. To examine whether <b>15i</b> was capable of stimulating host immunity, we chose 50 μM dose for in vitro studies, as it induced maximum killing of both promastigote and intracellular amastigote. To evaluate the changes in Th1/Th2 cytokines, J774 macrophages were infected with promastigotes, followed by treatment with <b>15i</b> for 48 h and the resulting supernatant was assessed for cytokine estimation. Enzyme-linked immunosorbent assay (ELISA) analysis showed no significant increase in Th1 cytokines (TNF-α and IL-12) or reduction in Th2 cytokines (TGF-β and IL-10) in <b>15i-</b>treated macrophages as compared to infected cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B). Because <b>15i</b> did not induce any apparent host-protective cytokine response, we hypothesized that it could exert its effect by direct killing of <i>L. donovani</i> via apoptosis or necrosis.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>15i-</b>treated <i>L. donovani</i> promastigotes underwent apoptosis: J774 macrophages infected with <i>L. donovani</i> promastigotes (24 h) were further incubated with 50 μM of <b>15i</b> for 48 h. (A) Th1 and (B) Th2 cytokines levels in cultured supernatant were evaluated by ELISA. (C) <i>L. donovani</i> parasites were incubated with 50 μM of <b>15i</b> for different time points and analyzed for membrane permeabilization using the SYTOX dye. Results were represented in percentages to the maximum normalized fluorescence as obtained with 0.1% Triton X-100 used for maximal promastigote permeabilization. (D) Exponential phase <i>L. donovani</i> parasite (1 × 10<sup>6</sup>) was incubated at maximum parasite inhibitory concentration of <b>15i</b> (50 μM) for 12, 24, and 48 h. Parasites incubated with 0.1% DMSO for 48 h were taken as the vehicle control. After incubation, promastigotes were stained with Annexin-V Alexa Fluor 488 and PI and analyzed by flow cytometry. (E) DNA fragmentation of parasites was analyzed by TUNEL assay. Log phase promastigotes were incubated with either vehicle (48 h) or <b>15i</b> (50 μM) for 48 h. TUNEL assay was carried out as mentioned in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Tunnel-stained parasites were then visualized by both phase contrast, as well as fluorescent microscopy. (F) Fluorogenic substrate BOC-GRR-AMC (<i>t</i>-butyloxycarbonyl-Gly-Arg-Arg-AMC) was used to determine metacaspase activity. Log phase promastigotes were treated with DMSO (0.1%), 15i (50 μM) either alone or in parasites pretreated with antipain (1 μM) or zVAD-fmk (100 μM) for 1 h. Activity is expressed as relative fluorescence unit and normalized to mg of protein obtained leishmanial cell lysates. The significance level is determined for the untreated vs treated groups, ns = nonsignificant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To address this issue, we first tried to understand whether the compound was inducing plasma membrane permeabilization of <i>L. donovani</i> promastigotes by lesion or pore formation that eventually resulted in parasitic cell death from osmolysis or necrosis. We checked for the cytosolic entry of SYTOX green in <b>15i-</b>treated parasites, which requires large-sized lesions in the membrane, typical of nonspecific pore formation. <i>L. donovani</i> promastigotes were incubated with both IC<sub>50</sub> as well as MIC of <b>15i</b> for different time points and then incubated with the SYTOX green dye. Flow-cytometric analysis revealed that only 3.63% increase in the fluorescence after 4 h treatment with MIC of <b>15i</b> as compared to maximum permeabilization achieved with 0.1% Triton X 100, used as the positive control (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). Negligible uptake of SYTOX green excluded the possibility of nonspecific pore formation and clearly indicated that <b>15i</b> did not kill the parasite via osmolysis-mediated necrosis. The apparent absence of necrotic cell death by <b>15i</b> encouraged us to check whether it could trigger apoptotic cell death machinery in the leishmanial parasite, as we previously observed antipromastigote activity of this compound by MTT assay. Phosphatidylserine externalization is a hallmark feature of cells undergoing apoptosis. Therefore, we next detected phosphatidylserine externalization by staining <b>15i-</b>treated promastigotes with both Annexin-V-coupled FITC, as well as propidium iodide (PI) to check for apoptosis or necrosis. The dot plots are represented in (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D), which clearly demonstrated that treatment with <b>15i</b> for 24 h could initiate early apoptosis as 52.18% of parasites was found in both Annexin-V/PI positive quadrants. This further increased to 62.18% at 48 h treatment with <b>15i</b>. On the other hand, only 7.3% of the promastigotes underwent apoptosis when treated with a vehicle [0.1% dimethyl sulfoxide (DMSO)] which was almost parallel to the control parasite (where 6.7% underwent apoptosis, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D). Programmed cell death of <b>15i-</b>treated parasites was subsequently evaluated at the nuclear level by detecting DNA fragmentation through terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Promastigotes showed bright green fluorescence denoting TUNEL positivity after treatment with <b>15i</b> for 48 h (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E). In contrast, control and vehicle-treated parasites showed red fluorescence because of counterstaining with PI (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E). Merged image of the <b>15i-</b>treated parasite also appeared as bright yellowish green because of TdT-labeled nuclei, which is indicative of programmed cell death. In addition to DNA degradation, changes in the structure and morphology of the parasites were observed by confocal microscopy. Promastigotes treated with <b>15i</b> appeared to be round in shape as compared to untreated promastigotes that were flagellated and elongated, as observed by bright field microscopy. Caspases are the primary executioners of apoptosis in mammalian cells, however, in protozoans, this function is accomplished by its protozoan counterpart, that is, metacaspases. Emerging evidence suggests that metacaspase initiates programmed cell death in leishmanial parasite and its activity is unaffected by caspase inhibitors; however, it is highly sensitive to serine protease inhibitors like antipain or TLCK.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32">(29−32)</a> We, therefore, evaluated the activation of metacaspases by treating <i>L. donovani</i> parasites with <b>15i</b> for 24 and 48 h, either in the presence or absence of caspase and metacaspase inhibitors. Our results suggested that <b>15i-</b>upregulated metacaspase activity by 3.8-fold (at 48 h), as compared to vehicle (0.1% DMSO)-treated parasites. This <b>15i-</b>mediated increase in metacaspase activity remained unaffected by the prior treatment of caspase inhibitors (zVAD-fmk, 100 μM) but significantly decreased in the presence of the metacaspase inhibitor (Antipain, 1 μM) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>F).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <b>15i-</b>Induced Mitochondrial-Programmed Cell Death of the Parasites</h3><div class="NLM_p">Mitochondrial dysfunction and loss in MMP (ΔΨ<sub>m</sub>) are early events in the induction of apoptosis in <i>L. donovani</i> parasites that are commonly induced by chemotherapeutic agents.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> To examine whether <b>15i</b> treatment in <i>L. donovani</i> promastigotes could change its MMP in a time-dependent fashion, ΔΨ<sub>m</sub> was evaluated using the fluorescent dye, JC-1. At higher potential, the JC-1 dye forms aggregates and fluoresces red in the mitochondria of control promastigotes. MMP loss is characterized by a shift of fluorescence signal from red to green (595–530 nm) as JC-1 at a lower potential forms monomers and emits green fluorescence in the cytoplasm. The maximum percentage of the control and vehicle-treated promastigotes emitted red fluorescence, indicating functionally intact mitochondria. On the other hand, in <b>15i</b>-treated parasites, the fluorescence signal shifted from red to green in a time-dependent fashion, thereby denoting the absence of mitochondrial JC-1 accumulation. Flow cytometric studies showed an increase of 33.15, 54.18, and 68.76% green fluorescent cells at 12–48 h post treatment (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). CCCP (mitochondrion uncoupler) was used as a positive control and we observed the fluorescence signal shifted from red to green remarkably in CCCP-treated parasites, which suggested JC-1 sensitivity toward membrane potential in leishmanial cells. This observation strongly suggested that <b>15i</b>-mediated disruption of MMP was perpetrated by an intrinsic pathway of apoptosis in <i>Leishmania</i> promastigotes. The dissipated mitochondrial membrane results in the release of cytochrome <i>c</i> from mitochondria to cytosol, which in turn hampers the effective functioning of the electron transport chain. Immunoblot results suggested that in vehicle-treated promastigotes, mitochondria remains functionally intact and cytochrome <i>c</i> is localized in the mitochondrial fraction (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). On the contrary, <b>15i</b> treatment rapidly induced the cytosolic translocation of cytochrome <i>c</i> in the parasite which was evident from an increased cytosolic abundance of cytochrome <i>c</i> with gradual disappearance in the mitochondrial fraction (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). The loss in membrane potential and leakage of cytochrome <i>c</i> directly affects mitochondrial electron transport chain function and ultimately disrupts ATP generation. Consequently, cells may undergo either necrosis or apoptosis. To study the fate of ATP generation in <b>15i-</b>treated <i>L. donovani</i> promastigotes, we performed bioluminescence assay and found that ATP levels were higher and comparable in control and DMSO-treated promastigotes (120 ± 11 and 118 ± 12 nM, respectively) but was subsequently lower in <b>15i-</b>treated parasites (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). Maximum inhibition was observed after 48 h treatment with >67% reduction in the ATP level in <b>15i-</b>treated parasites as compared to vehicle-treated parasites.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Determination of MMP loss, Cyt <i>c</i> release, ATP, ROS, and NO generation in 15i-treated promastigotes. (A) Exponential phase promastigotes were incubated with <b>15i</b> (50 μM) for 6–48 h or vehicle (0.1% DMSO). Parasites were also incubated with CCCP (50 μM), as the positive control. Changes in MMP were observed after the addition of the JC-1 dye in flow cytometry. (B) Immunoblot study to check the level of cytochrome <i>c</i> in mitochondrial (upper panel) and cytoplasmic (lower panel) fractions isolated from vehicle (0.1% DMSO, 48 h) or 15i-treated parasites (50 μM, 6–48 h). COX-IV and β-tubulin were used as the endogenous controls for mitochondrial and cytosolic fractions, respectively. (C) <i>L. donovani</i> parasites were incubated with either 0.1% DMSO or 50 μM of <b>15i</b> for 6–48 h. ATP content in the cytosol was determined as mentioned in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (D) Parasites were untreated, vehicle-treated or treated with <b>15i</b> compound at (50 μM) for different time periods and probed with H<sub>2</sub>DCFDA (20 μM). ROS generation was measured by flow cytometry as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (E) Log phase <i>L. donovani</i> promastigotes were incubated with <b>15i</b> (50 μM) for the respective time period followed by labeling with DAF-2DA (40 μM); fluorescence was measured as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Data are expressed as mean of at least 3 independent experiments done in duplicate. The significance level is determined for the untreated vs treated groups, **<i>p</i> < 0.005, ***<i>p</i> < 0.0004, ns = nonsignificant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In mammalian cells, increased cellular ROS generation has been known to be responsible for the depolarization of the mitochondrial membrane and subsequent cell death.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> To investigate whether the mitochondrial dysfunction observed in <i>L. donovani</i> promastigote treated with <b>15i</b> is promoted by ROS generation, we performed flow cytometry using cell-permeable dye 2′,7′-dichlorodihydrofluorescein diacetate (H<sub>2</sub>DCFDA), which is widely known as a ROS indicator. While the reduced form of H<sub>2</sub>DCFDA does not emit fluorescence, its oxidized fluorescent form 2′,7′-dichlorofluorescein (DCF) can be detected by flow cytometry. Our results showed that after 12 h incubation with <b>15i</b> at 50 μM concentrations, ROS generation was increased by 31.6% in the promastigotes which further increased to 41.4 and 58.2% at 24 and 48 h post treatment, respectively. On the contrary, promastigotes treated with the vehicle (0.1% DMSO) showed only 7% ROS positivity (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). Similar to ROS, NO is well-known for its antimicrobial effect against a variety of protozoan, bacterial, and viral pathogens.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36−39)</a> For identifying newer and more effective drugs against VL, trypanosomiasis, and tuberculosis, researchers have already reconsidered exploring the therapeutic potential of nitroheterocyclic compounds.<a onclick="showRef(event, 'ref12 ref13 ref40'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref40">(12,13,40)</a> Hence, we proceeded to investigate whether <b>15i</b> could induce NO generation for its leishmanicidal action. NO generation was detected by the DAF-2DA dye that, upon binding an oxidized species of NO, results in an irreversible DAF fluorescence, thereby implying local NO formation in living cells at an intracellular level. For these, we treated <i>L. donovani</i> promastigotes with <b>15i</b> for 6–18 h followed by incubation with 40 μM DAF-2DA and flow cytometry analysis. Treatment with <b>15i</b> at 50 μM, for 6 h, resulted in a 1.75 fold increase in DAF-2DA fluorescence (GMFC 35.89 ± SEM 3.55) as compared to the vehicle control (GMFC 20.48 ± 6.8). A maximum 3.6-fold (GMFC 74.86 ± 8.9) increase in fluorescence was observed following incubation of the parasite with <b>15i</b> for 12 h when compared to the vehicle-treated parasites (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>E). These results indicated that compound <b>15i</b>-mediated increase in NO and ROS generation exerts a synergistic effect on leishmanicidal action.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Pharmacokinetics Analysis</h3><div class="NLM_p">The mean plasma concentration versus time profiles of <b>15i</b> in mice are shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> and the estimated pharmacokinetic parameters were analyzed by WinNonlin software version 8.1 and the results are tabulated in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. After oral administration at 50 mg/kg dose, the maximum attainable concentration (<i>C</i><sub>max</sub>) and time taken to attain maximum concentration (<i>T</i><sub>max</sub>) were found to be 6860.00 ± 1955.09 ng/mL and 0.75 ± 0.00 h, respectively, which showed that compound <b>15i</b> has rapid absorption from the gut. The overall systemic exposure, that is, area under the concentration–time profile (AUC<sub>0–∞</sub>) of the compound was found to be 18195.95 ± 879.93 h·ng/mL. The apparent volume of distribution (<i>V</i><sub>d</sub>) and Cl were found to be 15.98 ± 1.02 L/Kg and 2.75 ± 0.13 L/h/kg, respectively. However, the time taken for the systemic levels to reduce to half (half-life, <i>t</i><sub>1/2</sub>) and elimination rate constant (<i>K</i><sub>e</sub>) were found to be 4.02 ± 0.07 h and 0.17 ± 0.003 h<sup>–1</sup>, respectively. The abovementioned pharmacokinetic results confirmed that compound <b>15i</b> has satisfactory oral exposure and hence may be considered for future optimization as a lead molecule.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Mean plasma concentrations vs time profile of compound <b>15i</b> in BALB/c mice at 50 mg/kg dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Oral Pharmacokinetics Parameters of CDRI Compound <b>15i</b> at 50 mg/kg Dose in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameters</th><th class="colsep0 rowsep0" align="center" char="±">compound <b>15i</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>e</sub> (h<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="char" char="±">0.17 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±">4.02 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char="±">0.75 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char="±">6860.00 ± 1955.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–48</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="char" char="±">18189.18 ± 880.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="char" char="±">18195.95 ± 879.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub> (L/kg)</td><td class="colsep0 rowsep0" align="char" char="±">15.98 ± 1.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (L/h/kg)</td><td class="colsep0 rowsep0" align="char" char="±">2.75 ± 0.13</td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Current chemotherapeutic interventions against VL demand more novel and safer drugs including patient compliances. Moreover, it should also overcome the barrier of drug resistance against leishmanial strain, as it is a new challenge, which is considered seriously by the scientific community. To throw light on this scenario, the concept of hybridization has been introduced where two or more pharmacophores are brought together in a single entity with individual intrinsic pharmacological activity. This strategy has been already implemented with great success in the discovery of potential leads in diseases like cancer<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and AIDS<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and efforts against VLs are currently underway. Recently, triclosan–caffeic acid hybrids were seen to have good antileishmanial activity against <i>L. (V.) panamensis</i>.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Hybrids of diselenide and sulfonamide also exhibit enhanced antileishmanial activity as compared to their parent components.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Hence, in search of new potential candidates, we took the initiative to bring together the pharmacores of quinoline and metranidazole within a single entity. This is because metronidazoles are broad spectrum antiprotozoan drugs, which are known to exert significant efficacy against experimental VL and have the potential to lower parasitic burden if used in combination with other compounds.<a onclick="showRef(event, 'ref45 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48 ref49">(45−49)</a> On other hand, quinolines and its derivatives have been reported for their activity against both in vitro and in vivo form of experimental visceral and cutaneous leishmaniasis (against strains like <i>L. donovani</i>, <i>L. chagasi</i>, <i>Leishmania major</i> etc.) with submicromolar IC<sub>50</sub> values.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> We have synthesized a series of quinoline–metronidazole hybrids and tested their efficacy against <i>L. donovani</i>, the causative agent of VL. Among all synthesized compounds <b>15b</b> and <b>15i</b> were the most promising candidates as they exhibit greater antileishmanial efficacy along with a good safety index and in vitro pharmacokinetics stability. Nevertheless, in case of the in vivo BALB/c model of VL, <b>15i</b> performed way better in clearing parasite burden as compared to <b>15b</b>. Moreover, <b>15i</b> maintained its in vivo safety index as confirmed by AST and ALT, which is further confirmed by the fact that all infected animal did not show any discomfort or uneasiness during or after therapy. Besides that, the oral pharmacokinetic profile of <b>15i</b> was also good as <b>15i</b> has a rapid absorption from the gut.</div><div class="NLM_p last">Antileishmanial activity can be attained either by upregulating the host immune response, which is an indirect approach or by directly acting upon the parasitic membrane or intracellular organelles. Several antileishmanial compounds like 18β-glycyrrhetinic acid,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Fucoidan,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and oleuropein,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> exhibited leishmanicidal effects against <i>L. donovani</i> in vitro, and also minimize the parasite burden in <i>L. donovani</i>-infected BALB/c mice by Th1 polarization, while drugs like miltefosine<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and amphotericin-B<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> induce the apoptotic machinery in the parasite. In order to gain a mechanistic overview of the mode of action of <b>15i</b>, we checked several biochemical and cell-biological parameters. In our case, we found that <b>15i</b> kills the parasite by initiating an apoptotic cascade rather than acting indirectly through host immunity. Apoptosis was also confirmed by DNA fragmentation as observed by the tunnel assay of <b>15i-</b>treated promastigotes, where the membrane of the parasite was intact thereby excluding the possibility of necrosis. Our study is in line with other antileishmanial hybrids such as cycloalka[<i>b</i>]thiophene and indoles that induce DNA fragmentation and initiate apoptotic cell death in leishmania.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In order to initiate an apoptotic cascade, <b>15i</b> enters the parasitic compartment without forming pores and then sequentially disturbs the membrane potential of mitochondria, which is an early event of apoptosis as observed by the failure of J-aggregate formation after JC-1 staining. Loss in MMP by <b>15i</b> resulted in the leakage of cytochrome <i>c</i> from mitochondria to cytosolic compartment. Our results are in accordance with Antinarelli et al., who previously demonstrated that different quinoline conjugates are known to induce depolarization of the MMP in promastigotes. Several other series of compounds are also known to exert their antileishmanial efficacy by depolarizing MMP, for instance, hybrid of β-carboline–quinazolinone diastereomer leads to apoptosis in <i>L. donovani</i> promastigotes by depolarizing the mitochondrial membrane.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Antileishmanial hybrid compounds are also known to exert their effect by inducing oxidative stress. For instance, β-carboline–quinazolinone hybrids inhibit <i>L. donovani</i> trypanothione reductase activity and induce oxidative stress by generating ROS.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Similarly, hybrids of β-carboline and 1,3,5-triazine also induce ROS formation in leishmania.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> In our study, we also found that <b>15i</b> has the ability to impair parasite resistance to oxidative stress by enhancing ROS and NO generation, which is crucial for controlling these kinetoplastid protozoan parasites as their life-cycle phase occurring in the acidified phagolysosome of macrophages. These dual characteristic features are attained because of its pharmacophore as quinoline derivatives exerted their antileishmanial effect by inducing the generation of ROS levels and metronidazole series are known to exhibit generation of reactive nitrogen species, including NO. A clear correlation between in vitro activity, safety index, and in vivo activity in conjunction with favorable pharmacokinetics properties suggest the potential of quinoline–metronidazole derivatives for the future development of specific clinical agents for counteracting leishmaniasis and other neglected parasitic diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthetic Methods</h3><div class="NLM_p">Reagents were obtained from commercial sources and used without further purification. Silica gel (100–200 mesh) was used to perform column chromatography. Progress of the chemical reactions was monitored by TLC (silica gel plates with fluorescence F254). Melting points were uncorrected. The <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 300, 400 MHz, and 75, 100 MHz, respectively, using CDCl<sub>3</sub> and DMSO-<i>d</i><sub>6</sub> as a solvent. All chemical shift values were described in ppm and their multiplicities expressed as: m = multiplet, q = quartet, t = triplet, dd = double doublet, brd = broad doublet, d = doublet, brs = broad singlet, and s = singlet. The ESI-MS spectra were recorded on an ion trap LCQ Advantage Max mass spectrometer (Thermo Electron Corporation) and HRMS spectra were recorded by Q-TOF (Agilent 6520). All the final compounds were >95% pure as determined by the HPLC method.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Synthetic Method for Preparing 2-(2-Methyl-5-nitro-imidazol-1-yl)-ethyl Ester Toluene-4-sulfonate (<b>11</b>)</h4><div class="NLM_p last">A mixture of metronidazole <b>9</b> (3.14 g, 20 mmol) and Et<sub>3</sub>N (3.0 mL, 22 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL). Then, the tosyl chloride <b>10</b> (3.83 g, 20.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added dropwise at 0 °C. The reaction mixture was stirred at room temperature for 5 h. The progress of the reaction was monitored by TLC. After completion of the reaction, 30 mL of ice water was added to the reaction mixture, layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined organic layers were washed with saturated NaHCO<sub>3</sub>, dried over anhy. Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. Compound <b>11</b> was obtained as white crystals, which were used for the next steps without further purification.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Synthetic Method for Compound Preparation (<b>13a–13b</b>)</h4><div class="NLM_p last">A solution of 2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl) ethyl-4-methylbenzenesulfonate <b>11</b> (5 g, 0.0153 mol) and 4-hydroxyacetophenone <b>12a</b>/3-hydroxyacetophenone <b>12b</b> (2.30 g, 0.0169 mol) in the presence of K<sub>2</sub>CO<sub>3</sub> in DMF (50 mL) was stirred at room temperature for 24 h. After the completion of the reaction (monitored by TLC), the reaction mixture was suspended in water (50 mL) and extracted with 3-fold with EtOAc (50 mL). After drying on anhy. Na<sub>2</sub>SO<sub>4,</sub> the combined organic layers were filtered and concentrated to dryness under reduced pressure to afford corresponding product <b>13a</b> 1-(3-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)ethanone or <b>13b</b> 1-(4-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)ethanone as yellow solid in good yield.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 1-(3-(2-(2-Methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)ethanone (<b>13a</b>)</h4><div class="NLM_p last">It was obtained as a pale yellow solid, yield 75%; mp: 130–132 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.97 (s, 1H), 7.54–7.57 (m, 1H), 7.34–7.40 (m, 2H), 7.00–7.03 (m, 1H), 4.74 (t, <i>J</i> = 4.7 Hz, 2H), 4.38 (t, <i>J</i> = 5.0 Hz, 2H),2.63 (s, 3H), 2.58 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 197.5, 158.0, 151.7, 138.6, 133.3, 129.9, 122.1, 119.7, 112.7, 66.8, 45.9, 26.7, 14.7. ESIMS (<i>m</i>/<i>z</i>): 290 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 290.1135; found, 290.1134.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Synthetic Method for Compound Preparation (<b>15a–15m</b>)</h4><div class="NLM_p last">A mixture containing relevant 2-aminoarylketone (1.0 equiv) and 1-(3-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)ethanone<b>13a</b>/1-(4-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)ethanone <b>13b</b> (1.0 equiv) were dissolved in TFA (25 mL) and the solution was heated for 3 h at 120 °C. After the completion of condensation reaction<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (monitored by TLC), the reaction mixture was allowed to attain room temperature. Then, the reaction mixture was neutralized with 0.4 mL of 10% NaOH, extracted with ethyl acetate, and organic layer was washed with water. Organic layer was then evaporated under vacuum and crude product was purified by silica gel column chromatography to obtain <b>15a–15m</b>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(3-(2-(2-Methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)-4-phenylquinoline (<b>15a</b>)</h4><div class="NLM_p last">It was obtained as a white solid (85%); mp: 171–173 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.28 (d, <i>J</i> = 8.8 Hz, 2H), 8.11 (d, <i>J</i> = 8.1 Hz, 1H), 8.04 (s, 1H), 7.97 (s, 1H), 7.82–7.77 (m, 2H), 7.61–7.53 (m, 6H), 7.04 (d, <i>J</i> = 8.8 Hz, 2H), 4.76–4.74 (m, 2H), 4.44–4.42 (m, 2H), 2.56 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): δ 159.1, 155.1, 151.7, 148.4, 148.0, 138.5, 137.5, 132.8, 131.4, 129.6, 129.4, 128.7, 128.6, 128.4, 126.3, 125.1, 124.7, 118.2, 114.5, 66.4, 45.2, 14.1; ESIMS (<i>m</i>/<i>z</i>): 451 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 451.1770; found, 451.1759.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-Methyl-2-(3-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)quinoline (<b>15b</b>)</h4><div class="NLM_p last">It was obtained as a white solid (69%); mp: 156–158 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.17 (d, <i>J</i> = 7.0 Hz, 1H), 8.00–7.98 (m, 2H), 7.74–7.66 (m, 4H), 7.57–7.54 (m, 1H), 7.41–7.38 (m, 1H), 6.90 (d, <i>J</i> = 6.4 Hz, 1H), 4.76–4.75 (m, 2H), 4.46–4.45 (m, 2H), 2.77 (s, 3H), 2.66 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 158.3, 156.3, 151.9, 148.0, 145.0, 141.6, 138.4, 133.4, 130.3, 130.0, 129.5, 127.4, 126.3, 123.7, 120.9, 119.7, 115.6, 112.9, 66.8, 46.1, 19.0, 14.8; ESIMS (<i>m</i>/<i>z</i>): 389 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 389.1614; found, 389.1597.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 6-Chloro-2-(3-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)-4-phenylquinoline (<b>15c</b>)</h4><div class="NLM_p last">It was obtained as a white solid (73%); mp: 189–191 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.14–8.10 (m, 3H), 7.98 (s, 1H), 7.83–7.82 (m, 1H), 7.75 (s, 1H), 7.65–7.62 (m, 1H), 7.57–7.51 (m, 5H), 6.95–6.93 (m, 2H), 4.76–4.73 (m, 2H), 4.42–4.39 (m, 2H), 2.64 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 159.1, 156.2, 151.8, 148.5, 147.2, 138.4, 137.8, 133.4, 132.7, 132.0, 131.5, 130.5, 129.4, 129.1, 128.9, 128.8, 126.3, 124.5, 119.5, 114.6, 66.8, 46.0, 14.7; ESIMS (<i>m</i>/<i>z</i>): 485 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>21</sub>ClN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 485.1380; found, 485.1376.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-Bromo-2-(3-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)-4-phenylquinoline (<b>15d</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid (84%); mp: 103–105 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.28 (d, <i>J</i> = 8.8 Hz, 2H), 8.12–8.10 (m, 1H), 8.04 (s, 1H), 7.98 (s, 1H), 7.80–7.76 (m, 4H), 7.60–7.52 (m, 3H), 7.05 (d, <i>J</i> = 8.8 Hz, 2H), 4.77–4.74 (m, 2H), 4.44–4.42 (m, 2H), 2.56 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): δ 159.2, 155.2, 151.8, 148.0, 147.2, 138.5, 136.7, 132.9, 131.7, 131.6, 131.3, 129.9, 129.5, 128.8, 126.6, 125.0, 124.5, 122.1, 118.3, 114.6, 66.5, 45.2, 14.1; ESIMS (<i>m</i>/<i>z</i>): 529 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>21</sub>BrN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 529.0875; found, 529.0868.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(3-(2-(2-Methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)-6-nitro-4-phenylquinoline (<b>15e</b>)</h4><div class="NLM_p last">It was obtained as a white solid (89%); mp: 229–231 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.84–8.83 (m, 1H), 8.50–8.47 (m, 1H), 8.35–7.33 (m, 1H), 7.97 (s, 1H), 7.91 (s, 1H), 7.78–7.74 (m, 2H), 7.62–7.54 (m, 5H), 7.45–7.41 (m, 1H), 6.99–6.96 (m, 1H), 4.79–4.77 (m, 2H), 4.49–4.46 (m, 2H), 2.67 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): δ 158.7, 158.3, 151.8, 150.7, 150.1, 145.0, 139.1, 138.5, 136.2, 132.9, 131.5, 130.1, 129.7, 129.3, 129.0, 124.2, 123.1, 122.3, 120.8, 120.5, 117.2, 112.9, 66.5, 45.2, 14.2; ESIMS (<i>m</i>/<i>z</i>): 496 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>21</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 496.1621; found, 496.1595.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-Chloro-4-(2-chlorophenyl)-2-(3-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)quinoline (<b>15f</b>)</h4><div class="NLM_p last">It was obtained as a white solid (88%); mp: 192–194 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.18 (d, <i>J</i> = 7.2 Hz, 1H), 7.97 (s, 1H), 7.76 (s, 1H), 7.72–7.66 (m, 3H), 7.60 (d, <i>J</i> = 6.2 Hz, 1H), 7.50–7.37 (m, 5H), 6.93–6.91 (m, 1H), 4.78–4.76 (m, 2H), 4.47–4.45 (m, 2H), 2.66 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 158.5, 156.3, 151.9, 146.9, 146.0, 140.8, 138.5, 136.3, 133.4, 133.3, 132.7, 131.8, 131.4, 130.8, 130.3, 130.2, 127.1, 126.7, 124.5, 121.0, 120.6, 116.1, 112.9, 66.9, 46.1, 14.9; ESIMS (<i>m</i>/<i>z</i>): 519 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 519.0991; found, 519.0976.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-Chloro-4-(2-fluorophenyl)-2-(3-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)quinoline (<b>15g</b>)</h4><div class="NLM_p last">It was obtained as a white solid (79%); mp: 202–204 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.18 (d, <i>J</i> = 7.1 Hz, 1H), 7.97 (s, 1H), 7.80 (s, 1H), 7.71–7.67 (m, 3H), 7.62 (s, 1H), 7.54–7.52 (m, 1H), 7.44–7.38 (m, 2H), 7.36–7.33 (m, 1H), 7.31–7.27 (m, 1H), 6.93–6.92 (m, 1H), 4.77–4.75 (m, 2H), 4.47–4.43 (m, 2H), 2.65 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 160.9, 158.5, 156.3, 151.9, 147.0, 142.8, 140.8, 133.5, 132.7, 131.8, 131.7, 131.7, 131.1, 131.0, 130.8, 130.2, 126.8, 125.2, 125.0, 124.7, 124.6, 124.4, 121.0, 120.9, 116.5, 116.3, 116.1, 112.9, 66.94, 46.2, 14.9; ESIMS (<i>m</i>/<i>z</i>): 503 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>20</sub>ClFN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup> 503.1286; found, 503.1284.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(4-(2-(2-Methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)-4-phenylquinoline (<b>15h</b>)</h4><div class="NLM_p last">It was obtained as a white solid (84%); mp: 141–143 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.19 (d, <i>J</i> = 8.0 Hz, 3H), 8.15–8.13 (m, 1H), 7.98–7.86 (m, 1H), 7.74–7.71 (m, 2H), 7.55–7.50 (m, 5H), 7.47–7.44 (m, 1H), 6.95–6.93 (m, 2H), 4.76–4.73 (m, 2H), 4.42–4.39 (m, 2H), 2.62 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 158.9, 156.0, 151.8, 149.2, 148.8, 138.5, 133.4, 133.2, 129.9, 129.6, 129.1, 128.6, 128.5, 126.2, 125.7, 125.6, 118.8, 114.6, 66.8, 46.0, 14.8; ESIMS (<i>m</i>/<i>z</i>): 451 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 451.1770; found, 451.1763.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-Methyl-2-(4-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)quinoline (<b>15i</b>)</h4><div class="NLM_p last">It was obtained as a white solid (78%); mp: 124–126 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.13–8.08 (m, 3H), 7.98–7.95 (m, 2H), 7.71–7.67 (m, 1H), 7.64 (s, 1H), 7.53–7.49 (m, 1H), 6.93 (d, <i>J</i> = 8.8 Hz, 2H), 4.74–4.72 (m, 2H), 4.40–4.38 (m, 2H), 2.74 (s, 3H), 2.63 (s, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): δ 158.9, 155.1, 151.7, 147.3, 144.9, 138.5, 132.8, 131.6, 129.4, 129.3, 128.5, 126.6, 125.8, 123.9, 118.6, 114.5, 66.4, 45.2, 18.3, 14.1; ESIMS (<i>m</i>/<i>z</i>): 389 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>22</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 389.1614; found, 389.1605.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6-Chloro-2-(4-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)-4-phenylquinoline (<b>15j</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid (83%); mp: 196–198 °C; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.29 (d, <i>J</i> = 8.8 Hz, 2H), 8.13 (d, <i>J</i> = 8.9 Hz, 1H), 8.04 (s, 2H), 7.80–7.77 (m, 1H), 7.72 (s, 1H), 7.63–7.57 (m, 5H), 7.05 (d, <i>J</i> = 8.5 Hz, 2H), 4.76–4.74 (m, 2H), 4.45–4.42 (m, 2H), 2.55 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 159.2, 156.2, 151.8, 148.5, 147.3, 137.8, 133.5, 132.9, 132.0, 131.6, 130.5, 129.5, 129.1, 128.9, 128.8, 126.4, 124.6, 119.5, 114.6, 66.9, 46.1, 14.8; ESIMS (<i>m</i>/<i>z</i>): 485 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>21</sub>ClN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 485.1380; found, 485.1370.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 7-Bromo-2-(4-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)-4-Phenylquinoline (<b>15k</b>)</h4><div class="NLM_p last">It was obtained as a white solid (71%); mp: 153–155 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.19 (d, <i>J</i> = 8.4 Hz, 1H), 8.12 (d, <i>J</i> = 8.7 Hz, 2H), 7.97 (s, 1H), 7.80 (d, <i>J</i> = 8.2 Hz, 1H), 7.73–7.66 (m, 4H), 7.47–7.40 (m, 3H), 6. 49 (d, <i>J</i> = 8.7 Hz, 2H), 4.75–4.73 (m, 2H), 4.41–4.39 (m, 2H), 2.64 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 158.9, 155.9, 151.7, 148.7, 147.8, 138.4, 137.2, 133.3, 132.9, 131.8, 131.1, 130.0, 129.7, 129.0, 126.3, 125.2, 122.8, 118.6, 114.5, 66.7, 45.9, 14.7; ESIMS (<i>m</i>/<i>z</i>): 529 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>21</sub>BrN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 529.0875; found, 529.0870.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6-Chloro-4-(2-chlorophenyl)-2-(4-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)quinoline (<b>15l</b>)</h4><div class="NLM_p last">It was obtained as a white solid (78%); mp: 217–219 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.12 (d, <i>J</i> = 8.8 Hz, 3H), 7.98 (s, 1H), 7.78 (s, 1H), 7.66–7.63 (m, 1H), 7.60–7.55 (m, 1H), 7.54–7.49 (m, 1H), 7.44–7.40 (m, 1H), 7.35–7.33 (m, 1H), 7.31–7.28 (m, 1H), 6.94 (d, <i>J</i> = 8.8 Hz, 2H), 4.75–4.73 (m, 2H), 4.41–4.39 (m, 2H), 2.64 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 160.9, 159.2, 158.4, 156.2, 151.8, 147.0, 142.6, 138.5, 133.4, 132.6, 132.2, 131.7, 131.6, 131.5, 131.0, 130.9, 130.7, 129.1, 126.5, 125.2, 125.1, 124.6, 124.4, 120.5, 116.4, 116.2, 114.6, 66.8, 46.0, 14.8; ESIMS (<i>m</i>/<i>z</i>): 519 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 519.0991; found, 519.0978.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-Chloro-4-(2-fluorophenyl)-2-(4-(2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethoxy)phenyl)quinoline (<b>15m</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid (88%); mp: 204–206 °C; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.14–8.11 (m, 3H), 7.98 (s, 1H), 7.74 (s, 1H), 7.65–7.63 (m, 1H), 7.59 (d, <i>J</i> = 6.3 Hz, 1H), 7.49–7.43 (m, 3H), 7.37–7.36 (m, 1H), 6.94 (d, <i>J</i> = 7.0 Hz, 2H), 4.76–4.74 (m, 2H), 4.42–4.40 (m, 2H), 2.64 (s, 3H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 159.2, 156.1, 151.8, 146.9, 145.8, 138.5, 136.3, 133.4, 133.3, 132.6, 132.1, 131.5, 131.4, 130.6, 130.2, 130.1, 129.1, 127.1, 126.4, 124.4, 120.0, 114.6, 66.8, 40.6, 14.8; ESIMS (<i>m</i>/<i>z</i>): 503 [M + H]<sup>+</sup>; HRMS (<i>m</i>/<i>z</i>): calcd for C<sub>27</sub>H<sub>20</sub>ClFN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 503.1286; found, 503.1284.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Biological Assays</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Maintenance of Cell Line and Parasite Culture</h4><div class="NLM_p last">Luciferase expressing <i>L. donovani</i> promastigotes strain (MHOM/IN/80/Dd8) was obtained as described elsewhere.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Briefly, the firefly luciferase gene (complete ORF) was amplified from pGEM-Luc plasmid DNA (Promega) and cloned in the pCRII-TOPO vector. The purified insert was obtained after digestion with the restriction enzyme SpeI and subsequently cloned into dephosphorylated pKS-Neo leishmania shuttle vector containing neomycin cascade to generate the pKS-Neo-luc construct. The orientation of the luc insert was confirmed after double digestion with restriction enzymes, that is, EcoRI and BamHI and selected in <i>Escherichia coli</i> before carrying out transfection. <i>L. donovani</i> promastigotes were transfected with pKS-Neo-luc construct by electroporation with a Gene Pulser (Bio-Rad) and the transfected parasites were cultured in M199 medium which was supplemented with 10% heat-inactivated fetal bovine serum (FBS) and G418 disulphate (20 μg/mL) at 24 °C. J774 macrophages cell line was maintained in complete RPMI medium as described previously.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Luciferase and MTT Assay</h4><div class="NLM_p last">In vitro antileishmanial activity of quinoline–metronidazole derivatives was assessed by luciferase assay using <i>Leishmania</i> parasite (MHOM/IN/80/Dd8 constitutively expressing firefly luciferase gene). Parasite multiplication was represented as relative luminescence unit (RLU) and the IC<sub>50</sub> value of the synthesized derivatives and standard drugs was determined as described earlier.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Antipromastigote activity of <b>15b</b> and <b>15i</b> was also assessed at various concentrations by MTT assay as described elsewhere.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The absorbance was recorded on a microplate spectrophotometer (BioTek Instruments, Winooski, VT, USA), and the data were represented as percentage viability of promastigotes in comparison with control cells.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Antiamastigote Assay</h4><div class="NLM_p last">Antileishmanial activity of quinoline–metronidazole derivatives against intracellular amastigotes was assessed by luciferase assay at different concentrations as described previously.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Parent molecules: metronidazole (Acros Organics, Belgium) and quinoline (Sigma-Aldrich, USA), compounds (<b>15b</b> and <b>15i</b>), and standard drug miltefosine (Synphabase, Switzerland) were subjected to serial dilution at a 2-fold concentration in RPMI medium, maintaining the final concentrations in a range between 3.125 and 100 μM prior to treatment in infected macrophages. The antiamastigote activity of <b>15b</b> and <b>15i</b> was also evaluated by Giemsa staining through microscopic counting of the number of amastigotes/100 macrophages.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Mammalian Cell Cytotoxicity Assay</h4><div class="NLM_p last">Vero cells and J774 macrophages were selected to assess the cytotoxic effects of <b>15b</b> and <b>15i</b> at different concentrations (12.5–400 μM) by MTT assay as described previously.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The 50% cellular cytotoxic concentration (CC<sub>50</sub>) and selectivity index (SI) of <b>15b</b> and <b>15i</b> were determined as described previously.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Animal Infection and Therapeutic Protocol</h4><div class="NLM_p last">The <i>L. donovani</i> strain MHOM/IN/80/Dd8 was maintained by serial passage in hamsters for the establishment of infection. Amastigotes were then isolated from the spleen of <i>L. donovani-</i>infected golden hamsters (2 months) and transformation into the promastigote form was obtained in M199 (pH 7.4) medium, enriched with 20% FBS (heat-inactivated), 25 mM HEPES, 2 mM glutamine, 100 μg/mL streptomycin, and 100 IU/mL penicillin. After serial passages for 2 times, stationary-phase promastigotes were collected from the culture medium and injected in BALB/c mice through the tail vein [2 × 10<sup>7</sup>/0.2 mL of phosphate-buffered saline (PBS)] to establish infection. The level of infection was determined by performing autopsy in the liver and spleen of 3–4 mice selected randomly at day 15 postinfection. Animals with similar levels of the organ parasitic load were further selected for the in vivo experiment. Treatment was initialized intraperitoneally (ip) for <b>15b</b> and <b>15i</b> and miltefosine was administered orally in 15 day infected BALB/c mice. Five animals/groups were used for the study and the groups were as follows: infected untreated, infected vehicle-treated (8% DMSO in PBS), infected miltefosine (a standard antileishmanial drug)-treated, infected quinoline-treated, infected metronidazole-treated, infected <b>15b</b>-treated, and infected <b>15i-</b>treated. Miltefosine (25 mg/kg) was suspended in triple distilled water and given orally, while <b>15b</b> and <b>15i</b> were dissolved in DMSO (8%). Animals were administered with <b>15b</b> and <b>15i</b> via intraperitoneal route for 5 consecutive days, and sacrificed at day 7 post-treatment, following which the liver and spleen parasite burden were assessed by Giemsa staining and expressed as LDU.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Ethics Statement for in Vivo Experiments</h4><div class="NLM_p last">All in vivo animal experiments were conducted as per the strict guidelines and recommendations provided by the specialized Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), New Delhi, India. Animals usage was officially permitted by the IAEC (Institutional Animal Ethical Committee) and all in vivo experiments were performed in agreement with the IAEC of the CSIR-CDRI (IAEC approval no: IAEC/2017/190). BALB/c mice of weight 20 ± 2 g were procured from the National Laboratory Animal Center, CSIR-CDRI (Lucknow, India) and maintained in suitable experimental conditions such as room temperature (24 ± 2 °C) and 40–60% relative humidity while on a regular 12 h light–dark cycle. The animals were acclimatized for a minimum period of 3 days prior to the experiment.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Th1/Th2 Cytokine Estimation</h4><div class="NLM_p last">The levels of Th1/Th2 cytokines in the cell culture supernatants of <b>15i</b>-treated infected macrophages was assessed using ELISA kit (BD Biosciences, USA) as described elsewhere.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Detection of Plasma Membrane Permeability</h4><div class="NLM_p last">Plasma membrane integrity was determined using the Sytox green dye as mentioned elsewhere<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> with some modifications. Briefly, promastigotes (4 × 10<sup>6</sup>/mL) were incubated with 50 μM <b>15i</b> for 0–360 min. This was followed by washing with PBS for two times and incubation with 2 μM Sytox green at 28 °C for 15 min. The promastigotes were then collected in fluorescence-activated cell sorting (FACS) tubes and the fluorescence emitted upon binding of the dye to intracellular nucleic acids was recorded by flow cytometry (BD FACSCalibur platform, with excitation and emission wavelengths at 485 and 535 nm, respectively). 0.1% Triton X-100 was used to obtain maximal promastigote permeabilization and data were represented with respect to the fluorescence obtained in this sample.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Apoptosis Detection by Annexin V/PI Staining</h4><div class="NLM_p last">Phosphatidylserine externalization in vehicle or <b>15i</b>-treated <i>L. donovani</i> promastigotes (12–48 h) was determined by using the Apoptosis Detection Kit (Sigma-Aldrich, USA) as described previously.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Analysis of stained promastigotes was performed in BD FACSCalibur platform and CellQuest software was used for data interpretation.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> TUNEL Assay</h4><div class="NLM_p last">Fragmentation of DNA within the <i>L. donovani</i> parasite was analyzed by terminal deoxynucleotidyltranferase (TdT)-mediated dUTP nick end labeling (TUNEL) using APO BrdU TUNEL Assay Kit (Molecular Probes, USA) as per the manufacturer’s instructions. Briefly, 1 × 10<sup>5</sup> parasites were harvested after treatment with 50 μM <b>15i</b> for 48 h and samples treated with DMSO (0.1%) were then used as the vehicle control. The experiment was performed as described previously.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Samples were finally observed under a confocal microscope (LSM, Zeiss, Germany) and analyzed on adobe Photoshop software 7.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Determination of Metacaspase-Like Protease Activity</h4><div class="NLM_p last">Metacaspase activity was determined by using the substrate, BOC-GRR-AMC. Briefly, 5 × 10<sup>6</sup> exponential phase parasites were either untreated or incubated with DMSO (0.1%), <b>15i</b> (50 μM) either alone or in parasites pretreated with antipain (1 μM), zVAD-fmk (z-Val-Ala-Asp-fmk) (100 μM) for 1 h. The cells were then pulled, subjected to lysis in cell lysis buffer and resuspended in metacaspase buffer to detect metacaspase activities. Furthermore, cell lysates were then subjected to 100 μM fluorogenic substrate BOC-GRR-AMC and 1× reaction buffer supplemented with 100 μM dithiothreitol. Samples were then incubated at 37 °C for 2 h and the released 7-amino-4-methylcoumarin (AMC) was detected by fluorometry (BMG POLARstar Galaxy, Virginia, USA), with excitation and emission wavelengths at 380 and 460 nm, respectively. The results were represented as relative fluorescence units and normalized with cellular protein extracts in mg.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Measurement of MMP Change</h4><div class="NLM_p last">Change in MMP (ΔΨ<sub>m</sub>) in <b>15i</b>-treated promastigotes (6–48 h) was evaluated using JC-1 dye (MitoProbe JC-1 Assay Kit, Molecular Probes, USA) as described previously.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The experimental data were recorded in BD FACSCalibur platform and analyzed by CellQuest Software.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Cytochrome <i>c</i> Detection in the Mitochondrial and Cytosolic Fraction of <i>L. donovani</i></h4><div class="NLM_p last">Mitochondria fractions were obtained from untreated and <b>15i</b>-treated <i>L. donovani</i> promastigotes using the ApoAlert cell fractionation kit (Takara, Japan) as per the manufacturer’s instructions, and stored at −20 °C at a final protein concentration of 7–8 mg/mL. Cytosolic lysates of control and <b>15i</b>-treated promastigotes were prepared as described elsewhere.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> After cell fractionation, mitochondrial and cytosolic levels of cytochrome <i>c</i> were determined by immunoblot as described previously.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Determination of ATP Generation</h4><div class="NLM_p last">Promastigotes (2 × 10<sup>6</sup>) were treated with 50 μM <b>15i</b> for varying time periods, and the amount of ATP content was evaluated by using the luciferase ATP assay kit (Invitrogen, Inc., Ltd. USA), as described previously.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> ROS Measurement</h4><div class="NLM_p last">Promastigotes (2 × 10<sup>6</sup> cells/mL) were incubated with 50 μM <b>15i</b> for different time points (12–48 h) and DMSO (0.1%)-treated parasites were used as the vehicle control. Parasites were then harvested, followed by resuspension in PBS. Thereafter, 20 μM (DCFDA) was added to the parasites and incubation was performed for 20 min in the dark at 37 °C.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Thereafter, analysis was performed on BD FACSCalibur platform at 530 nm wavelength.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> NO Measurement</h4><div class="NLM_p last">Promastigotes (2 × 10<sup>6</sup> cells/mL) were incubated with 50 μM <b>15i</b> for different time points (6–18 h) and DMSO (0.1%)-treated parasites were used as the vehicle control. Promastigotes were finally collected, followed by resuspension in PBS, and incubated with 40 μM of DAF-2DA at 37 °C for 45 min in the dark. The resultant fluorescence was measured and analyzed on BD FACSCalibur platform.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> UPLC Conditions for in Vitro PK Study</h4><div class="NLM_p last">Compounds <b>15b</b> and <b>15i</b> were analyzed on Shimadzu UPLC system equipped with the photodiode array detector. Chromatographic separation of both compounds was achieved with a mobile phase composition of acetonitrile: formic acid (0.1%) on a C18 column (100 × 4.6 mm, 5.0 μm). The mobile phase ratio for compound <b>15b</b> and <b>15i</b> were optimized as 50:50 (v/v) and 40:60 (v/v), respectively. The flow rates for elution of compound <b>15b</b> and <b>15i</b> were set as 1.0 and 0.8 mL/min, respectively.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> In Vitro SGF and SIF Stability</h4><div class="NLM_p last">SGF and SIF were prepared as per USP specifications.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The stability studies of compound <b>15b</b> and <b>15i</b> in SGF and SIF were performed at 10 μg/mL in triplicate. Briefly, SGF and SIF were taken in two separate glass test tubes and preincubated in shaking water bath for 10–15 min at 37 ± 2 °C. Afterward, aliquots of <b>15b</b> and <b>15i</b> were spiked separately in SGF and SIF and 100 μL of the incubation mixture was withdrawn at 0, 5, 10, 15, 30, 45, 60, 90, and 120 min. Each sample was quenched with acetonitrile 1:2 (% v/v), vortexed, and centrifuged for 10 000 rpm. The supernatant was then analyzed by the UPLC system.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> In Vitro Plasma Stability</h4><div class="NLM_p last">The plasma stability of <b>15b</b> and <b>15i</b> was performed at 10 μg/mL in triplicate. The blank rat plasma was taken in test tubes and preincubated in shaking water bath for 10 min at 37 ± 0.2 °C. Afterward, aliquots of compound <b>15b</b> and <b>15i</b> were spiked to incubated plasma and samples were withdrawn at 0, 5, 10, 15, 30, 45, 60, 90, and 120 min. Precipitation was carried out with the addition of acetonitrile in the ratio of 1:2 (v/v) at each time intervals, followed by vortexing and centrifugation for 10 min at 10 000 rpm. Supernatants were separated and subjected for analysis by UPLC.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> In Vitro Microsomal Stability</h4><div class="NLM_p last">Microsomal stability of <b>15b</b> and <b>15i</b> was performed from RLM in triplicate. Briefly, in each glass tube, 446.25 μL of Tris buffer (50 mM, pH 7.4), magnesium chloride (MgCl<sub>2</sub>, 40 μM), and RLM protein (0.5 mg/mL) were spiked and incubated for at 37 ± 0.2 °C for 5 min. Then, compounds <b>15b</b> and <b>15i</b> (10 μg/mL) were spiked separately in this preincubation mixture. Positive and negative controls were also performed in RLM for validation of assays and microsomal activity. Initiation of the reaction was performed by adding NADPH (24 mM) followed by incubation for 1 h. The reaction was terminated by adding ice-chilled acetonitrile (100 μL) to the reaction mixture (50 μL) collected at predefined time points (0, 5, 10, 15, 30, 45, and 60 min). Samples were vortex mixed for 5 min, followed by centrifugation for 10 min at 10 000 rpm. The 20 μL of supernatant was directly analyzed by UPLC.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Data Analysis</h4><div class="NLM_p last">The percentage of compound remaining intact at different time intervals after incubation was determined by the <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> and the in vitro metabolic half-life (<i>t</i><sub>1/2</sub>) was determined by plotting the natural logarithm of percentage compound remaining versus time.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> The slope of the curve was represented as depletion rate constant <i>K</i> (min<sup>–1</sup>). The half-life of metabolic stability was estimated using the first-order <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>. The in vitro intrinsic clearance (CL<sub>int</sub>) was calculated through the <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>.<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_m001.gif" alt="" id="_i59" /></img><span class="labelSpan">(1)</span></span><span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_m002.gif" alt="" id="_i60" /></img><span class="labelSpan">(2)</span></span><span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_m003.gif" alt="" id="_i61" /></img><span class="labelSpan">(3)</span></span>where <i>K</i> represents the depletion rate constant and it was calculated from the slope of linear regression from natural log percentage of the substrate remaining versus incubation time.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> In Vivo Pharmacokinetic Study</h4><div class="NLM_p last">In vivo oral PK study of compound <b>15i</b> was performed in BALB/c male mice (<i>n</i> = 5). The compound was administered at 50 mg/kg dose via oral gavage to each mice and the oral suspension was formulated in (0.25% CMC solution and 5% Tween 80). Blood samples were collected from the retro-orbital plexus of mice under light ether anesthesia into heparin-containing microfuge tubes at 0.25, 0.5, 1, 3, 5, 7, 9, 12, 24, and 48 h of postdose. Plasma was harvested by centrifugation of blood at 10 000 rpm for 10 min and stored at −20 ± 2 °C until bioanalysis. The protein precipitation method was employed for sample processing by using acetonitrile (200 μL/100 μL plasma) as protein precipitant containing medicarpin as internal standard. The supernatant was injected for LC-MS/MS.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Statistical Analysis</h4><div class="NLM_p last">Data are represented as the mean ± SD of three separate experiments. To calculate the statistical significance between the groups under study, we used the software GraphPad Prism (version 5) and the differences between the experimental sets were analyzed by one-way ANOVA followed by Tukey’s post. <i>P</i> < 0.05 was considered statistically significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00628" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00628" class="ext-link">10.1021/acs.jmedchem.9b00628</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00628/suppl_file/jm9b00628_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra of all compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00628/suppl_file/jm9b00628_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00628/suppl_file/jm9b00628_si_001.csv">jm9b00628_si_001.csv (1.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00628/suppl_file/jm9b00628_si_002.pdf">jm9b00628_si_002.pdf (3.94 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00628" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koneni V. Sashidhara</span> - <span class="hlFld-Affiliation affiliation">Medicinal
and Process Chemistry Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7219042d0113011a1b161a130013321116001b5c0017015c1b1c"><span class="__cf_email__" data-cfemail="f79c81a88496849f9e939f968596b79493859ed9859284d99e99">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susanta Kar</span> - <span class="hlFld-Affiliation affiliation">Parasitology Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9907-539X" title="Orcid link">http://orcid.org/0000-0002-9907-539X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f3808680929d8792989281b39097819add819680dd9a9d"><span class="__cf_email__" data-cfemail="097a7c7a68677d6862687b496a6d7b60277b6c7a276067">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akanksha Upadhyay</span> - <span class="hlFld-Affiliation affiliation">Medicinal
and Process Chemistry Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pragya Chandrakar</span> - <span class="hlFld-Affiliation affiliation">Parasitology Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sampa Gupta</span> - <span class="hlFld-Affiliation affiliation">Medicinal
and Process Chemistry Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naveen Parmar</span> - <span class="hlFld-Affiliation affiliation">Parasitology Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandeep Kumar Singh</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics
and Metabolism Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mamunur Rashid</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics
and Metabolism Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pragati Kushwaha</span> - <span class="hlFld-Affiliation affiliation">Medicinal
and Process Chemistry Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Muhammad Wahajuddin</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetics
and Metabolism Division, 
    , , and , CSIR-Central Drug
Research Institute, BS-10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India</span>; 
    <span class="hlFld-Affiliation affiliation">Academy
of Scientific and Innovative Research (AcSIR), Anusandhan Bhawan, New Delhi 110025, India</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.U and P.C. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was funded by the Department of Science and Technology (grant no. SB/FT/LS-310/2012), Council of Scientific and Industrial Research (CSIR NWP BSC0114). N.P., A.U., P.K., M.R. received fellowship from UGC (New Delhi), P.C., P.V., and S.G., S.K.S. are the recipients of fellowships from CSIR (New Delhi). The transgenic <i>L. donovani</i> promastigotes was a kind gift from Dr. Neena Goyal, Division of Biochemistry, CSIR-CDRI, Lucknow, India. The authors are thankful to Anuradha Seth for copy-editing the manuscript. The authors would also like to acknowledge the Director, CSIR-CDRI, Lucknow, for facilitating the research. Authors are also thankful to the sophisticated analytical instrumentation facility of CSIR-CDRI for providing support with the confocal microscopy and flow cytometry experiments. This manuscript has CDRI Communication no. 9845.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">VL</td><td class="NLM_def"><p class="first last">visceral leishmaniasis</p></td></tr><tr><td class="NLM_term">MET-OH</td><td class="NLM_def"><p class="first last">metronidazole</p></td></tr><tr><td class="NLM_term">ROI</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">human African trypanosomiasis</p></td></tr><tr><td class="NLM_term">RNI</td><td class="NLM_def"><p class="first last">reactive nitrogen species</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">ALT</td><td class="NLM_def"><p class="first last">alanine aminotransferase</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">AST</td><td class="NLM_def"><p class="first last">aspartate aminotransferase</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">maximum inhibitory concentration</p></td></tr><tr><td class="NLM_term">CC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% reduction of viability of treated cells with respect to untreated cells</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">mitochondrial membrane potential</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">FITC</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">SGF</td><td class="NLM_def"><p class="first last">simulated gastric fluid</p></td></tr><tr><td class="NLM_term">TUNEL</td><td class="NLM_def"><p class="first last">terminal deoxynucleotidyl transferase dUTP nick end labeling</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">SIF</td><td class="NLM_def"><p class="first last">simulated intestinal fluid</p></td></tr><tr><td class="NLM_term"><i>K</i></td><td class="NLM_def"><p class="first last">depletion rate constant</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-time</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">infrared spectroscopy</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>COOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>e</sub></td><td class="NLM_def"><p class="first last">elimination rate constant</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">LDU</td><td class="NLM_def"><p class="first last">Leishmania Donovan unit</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence-activated cell sorting</p></td></tr><tr><td class="NLM_term">BOC-GRR-AMC</td><td class="NLM_def"><p class="first last"><i>t</i>-butyloxycarbonyl-Gly-Arg-Arg-AMC</p></td></tr><tr><td class="NLM_term">zVAD-fmk</td><td class="NLM_def"><p class="first last">z-Val-Ala-Asp-fmk</p></td></tr><tr><td class="NLM_term">RLU</td><td class="NLM_def"><p class="first last">relative luminescence unit</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chappuis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghalib, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeling, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelaert, M.</span></span> <span> </span><span class="NLM_article-title">Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1038/nrmicro1748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1038%2Fnrmicro1748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=17938629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKltbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=873-882&author=F.+Chappuisauthor=S.+Sundarauthor=A.+Hailuauthor=H.+Ghalibauthor=S.+Rijalauthor=R.+W.+Peelingauthor=J.+Alvarauthor=M.+Boelaert&title=Visceral+leishmaniasis%3A+What+are+the+needs+for+diagnosis%2C+treatment+and+control%3F&doi=10.1038%2Fnrmicro1748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?</span></div><div class="casAuthors">Chappuis, Francois; Sundar, Shyam; Hailu, Asrat; Ghalib, Hashim; Rijal, Suman; Peeling, Rosanna W.; Alvar, Jorge; Boelaert, Marleen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">873-882</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Visceral leishmaniasis (VL) is a systemic protozoan disease that is transmitted by phlebotomine sandflies.  Poor and neglected populations in East Africa and the Indian sub-continent are particularly affected.  Early and accurate diagnosis and treatment remain key components of VL control.  In addn. to improved diagnostic tests, accurate and simple tests are needed to identify treatment failures.  Miltefosine, paromomycin and liposomal amphotericin B are gradually replacing pentavalent antimonials and conventional amphotericin B as the preferred treatments in some regions, but in other areas these drugs are still being evaluated in both mono- and combination therapies.  New diagnostic tools and new treatment strategies will only have an impact if they are made widely available to patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra_fthzaSpxrVg90H21EOLACvtfcHk0lgMXUMBX50Uog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKltbzJ&md5=b7e8a768d6c6cb32a310515cff4da9f7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1748%26sid%3Dliteratum%253Aachs%26aulast%3DChappuis%26aufirst%3DF.%26aulast%3DSundar%26aufirst%3DS.%26aulast%3DHailu%26aufirst%3DA.%26aulast%3DGhalib%26aufirst%3DH.%26aulast%3DRijal%26aufirst%3DS.%26aulast%3DPeeling%26aufirst%3DR.%2BW.%26aulast%3DAlvar%26aufirst%3DJ.%26aulast%3DBoelaert%26aufirst%3DM.%26atitle%3DVisceral%2520leishmaniasis%253A%2520What%2520are%2520the%2520needs%2520for%2520diagnosis%252C%2520treatment%2520and%2520control%253F%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2007%26volume%3D5%26spage%3D873%26epage%3D882%26doi%3D10.1038%2Fnrmicro1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravia, N. G.</span></span> <span> </span><span class="NLM_article-title">Advances in leishmaniasis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">1561</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(05)67629-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2FS0140-6736%2805%2967629-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16257344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2005&pages=1561-1577&author=H.+W.+Murrayauthor=J.+D.+Bermanauthor=C.+R.+Daviesauthor=N.+G.+Saravia&title=Advances+in+leishmaniasis&doi=10.1016%2Fs0140-6736%2805%2967629-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in leishmaniasis</span></div><div class="casAuthors">Murray, Henry W.; Berman, Jonathan D.; Davies, Clive R.; Saravia, Nancy G.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">9496</span>),
    <span class="NLM_cas:pages">1561-1577</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Governed by parasite and host factors and immunoinflammatory responses, the clin. spectrum of leishmaniasis encompasses subclin. (inapparent), localized (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral).  Symptomatic disease is subacute or chronic and diverse in presentation and outcome.  Clin. characteristics vary further by endemic region.  Despite T-cell-dependent immune responses, which produce asymptomatic and self-healing infection, or appropriate treatment, intracellular infection is probably life-long since targeted cells (tissue macrophages) allow residual parasites to persist.  There is an epidemic of cutaneous leishmaniasis in Afghanistan and Pakistan and of visceral infection in India and Sudan.  Diagnosis relies on visualising parasites in tissue or serol.; culture and detection of parasite DNA are useful in the lab.  Pentavalent antimony is the conventional treatment; however, resistance of visceral infection in India has spawned new treatment approaches-amphotericin B and its lipid formulations, injectable paromomycin, and oral miltefosine.  Despite tangible advances in diagnosis, treatment, and basic scientific research, leishmaniasis is embedded in poverty and neglected.  Current obstacles to realistic prevention and proper management include inadequate vector (sandfly) control, no vaccine, and insufficient access to or impetus for developing affordable new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokA_8nOIgmnLVg90H21EOLACvtfcHk0lgMXUMBX50Uog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsbfK&md5=1534e930a9753fe2584d1c32451b549a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2967629-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252967629-5%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DH.%2BW.%26aulast%3DBerman%26aufirst%3DJ.%2BD.%26aulast%3DDavies%26aufirst%3DC.%2BR.%26aulast%3DSaravia%26aufirst%3DN.%2BG.%26atitle%3DAdvances%2520in%2520leishmaniasis%26jtitle%3DLancet%26date%3D2005%26volume%3D366%26spage%3D1561%26epage%3D1577%26doi%3D10.1016%2Fs0140-6736%2805%2967629-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desjeux, P.</span></span> <span> </span><span class="NLM_article-title">Leishmaniasis: Current situation and new perspectives</span>. <i>Comp. Immunol. Microbiol. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/j.cimid.2004.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.cimid.2004.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=15225981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD2czitl2qtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=305-318&author=P.+Desjeux&title=Leishmaniasis%3A+Current+situation+and+new+perspectives&doi=10.1016%2Fj.cimid.2004.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Leishmaniasis: current situation and new perspectives</span></div><div class="casAuthors">Desjeux P</div><div class="citationInfo"><span class="NLM_cas:title">Comparative immunology, microbiology and infectious diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">305-18</span>
        ISSN:<span class="NLM_cas:issn">0147-9571</span>.
    </div><div class="casAbstract">Leishmaniasis represents a complex of diseases with an important clinical and epidemiological diversity.  Visceral leishmaniasis (VL) is of higher priority than cutaneous leishmaniasis (CL) as it is a fatal disease in the absence of treatment.  Anthroponotic VL foci are of special concern as they are at the origin of frequent and deathly epidemics (e.g.  Sudan).  Leishmaniasis burden remains important: 88 countries, 350 million people at risk, 500,000 new cases of VL per year, 1-1.5 million for CL and DALYs: 2.4 millions.  Most of the burden is concentrated on few countries which allows clear geographic priorities.  Leishmaniasis is still an important public health problem due to not only environmental risk factors such as massive migrations, urbanisation, deforestation, new irrigation schemes, but also to individual risk factors: HIV, malnutrition, genetic, etc em leader Leishmaniasis is part of those diseases which still requires improved control tools.  Consequently WHO/TDR research for leishmaniasis has been more and more focusing on the development of new tools such as diagnostic tests, drugs and vaccines.  The ongoing effort has already produced significant results.  The newly available control tools should allow a scaling up of control activities in priority areas.  In anthroponotic foci, the feasibility of getting a strong impact on mortality, morbidity and transmission, is high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSI9DJyGjvUp-kdrW1FkXG-fW6udTcc2eYrLCldXyLQD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czitl2qtA%253D%253D&md5=5720ef59954ab0a8062fe83d127d1768</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cimid.2004.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cimid.2004.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DDesjeux%26aufirst%3DP.%26atitle%3DLeishmaniasis%253A%2520Current%2520situation%2520and%2520new%2520perspectives%26jtitle%3DComp.%2520Immunol.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2004%26volume%3D27%26spage%3D305%26epage%3D318%26doi%3D10.1016%2Fj.cimid.2004.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbwang, J.</span></span> <span> </span><span class="NLM_article-title">Childhood visceral leishmaniasis</span>. <i>Indian J. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16778316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD28zmtl2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2006&pages=353-356&author=S.+K.+Bhattacharyaauthor=D.+Surauthor=J.+Karbwang&title=Childhood+visceral+leishmaniasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Childhood visceral leishmaniasis</span></div><div class="casAuthors">Bhattacharya S K; Sur Dipika; Karbwang Juntra</div><div class="citationInfo"><span class="NLM_cas:title">The Indian journal of medical research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-6</span>
        ISSN:<span class="NLM_cas:issn">0971-5916</span>.
    </div><div class="casAbstract">Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani and transmitted by the bite of infected sandfly Phlebotomus argentipes.  Nearly half of the VL cases occur in children (childhood or paediatric VL).  The clinical manifestations of childhood VL are more or less same as in the adults.  Prolonged fever with anorexia and loss of appetite are the major presenting features.  Marked enlargement of the spleen and liver (spleen larger than liver) with moderate to severe anaemia and changes in hair take place.  Bacterial infection is a common coinfection and intestinal parasitic infestations are very common in children with VL.  Liver function tests, blood, urine and stool may show abnormalities.  Confirmation of diagnosis is made by demonstration of parasite by microscopic examination and culture of materials obtained by bone marrow aspiration or splenic puncture.  Sodium antimony gluconate (stibogluconate) has been the drug of choice for over past 50 yr.  Pentamidine isothionate, though effective is relatively toxic.  Amphotericin B is the most effective drug for the treatment of VL.  Miltefosine is the first-ever oral drug, is highly effective.  Post kala-azar dermal leishmaniasis (PKDL) in children poses a therapeutic challenge.  In the absence of an ideal vaccine for VL, control measures would essentially include prevention of transmission through vector control and community awareness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdd__WUPJVrw5nADWVYHg1fW6udTcc2eYrLCldXyLQD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zmtl2gtw%253D%253D&md5=71b08f78608d9311ab6930cb6490595c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DSur%26aufirst%3DD.%26aulast%3DKarbwang%26aufirst%3DJ.%26atitle%3DChildhood%2520visceral%2520leishmaniasis%26jtitle%3DIndian%2520J.%2520Med.%2520Res.%26date%3D2006%26volume%3D123%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span> <span> </span><span class="NLM_article-title">Drug resistance in indian visceral leishmaniasis</span>. <i>Trop. Med. Int. Health</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.1046/j.1365-3156.2001.00778.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1046%2Fj.1365-3156.2001.00778.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11703838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD3MnltFOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=849-854&author=S.+Sundar&title=Drug+resistance+in+indian+visceral+leishmaniasis&doi=10.1046%2Fj.1365-3156.2001.00778.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance in Indian visceral leishmaniasis</span></div><div class="casAuthors">Sundar S</div><div class="citationInfo"><span class="NLM_cas:title">Tropical medicine & international health : TM & IH</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">849-54</span>
        ISSN:<span class="NLM_cas:issn">1360-2276</span>.
    </div><div class="casAbstract">Throughout the world, pentavalent antimonial compounds (Sb(v)) have been the mainstay of antileishmanial therapy for more than 50 years.  Sb(v) has been highly effective in the treatment of Indian visceral leishmaniasis (VL: kala-azar) at a low dose (10 mg/kg) for short durations (6-10 days).  But in the early 1980s reports of its ineffectiveness emerged, and the dose of Sb(v) was eventually raised to 20 mg/kg for 30-40 days.  This regimen cures most patients with VL except in India, where the proportion of patients unresponsive to Sb(v) has steadily increased.  In hyperendemic districts of north Bihar, 50-65% patients fail treatment with Sb(v).  Important reasons are rampant use of subtherapeutic doses, incomplete duration of treatment and substandard drugs.  In vitro experiments have established emergence of Sb(v) resistant strains of Leishmania donovani, as isolates from unresponsive patients require 3-5 times more Sb(v) to reach similarly effectiveness against the parasite as in Sb(v) responders.  Anthroponotic transmission in India has been an important factor in rapid increase in the Sb(v) refractoriness.  Pentamidine was the first drug to be used and cured 99% of these refractory patients, but over time even with double the amount of initial doses, it cures only 69-78% patients now and its use has largely been abandoned in India.  Despite several disadvantages, amphotericin B is the only drug available for use in these areas and should be used as first-line drug instead of Sb(v).  The new oral antileishmanial drug miltefosine is likely to be the first-line drug in future.  Unfortunately, development of newer antileishmanial drugs is rare; two promising drugs, aminosidine and sitamaquine, may be developed for use in the treatment of VL.  Lipid associated amphotericin B has an excellent safety and efficacy profile, but remains out of reach for most patients because of its high cost.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNUjLeVs7MGevW160gIxP_fW6udTcc2eYrLCldXyLQD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnltFOqsQ%253D%253D&md5=5a51e3af86ed330f99315841ec1d44ec</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-3156.2001.00778.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-3156.2001.00778.x%26sid%3Dliteratum%253Aachs%26aulast%3DSundar%26aufirst%3DS.%26atitle%3DDrug%2520resistance%2520in%2520indian%2520visceral%2520leishmaniasis%26jtitle%3DTrop.%2520Med.%2520Int.%2520Health%26date%3D2001%26volume%3D6%26spage%3D849%26epage%3D854%26doi%3D10.1046%2Fj.1365-3156.2001.00778.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freitas-Junior, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira-Neto, J. L.</span></span> <span> </span><span class="NLM_article-title">Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?</span>. <i>Int. J. Parasitol.: Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2012.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ijpddr.2012.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24533267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1KmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=11-19&author=L.+H.+Freitas-Juniorauthor=E.+Chatelainauthor=H.+A.+Kimauthor=J.+L.+Siqueira-Neto&title=Visceral+leishmaniasis+treatment%3A+What+do+we+have%2C+what+do+we+need+and+how+to+deliver+it%3F&doi=10.1016%2Fj.ijpddr.2012.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?</span></div><div class="casAuthors">Freitas-Junior, Lucio H.; Chatelain, Eric; Kim, Helena Andrade; Siqueira-Neto, Jair L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Parasitology: Drugs and Drug Resistance</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-19</span>CODEN:
                <span class="NLM_cas:coden">IJPDAX</span>;
        ISSN:<span class="NLM_cas:issn">2211-3207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Leishmaniasis is one of the most neglected tropical disease in terms of drug discovery and development.  Most antileishmanial drugs are highly toxic, present resistance issues or require hospitalization, being therefore not adequate to the field.  Recently improvements have been achieved by combination therapy, reducing the time and cost of treatment.  Nonetheless, new drugs are still urgently needed.  In this review, we describe the current visceral leishmaniasis (VL) treatments and their limitations.  We also discuss the new strategies in the drug discovery field including the development and implementation of high-throughput screening (HTS) assays and the joint efforts of international teams to deliver clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsxC-9pemCbVg90H21EOLACvtfcHk0lgEV9si2E4DMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1KmtLY%253D&md5=bc79e6a916e0dac45ec0879ecdc27e03</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2012.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2012.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DH.%2BA.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26atitle%3DVisceral%2520leishmaniasis%2520treatment%253A%2520What%2520do%2520we%2520have%252C%2520what%2520do%2520we%2520need%2520and%2520how%2520to%2520deliver%2520it%253F%26jtitle%3DInt.%2520J.%2520Parasitol.%253A%2520Drugs%2520Drug%2520Resist.%26date%3D2012%26volume%3D2%26spage%3D11%26epage%3D19%26doi%3D10.1016%2Fj.ijpddr.2012.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jha, T. K.</span></span> <span> </span><span class="NLM_article-title">Drug unresponsiveness & combination therapy for kala-azar</span>. <i>Indian J. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16778318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslShsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2006&pages=389-398&author=T.+K.+Jha&title=Drug+unresponsiveness+%26+combination+therapy+for+kala-azar"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Drug unresponsiveness & combination therapy for kala-azar</span></div><div class="casAuthors">Jha, T. K.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Medical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">389-398</span>CODEN:
                <span class="NLM_cas:coden">IMIREV</span>;
        ISSN:<span class="NLM_cas:issn">0971-5916</span>.
    
            (<span class="NLM_cas:orgname">Indian Council of Medical Research</span>)
        </div><div class="casAbstract">A review.  Pentavalent antimonials (Sbv) have been successfully used for treatment of kala-azar since last six decades.  Since 1970s its conventional dosages have failed to achieve with 60 per cent unresponsiveness reported with WHO regimen in Bihar (India).  Pentamidine initially used as a second line of drug, acquired resistance (25%) even with prolonged dosage.  Newer oral drug miltefosine is a potent antileishmanial drug with longer half-life, a property likely to acquire resistance.  Paromomycin has undergone extensive clin. trials in Indian kala-azar patients.  Being an aminoglycoside, acquired resistance is likely to occur when used as a monotherapy.  To encounter the problem of treatment failure in kala-azar and to reduce length of therapy, combination of at least two effective antileishmanial agents is a desirable option.  In India sodium stibogluconate (SSG) in std. dose has been combined with other antileishmanial agents including paromomycin without encouraging result.  Infection with Leishmania donovani depresses cell-mediated immunity.  Immunol. balance is tilted in favor of Th2 suppressive cytokines over Th1 producing protective cytokines.  Interferon gamma (IFN-γ) has been used in combination with Sbv in Indian kala-azar patients with unexpectedly discouraging results.  Combination of two most potent leishmanicidal drugs amphotericin B and miltefosine which are not dependent on host immune system, may shorten the course of therapy besides encountering unresponsiveness.  A combination therapy should be preferred when treating kala-azar assocd. with HIV/AIDS.  Immunotherapy with exogenous Th1 stimulating cytokines or use of antileishmanial vaccine in combination with a potent chemotherapeutic agent is a future option.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-54SmIfUxDrVg90H21EOLACvtfcHk0lh5M-Fxo4_6dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslShsLk%253D&md5=680b3b0388d8d302f54258407d3ababa</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJha%26aufirst%3DT.%2BK.%26atitle%3DDrug%2520unresponsiveness%2520%2526%2520combination%2520therapy%2520for%2520kala-azar%26jtitle%3DIndian%2520J.%2520Med.%2520Res.%26date%3D2006%26volume%3D123%26spage%3D389%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">More, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makharia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, H. W.</span></span> <span> </span><span class="NLM_article-title">Failure of pentavalent antimony in visceral leishmaniasis in india: Report from the center of the indian epidemic</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1104</span>– <span class="NLM_lpage">1107</span>, <span class="refDoi"> DOI: 10.1086/318121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1086%2F318121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11049798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD3M7htVagug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2000&pages=1104-1107&author=S.+Sundarauthor=D.+K.+Moreauthor=M.+K.+Singhauthor=V.+P.+Singhauthor=S.+Sharmaauthor=A.+Makhariaauthor=P.+C.+K.+Kumarauthor=H.+W.+Murray&title=Failure+of+pentavalent+antimony+in+visceral+leishmaniasis+in+india%3A+Report+from+the+center+of+the+indian+epidemic&doi=10.1086%2F318121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic</span></div><div class="casAuthors">Sundar S; More D K; Singh M K; Singh V P; Sharma S; Makharia A; Kumar P C; Murray H W</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1104-7</span>
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    </div><div class="casAbstract">In India, 320 patients with visceral leishmaniasis (209 in the state of Bihar and 11 in the neighboring state of Uttar Pradesh) received identical pentavalent antimony (Sb) treatment.  Sb induced long-term cure in 35% (95% confidence interval [CI], 28%-42%) of those in Bihar versus 86% (95% CI, 79%-93%) of those in Uttar Pradesh.  In Bihar, the center of the Indian epidemic, traditional Sb treatment should be abandoned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgpGjHbUAdr9yzdcP07UmufW6udTcc2eZsC2stliDvWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7htVagug%253D%253D&md5=96fce619cd1c5006ec9c168b2c01bb2d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1086%2F318121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F318121%26sid%3Dliteratum%253Aachs%26aulast%3DSundar%26aufirst%3DS.%26aulast%3DMore%26aufirst%3DD.%2BK.%26aulast%3DSingh%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DMakharia%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DP.%2BC.%2BK.%26aulast%3DMurray%26aufirst%3DH.%2BW.%26atitle%3DFailure%2520of%2520pentavalent%2520antimony%2520in%2520visceral%2520leishmaniasis%2520in%2520india%253A%2520Report%2520from%2520the%2520center%2520of%2520the%2520indian%2520epidemic%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2000%26volume%3D31%26spage%3D1104%26epage%3D1107%26doi%3D10.1086%2F318121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, Z.</span></span> <span> </span><span class="NLM_article-title">Miltefosine: First oral drug for treatment of visceral leishmaniasis</span>. <i>Med. J. Armed Forces India</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/s0377-1237(06)80162-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fs0377-1237%2806%2980162-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27407849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BC2s7pvFamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=66-67&author=V.+Agrawalauthor=Z.+Singh&title=Miltefosine%3A+First+oral+drug+for+treatment+of+visceral+leishmaniasis&doi=10.1016%2Fs0377-1237%2806%2980162-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Miltefosine: First Oral Drug for Treatment of Visceral Leishmaniasis</span></div><div class="casAuthors">Agrawal V K; Singh Zile</div><div class="citationInfo"><span class="NLM_cas:title">Medical journal, Armed Forces India</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-7</span>
        ISSN:<span class="NLM_cas:issn">0377-1237</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDxnorIE-IzTMsgLhIoICsfW6udTcc2eZsC2stliDvWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7pvFamtg%253D%253D&md5=364eb5067ac60232accb95dca2d0dee3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fs0377-1237%2806%2980162-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0377-1237%252806%252980162-0%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DV.%26aulast%3DSingh%26aufirst%3DZ.%26atitle%3DMiltefosine%253A%2520First%2520oral%2520drug%2520for%2520treatment%2520of%2520visceral%2520leishmaniasis%26jtitle%3DMed.%2520J.%2520Armed%2520Forces%2520India%26date%3D2006%26volume%3D62%26spage%3D66%26epage%3D67%26doi%3D10.1016%2Fs0377-1237%2806%2980162-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, J.</span></span> <span> </span><span class="NLM_article-title">Treatment of american cutaneous leishmaniasis with miltefosine, an oral agent</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">E57</span>– <span class="NLM_lpage">E61</span>, <span class="refDoi"> DOI: 10.1086/322689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1086%2F322689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11528586" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=E57-E61&author=J.+Sotoauthor=J.+Toledoauthor=P.+Gutierrezauthor=R.+S.+Nichollsauthor=J.+Padillaauthor=J.+Engelauthor=C.+Fischerauthor=A.+Vossauthor=J.+Berman&title=Treatment+of+american+cutaneous+leishmaniasis+with+miltefosine%2C+an+oral+agent&doi=10.1086%2F322689"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1086%2F322689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F322689%26sid%3Dliteratum%253Aachs%26aulast%3DSoto%26aufirst%3DJ.%26aulast%3DToledo%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DP.%26aulast%3DNicholls%26aufirst%3DR.%2BS.%26aulast%3DPadilla%26aufirst%3DJ.%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DVoss%26aufirst%3DA.%26aulast%3DBerman%26aufirst%3DJ.%26atitle%3DTreatment%2520of%2520american%2520cutaneous%2520leishmaniasis%2520with%2520miltefosine%252C%2520an%2520oral%2520agent%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2001%26volume%3D33%26spage%3DE57%26epage%3DE61%26doi%3D10.1086%2F322689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monge-Maillo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Vélez, R.</span></span> <span> </span><span class="NLM_article-title">Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.1093/cid/civ004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1093%2Fcid%2Fciv004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25601455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvns1ektg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=1398-1404&author=B.+Monge-Mailloauthor=R.+L%C3%B3pez-V%C3%A9lez&title=Miltefosine+for+visceral+and+cutaneous+leishmaniasis%3A+drug+characteristics+and+evidence-based+treatment+recommendations&doi=10.1093%2Fcid%2Fciv004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations</span></div><div class="casAuthors">Monge-Maillo Begona; Lopez-Velez Rogelio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1398-404</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Miltefosine is the only recognized oral agent with potential to treat leishmaniasis.  Miltefosine had demonstrated very good cure rates for visceral leishmaniasis (VL) in India, Nepal, and Bangladesh, but high rates of clinical failures have been recently reported.  Moderate efficacy has been observed for VL in East Africa, whereas data from Mediterranean countries and Latin America are scarce.  Results have not been very promising for patients coinfected with VL and human immunodeficiency virus.  However, miltefosine's long half-life and its oral administration could make it a good option for maintenance prophylaxis.  Good evidence of efficacy has been documented in Old World cutaneous leishmaniasis (CL), and different cure rates among New World CL have been obtained depending on the geographical areas and species involved.  Appropriate regimens for New World mucocutaneous leishmaniasis need to be established, although longer treatment duration seems to confer better results.  Strategies to prevent the development and spread of miltefosine resistance are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoSEc0tthPZDMsgLhIoICsfW6udTcc2eYhp-tmjx9vAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvns1ektg%253D%253D&md5=8acd6993f6d425cf6d381a3f6cacadd8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciv004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciv004%26sid%3Dliteratum%253Aachs%26aulast%3DMonge-Maillo%26aufirst%3DB.%26aulast%3DL%25C3%25B3pez-V%25C3%25A9lez%26aufirst%3DR.%26atitle%3DMiltefosine%2520for%2520visceral%2520and%2520cutaneous%2520leishmaniasis%253A%2520drug%2520characteristics%2520and%2520evidence-based%2520treatment%2520recommendations%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D60%26spage%3D1398%26epage%3D1404%26doi%3D10.1093%2Fcid%2Fciv004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">TheREnantiomer of the Antitubercular Drug PA-824 as a Potential Oral Treatment for Visceral Leishmaniasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4699</span>– <span class="NLM_lpage">4706</span>, <span class="refDoi"> DOI: 10.1128/aac.00722-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.00722-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=23856774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVygtb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=4699-4706&author=S.+Pattersonauthor=S.+Wyllieauthor=L.+Stojanovskiauthor=M.+R.+Perryauthor=F.+R.+C.+Simeonsauthor=S.+Norvalauthor=M.+Osuna-Cabelloauthor=M.+De+Ryckerauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=TheREnantiomer+of+the+Antitubercular+Drug+PA-824+as+a+Potential+Oral+Treatment+for+Visceral+Leishmaniasis&doi=10.1128%2Faac.00722-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral leishmaniasis</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan; Stojanovski, Laste; Perry, Meghan R.; Simeons, Frederick R. C.; Norval, Suzanne; Osuna-Cabello, Maria; De Rycker, Manu; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4699-4706</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The novel nitroimidazopyran agent (S)-PA-824 has potent antibacterial activity against Mycobacterium tuberculosis in vitro and in vivo and is currently in phase II clin. trials for tuberculosis (TB).  In contrast to M. tuberculosis, where (R)-PA-824 is inactive, we report here that both enantiomers of PA-824 show potent parasiticidal activity against Leishmania donovani, the causative agent of visceral leishmaniasis (VL).  In leishmania-infected macrophages, (R)-PA-824 is 6-fold more active than (S)-PA-824.  Both des-nitro analogs are inactive, underlining the importance of the nitro group in the mechanism of action.  Although the in vitro and in vivo pharmacol. profiles of the two enantiomers are similar, (R)-PA-824 is more efficacious in the murine model of VL, with >99% suppression of parasite burden when administered orally at 100 mg kg of body wt.-1, twice daily for 5 days.  In M. tuberculosis, (S)-PA-824 is a prodrug that is activated by a deazaflavin-dependent nitroreductase (Ddn), an enzyme which is absent in Leishmania spp.  Unlike the case with nifurtimox and fexinidazole, transgenic parasites overexpressing the leishmania nitroreductase are not hypersensitive to either (R)-PA-824 or (S)-PA-824, indicating that this enzyme is not the primary target of these compds.  Drug combination studies in vitro indicate that fexinidazole and (R)-PA-824 are additive whereas (S)-PA-824 and (R)-PA-824 show mild antagonistic behavior.  Thus, (R)-PA-824 is a promising candidate for late lead optimization for VL and may have potential for future use in combination therapy with fexinidazole, currently in phase II clin. trials against VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1xswg68vjdLVg90H21EOLACvtfcHk0ljrocx2aZkelw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVygtb7I&md5=401760844c66c37003791c9dcf83392b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2Faac.00722-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.00722-13%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPerry%26aufirst%3DM.%2BR.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DTheREnantiomer%2520of%2520the%2520Antitubercular%2520Drug%2520PA-824%2520as%2520a%2520Potential%2520Oral%2520Treatment%2520for%2520Visceral%2520Leishmaniasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D4699%26epage%3D4706%26doi%3D10.1128%2Faac.00722-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e09744</span>, <span class="refDoi"> DOI: 10.7554/elife.09744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.7554%2Felife.09744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27215734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFamtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e09744&author=S.+Pattersonauthor=S.+Wyllieauthor=S.+Norvalauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=J.+L.+Auerauthor=M.+Osuna-Cabelloauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=The+anti-tubercular+drug+delamanid+as+a+potential+oral+treatment+for+visceral+leishmaniasis&doi=10.7554%2Felife.09744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan; Norval, Suzanne; Stojanovski, Laste; Simeons, Frederick R. C.; Auer, Jennifer L.; Osuna-Cabello, Maria; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e09744/1-e09744/21</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">There is an urgent requirement for safe, oral and cost-effective drugs for the treatment of visceral leishmaniasis (VL).  We report that delamanid (OPC-67683), an approved drug for multi-drug resistant tuberculosis, is a potent inhibitor of Leishmaniadonovani both in vitro and in vivo.  Twice-daily oral dosing of delamanid at 30 mg kg-1 for 5 days resulted in sterile cures in a mouse model of VL.  Treatment with lower doses revealed a U-shaped (hormetic) dose-response curve with greater parasite suppression at 1 mg kg-1 than at 3 mg kg-1 (5 or 10 day dosing).  Dosing delamanid for 10 days confirmed the hormetic dose-response and improved the efficacy at all doses investigated.  Mechanistic studies reveal that delamanid is rapidly metabolised by parasites via an enzyme, distinct from the nitroreductase that activates fexinidazole.  Delamanid has the potential to be repurposed as a much-needed oral therapy for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqepWvGUGZ0cbVg90H21EOLACvtfcHk0ljrocx2aZkelw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFamtLw%253D&md5=1a704d1acb52b08cae5f73cf625f293a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.7554%2Felife.09744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252Felife.09744%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DAuer%26aufirst%3DJ.%2BL.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DThe%2520anti-tubercular%2520drug%2520delamanid%2520as%2520a%2520potential%2520oral%2520treatment%2520for%2520visceral%2520leishmaniasis%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De09744%26doi%3D10.7554%2Felife.09744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">119re1</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1126%2Fscitranslmed.3003326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=22301556" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=119re1&author=S.+Wyllieauthor=S.+Pattersonauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=S.+Norvalauthor=R.+Kimeauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=The+anti-trypanosome+drug+fexinidazole+shows+potential+for+treating+visceral+leishmaniasis&doi=10.1126%2Fscitranslmed.3003326"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003326%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DKime%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DThe%2520anti-trypanosome%2520drug%2520fexinidazole%2520shows%2520potential%2520for%2520treating%2520visceral%2520leishmaniasis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D119re1%26doi%3D10.1126%2Fscitranslmed.3003326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukkavilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinjari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengottuvelan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadekar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothuri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koiram, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harisudhan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moinuddin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachharajani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span> <span> </span><span class="NLM_article-title">In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of dndi-vl-2098, a potential oral treatment for visceral leishmaniasis</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejps.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25261338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Gms73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2014&pages=147-155&author=R.+Mukkavilliauthor=J.+Pinjariauthor=B.+Patelauthor=S.+Sengottuvelanauthor=S.+Mondalauthor=A.+Gadekarauthor=M.+Vermaauthor=J.+Patelauthor=L.+Pothuriauthor=G.+Chandrashekarauthor=P.+Koiramauthor=T.+Harisudhanauthor=A.+Moinuddinauthor=D.+Launayauthor=N.+Vachharajaniauthor=V.+Ramanathanauthor=D.+Martin&title=In+vitro+metabolism%2C+disposition%2C+preclinical+pharmacokinetics+and+prediction+of+human+pharmacokinetics+of+dndi-vl-2098%2C+a+potential+oral+treatment+for+visceral+leishmaniasis&doi=10.1016%2Fj.ejps.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis</span></div><div class="casAuthors">Mukkavilli, Rao; Pinjari, Jakir; Patel, Bhavesh; Sengottuvelan, Shankar; Mondal, Subodh; Gadekar, Ajit; Verma, Manas; Patel, Jignesh; Pothuri, Lavanya; Chandrashekar, Gopu; Koiram, Prabhakar; Harisudhan, Tanukrishnan; Moinuddin, Ansari; Launay, Delphine; Vachharajani, Nimish; Ramanathan, Vikram; Martin, Denis</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-155</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The in vitro metab. and in vivo pharmacokinetic (PK) properties of DNDI-VL-2098, a potential oral agent for Visceral Leishmaniasis (VL) were studied and used to predict its human pharmacokinetics.  DNDI-VL-2098 showed a low soly. (10 μM) and was highly permeable (>200 nm/s) in the Caco-2 model.  It was stable in vitro in liver microsomes and hepatocytes and no metabolite was detectable in circulating plasma from dosed animals suggesting very slow, if any, metab. of the compd.  DNDI-VL-2098 was moderate to highly bound to plasma proteins across the species tested (94-98%).  DNDI-VL-2098 showed satisfactory PK properties in mouse, hamster, rat and dog with a low blood clearance (<15% of hepatic blood flow except hamster), a vol. of distribution of about 3 times total body water, acceptable half-life (1-6 h across the species) and good oral bioavailability (37-100%).  Allometric scaling of the preclin. PK data to human gave a blood half-life of approx. 20 h suggesting that the compd. could be a once-a-day drug.  Based on the above assumptions, the min. efficacious dose predicted for a 50 kg human was 150 mg and 300 mg, using efficacy results in the mouse and hamster, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg5azRMLSQ37Vg90H21EOLACvtfcHk0lgVUtu20J-rdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Gms73N&md5=9d351c194ceba25f2dc23be54bb1ba33</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DMukkavilli%26aufirst%3DR.%26aulast%3DPinjari%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DSengottuvelan%26aufirst%3DS.%26aulast%3DMondal%26aufirst%3DS.%26aulast%3DGadekar%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DPothuri%26aufirst%3DL.%26aulast%3DChandrashekar%26aufirst%3DG.%26aulast%3DKoiram%26aufirst%3DP.%26aulast%3DHarisudhan%26aufirst%3DT.%26aulast%3DMoinuddin%26aufirst%3DA.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DVachharajani%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DV.%26aulast%3DMartin%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520metabolism%252C%2520disposition%252C%2520preclinical%2520pharmacokinetics%2520and%2520prediction%2520of%2520human%2520pharmacokinetics%2520of%2520dndi-vl-2098%252C%2520a%2520potential%2520oral%2520treatment%2520for%2520visceral%2520leishmaniasis%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D65%26spage%3D147%26epage%3D155%26doi%3D10.1016%2Fj.ejps.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foth, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Activation of bicyclic nitro-drugs by a novel nitroreductase (ntr2) in leishmania</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e1005971</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1005971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1371%2Fjournal.ppat.1005971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27812217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitV2mt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=e1005971&author=S.+Wyllieauthor=A.+J.+Robertsauthor=S.+Norvalauthor=S.+Pattersonauthor=B.+J.+Fothauthor=M.+Berrimanauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=Activation+of+bicyclic+nitro-drugs+by+a+novel+nitroreductase+%28ntr2%29+in+leishmania&doi=10.1371%2Fjournal.ppat.1005971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of bicyclic nitro-drugs by a novel nitroreductase (NTR2) in Leishmania</span></div><div class="casAuthors">Wyllie, Susan; Roberts, Adam J.; Norval, Suzanne; Patterson, Stephen; Foth, Bernardo J.; Berriman, Matthew; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1005971/1-e1005971/22</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Drug discovery pipelines for the "neglected diseases" are now heavily populated with nitroheterocyclic compds.  Recently, the bicyclic nitro-compds. (R)-PA-824, DNDI-VL-2098 and delamanid have been identified as potential candidates for the treatment of visceral leishmaniasis.  Using a combination of quant. proteomics and whole genome sequencing of susceptible and drug-resistant parasites we identified a putative NAD(P)H oxidase as the activating nitroreductase (NTR2).  Whole genome sequencing revealed that deletion of a single cytosine in the gene for NTR2 that is likely to result in the expression of a non-functional truncated protein.  Susceptibility of leishmania was restored by reintroduction of the wild-type gene into the resistant line, which was accompanied by the ability to metabolise these compds.  Overexpression of NTR2 in wild-type parasites rendered cells hyper-sensitive to bicyclic nitro-compds., but only marginally to the monocyclic nitro-drugs, nifurtimox and fexinidazole sulfone, known to be activated by a mitochondrial oxygen-insensitive nitroreductase (NTR1).  Conversely, a double knockout NTR2 null cell line was completely resistant to bicyclic nitro-compds. and only marginally resistant to nifurtimox.  Sensitivity was fully restored on expression of NTR2 in the null background.  Thus, NTR2 is necessary and sufficient for activation of these bicyclic nitro-drugs.  Recombinant NTR2 was capable of reducing bicyclic nitro-compds. in the same rank order as drug sensitivity in vitro.  These findings may aid the future development of better, novel anti-leishmanial drugs.  Moreover, the discovery of anti-leishmanial nitro-drugs with independent modes of activation and independent mechanisms of resistance alleviates many of the concerns over the continued development of these compd. series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnnO9nEnuzw7Vg90H21EOLACvtfcHk0lgVUtu20J-rdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitV2mt7g%253D&md5=0506a45a0a29a613f96c1b874af54b96</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1005971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1005971%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DFoth%26aufirst%3DB.%2BJ.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DActivation%2520of%2520bicyclic%2520nitro-drugs%2520by%2520a%2520novel%2520nitroreductase%2520%2528ntr2%2529%2520in%2520leishmania%26jtitle%3DPLoS%2520Pathog.%26date%3D2016%26volume%3D12%26spage%3De1005971%26doi%3D10.1371%2Fjournal.ppat.1005971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bongarzone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">The concept of privileged structures in rational drug design: Focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1517/17460441.2011.550914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1517%2F17460441.2011.550914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=22647203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlehsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=251-268&author=S.+Bongarzoneauthor=M.+L.+Bolognesi&title=The+concept+of+privileged+structures+in+rational+drug+design%3A+Focus+on+acridine+and+quinoline+scaffolds+in+neurodegenerative+and+protozoan+diseases&doi=10.1517%2F17460441.2011.550914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases</span></div><div class="casAuthors">Bongarzone, Salvatore; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-268</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  For nearly 20 years, privileged structures have offered an optimal source of core scaffolds and capping fragments for the design of combinatorial libraries directed at a broad spectrum of targets.  From describing structures promiscuous within a given target family, the concept has evolved to include frameworks that can modulate proteins lacking a strict target class relation.  Based on a literature search from 2000 to 2010, we discuss how two privileged motifs, quinolines and acridines, are particularly recurrent in compds. active against two quite different pathologies, neurodegenerative and protozoan diseases.  As privileged structures, quinolines and acridines could improve the productivity of drug discovery projects in the field of neurodegenerative and protozoan diseases.  They could be particularly relevant for protozoan diseases because of the importance of cost-effective strategies and less stringent intellectual property concerns.  Furthermore, because of their inherent affinity for various targets, privileged structures could offer a viable starting point in the search for novel multi-target ligands.  Finally, from a broader perspective, they can serve as effective probes for investigating unknown but interrelated mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH8GsG8UoG17Vg90H21EOLACvtfcHk0lgVUtu20J-rdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlehsr8%253D&md5=a06cb7c7bdd8561ee6138bf8453082c9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.550914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.550914%26sid%3Dliteratum%253Aachs%26aulast%3DBongarzone%26aufirst%3DS.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DThe%2520concept%2520of%2520privileged%2520structures%2520in%2520rational%2520drug%2520design%253A%2520Focus%2520on%2520acridine%2520and%2520quinoline%2520scaffolds%2520in%2520neurodegenerative%2520and%2520protozoan%2520diseases%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D251%26epage%3D268%26doi%3D10.1517%2F17460441.2011.550914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keri, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S. A.</span></span> <span> </span><span class="NLM_article-title">Quinoline: A promising antitubercular target</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2014.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.biopha.2014.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25458785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGisbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=1161-1175&author=R.+S.+Keriauthor=S.+A.+Patil&title=Quinoline%3A+A+promising+antitubercular+target&doi=10.1016%2Fj.biopha.2014.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline: A promising antitubercular target</span></div><div class="casAuthors">Keri, Rangappa S.; Patil, Siddappa A.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1161-1175</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Tuberculosis (TB) remains a global public health problem in recent years.  TB originated mainly from various strains of Mycobacterium tuberculosis, is a highly infectious and chronic disease with high infection rate since ancient times.  Since the last 50 years, the same long-duration, multidrug treatment plan is being followed for the treatment of tuberculosis.  Due to the development of resistance to conventional antibiotics there is a need for new therapeutic strategies to combat M. tuberculosis.  Subsequently, there is an urgent need for the development of new drug mols. with newer targets and with an alternative mechanism of action.  Among hetrocyclic compds., quinoline compds. are important privileged structure in medicinal chem., are widely used as "parental" compds. to synthesize mols. with medical benefits, esp. with anti-malarial and anti-microbial activities.  Certain, quinoline-based compds., also show effective anti-TB activity.  This broad spectrum of biol. and biochem. activities has been further facilitated by the synthetic versatility of quinoline, which allows the generation of a large no. of structurally diverse derivs.  To pave the way for future research, there is a need to collect the latest information in this promising area.  In the present review, we have collated published reports on this versatile core to provide an insight so that its full therapeutic potential can be utilized for the treatment tuberculosis.  It is hoped that, this review will be helpful for new thoughts in the quest for rational designs of more active and less toxic quinoline-based anti-TB drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLb6nFd3vm9bVg90H21EOLACvtfcHk0lg-s6PAqzExng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGisbvL&md5=21f7da91946ed726e9d2931e31784ea7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2014.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DKeri%26aufirst%3DR.%2BS.%26aulast%3DPatil%26aufirst%3DS.%2BA.%26atitle%3DQuinoline%253A%2520A%2520promising%2520antitubercular%2520target%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2014%26volume%3D68%26spage%3D1161%26epage%3D1175%26doi%3D10.1016%2Fj.biopha.2014.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span> <span> </span><span class="NLM_article-title">Quinoline as a privileged scaffold in cancer drug discovery</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1508</span>, <span class="refDoi"> DOI: 10.2174/092986711795328382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.2174%2F092986711795328382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21428893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslOit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1488-1508&author=V.+R.+Solomonauthor=H.+Lee&title=Quinoline+as+a+privileged+scaffold+in+cancer+drug+discovery&doi=10.2174%2F092986711795328382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline as a privileged scaffold in cancer drug discovery</span></div><div class="casAuthors">Solomon, V. R.; Lee, H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1488-1508</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Quinoline (1-azanaphthalene) is a heterocyclic arom. nitrogen compd. characterized by a double-ring structure that contains a benzene ring fused to pyridine at two adjacent carbon atoms.  Quinoline compds. are widely used as "parental" compds. to synthesize mols. with medical benefits, esp. with anti-malarial and anti-microbial activities.  Certain quinoline-based compds. also show effective anticancer activity.  This broad spectrum of biol. and biochem. activities has been further facilitated by the synthetic versatility of quinoline, which allows the generation of a large no. of structurally diverse derivs.  This includes numerous analogs derived from substitution of the quinoline ring system, and derivatization of quinoline ring structure.  Quinoline and its analogs have recently been examd. for their modes of function in the inhibition of tyrosine kinases, proteasome, tubulin polymn. and DNA repair.  In this review, we have summarized our knowledge on quinoline compds. with respect to their anticancer activities, mechanisms of action, structure-activity relationship (SAR), and selective and specific activity against various cancer drug targets.  In particular, we focus our review on in vitro and in vivo anticancer activities of quinoline and its analogs in the context of cancer drug development and refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwaNwDSFVcrLVg90H21EOLACvtfcHk0lg-s6PAqzExng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslOit70%253D&md5=9c8cb8b477523b99bbe6d8b08eca00de</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F092986711795328382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795328382%26sid%3Dliteratum%253Aachs%26aulast%3DSolomon%26aufirst%3DV.%2BR.%26aulast%3DLee%26aufirst%3DH.%26atitle%3DQuinoline%2520as%2520a%2520privileged%2520scaffold%2520in%2520cancer%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1488%26epage%3D1508%26doi%3D10.2174%2F092986711795328382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlahopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critselis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voutsas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschovi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxevanis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrousos, G.</span></span> <span> </span><span class="NLM_article-title">New use for old drugs? Prospective targets of chloroquines in cancer therapy</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.2174/1389450115666140714121514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.2174%2F1389450115666140714121514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25023646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGisrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=843-851&author=S.+Vlahopoulosauthor=E.+Critselisauthor=I.+Voutsasauthor=S.+Perezauthor=M.+Moschoviauthor=C.+Baxevanisauthor=G.+Chrousos&title=New+use+for+old+drugs%3F+Prospective+targets+of+chloroquines+in+cancer+therapy&doi=10.2174%2F1389450115666140714121514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy</span></div><div class="casAuthors">Vlahopoulos, Spiros; Critselis, Elena; Voutsas, Ioannis F.; Perez, Sonia A.; Moschovi, Maria; Baxevanis, Constantin N.; Chrousos, George P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">843-851</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  During the last decade research is gradually repositioning the antimalarial drug chloroquine, and certain related quinoline derivs., as anticancer agents.  Chloroquine and hydroxychloroquine, in particular, have relatively wellcharacterized toxicity profiles due to several decades of use for treatment of malaria.  Previously published review articles provide an excellent overview of the diversity of chloroquine effects on cancer cells, both in the cell culture as well as on human tumors grafted into mice; and an account of the increasing pace of incorporation of hydroxychloroquine in combination treatment schemes for clin. studies.  In this review we present some features that are common between cancers that are sensitive to quinoline derivs., in particular features that are amenable to pharmaceutical intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKPhn3gaHU8bVg90H21EOLACvtfcHk0lg-s6PAqzExng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGisrvJ&md5=5a40a706c855bf76ed9ca3345d887e34</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1389450115666140714121514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450115666140714121514%26sid%3Dliteratum%253Aachs%26aulast%3DVlahopoulos%26aufirst%3DS.%26aulast%3DCritselis%26aufirst%3DE.%26aulast%3DVoutsas%26aufirst%3DI.%26aulast%3DPerez%26aufirst%3DS.%26aulast%3DMoschovi%26aufirst%3DM.%26aulast%3DBaxevanis%26aufirst%3DC.%26aulast%3DChrousos%26aufirst%3DG.%26atitle%3DNew%2520use%2520for%2520old%2520drugs%253F%2520Prospective%2520targets%2520of%2520chloroquines%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2014%26volume%3D15%26spage%3D843%26epage%3D851%26doi%3D10.2174%2F1389450115666140714121514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loiseau, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cojean, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrével, J.</span></span> <span> </span><span class="NLM_article-title">Sitamaquine as a putative antileishmanial drug candidate: From the mechanism of action to the risk of drug resistance</span>. <i>Parasite</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1051/parasite/2011182115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1051%2Fparasite%2F2011182115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21678786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnht12hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=115-119&author=P.+M.+Loiseauauthor=S.+Cojeanauthor=J.+Schr%C3%A9vel&title=Sitamaquine+as+a+putative+antileishmanial+drug+candidate%3A+From+the+mechanism+of+action+to+the+risk+of+drug+resistance&doi=10.1051%2Fparasite%2F2011182115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance</span></div><div class="casAuthors">Loiseau P M; Cojean S; Schrevel J</div><div class="citationInfo"><span class="NLM_cas:title">Parasite (Paris, France)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-9</span>
        ISSN:<span class="NLM_cas:issn">1252-607X</span>.
    </div><div class="casAbstract">Sitamaquine is a 8-aminoquinoline in development for the treatment of visceral leishmaniasis by oral route, no activity being observed on the experimental cutaneous leishmaniasis experimental models.  Recent data explain how sitamaquine accumulate in Leishmania parasites, however its molecular targets remain to be identified.  An advantage of sitamaquine is its short elimination half-life, preventing a rapid resistance emergence.  The antileishmanial action of its metabolites is not known.  The selection of a sitamaquine-resistant clone of L. donovani in laboratory and the phase II clinical trials pointing out some adverse effects such as methemoglobinemia and nephrotoxicity are considered for a further development decision.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXINeSec3k29K0qsdY6Nc1fW6udTcc2eaf7S3yxyIjxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnht12hsg%253D%253D&md5=97ea4b0043ef7d33a16fd9b332d2a5fa</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1051%2Fparasite%2F2011182115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fparasite%252F2011182115%26sid%3Dliteratum%253Aachs%26aulast%3DLoiseau%26aufirst%3DP.%2BM.%26aulast%3DCojean%26aufirst%3DS.%26aulast%3DSchr%25C3%25A9vel%26aufirst%3DJ.%26atitle%3DSitamaquine%2520as%2520a%2520putative%2520antileishmanial%2520drug%2520candidate%253A%2520From%2520the%2520mechanism%2520of%2520action%2520to%2520the%2520risk%2520of%2520drug%2520resistance%26jtitle%3DParasite%26date%3D2011%26volume%3D18%26spage%3D115%26epage%3D119%26doi%3D10.1051%2Fparasite%2F2011182115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque-Ortega, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanys, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamarro, F.</span></span> <span> </span><span class="NLM_article-title">Tafenoquine, an antiplasmodial 8-aminoquinoline, targets leishmania respiratory complex iii and induces apoptosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5344</span>– <span class="NLM_lpage">5351</span>, <span class="refDoi"> DOI: 10.1128/aac.00790-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.00790-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=20837758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2msr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=5344-5351&author=L.+Carvalhoauthor=J.+R.+Luque-Ortegaauthor=J.+I.+Manzanoauthor=S.+Castanysauthor=L.+Rivasauthor=F.+Gamarro&title=Tafenoquine%2C+an+antiplasmodial+8-aminoquinoline%2C+targets+leishmania+respiratory+complex+iii+and+induces+apoptosis&doi=10.1128%2Faac.00790-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tafenoquine, an antiplasmodial 8-aminoquinoline, targets Leishmania respiratory complex III and induces apoptosis</span></div><div class="casAuthors">Carvalho, Luis; Luque-Ortega, Juan Roman; Manzano, Jose Ignacio; Castanys, Santiago; Rivas, Luis; Gamarro, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5344-5351</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tafenoquine (TFQ), an 8-aminoquinoline analog of primaquine, which is under clin. trial (phase IIb/III) for the treatment and prevention of malaria, may represent an alternative treatment for leishmaniasis.  Here, the authors have studied the mechanism of action of TFQ against Leishmania parasites.  TFQ impaired the overall bioenergetic metab. of Leishmania promastigotes, causing a rapid drop in intracellular ATP levels without affecting plasma membrane permeability.  TFQ induced mitochondrial dysfunction through the inhibition of cytochrome c reductase (respiratory complex III) with a decrease in the oxygen consumption rate and depolarization of mitochondrial membrane potential.  This was accompanied by ROS prodn., elevation of intracellular Ca2+ levels and concomitant nuclear DNA fragmentation.  It is concluded that TFQ targets Leishmania mitochondria, leading to an apoptosis-like death process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqub4UUn4WPo7Vg90H21EOLACvtfcHk0lg_a4mUBhWEnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2msr%252FO&md5=966bb6693b6e5cf4a16482a642b5e9e4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2Faac.00790-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.00790-10%26sid%3Dliteratum%253Aachs%26aulast%3DCarvalho%26aufirst%3DL.%26aulast%3DLuque-Ortega%26aufirst%3DJ.%2BR.%26aulast%3DManzano%26aufirst%3DJ.%2BI.%26aulast%3DCastanys%26aufirst%3DS.%26aulast%3DRivas%26aufirst%3DL.%26aulast%3DGamarro%26aufirst%3DF.%26atitle%3DTafenoquine%252C%2520an%2520antiplasmodial%25208-aminoquinoline%252C%2520targets%2520leishmania%2520respiratory%2520complex%2520iii%2520and%2520induces%2520apoptosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D5344%26epage%3D5351%26doi%3D10.1128%2Faac.00790-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antinarelli, L. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, R. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, I. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coimbra, E. S.</span></span> <span> </span><span class="NLM_article-title">4-aminoquinoline derivatives as potential antileishmanial agents</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1111%2Fcbdd.12540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25682728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKnsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2015&pages=704-714&author=L.+M.+R.+Antinarelliauthor=R.+M.+P.+Diasauthor=I.+O.+Souzaauthor=W.+P.+Limaauthor=J.+Gameiroauthor=A.+D.+da+Silvaauthor=E.+S.+Coimbra&title=4-aminoquinoline+derivatives+as+potential+antileishmanial+agents&doi=10.1111%2Fcbdd.12540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aminoquinoline Derivatives as Potential Antileishmanial Agents</span></div><div class="casAuthors">Antinarelli, Luciana M. R.; Dias, Rafael M. P.; Souza, Isabela O.; Lima, Wallace P.; Gameiro, Jacy; da Silva, Adilson D.; Coimbra, Elaine S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">704-714</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The leishmanicidal activity of a series of 4-aminoquinoline (AMQ) derivs. was assayed against Leishmania amazonensis.  This activity against the intracellular parasite was found stronger than for L. amazonensis promastigotes.  Neither compd. was cytotoxic against macrophages.  The compd. AMQ-j, which exhibited a strong activity against promastigotes and amastigotes of L. amazonensis (IC50 values of 5.9 and 2.4 μg/mL, resp.) and similar leishmanicidal activity to ref. drugs, was chosen for studies regarding its possible mechanism of action toward parasite death.  The results showed that the compd. AMQ-j induced depolarization of the mitochondrial membrane potential in promastigotes and in L. amazonensis-infected macrophages, but not in uninfected macrophages.  Furthermore, the depolarization of the mitochondrial membrane potential was dose dependent in infected macrophages.  The authors have established that promastigotes and L. amazonensis-infected macrophages treated with AMQ-j were submitted to oxidative stress.  This is in line with the increase in the level of reactive oxygen species (ROS).  Leishmania amazonensis-infected macrophages treated with AMQ-j did not show a significant increase in the prodn. of nitric oxide.  The authors' results indicate the effective and selective action of AMQ-j against L. amazonensis, and its mechanism of action appears to be mediated by mitochondrial dysfunction assocd. with ROS prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_9QP5g9WmbVg90H21EOLACvtfcHk0lg_a4mUBhWEnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKnsLrO&md5=0088fe4550916838d190d4d406e87d1c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12540%26sid%3Dliteratum%253Aachs%26aulast%3DAntinarelli%26aufirst%3DL.%2BM.%2BR.%26aulast%3DDias%26aufirst%3DR.%2BM.%2BP.%26aulast%3DSouza%26aufirst%3DI.%2BO.%26aulast%3DLima%26aufirst%3DW.%2BP.%26aulast%3DGameiro%26aufirst%3DJ.%26aulast%3Dda%2BSilva%26aufirst%3DA.%2BD.%26aulast%3DCoimbra%26aufirst%3DE.%2BS.%26atitle%3D4-aminoquinoline%2520derivatives%2520as%2520potential%2520antileishmanial%2520agents%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2015%26volume%3D86%26spage%3D704%26epage%3D714%26doi%3D10.1111%2Fcbdd.12540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coimbra, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antinarelli, L. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, I. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinel, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, R. P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, A. D.</span></span> <span> </span><span class="NLM_article-title">Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2016.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.cbi.2016.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27789199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=2016&pages=50-57&author=E.+S.+Coimbraauthor=L.+M.+R.+Antinarelliauthor=N.+P.+Silvaauthor=I.+O.+Souzaauthor=R.+S.+Meinelauthor=M.+N.+Rochaauthor=R.+P.+P.+Soaresauthor=A.+D.+da+Silva&title=Quinoline+derivatives%3A+Synthesis%2C+leishmanicidal+activity+and+involvement+of+mitochondrial+oxidative+stress+as+mechanism+of+action&doi=10.1016%2Fj.cbi.2016.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action</span></div><div class="casAuthors">Coimbra, Elaine S.; Antinarelli, Luciana M. R.; Silva, Natalia P.; Souza, Isabela O.; Meinel, Raissa S.; Rocha, Marcele N.; Soares, Rodrigo P. P.; da Silva, Adilson D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-57</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Leishmaniasis comprise a spectrum of diseases caused by protozoa parasites from the genus Leishmania, affecting millions of people worldwide, mainly in subtropical countries.  Most antileishmanial drugs are highly toxic, present resistance issues or require long-term treatment.  Consequently, new drugs are urgently needed.  Quinoline-contg. compds. have displayed an impressive array of biol. properties over the years, including antileishmanial activity.  In the present study, we report the synthesis and evaluation of novel quinoline derivs. (QuinDer) against Leishmania species and cytotoxic effect on mammalian cells.  The ROS prodn. and mitochondrial membrane potential analyses were also studied.  The compd. QuinDer1 showed activity on L. amazonensis and L. braziliensis promastigotes and this compd. exhibited a strong inhibition of the proliferation of L. amazonensis amastigotes at nM concn. (IC50 of 0.0911 μM), being 139 times more active than miltefosine (IC50 of 12.7 μM), used as ref. drug.  This compd. presents low cytotoxicity toward murine macrophages and human erythrocytes.  In addn., promastigotes of L. amazonensis treated with the compd. QuinDer1 present high generation of ROS levels with low alterations in mitochondrial membrane potential and maintenance of parasite membrane integrity.  No substantial NO prodn. in infected-macrophages treated with this compd. was detected.  These results suggest that the compd. QuinDer 1 is a potent and selective antileishmanial agent by mitochondrial oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZvTzyH_xDcLVg90H21EOLACvtfcHk0liwomDg6Vi98g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqsLjE&md5=8a388b91fca68966948242c8035552ea</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DCoimbra%26aufirst%3DE.%2BS.%26aulast%3DAntinarelli%26aufirst%3DL.%2BM.%2BR.%26aulast%3DSilva%26aufirst%3DN.%2BP.%26aulast%3DSouza%26aufirst%3DI.%2BO.%26aulast%3DMeinel%26aufirst%3DR.%2BS.%26aulast%3DRocha%26aufirst%3DM.%2BN.%26aulast%3DSoares%26aufirst%3DR.%2BP.%2BP.%26aulast%3Dda%2BSilva%26aufirst%3DA.%2BD.%26atitle%3DQuinoline%2520derivatives%253A%2520Synthesis%252C%2520leishmanicidal%2520activity%2520and%2520involvement%2520of%2520mitochondrial%2520oxidative%2520stress%2520as%2520mechanism%2520of%2520action%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2016%26volume%3D260%26spage%3D50%26epage%3D57%26doi%3D10.1016%2Fj.cbi.2016.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-L.</span></span> <span> </span><span class="NLM_article-title">Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent helicobacter pylori urease inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">7531</span>– <span class="NLM_lpage">7536</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.bmc.2009.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=19804978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ylurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7531-7536&author=W.-J.+Maoauthor=P.-C.+Lvauthor=L.+Shiauthor=H.-Q.+Liauthor=H.-L.+Zhu&title=Synthesis%2C+molecular+docking+and+biological+evaluation+of+metronidazole+derivatives+as+potent+helicobacter+pylori+urease+inhibitors&doi=10.1016%2Fj.bmc.2009.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors</span></div><div class="casAuthors">Mao, Wen-Jun; Lv, Peng-Cheng; Shi, Lei; Li, Huan-Qiu; Zhu, Hai-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7531-7536</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fourteen metronidazole derivs. (compds. 3a-f and 4b-h) have been synthesized by coupling of metronidazole and salicylic acid derivs.  All of them are reported for the first time.  Their chem. structures are characterized by 1H NMR, MS, and elemental anal.  The inhibitory activities against Helicobacter pylori urease have been investigated in vitro and many compds. have showed promising potential inhibitory activities of H. pylori urease.  The effect of compds. 4b (IC50 = 26 μM) and 4g (I) (IC50 = 12 μM) was comparable with that of acetohydroxamic acid, a well known H. pylori urease inhibitor used as a pos. control.  The exptl. values of IC50 showed that inhibitor was potent urease inhibitor.  A docking anal. using the 4.0 program could explain the inhibitory activities of compd. 4g against H. pylori urease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg_ZR_XnNdNLVg90H21EOLACvtfcHk0liwomDg6Vi98g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ylurzO&md5=4d0b0072bd2983c3a905f18e152ad5e8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DW.-J.%26aulast%3DLv%26aufirst%3DP.-C.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DZhu%26aufirst%3DH.-L.%26atitle%3DSynthesis%252C%2520molecular%2520docking%2520and%2520biological%2520evaluation%2520of%2520metronidazole%2520derivatives%2520as%2520potent%2520helicobacter%2520pylori%2520urease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7531%26epage%3D7536%26doi%3D10.1016%2Fj.bmc.2009.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anthwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajesh, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawat, M. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushwaha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maikhuri, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawat, D. S.</span></span> <span> </span><span class="NLM_article-title">Novel metronidazole-chalcone conjugates with potential to counter drug resistance in trichomonas vaginalis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.03.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2014.03.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24727243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=89-94&author=A.+Anthwalauthor=U.+C.+Rajeshauthor=M.+S.+M.+Rawatauthor=B.+Kushwahaauthor=J.+P.+Maikhuriauthor=V.+L.+Sharmaauthor=G.+Guptaauthor=D.+S.+Rawat&title=Novel+metronidazole-chalcone+conjugates+with+potential+to+counter+drug+resistance+in+trichomonas+vaginalis&doi=10.1016%2Fj.ejmech.2014.03.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis</span></div><div class="casAuthors">Anthwal, Amit; Rajesh, U. Chinna; Rawat, M. S. M.; Kushwaha, Bhavana; Maikhuri, Jagdamba P.; Sharma, Vishnu L.; Gupta, Gopal; Rawat, Diwan S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-94</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Trichomoniasis is the most prevalent, curable sexually transmitted disease (STD), which increases risk of viral STDs and HIV.  However, drug resistance has been developed by some strains of Trichomonas vaginalis against Metronidazole (MTZ), the FDA approved drug against trichomoniasis.  In the present study twenty two chalcone hybrids of metronidazole have been synthesized in a quest to get new mols. with higher potential against metronidazole-resistant T. vaginalis.  All new hybrid mols. were found active against T. vaginalis with varying levels of activity against MTZ-susceptible and resistant strains.  Eight compds. (4a, 4c, 4d, 4e, 4f, 4h, 4q and 4s) were found as active as the std. drug with an MIC of 1.56 μg/mL against MTZ-susceptible strain.  However, compds. 4e, 4h and 4m were 4-times more active than MTZ against drug-resistant T. vaginalis, amongst which 4e and 4h were most promising against both susceptible and resistant strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoksCW6pBl6oLVg90H21EOLACvtfcHk0liwomDg6Vi98g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWnt74%253D&md5=1fe0abb810d598fc18bc90ad9e5bc219</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.03.076%26sid%3Dliteratum%253Aachs%26aulast%3DAnthwal%26aufirst%3DA.%26aulast%3DRajesh%26aufirst%3DU.%2BC.%26aulast%3DRawat%26aufirst%3DM.%2BS.%2BM.%26aulast%3DKushwaha%26aufirst%3DB.%26aulast%3DMaikhuri%26aufirst%3DJ.%2BP.%26aulast%3DSharma%26aufirst%3DV.%2BL.%26aulast%3DGupta%26aufirst%3DG.%26aulast%3DRawat%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520metronidazole-chalcone%2520conjugates%2520with%2520potential%2520to%2520counter%2520drug%2520resistance%2520in%2520trichomonas%2520vaginalis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D89%26epage%3D94%26doi%3D10.1016%2Fj.ejmech.2014.03.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Mayoral, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">do Carmo Carreiras, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, E.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Friedländer Reaction</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">2652</span>– <span class="NLM_lpage">2671</span>, <span class="refDoi"> DOI: 10.1021/cr800482c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr800482c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2652-2671&author=J.+Marco-Contellesauthor=E.+P%C3%A9rez-Mayoralauthor=A.+Samadiauthor=M.+do+Carmo+Carreirasauthor=E.+Soriano&title=Recent+Advances+in+the+Friedl%C3%A4nder+Reaction&doi=10.1021%2Fcr800482c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Friedlander Reaction</span></div><div class="casAuthors">Marco-Contelles, Jose; Perez-Mayoral, Elena; Samadi, Abdelouahid; Carreiras, Maria do Carmo; Soriano, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2652-2671</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review is an update of the Friedlander reaction from the most significant literature from 1981 to the present.  A particular emphasis is on the development of novel catalysts, exptl. conditions as well as an application toward natural products synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8jFyV0XzFYLVg90H21EOLACvtfcHk0lgQdTOUQT41PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVSltrY%253D&md5=247618f98000f1a747a443a1648854bc</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcr800482c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr800482c%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez-Mayoral%26aufirst%3DE.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3Ddo%2BCarmo%2BCarreiras%26aufirst%3DM.%26aulast%3DSoriano%26aufirst%3DE.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Friedl%25C3%25A4nder%2520Reaction%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2652%26epage%3D2671%26doi%3D10.1021%2Fcr800482c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaabani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soleimani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badri, Z.</span></span> <span> </span><span class="NLM_article-title">Triflouroacetic acid as an efficient catalyst for the synthesis of quinoline</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">635</span>, <span class="refDoi"> DOI: 10.1080/00397910601055230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1080%2F00397910601055230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlSqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=629-635&author=A.+Shaabaniauthor=E.+Soleimaniauthor=Z.+Badri&title=Triflouroacetic+acid+as+an+efficient+catalyst+for+the+synthesis+of+quinoline&doi=10.1080%2F00397910601055230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroacetic acid as an efficient catalyst for the synthesis of quinoline</span></div><div class="casAuthors">Shaabani, Ahmad; Soleimani, Ebrahim; Badri, Zahra</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">629-635</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Trifluoroacetic acid efficiently catalyzed the Friedlander synthesis of quinolines through a condensation reaction of an 2-aminoaryl ketone with an activated α-CH acid such as cyclic or acyclic β-dicarbonyl or cyclic ketone compds. under solvent-free conditions with high yields within several minutes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVzMAFyqorIrVg90H21EOLACvtfcHk0lgQdTOUQT41PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlSqtrg%253D&md5=c774b59c1cbc2013dedd25de377e9639</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F00397910601055230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910601055230%26sid%3Dliteratum%253Aachs%26aulast%3DShaabani%26aufirst%3DA.%26aulast%3DSoleimani%26aufirst%3DE.%26aulast%3DBadri%26aufirst%3DZ.%26atitle%3DTriflouroacetic%2520acid%2520as%2520an%2520efficient%2520catalyst%2520for%2520the%2520synthesis%2520of%2520quinoline%26jtitle%3DSynth.%2520Commun.%26date%3D2007%26volume%3D37%26spage%3D629%26epage%3D635%26doi%3D10.1080%2F00397910601055230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zalila, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Fadili, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desponds, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasel, N.</span></span> <span> </span><span class="NLM_article-title">Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in <i>Leishmania major</i></span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2010.07443.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1111%2Fj.1365-2958.2010.07443.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21166905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=222-239&author=H.+Zalilaauthor=I.+J.+Gonz%C3%A1lezauthor=A.+K.+El-Fadiliauthor=M.+B.+Delgadoauthor=C.+Despondsauthor=C.+Schaffauthor=N.+Fasel&title=Processing+of+metacaspase+into+a+cytoplasmic+catalytic+domain+mediating+cell+death+in+Leishmania+major&doi=10.1111%2Fj.1365-2958.2010.07443.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in Leishmania major</span></div><div class="casAuthors">Zalila, Habib; Gonzalez, Iveth J.; El-Fadili, Amal Kuendig; Delgado, Maria Belen; Desponds, Chantal; Schaff, Cedric; Fasel, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">222-239</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Metacaspases are cysteine peptidases that could play a role similar to caspases in the cell death program of plants, fungi and protozoa.  The human protozoan parasite Leishmania major expresses a single metacaspase (LmjMCA) harboring a central domain with the catalytic dyad histidine and cysteine as found in caspases.  In this study, we investigated the processing sites important for the maturation of LmjMCA catalytic domain, the cellular localization of LmjMCA polypeptides, and the functional role of the catalytic domain in the cell death pathway of Leishmania parasites.  Although LmjMCA polypeptide precursor form harbors a functional mitochondrial localization signal (MLS), we detd. that LmjMCA polypeptides are mainly localized in the cytoplasm.  In stress conditions, LmjMCA precursor forms were extensively processed into sol. forms contg. the catalytic domain.  This domain was sufficient to enhance sensitivity of parasites to hydrogen peroxide by impairing the mitochondrion.  These data provide exptl. evidences of the importance of LmjMCA processing into an active catalytic domain and of its role in disrupting mitochondria, which could be relevant in the design of new drugs to fight leishmaniasis and likely other protozoan parasitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOQrLYvT3z27Vg90H21EOLACvtfcHk0lgQdTOUQT41PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGrurs%253D&md5=043857c6d1cd7e5d794b8fb7d48389e7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2010.07443.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2010.07443.x%26sid%3Dliteratum%253Aachs%26aulast%3DZalila%26aufirst%3DH.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DI.%2BJ.%26aulast%3DEl-Fadili%26aufirst%3DA.%2BK.%26aulast%3DDelgado%26aufirst%3DM.%2BB.%26aulast%3DDesponds%26aufirst%3DC.%26aulast%3DSchaff%26aufirst%3DC.%26aulast%3DFasel%26aufirst%3DN.%26atitle%3DProcessing%2520of%2520metacaspase%2520into%2520a%2520cytoplasmic%2520catalytic%2520domain%2520mediating%2520cell%2520death%2520in%2520Leishmania%2520major%26jtitle%3DMol.%2520Microbiol.%26date%3D2011%26volume%3D79%26spage%3D222%26epage%3D239%26doi%3D10.1111%2Fj.1365-2958.2010.07443.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaisankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumder, H. K.</span></span> <span> </span><span class="NLM_article-title">Disuccinyl betulin triggers metacaspase-dependent endonuclease g-mediated cell death in unicellular protozoan parasite <i>Leishmania donovani</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2186</span>– <span class="NLM_lpage">2201</span>, <span class="refDoi"> DOI: 10.1128/aac.02193-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.02193-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24468787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVSls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=2186-2201&author=S.+Chowdhuryauthor=T.+Mukherjeeauthor=S.+R.+Chowdhuryauthor=S.+Senguptaauthor=S.+Mukhopadhyayauthor=P.+Jaisankarauthor=H.+K.+Majumder&title=Disuccinyl+betulin+triggers+metacaspase-dependent+endonuclease+g-mediated+cell+death+in+unicellular+protozoan+parasite+Leishmania+donovani&doi=10.1128%2Faac.02193-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Disuccinyl betulin triggers metacaspase-dependent endonuclease G-mediated cell death in unicellular protozoan parasite Leishmania donovani</span></div><div class="casAuthors">Chowdhury, Sayan; Mukherjee, Tulika; Chowdhury, Somenath Roy; Sengupta, Souvik; Mukhopadhyay, Sibabrata; Jaisankar, Parasuraman; Majumder, Hemanta K.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2186-2201, 17 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The unicellular organism Leishmania undergoes apoptosis-like cell death in response to external stress or exposure to antileishmanial agents.  Here, we showed that 3-O,28-O-disuccinyl betulin (DiSB), a potent topoisomerase type IB inhibitor, induced parasitic cell death by generating oxidative stress.  The characteristic feature of the death process resembled the programmed cell death (PCD) seen in higher eukaryotes.  In the current study, the generation of reactive oxygen species (ROS), followed by the depolarization of mitochondrial membrane potential (ΔΨm), caused a loss in ATP prodn. in Leishmania parasites.  This further gave pos. feedback to produce a large amt. of ROS, which in turn caused oxidative DNA lesions and genomic DNA fragmentation.  The treatment of promastigotes with DiSB induced high expression levels of metacaspase protein that led to cell death in this unicellular organism.  The PCD was insensitive to benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD-fmk), suggesting that the death process was not assocd. with the activation of caspases.  DiSB treatment translocated Leishmania donovani endonuclease G (LdEndoG) from mitochondria to the nucleus, which was responsible for the DNA degrdn. process.  Conditional antisense knockdown of L. donovani metacaspase (LdMC), as well as EndoG, -subverted death of the parasite and rescued cell cycle arrest in G1 phase.  The present study on the effector mols. assocd. with the PCD pathway of the parasite should help to manifest the mechanisms of PCD and also might be exploited in antileishmanial chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruBDSKpSSWNbVg90H21EOLACvtfcHk0lgXSYavOzSdrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVSls7c%253D&md5=94babff29a54bce89b74c94f2f1202df</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2Faac.02193-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.02193-13%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DT.%26aulast%3DChowdhury%26aufirst%3DS.%2BR.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DJaisankar%26aufirst%3DP.%26aulast%3DMajumder%26aufirst%3DH.%2BK.%26atitle%3DDisuccinyl%2520betulin%2520triggers%2520metacaspase-dependent%2520endonuclease%2520g-mediated%2520cell%2520death%2520in%2520unicellular%2520protozoan%2520parasite%2520Leishmania%2520donovani%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D2186%26epage%3D2201%26doi%3D10.1128%2Faac.02193-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gannavaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvapandiyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debrabant, A.</span></span> <span> </span><span class="NLM_article-title">Characterization of Metacaspases with Trypsin-Like Activity and Their Putative Role in Programmed Cell Death in the Protozoan ParasiteLeishmania</span>. <i>Eukaryotic Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1745</span>– <span class="NLM_lpage">1757</span>, <span class="refDoi"> DOI: 10.1128/ec.00123-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Fec.00123-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=17715367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Smu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1745-1757&author=N.+Leeauthor=S.+Gannavaramauthor=A.+Selvapandiyanauthor=A.+Debrabant&title=Characterization+of+Metacaspases+with+Trypsin-Like+Activity+and+Their+Putative+Role+in+Programmed+Cell+Death+in+the+Protozoan+ParasiteLeishmania&doi=10.1128%2Fec.00123-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of metacaspases with trypsin-like activity and their putative role in programmed cell death in the protozoan parasite Leishmania</span></div><div class="casAuthors">Lee, Nancy; Gannavaram, Sreenivas; Selvapandiyan, Angamuthu; Debrabant, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Eukaryotic Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1745-1757</span>CODEN:
                <span class="NLM_cas:coden">ECUEA2</span>;
        ISSN:<span class="NLM_cas:issn">1535-9778</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In this report, we have characterized two metacaspases of Leishmania donovani, L. donovani metacaspase-1 (LdMC1) and LdMC2.  These two proteins show 98% homol. with each other, and both contain a characteristic C-terminal proline-rich domain.  Both genes are transcribed in promastigotes and axenic amastigotes of L. donovani; however, LdMC1 shows increased mRNA levels in axenic amastigotes.  An anti-LdMC antibody was obtained and showed reactivity with a single ∼42-kDa protein band in both promastigote and axenic amastigote parasite whole-cell lysates by Western blotting.  Pulse-chase expts. suggest that LdMCs are not synthesized as proenzymes, and immunofluorescence studies show that LdMCs are assocd. with the acidocalcisome compartments of L. donovani.  Enzymic assays of immunopptd. LdMCs show that native LdMCs efficiently cleave trypsin substrates and are unable to cleave caspase-specific substrates.  Consistently, LdMC activity is insensitive to caspase inhibitors and is efficiently inhibited by trypsin inhibitors, such as leupeptin, antipain, and Nα-tosyl-L-lysine-chloromethyl ketone (TLCK).  In addn., our results show that LdMC activity was induced in parasites treated with hydrogen peroxide, a known trigger of programmed cell death (PCD) in Leishmania and that parasites overexpressing metacaspases are more sensitive to hydrogen peroxide-induced PCD.  These findings suggest that Leishmania metacaspases are not responsible for the caspase-like activities reported in this organism and suggest a possible role for LdMCs as effector mols. in Leishmania PCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMY4mcGuffRrVg90H21EOLACvtfcHk0lgXSYavOzSdrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Smu73E&md5=adc971bcf7476d69c8a5fc8cb738e3ea</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2Fec.00123-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fec.00123-07%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DN.%26aulast%3DGannavaram%26aufirst%3DS.%26aulast%3DSelvapandiyan%26aufirst%3DA.%26aulast%3DDebrabant%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520Metacaspases%2520with%2520Trypsin-Like%2520Activity%2520and%2520Their%2520Putative%2520Role%2520in%2520Programmed%2520Cell%2520Death%2520in%2520the%2520Protozoan%2520ParasiteLeishmania%26jtitle%3DEukaryotic%2520Cell%26date%3D2007%26volume%3D6%26spage%3D1745%26epage%3D1757%26doi%3D10.1128%2Fec.00123-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adak, S.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic reticulum stress-induced apoptosis in leishmania through Ca<sup>2+</sup>-dependent and caspase-independent mechanism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">13638</span>– <span class="NLM_lpage">13646</span>, <span class="refDoi"> DOI: 10.1074/jbc.m110.201889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1074%2Fjbc.m110.201889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21330370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVKmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=13638-13646&author=S.+Dolaiauthor=S.+Palauthor=R.+K.+Yadavauthor=S.+Adak&title=Endoplasmic+reticulum+stress-induced+apoptosis+in+leishmania+through+Ca2%2B-dependent+and+caspase-independent+mechanism&doi=10.1074%2Fjbc.m110.201889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic Reticulum Stress-induced Apoptosis in Leishmania through Ca2+-dependent and Caspase-independent Mechanism</span></div><div class="casAuthors">Dolai, Subhankar; Pal, Swati; Yadav, Rajesh K.; Adak, Subrata</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">13638-13646</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Numerous reports have shown that mitochondrial dysfunctions play a major role in apoptosis of Leishmania parasites, but the endoplasmic reticulum (ER) stress-induced apoptosis in Leishmania remains largely unknown.  In this study, we investigate ER stress-induced apoptotic pathways in Leishmania major using tunicamycin as an ER stress inducer.  ER stress activates the expression of ER-localized chaperone protein BIP/GRP78 (binding protein/identical to the 78-kDa glucose-regulated protein) with concomitant generation of intracellular reactive oxygen species.  Upon exposure to ER stress, the elevation of cytosolic Ca2+ level is obsd. due to release of Ca2+ from internal stores.  Increase in cytosolic Ca2+ causes mitochondrial membrane potential depolarization and ATP loss as ablation of Ca2+ by blocking voltage-gated cation channels with verapamil preserves mitochondrial membrane potential and cellular ATP content.  Furthermore, ER stress-induced reactive oxygen species (ROS)-dependent release of cytochrome c and endonuclease G from mitochondria to cytosol and subsequent translocation of endonuclease G to nucleus are obsd.  Inhibition of caspase-like proteases with the caspase inhibitor benzyloxycarbonyl-VAD-fluoromethyl ketone or metacaspase inhibitor antipain does not prevent nuclear DNA fragmentation and phosphatidylserine exposure.  Conversely, significant protection in tunicamycin-induced DNA degrdn. and phosphatidylserine exposure was achieved by either pretreatment of antioxidants (N-acetyl-L-cysteine, GSH, and L-cysteine), chem. chaperone (4-phenylbutyric acid), or addn. of Ca2+ chelator (1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid-acetoxymethyl ester).  Taken together, these data strongly demonstrate that ER stress-induced apoptosis in L. major is dependent on ROS and Ca2+-induced mitochondrial toxicity but independent of caspase-like proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-5MjZA1-pC7Vg90H21EOLACvtfcHk0lgXSYavOzSdrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVKmu7g%253D&md5=26ec203a8463227be3674197282b8972</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m110.201889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m110.201889%26sid%3Dliteratum%253Aachs%26aulast%3DDolai%26aufirst%3DS.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DR.%2BK.%26aulast%3DAdak%26aufirst%3DS.%26atitle%3DEndoplasmic%2520reticulum%2520stress-induced%2520apoptosis%2520in%2520leishmania%2520through%2520Ca2%252B-dependent%2520and%2520caspase-independent%2520mechanism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D13638%26epage%3D13646%26doi%3D10.1074%2Fjbc.m110.201889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reimão, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniwaki, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinconi, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama-Yasunaka, J. K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uliana, S. R. B.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial activity of the estrogen receptor modulator raloxifene</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e2842</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0002842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1371%2Fjournal.pntd.0002842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24810565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SjtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e2842&author=J.+Q.+Reim%C3%A3oauthor=D.+C.+Miguelauthor=N.+N.+Taniwakiauthor=C.+T.+Trinconiauthor=J.+K.+U.+Yokoyama-Yasunakaauthor=S.+R.+B.+Uliana&title=Antileishmanial+activity+of+the+estrogen+receptor+modulator+raloxifene&doi=10.1371%2Fjournal.pntd.0002842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antileishmanial activity of the estrogen receptor modulator raloxifene</span></div><div class="casAuthors">Reimao, Juliana Q.; Miguel, Danilo C.; Taniwaki, Noemi N.; Trinconi, Cristiana T.; Yokoyama-Yasunaka, Jenicer K. U.; Uliana, Silvia R. B.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2842/1-e2842/11, 11</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The treatment of leishmaniasis relies mostly on parenteral drugs with potentially serious adverse effects.  Addnl., parasite resistance in the treatment of leishmaniasis was demonstrated for the majority of drugs available, making the search for more effective and less toxic drugs and treatment regimens a priority for the control of leishmaniasis.  The aims of this study were to evaluate the antileishmanial activity of raloxifene in vitro and in vivo and to investigate its mechanism of action against Leishmania amazonensis.  Raloxifene was shown to possess antileishmanial activity in vitro against several species with EC50 values ranging from 30.2 to 38.0 mM against promastigotes and from 8.8 to 16.2 μM against intracellular amastigotes.  Raloxifene's mechanism of action was investigated through transmission electron microscopy and labeling with propidium iodide, DiSBAC2(3), rhodamine 123, and monodansylcadaverine.  Microscopic examns. showed that raloxifene treated parasites displayed autophagosomes and mitochondrial damage while the plasma membrane remained continuous.  Nonetheless, plasma membrane potential was rapidly altered upon raloxifene treatment with initial hyperpolarization followed by depolarization.  Loss of mitochondrial membrane potential was also verified.  Treatment of L. amazonensis - infected BALB/c mice with raloxifene led to significant decrease in lesion size and parasite burden.  The results of this work extend the investigation of selective estrogen receptor modulators as potential candidates for leishmaniasis treatment.  The antileishmanial activity of raloxifene was demonstrated in vitro and in vivo.  Raloxifene produces functional disorder on the plasma membrane of L. amazonensis promastigotes and leads to functional and morphol. disruption of mitochondria, which culminate in cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBJXO7S2QB-rVg90H21EOLACvtfcHk0lgXSYavOzSdrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SjtLbL&md5=0a795c1239e6fb1fc80f2d4b10a72883</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0002842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0002842%26sid%3Dliteratum%253Aachs%26aulast%3DReim%25C3%25A3o%26aufirst%3DJ.%2BQ.%26aulast%3DMiguel%26aufirst%3DD.%2BC.%26aulast%3DTaniwaki%26aufirst%3DN.%2BN.%26aulast%3DTrinconi%26aufirst%3DC.%2BT.%26aulast%3DYokoyama-Yasunaka%26aufirst%3DJ.%2BK.%2BU.%26aulast%3DUliana%26aufirst%3DS.%2BR.%2BB.%26atitle%3DAntileishmanial%2520activity%2520of%2520the%2520estrogen%2520receptor%2520modulator%2520raloxifene%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De2842%26doi%3D10.1371%2Fjournal.pntd.0002842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Silva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inacio, J. D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canto-Cavalheiro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida-Amaral, E. E.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in <i>Leishmania amazonensis</i></span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e14666</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0014666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1371%2Fjournal.pone.0014666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21346801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e14666&author=F.+Fonseca-Silvaauthor=J.+D.+F.+Inacioauthor=M.+M.+Canto-Cavalheiroauthor=E.+E.+Almeida-Amaral&title=Reactive+oxygen+species+production+and+mitochondrial+dysfunction+contribute+to+quercetin+induced+death+in+Leishmania+amazonensis&doi=10.1371%2Fjournal.pone.0014666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis</span></div><div class="casAuthors">Fonseca-Silva, Fernanda; Inacio, Job D. F.; Canto-Cavalheiro, Marilene M.; Almeida-Amaral, Elmo Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e14666</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Leishmaniasis, a parasitic disease caused by protozoa of the genus Leishmania, affects more than 12 million people worldwide.  Quercetin has generated considerable interest as a pharmaceutical compd. with a wide range of therapeutic activities.  One such activity is exhibited against the bloodstream parasite Trypanosoma brucei and amastigotes of Leishmania donovani.  However, the mechanism of protozoan action of quercetin has not been studied.  Methodol./Principal Findings: In the present study, we report here the mechanism for the antileishmanial activity of quercetin against Leishmania amazonensis promastigotes.  Quercetin inhibited L. amazonensis promastigote growth in a dose- and time- dependent manner beginning at 48 h of treatment and with max. growth inhibition obsd. at 96 h.  The IC50 for quercetin at 48 h was 31.4 μM.  Quercetin increased ROS generation in a dose-dependent manner after 48 h of treatment.  The antioxidant GSH and NAC each significantly reduced quercetin-induced cell death.  In addn., quercetin caused mitochondrial dysfunction due to collapse of mitochondrial membrane potential.  Conclusions/Significance: The effects of several drugs that interfere directly with mitochondrial physiol. in parasites such as Leishmania have been described.  The unique mitochondrial features of Leishmania make this organelle an ideal drug target while minimizing toxicity.  Quercetin has been described as a pro-oxidant, generating ROS which are responsible for cell death in some cancer cells.  Mitochondrial membrane potential loss can be brought about by ROS added directly in vitro or induced by chem. agents.  Taken together, our results demonstrate that quercetin eventually exerts its antileishmanial effect on L. amazonensis promastigotes due to the generation of ROS and disrupted parasite mitochondrial function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovyf7ofWnI67Vg90H21EOLACvtfcHk0ljoTlOvZqCjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlOqsrk%253D&md5=2409cab097fcbf3fec0ea81831a4a0c2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0014666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0014666%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca-Silva%26aufirst%3DF.%26aulast%3DInacio%26aufirst%3DJ.%2BD.%2BF.%26aulast%3DCanto-Cavalheiro%26aufirst%3DM.%2BM.%26aulast%3DAlmeida-Amaral%26aufirst%3DE.%2BE.%26atitle%3DReactive%2520oxygen%2520species%2520production%2520and%2520mitochondrial%2520dysfunction%2520contribute%2520to%2520quercetin%2520induced%2520death%2520in%2520Leishmania%2520amazonensis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De14666%26doi%3D10.1371%2Fjournal.pone.0014666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonchoroff, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perl, A.</span></span> <span> </span><span class="NLM_article-title">Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling</span>. <i>J. Immunol</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">1466</span>– <span class="NLM_lpage">1479</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=9973403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADyaK1MXhtVSmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=1466-1479&author=K.+Bankiauthor=E.+Hutterauthor=N.+J.+Gonchoroffauthor=A.+Perl&title=Elevation+of+mitochondrial+transmembrane+potential+and+reactive+oxygen+intermediate+levels+are+early+events+and+occur+independently+from+activation+of+caspases+in+Fas+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling</span></div><div class="casAuthors">Banki, Katalin; Hutter, Eliza; Gonchoroff, Nick J.; Perl, Andras</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1466-1479</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Stimulation of the CD95/Fas/Apo-1 receptor leads to apoptosis through activation of the caspase family of cysteine proteases and disruption of the mitochondrial transmembrane potential (Δψm).  We show that, in Jurkat human T cells and peripheral blood lymphocytes, Fas-induced apoptosis is preceded by 1) an increase in reactive oxygen intermediates (ROI) and 2) an elevation of Δψm.  These events are followed by externalization of phosphatidylserine (PS), disruption of Δψm, and cell death.  The caspase inhibitor peptides, DEVD-CHO, Z-VAD.fmk, and Boc-Asp.fmk, blocked Fas-induced PS externalization, disruption of Δψm, and cell death, suggesting that these events are sequelae of caspase activation.  By contrast, in the presence of caspase inhibitors, ROI levels and Δψm of Fas-stimulated cells remained elevated.  Because ROI levels and Δψm are regulated by the supply of reducing equiv. from the pentose phosphate pathway (PPP), we studied the impact of transaldolase (TAL), a key enzyme of the PPP, on Fas signaling.  Overexpression of TAL accelerated Fas-induced mitochondrial ROI prodn., Δψm elevation, activation of caspase-8 and caspase-3, proteolysis of poly(A)DP-ribose polymerase, and PS externalization.  Addnl., suppression of TAL diminished these activities.  Therefore, by controlling the balance between mitochondrial ROI prodn. and metabolic supply of reducing equiv. through the PPP, TAL regulates susceptibility to Fas-induced apoptosis.  Early increases in ROI levels and Δψm as well as the dominant effect of TAL expression on activation of caspase-8/Fas-assocd. death domain-like IL-1β-converting enzyme, the most upstream member of the caspase cascade, suggest a pivotal role for redox signaling at the initiation of Fas-mediated apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg2oR-I5qcr7Vg90H21EOLACvtfcHk0ljoTlOvZqCjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtVSmt78%253D&md5=9acd91942c4bcea2a8b479adebf876f5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanki%26aufirst%3DK.%26aulast%3DHutter%26aufirst%3DE.%26aulast%3DGonchoroff%26aufirst%3DN.%2BJ.%26aulast%3DPerl%26aufirst%3DA.%26atitle%3DElevation%2520of%2520mitochondrial%2520transmembrane%2520potential%2520and%2520reactive%2520oxygen%2520intermediate%2520levels%2520are%2520early%2520events%2520and%2520occur%2520independently%2520from%2520activation%2520of%2520caspases%2520in%2520Fas%2520signaling%26jtitle%3DJ.%2520Immunol%26date%3D1999%26volume%3D162%26spage%3D1466%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akaike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide and virus infection</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2567.2000.00142.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1046%2Fj.1365-2567.2000.00142.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11106932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2000&pages=300-308&author=T.+Akaikeauthor=H.+Maeda&title=Nitric+oxide+and+virus+infection&doi=10.1046%2Fj.1365-2567.2000.00142.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide and virus infection</span></div><div class="casAuthors">Akaike, T.; Maeda, H.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 100 refs.  Nitric oxide (NO) has complex and diverse functions in physiol. and pathophysiol. phenomena.  The mechanisms of many events induced by NO are now well defined, so that a fundamental understanding of NO biol. is almost established.  Accumulated evidence suggests that NO and oxygen radicals such as superoxide are key mols. in the pathogenesis of various infectious diseases.  NO biosynthesis, particularly through expression of an inducible NO synthase (iNOS), occurs in a variety of microbial infections.  Although antimicrobial activity of NO is appreciated for bacteria and protozoa, NO has opposing effects in virus infections such as influenza virus pneumonia and certain other neurotropic virus infections.  INOS produces an excessive amt. of NO for long periods, which allows generation of a highly reactive nitrogen oxide species, peroxynitrite, via a radical coupling reaction of NO with superoxide.  Thus, peroxynitrite causes oxidative tissue injury through potent oxidn. and nitration reactions of various biomols.  NO also appears to affect a host's immune response, with immunopathol. consequences.  For example, overprodn. of NO in virus infections in mice is reported to suppress type 1 helper T-cell-dependent immune responses, leading to type 2 helper T-cell-biased immunol. host responses.  Thus, NO may be a host response modulator rather than a simple antiviral agent.  The unique biol. properties of NO are further illustrated by the authors' recent data suggesting that viral mutation and evolution may be accelerated by NO-induced oxidative stress.  Here, the authors discuss these multiple roles of NO in pathogenesis of virus infections as related to both non-specific inflammatory responses and immunol. host reactions modulated by NO during infections in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsp4S51nRXz7Vg90H21EOLACvtfcHk0ljoTlOvZqCjlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslWnurs%253D&md5=0cbd4bb6eba7ab491372b7db76b03722</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2567.2000.00142.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2567.2000.00142.x%26sid%3Dliteratum%253Aachs%26aulast%3DAkaike%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DNitric%2520oxide%2520and%2520virus%2520infection%26jtitle%3DImmunology%26date%3D2000%26volume%3D101%26spage%3D300%26epage%3D308%26doi%3D10.1046%2Fj.1365-2567.2000.00142.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, M. U.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">8841</span>– <span class="NLM_lpage">8848</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.16.8841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1073%2Fpnas.97.16.8841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10922044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls12ltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=8841-8848&author=C.+Nathanauthor=M.+U.+Shiloh&title=Reactive+oxygen+and+nitrogen+intermediates+in+the+relationship+between+mammalian+hosts+and+microbial+pathogens&doi=10.1073%2Fpnas.97.16.8841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens</span></div><div class="casAuthors">Nathan, Carl; Shiloh, Michael U.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8841-8848</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review with 108 refs.  This review summarizes recent evidence from knock-out mice on the role of reactive oxygen intermediates and reactive nitrogen intermediates (RNI) in mammalian immunity.  Reflections on redundancy in immunity help explain an apparent paradox: the phagocyte oxidase and inducible nitric oxide synthase are each nonredundant, and yet also mutually redundant, in host defense.  In combination, the contribution of these two enzymes appears to be greater than previously appreciated.  The remainder of this review focuses on a relatively new field, the basis of microbial resistance to RNI.  Exptl. tuberculosis provides an important example of an extended, dynamic balance between host and pathogen in which RNI play a major role.  In diseases such as tuberculosis, a mol. understanding of host-pathogen interactions requires characterization of the defenses used by microbes against RNI, analogous to our understanding of defenses against reactive oxygen intermediates.  Genetic and biochem. approaches have identified candidates for RNI-resistance genes in Mycobacterium tuberculosis and other pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgw49tYRs8cbVg90H21EOLACvtfcHk0lh6VrY2Nvlyqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls12ltLo%253D&md5=5e6589928a67892c82daa76a107c328b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.16.8841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.16.8841%26sid%3Dliteratum%253Aachs%26aulast%3DNathan%26aufirst%3DC.%26aulast%3DShiloh%26aufirst%3DM.%2BU.%26atitle%3DReactive%2520oxygen%2520and%2520nitrogen%2520intermediates%2520in%2520the%2520relationship%2520between%2520mammalian%2520hosts%2520and%2520microbial%2520pathogens%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D8841%26epage%3D8848%26doi%3D10.1073%2Fpnas.97.16.8841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunet, L. R.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide in parasitic infections</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1457</span>– <span class="NLM_lpage">1467</span>, <span class="refDoi"> DOI: 10.1016/s1567-5769(01)00090-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fs1567-5769%2801%2900090-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11515811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFSmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=1457-1467&author=L.+R.+Brunet&title=Nitric+oxide+in+parasitic+infections&doi=10.1016%2Fs1567-5769%2801%2900090-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide in parasitic infections</span></div><div class="casAuthors">Brunet, Laura Rosa</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1457-1467</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with refs.  Nitric oxide (NO) is implicated as an integral component of the host armament against invading parasites.  Strongest evidence has come from lab. models of protozoan infections.  During malaria, toxoplasmosis and leishmaniasis, to name just a few, the preferential prodn. of pro-inflammatory cytokines predisposes to the increased synthesis of NO, which mediates host protection through either direct parasite killing or by limiting parasite growth.  More recently, evidence has been put forward for a beneficial role of NO during helminthic infections.  In the case of Schistosomiasis mansoni, for example, NO plays a role in regulation of egg-induced inflammation, preventing hepatocyte death and widespread tissue damage.  In spite of these findings, rather than being the ultimate panacea, NO prodn. requires tight control to limit cytotoxic damage to the host's own cells.  Unregulated prodn. may lead to a variety of damaging effects including alterations to normal neurol. functions during cerebral malaria and intestinal pathol. during trichinosis.  In this review, I will summarize the role of NO during a no. of parasitic infections, drawing on specific examples of disease caused by protozoan and metazoan parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmTB45_qWsbLVg90H21EOLACvtfcHk0lh6VrY2Nvlyqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFSmt74%253D&md5=6f3db0441c98b86f696967244230ea17</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fs1567-5769%2801%2900090-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1567-5769%252801%252900090-x%26sid%3Dliteratum%253Aachs%26aulast%3DBrunet%26aufirst%3DL.%2BR.%26atitle%3DNitric%2520oxide%2520in%2520parasitic%2520infections%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2001%26volume%3D1%26spage%3D1457%26epage%3D1467%26doi%3D10.1016%2Fs1567-5769%2801%2900090-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockett, K. A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide and parasitic disease</span>. <i>Adv. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/s0065-308x(08)60218-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fs0065-308x%2808%2960218-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=8881597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADyaK2s%252FjsF2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=1-56&author=I.+A.+Clarkauthor=K.+A.+Rockett&title=Nitric+oxide+and+parasitic+disease&doi=10.1016%2Fs0065-308x%2808%2960218-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide and parasitic disease</span></div><div class="casAuthors">Clark I A; Rockett K A</div><div class="citationInfo"><span class="NLM_cas:title">Advances in parasitology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-56</span>
        ISSN:<span class="NLM_cas:issn">0065-308X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjBJbJGv_aUiCEBeYuoi7AfW6udTcc2ebp5NgA36u8crntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FjsF2nuw%253D%253D&md5=a724770d14a2ed6b58f44ef94fc5fec2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fs0065-308x%2808%2960218-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0065-308x%252808%252960218-3%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DI.%2BA.%26aulast%3DRockett%26aufirst%3DK.%2BA.%26atitle%3DNitric%2520oxide%2520and%2520parasitic%2520disease%26jtitle%3DAdv.%2520Parasitol.%26date%3D1996%26volume%3D37%26spage%3D1%26epage%3D56%26doi%3D10.1016%2Fs0065-308x%2808%2960218-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Assessing the essentiality of <i>Leishmania donovani</i> nitroreductase and its role in nitro drug activation</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1128/aac.01788-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.01788-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=23208716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVCrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=901-906&author=S.+Wyllieauthor=S.+Pattersonauthor=A.+H.+Fairlamb&title=Assessing+the+essentiality+of+Leishmania+donovani+nitroreductase+and+its+role+in+nitro+drug+activation&doi=10.1128%2Faac.01788-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activation</span></div><div class="casAuthors">Wyllie, Susan; Patterson, Stephen; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">901-906</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The nitroimidazole fexinidazole has potential as a safe and effective oral drug therapy for the treatment of visceral leishmaniasis.  To date, nitroheterocyclics have not been used in the treatment of leishmaniasis, and relatively little is known about their mechanism of action.  In African trypanosomes, nitro drugs are reductively activated by a type I nitroreductase (NTR), absent in mammalian cells.  Modulation of nitroreductase levels in Trypanosoma brucei directly affected sensitivity to nitro compds., with reduced concns. of the enzyme leading to moderate nitro drug resistance.  In view of the progression of fexinidazole into clin. development for visceral leishmaniasis, here the authors assess the essentiality of the nitroreductase in Leishmania donovani and the effect of modulating nitroreductase levels on susceptibility to fexinidazole.  The failure to directly replace both endogenous copies of the NTR gene, except in the presence of an ectopic copy of the gene, suggests that the NTR gene is essential for the growth and survival of L. donovani promastigotes.  Loss of a single chromosomal copy of the L. donovani NTR gene resulted in parasites that were mildly resistant (<2-fold) to the predominant in vivo metabolite of fexinidazole, while parasites overexpressing NTR were 18-fold more susceptible.  Leishmania NTR plays a pivotal role in fexinidazole activation.  Reliance on a single enzyme for prodrug activation may leave fexinidazole vulnerable to the emergence of drug resistance.  However, the essentiality of the NTR in L. donovani promastigotes, combined with the limited resistance shown by NTR single knockout cells, suggests that the potential for the spread of NTR-based resistance to fexinidazole may be limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg4Xp29BI2LVg90H21EOLACvtfcHk0lh6VrY2Nvlyqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVCrur8%253D&md5=36c765efc47253bfabbadf48c2b9a9f7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2Faac.01788-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.01788-12%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DAssessing%2520the%2520essentiality%2520of%2520Leishmania%2520donovani%2520nitroreductase%2520and%2520its%2520role%2520in%2520nitro%2520drug%2520activation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D901%26epage%3D906%26doi%3D10.1128%2Faac.01788-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kucuksayan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozben, T.</span></span> <span> </span><span class="NLM_article-title">Hybrid compounds as multitarget directed anticancer agents</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">907</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160927155515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.2174%2F1568026616666160927155515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27697050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFems74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=907-918&author=E.+Kucuksayanauthor=T.+Ozben&title=Hybrid+compounds+as+multitarget+directed+anticancer+agents&doi=10.2174%2F1568026616666160927155515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Hybrid Compounds as Multitarget Directed Anticancer Agents</span></div><div class="casAuthors">Kucuksayan, Ertan; Ozben, Tomris</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">907-918</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Cancer is a multifactorial disease including interactions of complex genetic and environmental factors.  Clin. efficacy of anticancer chemotherapies is hampered by various factors including multidrug resistance (MDR).  There is a strong need to discover more potent novel cancer drugs to kill cancer cells selectively.  The recent new strategy for cancer treatment involves the design and synthesis of hybrid compds. as multitargeted anticancer agents.  In this review, we focus on studies using hybrid compds. which were designed and synthesized from two or more different bioactive moieties conjugating them into a single hybrid drug.  Hybrid compds. having more than a single target have been considered as more efficient and potent anticancer agents, since it is almost impossible to destroy cancer cells with a single target.  Hybrid compds. overcome many disadvantages of single cancer drugs such as low soly., adverse effects, and multi drug resistance.  We have compiled the data of recent studies using the new hybrid anticancer drugs in cancer treatment.  Thus, the design, synthesis and clin. trials of new hybrid compds. should be continued and supported in future.  Results of recent studies have proved that they have a great potential to be used as novel anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOJ7wNU8XJLVg90H21EOLACvtfcHk0lj2kYz6p4KO8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFems74%253D&md5=9018c95a6277fc3fdafa47514587efff</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160927155515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160927155515%26sid%3Dliteratum%253Aachs%26aulast%3DKucuksayan%26aufirst%3DE.%26aulast%3DOzben%26aufirst%3DT.%26atitle%3DHybrid%2520compounds%2520as%2520multitarget%2520directed%2520anticancer%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D907%26epage%3D918%26doi%3D10.2174%2F1568026616666160927155515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannecouque, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Anti-hiv drug discovery and development: Current innovations and future trends</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2849</span>– <span class="NLM_lpage">2878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00497</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00497" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCjur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2849-2878&author=P.+Zhanauthor=C.+Pannecouqueauthor=E.+De+Clercqauthor=X.+Liu&title=Anti-hiv+drug+discovery+and+development%3A+Current+innovations+and+future+trends&doi=10.1021%2Facs.jmedchem.5b00497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends</span></div><div class="casAuthors">Zhan, Peng; Pannecouque, Christophe; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2849-2878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains, poor bioavailability, and cumulative toxicities, and so there is a need for alternative strategies of antiretroviral drug discovery and addnl. therapeutic agents with novel action modes or targets.  From this perspective, we first review current strategies of antiretroviral drug discovery and optimization, with the aid of selected examples from the recent literature.  We highlight the development of phosphate ester-based prodrugs as a means to improve the aq. soly. of HIV inhibitors, and the introduction of the substrate envelope hypothesis as a new approach for overcoming HIV drug resistance.  Finally, we discuss future directions for research, including opportunities for exploitation of novel antiretroviral targets, and the strategy of activation of latent HIV reservoirs as a means to eradicate the virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3sWUJPJgQN7Vg90H21EOLACvtfcHk0lj2kYz6p4KO8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCjur3E&md5=de3f5aee273b0dd6f7e84e20410d06d7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00497%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DAnti-hiv%2520drug%2520discovery%2520and%2520development%253A%2520Current%2520innovations%2520and%2520future%2520trends%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2849%26epage%3D2878%26doi%3D10.1021%2Facs.jmedchem.5b00497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yepes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agut, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vélez, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardona, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robledo, S. M.</span></span> <span> </span><span class="NLM_article-title">Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2017.09.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=29028533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=73-83&author=E.+Oteroauthor=E.+Garc%C3%ADaauthor=G.+Palaciosauthor=L.+M.+Yepesauthor=M.+Cardaauthor=R.+Agutauthor=I.+D.+V%C3%A9lezauthor=W.+I.+Cardonaauthor=S.+M.+Robledo&title=Triclosan-caffeic+acid+hybrids%3A+Synthesis%2C+leishmanicidal%2C+trypanocidal+and+cytotoxic+activities&doi=10.1016%2Fj.ejmech.2017.09.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities</span></div><div class="casAuthors">Otero, Elver; Garcia, Elisa; Palacios, Genesis; Yepes, Lina M.; Carda, Miguel; Agut, Raul; Velez, Ivan D.; Cardona, Wilson I.; Robledo, Sara M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis, cytotoxicity, anti-leishmanial and anti-trypanosomal activities of twelve triclosan-caffeic acid hybrids are described herein.  The structure of the synthesized products was elucidated by a combination of spectrometric analyses.  The synthesized compds. were evaluated against amastigotes forms of L. (V) panamensis, which is the most prevalent Leishmania species in Colombia, and against Trypanosoma cruzi, which is the pathogenic species to humans.  Cytotoxicity was evaluated against human U-937 macrophages.  Eight compds. were active against L.(V) panamensis and eight of them against T. cruzi with EC50 values <40 μM.  Most of the compds. showed antiprotozoal activity and with exception of 3-(5-Chloro-2-(2,4-dichlorophenoxy)phenoxy)propyl (E)-3(3,4-dihydroxyphenyl)prop-2-enoate, 3-(5-Chloro-2-(2,4-dichlorophenoxy)phenoxy)propyl (E)-3(3,4-dimethoxyphenyl)prop-2-enoate and 7-(5-Chloro-2-(2,4-dichlorophenoxy)phenoxy)heptyl (E)-3(3,4-dimethoxyphenyl)prop-2-enoate, the remaining compds. were toxic for mammalian cells, yet they have potential to be considered as candidates for anti-trypanosomal and anti-leishmanial drug development.  The activity is dependent on the length of the alkyl linker with compd. 4-(5-Chloro-2-(2,4-dichlorophenoxy)phenoxy)butyl(E)-3(3,4-dihydroxyphenyl)prop-2-enoate, bearing a four-carbon alkyl chain, the most performing hybrid.  In general, hydroxyl groups increase both activity and cytotoxicity and the presence of the double bond in the side chain is not decisive for cytotoxicity and antiprotozoal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrts5tpwO8g7rVg90H21EOLACvtfcHk0lj2kYz6p4KO8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvN&md5=26c3cb38fd18d986d78cdc536a2d27ac</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.064%26sid%3Dliteratum%253Aachs%26aulast%3DOtero%26aufirst%3DE.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DE.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DYepes%26aufirst%3DL.%2BM.%26aulast%3DCarda%26aufirst%3DM.%26aulast%3DAgut%26aufirst%3DR.%26aulast%3DV%25C3%25A9lez%26aufirst%3DI.%2BD.%26aulast%3DCardona%26aufirst%3DW.%2BI.%26aulast%3DRobledo%26aufirst%3DS.%2BM.%26atitle%3DTriclosan-caffeic%2520acid%2520hybrids%253A%2520Synthesis%252C%2520leishmanicidal%252C%2520trypanocidal%2520and%2520cytotoxic%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D141%26spage%3D73%26epage%3D83%26doi%3D10.1016%2Fj.ejmech.2017.09.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baquedano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espuelas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguewa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Font, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palop, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartín, C.</span></span> <span> </span><span class="NLM_article-title">Novel hybrid selenosulfonamides as potent antileishmanial agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.12.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2013.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24448421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlyitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=116-123&author=Y.+Baquedanoauthor=E.+Morenoauthor=S.+Espuelasauthor=P.+Nguewaauthor=M.+Fontauthor=K.+J.+Gutierrezauthor=A.+Jim%C3%A9nez-Ruizauthor=J.+A.+Palopauthor=C.+Sanmart%C3%ADn&title=Novel+hybrid+selenosulfonamides+as+potent+antileishmanial+agents&doi=10.1016%2Fj.ejmech.2013.12.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel hybrid selenosulfonamides as potent antileishmanial agents</span></div><div class="casAuthors">Baquedano, Ylenia; Moreno, Esther; Espuelas, Socorro; Nguewa, Paul; Font, Maria; Gutierrez, Kilian Jesus; Jimenez-Ruiz, Antonio; Palop, Juan Antonio; Sanmartin, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-123</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Diselenide and sulfonamide derivs. have recently attracted considerable interest as leishmanicidal agents in drug discovery.  In this study, a novel series of sixteen hybrid selenosulfonamides has been synthesized and screened for their in vitro activity against Leishmania infantum intracellular amastigotes and THP-1 cells.  These assays revealed that most of the compds. exhibited antileishmanial activity in the low micromolar range and led us to identify three lead compds. with IC50 values ranging from 0.83-1.47 μM and selectivity indexes (SI) over 17, much higher than those obsd. for the ref. drugs miltefosine and edelfosine.  When evaluated against intracellular amastigotes, the most active compd. (IC50 = 2.8 μM), showed higher activity and much less toxicity against THP-1 cells than edelfosine.  These compds. could potentially serve as templates for future drug-optimization and drug-development efforts for their use as therapeutic agents in developing countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRo75gUYjPALVg90H21EOLACvtfcHk0lg0PLhHVHeayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlyitb4%253D&md5=3f59d79b9fe230dc379a791b8b8ff98e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DBaquedano%26aufirst%3DY.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DEspuelas%26aufirst%3DS.%26aulast%3DNguewa%26aufirst%3DP.%26aulast%3DFont%26aufirst%3DM.%26aulast%3DGutierrez%26aufirst%3DK.%2BJ.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DPalop%26aufirst%3DJ.%2BA.%26aulast%3DSanmart%25C3%25ADn%26aufirst%3DC.%26atitle%3DNovel%2520hybrid%2520selenosulfonamides%2520as%2520potent%2520antileishmanial%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D74%26spage%3D116%26epage%3D123%26doi%3D10.1016%2Fj.ejmech.2013.12.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Somaratne, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranawaka, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaruwan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wipuladasa, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Silva, S. H. P.</span></span> <span> </span><span class="NLM_article-title">Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in <i>Leishmania donovani</i> cutaneous leishmaniasis</span>. <i>J. Dermatol. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1080/09546634.2018.1472738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1080%2F09546634.2018.1472738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=29764246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtV2gu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=87-91&author=V.+N.+Somaratneauthor=R.+R.+Ranawakaauthor=H.+M.+Jayaruwanauthor=D.+M.+Wipuladasaauthor=S.+H.+P.+de+Silva&title=Randomized%2C+double-blind+study+on+intralesional+metronidazole+versus+intralesional+sodium+stibogluconate+in+Leishmania+donovani+cutaneous+leishmaniasis&doi=10.1080%2F09546634.2018.1472738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis</span></div><div class="casAuthors">Somaratne, Vijani N.; Ranawaka, Ranthilaka R.; Jayaruwan, H. M.; Wipuladasa, D. M.; de Silva, S. H. Padmal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Treatment</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-91</span>CODEN:
                <span class="NLM_cas:coden">JDTREY</span>;
        ISSN:<span class="NLM_cas:issn">0954-6634</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The aim of our study was to assess the efficacy of intralesional metronidazole on Leishmania donovani cutaneous leishmaniasis (CL).  A total of 188 patients with CL were randomly allocated to intralesional sodium stibogluconate (SSG) and intralesional metronidazole.  Cure was assessed after 1-10 injections.  Cure rates were assessed for statistical significance using chi-square test at p = .05 level (SLCTR/2014/028).  When the treatment cutoff was taken at 100%, the rate of cure for SSG (n = 64, 65.6%) was higher than that of metronidazole (n = 45, 48.9%): statistically significant at p < .05 level (Yates cor. chi-square 5.37, df = 1, p < .5).  When the treatment cutoff was taken at >80%, the rate of cure for SSG (n = 75, 77.1%) was also higher than that of metronidazole (n = 58, 63.0%): statistically significant at p < .05 level (Yates cor. chi-square 4.46, df = 1, p < .5).  Since it is based on a smaller sample, we estd. the statistical power of the test at a cutoff of 100% [above 80%] results identified a risk ratio of 1.4 [1.3], and a statistical power based on normal approxn. at 74.8% [70.0%], resp.  This study showed that intralesional SSG has the best response against CL, while intralesional metronidazole was an effective alternative treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs0EZkmfPH1rVg90H21EOLACvtfcHk0lg0PLhHVHeayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtV2gu7zO&md5=57fbb127bc146acdefc1394efa594a1d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F09546634.2018.1472738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09546634.2018.1472738%26sid%3Dliteratum%253Aachs%26aulast%3DSomaratne%26aufirst%3DV.%2BN.%26aulast%3DRanawaka%26aufirst%3DR.%2BR.%26aulast%3DJayaruwan%26aufirst%3DH.%2BM.%26aulast%3DWipuladasa%26aufirst%3DD.%2BM.%26aulast%3Dde%2BSilva%26aufirst%3DS.%2BH.%2BP.%26atitle%3DRandomized%252C%2520double-blind%2520study%2520on%2520intralesional%2520metronidazole%2520versus%2520intralesional%2520sodium%2520stibogluconate%2520in%2520Leishmania%2520donovani%2520cutaneous%2520leishmaniasis%26jtitle%3DJ.%2520Dermatol.%2520Treat.%26date%3D2019%26volume%3D30%26spage%3D87%26epage%3D91%26doi%3D10.1080%2F09546634.2018.1472738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gangneux, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dullin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulahian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garin, Y. J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derouin, F.</span></span> <span> </span><span class="NLM_article-title">Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by <i>Leishmania infantum</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1128/aac.43.1.172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.43.1.172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=9869587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADyaK1MXpvFGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1999&pages=172-174&author=J.-P.+Gangneuxauthor=M.+Dullinauthor=A.+Sulahianauthor=Y.+J.-F.+Garinauthor=F.+Derouin&title=Experimental+evaluation+of+second-line+oral+treatments+of+visceral+leishmaniasis+caused+by+Leishmania+infantum&doi=10.1128%2Faac.43.1.172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum</span></div><div class="casAuthors">Gangneux, Jean-Pierre; Dullin, Michael; Sulahian, Annie; Garin, Yves Jean-Francois; Derouin, Francis</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-174</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In a murine model of Leishmania infantum visceral leishmaniasis, metronidazole, ketoconazole, fluconazole, itraconazole, and terbinafine were less effective than antimonial agents in reducing hepatic parasite load.  Ketoconazole potentiated the effect of meglumine antimoniate ref. therapy through its marked activity against spleen infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1v0O2D2RmLVg90H21EOLACvtfcHk0lg0PLhHVHeayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXpvFGmug%253D%253D&md5=ae65e257ae1e318a080bc43d97eeccce</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2Faac.43.1.172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.43.1.172%26sid%3Dliteratum%253Aachs%26aulast%3DGangneux%26aufirst%3DJ.-P.%26aulast%3DDullin%26aufirst%3DM.%26aulast%3DSulahian%26aufirst%3DA.%26aulast%3DGarin%26aufirst%3DY.%2BJ.-F.%26aulast%3DDerouin%26aufirst%3DF.%26atitle%3DExperimental%2520evaluation%2520of%2520second-line%2520oral%2520treatments%2520of%2520visceral%2520leishmaniasis%2520caused%2520by%2520Leishmania%2520infantum%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1999%26volume%3D43%26spage%3D172%26epage%3D174%26doi%3D10.1128%2Faac.43.1.172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">del
Estal, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moya, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucero, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, R.</span></span> <span> </span><span class="NLM_article-title">Metronidazole therapy for visceral leishmaniasis</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1162</span>, <span class="refDoi"> DOI: 10.1093/clinids/19.6.1161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1093%2Fclinids%2F19.6.1161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=7888556" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=1161-1162&author=P.+L.+del%0AEstalauthor=M.+S.+Moyaauthor=T.+Martinauthor=M.+J.+Luceroauthor=R.+Salgado&title=Metronidazole+therapy+for+visceral+leishmaniasis&doi=10.1093%2Fclinids%2F19.6.1161"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F19.6.1161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F19.6.1161%26sid%3Dliteratum%253Aachs%26aulast%3Ddel%2BEstal%26aufirst%3DP.%2BL.%26aulast%3DMoya%26aufirst%3DM.%2BS.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DLucero%26aufirst%3DM.%2BJ.%26aulast%3DSalgado%26aufirst%3DR.%26atitle%3DMetronidazole%2520therapy%2520for%2520visceral%2520leishmaniasis%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1994%26volume%3D19%26spage%3D1161%26epage%3D1162%26doi%3D10.1093%2Fclinids%2F19.6.1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianciardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasanella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foglia Manzillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, G.</span></span> <span> </span><span class="NLM_article-title">The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1007/s00436-004-1170-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1007%2Fs00436-004-1170-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=15278443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD2cvhtF2gsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=486-492&author=P.+Bianciardiauthor=A.+Fasanellaauthor=V.+Foglia+Manzilloauthor=T.+Trottaauthor=A.+Paganoauthor=S.+Sorinoauthor=L.+Gradoniauthor=G.+Oliva&title=The+efficacy+of+enrofloxacin%2C+alone+or+combined+with+metronidazole%2C+in+the+therapy+of+canine+leishmaniasis&doi=10.1007%2Fs00436-004-1170-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis</span></div><div class="casAuthors">Bianciardi Paolo; Fasanella Antonio; Foglia Manzillo Valentina; Trotta Teresa; Pagano Annalisa; Sorino Simona; Gradoni Luigi; Oliva Gaetano</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">486-92</span>
        ISSN:<span class="NLM_cas:issn">0932-0113</span>.
    </div><div class="casAbstract">We evaluated the efficacy of enrofloxacin, alone or combined with metronidazole, against Leishmania infantum.  The in vitro activity of this fluoroquinolone was assessed using two different methods: a direct test aimed at assessing the drug activity on the parasite, and an indirect test aimed at evaluating the drug effect on macrophage killing, lymphomonocyte activation and nitric oxide production.  An in vivo test was also performed on 36 dogs with leishmaniasis, subdivided into three groups, one treated with enrofloxacin, another with enrofloxacin plus metronidazole, and a control group with meglumine antimoniate.  The direct test did not show any action of enrofloxacin on the parasite, while the indirect testing showed an enhancement of macrophage killing and an increase in nitric oxide production.  These findings show that enrofloxacin does not exert a direct anti-leishmanial activity in vitro.  However, on the basis of the positive immunostimulation results shown in vitro and the clinical improvement, particularly of the cutaneous lesions, obtained in several dogs in the in vivo trial, the use of enrofloxacin in association with a specific anti-leishmanial drug can be proposed in the therapeutic protocol of canine leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtlNK0ZLY7al1C8OJBvdfbfW6udTcc2eabXWX9W2bBVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvhtF2gsg%253D%253D&md5=1901e6faca1668e0f2ad4eeb1256520d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2Fs00436-004-1170-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-004-1170-0%26sid%3Dliteratum%253Aachs%26aulast%3DBianciardi%26aufirst%3DP.%26aulast%3DFasanella%26aufirst%3DA.%26aulast%3DFoglia%2BManzillo%26aufirst%3DV.%26aulast%3DTrotta%26aufirst%3DT.%26aulast%3DPagano%26aufirst%3DA.%26aulast%3DSorino%26aufirst%3DS.%26aulast%3DGradoni%26aufirst%3DL.%26aulast%3DOliva%26aufirst%3DG.%26atitle%3DThe%2520efficacy%2520of%2520enrofloxacin%252C%2520alone%2520or%2520combined%2520with%2520metronidazole%252C%2520in%2520the%2520therapy%2520of%2520canine%2520leishmaniasis%26jtitle%3DParasitol.%2520Res.%26date%3D2004%26volume%3D93%26spage%3D486%26epage%3D492%26doi%3D10.1007%2Fs00436-004-1170-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löfmark, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlund, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nord, C. E.</span></span> <span> </span><span class="NLM_article-title">Metronidazole is still the drug of choice for treatment of anaerobic infections</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">S16</span>– <span class="NLM_lpage">S23</span>, <span class="refDoi"> DOI: 10.1086/647939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1086%2F647939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=20067388" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=S16-S23&author=S.+L%C3%B6fmarkauthor=C.+Edlundauthor=C.+E.+Nord&title=Metronidazole+is+still+the+drug+of+choice+for+treatment+of+anaerobic+infections&doi=10.1086%2F647939"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1086%2F647939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F647939%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6fmark%26aufirst%3DS.%26aulast%3DEdlund%26aufirst%3DC.%26aulast%3DNord%26aufirst%3DC.%2BE.%26atitle%3DMetronidazole%2520is%2520still%2520the%2520drug%2520of%2520choice%2520for%2520treatment%2520of%2520anaerobic%2520infections%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D50%26spage%3DS16%26epage%3DS23%26doi%3D10.1086%2F647939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loiseau, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bories, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres de Ortiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas de
Arias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhfakh, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franck, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figadere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocquemiller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournet, A.</span></span> <span> </span><span class="NLM_article-title">Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4950</span>– <span class="NLM_lpage">4956</span>, <span class="refDoi"> DOI: 10.1128/aac.49.12.4950-4956.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.49.12.4950-4956.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16304157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=4950-4956&author=H.+Nakayamaauthor=P.+M.+Loiseauauthor=C.+Boriesauthor=S.+Torres+de+Ortizauthor=A.+Schininiauthor=E.+Sernaauthor=A.+Rojas+de%0AAriasauthor=M.+A.+Fakhfakhauthor=X.+Franckauthor=B.+Figadereauthor=R.+Hocquemillerauthor=A.+Fournet&title=Efficacy+of+orally+administered+2-substituted+quinolines+in+experimental+murine+cutaneous+and+visceral+leishmaniases&doi=10.1128%2Faac.49.12.4950-4956.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases</span></div><div class="casAuthors">Nakayama, Hector; Loiseau, Philippe M.; Bories, Christian; Torres de Ortiz, Susana; Schinini, Alicia; Serna, Elsa; Rojas de Arias, Antonieta; Fakhfakh, Mohamed A.; Franck, Xavier; Figadere, Bruno; Hocquemiller, Reynald; Fournet, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4950-4956</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report in this study the in vivo efficacy of nine 2-substituted quinolines on the Leishmania amazonensis cutaneous infection murine model and on the Leishmania infantum and Leishmania donovani visceral infection murine models.  In the case of the L. amazonensis model, quinolines were administered orally at 25 mg/kg twice daily for 15 days.  Some of quinolines reduced by 80 to 90% the parasite burdens in the lesion, whereas N-methylglucamine antimoniate (Glucantime), administered by s.c. injections at 100 mg [28 mg Sb(V)] per kg of body wt. daily, reduced the parasite burdens by 98%.  In visceral leishmaniasis due to L. infantum, mice treated orally at 25 mg/kg daily for 10 days with various quinolines showed a significant redn. of parasite burdens in the liver and spleen.  These quinolines were significantly more effective than meglumine antimoniate to reduce the parasite burden in both the liver and spleen.  Also, the oral in vivo activity of three quinolines were detd. against L. donovani (LV 9) at 12.5 and 25 mg/kg for 10 days.  Their activity was compared with that of miltefosine at 7.5 mg/kg.  Miltefosine, 2-n-propylquinoline, and another quinoline at 12.5 mg/kg significantly reduced the parasite burdens in the liver by 72, 66, and 61%, resp.  From the present study, one of quinolines (compd. 5) is the most promising compd. against both cutaneous and visceral leishmaniasis.  The double antileishmanial and antiviral activities of these compds. suggest that this series could be a potential treatment for coinfection of Leishmania-human immunodeficiency virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5nMRJk3YOA7Vg90H21EOLACvtfcHk0liwa7aSWAwIzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsr%252FP&md5=45528bab61c8b85282601a2d5198e7d4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2Faac.49.12.4950-4956.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.49.12.4950-4956.2005%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DLoiseau%26aufirst%3DP.%2BM.%26aulast%3DBories%26aufirst%3DC.%26aulast%3DTorres%2Bde%2BOrtiz%26aufirst%3DS.%26aulast%3DSchinini%26aufirst%3DA.%26aulast%3DSerna%26aufirst%3DE.%26aulast%3DRojas%2Bde%2BArias%26aufirst%3DA.%26aulast%3DFakhfakh%26aufirst%3DM.%2BA.%26aulast%3DFranck%26aufirst%3DX.%26aulast%3DFigadere%26aufirst%3DB.%26aulast%3DHocquemiller%26aufirst%3DR.%26aulast%3DFournet%26aufirst%3DA.%26atitle%3DEfficacy%2520of%2520orally%2520administered%25202-substituted%2520quinolines%2520in%2520experimental%2520murine%2520cutaneous%2520and%2520visceral%2520leishmaniases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D4950%26epage%3D4956%26doi%3D10.1128%2Faac.49.12.4950-4956.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yousuf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adhikari, S.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against <i>Leishmania donovani</i></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2016.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27598235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWisL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=468-479&author=M.+Yousufauthor=D.+Mukherjeeauthor=S.+Deyauthor=C.+Palauthor=S.+Adhikari&title=Antileishmanial+ferrocenylquinoline+derivatives%3A+Synthesis+and+biological+evaluation+against+Leishmania+donovani&doi=10.1016%2Fj.ejmech.2016.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani</span></div><div class="casAuthors">Yousuf, Md.; Mukherjee, Debarati; Dey, Somaditya; Pal, Chiranjib; Adhikari, Susanta</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">468-479</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The emergence of resistance against existing antileishmanial drugs necessitates the search for new classes of antileishmanial compds.  Herein a series of structurally diverse ferrocenylquinolines have been synthesized and evaluated for in vitro antileishmanial activity against Leishmania donovani using the MTT assay.  Thirteen (M2-M14) substituted ferrocenylquinoline congeners possessing triazole rings were generated by palladium mediated Suzuki-Miyaura coupling reaction of 5-iodoferrocenylquinolinetriazole and substituted arylboronic acids.  All the synthesized compds. were tested for its antileishmanial activity using both promastigote and amastigote stages of L. donovani.  Among them, three compds. (M4, M7 and M9) exhibited promising anti-promastigote activity, with an IC50 value of 28.7 μM, 22.1 μM and 28 μM, resp., and no cytotoxicity toward host splenocytes.  These three compds. are equally effective against the intracellular amastigote stage of L. donovani showing the IC50 values of 16 μM (M4), 8 μM (M7) and 16 μM (M9), resp., with consistent nitric oxide generation as required for parasite clearance.  From the battery of tests conducted in this study, it appears that these compds. induce parasite death by promoting cell cycle arrest and triggering apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY6jkOM05-S7Vg90H21EOLACvtfcHk0liwa7aSWAwIzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWisL%252FL&md5=18fc8b652426881a980226a25381a981</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DYousuf%26aufirst%3DM.%26aulast%3DMukherjee%26aufirst%3DD.%26aulast%3DDey%26aufirst%3DS.%26aulast%3DPal%26aufirst%3DC.%26aulast%3DAdhikari%26aufirst%3DS.%26atitle%3DAntileishmanial%2520ferrocenylquinoline%2520derivatives%253A%2520Synthesis%2520and%2520biological%2520evaluation%2520against%2520Leishmania%2520donovani%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D468%26epage%3D479%26doi%3D10.1016%2Fj.ejmech.2016.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, P. K.</span></span> <span> </span><span class="NLM_article-title">18 -Glycyrrhetinic Acid Triggers Curative Th1 Response and Nitric Oxide Up-Regulation in Experimental Visceral Leishmaniasis Associated with the Activation of NF- B</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1169</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.175.2.1161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.4049%2Fjimmunol.175.2.1161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16002718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvV2qu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2005&pages=1161-1169&author=A.+Ukilauthor=A.+Biswasauthor=T.+Dasauthor=P.+K.+Das&title=18+-Glycyrrhetinic+Acid+Triggers+Curative+Th1+Response+and+Nitric+Oxide+Up-Regulation+in+Experimental+Visceral+Leishmaniasis+Associated+with+the+Activation+of+NF-+B&doi=10.4049%2Fjimmunol.175.2.1161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">18β-Glycyrrhetinic Acid Triggers Curative Th1 Response and Nitric Oxide Up-Regulation in Experimental Visceral Leishmaniasis Associated with the Activation of NF-κB</span></div><div class="casAuthors">Ukil, Anindita; Biswas, Aruna; Das, Tapasi; Das, Pijush K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1161-1169</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The efficacy of 18β-glycyrrhetinic acid (GRA), a pentacyclic triterpene belonging to the β-amyrin series of plant origin, was evaluated in exptl. visceral leishmaniasis.  GRA is reported to have antitumor and immunoregulatory activities, which may be attributable in part to the induction of NO.  Indeed, an 11-fold increase in NO prodn. was obsd. with 20 μM GRA in mouse peritoneal macrophages infected with Leishmania donovani promastigotes.  In addn. to having appreciable inhibitory effects on amastigote multiplication within macrophages (IC50, 4.6 μg/mL), complete elimination of liver and spleen parasite burden was achieved by GRA at a dose of 50 mg/kg/day, given three times, 5 days apart, in a 45-day mouse model of visceral leishmaniasis.  GRA treatment resulted in reduced levels of IL-10 and IL-4, but increased levels of IL-12, IFN-γ, TNF-α, and inducible NO synthase, reflecting a switch of CD4+ differentiation from Th2 to Th1.  This treatment is likely to activate immunity, thereby imparting resistance to reinfection.  GRA induced NF-κB migration into the nucleus of parasite-infected cells and caused a diminishing presence of IκB in the cytoplasm.  The lower level of cytoplasmic IκBα in GRA-treated cells resulted from increased phosphorylation of IκBα and higher activity of IκB kinase (IKK).  Addnl. expts. demonstrated that GRA does not directly affect IKK activity.  These results suggest that GRA exerts its effects at some level upstream of IKK in the signaling pathway and induces the prodn. of proinflammatory mediators through a mechanism that, at least in part, involves induction of NF-κB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_7G4pZJbY8LVg90H21EOLACvtfcHk0lhG8oZjV3GvBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvV2qu74%253D&md5=b61bb00578133072ad516283f8f2afbf</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.175.2.1161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.175.2.1161%26sid%3Dliteratum%253Aachs%26aulast%3DUkil%26aufirst%3DA.%26aulast%3DBiswas%26aufirst%3DA.%26aulast%3DDas%26aufirst%3DT.%26aulast%3DDas%26aufirst%3DP.%2BK.%26atitle%3D18%2520-Glycyrrhetinic%2520Acid%2520Triggers%2520Curative%2520Th1%2520Response%2520and%2520Nitric%2520Oxide%2520Up-Regulation%2520in%2520Experimental%2520Visceral%2520Leishmaniasis%2520Associated%2520with%2520the%2520Activation%2520of%2520NF-%2520B%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D175%26spage%3D1161%26epage%3D1169%26doi%3D10.4049%2Fjimmunol.175.2.1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu Ball, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, P. K.</span></span> <span> </span><span class="NLM_article-title">The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of map kinases through specific protein kinase c isoforms</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">274</span>, <span class="refDoi"> DOI: 10.1038/cmi.2013.68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1038%2Fcmi.2013.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24561457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVagtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=263-274&author=G.+Sharmaauthor=S.+Karauthor=W.+Basu+Ballauthor=K.+Ghoshauthor=P.+K.+Das&title=The+curative+effect+of+fucoidan+on+visceral+leishmaniasis+is+mediated+by+activation+of+map+kinases+through+specific+protein+kinase+c+isoforms&doi=10.1038%2Fcmi.2013.68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms</span></div><div class="casAuthors">Sharma, Gunjan; Kar, Susanta; Basu Ball, Writoban; Ghosh, Kuntal; Das, Pijush K.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-274</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Fucoidan can cure both antimony-sensitive and antimony-resistant visceral leishmaniasis through immune activation.  However, the signaling events underlying this cellular response remain uncharacterized.  The present study reveals that fucoidan induces activation of p38 and ERK1/2 and NF-κB DNA binding in both normal and Leishmania donovani-infected macrophages, as revealed by western blotting and electrophoretic mobility shift assay (EMSA), resp.  Pharmacol. inhibition of p38, ERK1/2 or the NF-κB pathway markedly attenuated fucoidan-induced pro-inflammatory cytokine synthesis and inducible nitric oxide synthase (iNOS) gene transcription, resulting in a redn. of parasite clearance.  To decipher the underlying mechanism of fucoidan-mediated parasite suppression, the expression and functionality of various protein kinase C (PKC) isoforms were evaluated by immunoblotting and enzyme activity assay.  Fucoidan elicited an increase in expression and activity of PKC-α, -βI and -βII isoforms in infected macrophages.  Functional knockdown of PKC-α and -β resulted in downregulation of p38 and ERK1/2, along with a marked redn. of IL-12 and TNF-α prodn. in fucoidan-treated infected macrophages.  Collectively, these results suggest that the curative effect of fucoidan is mediated by PKC-dependent activation of the mitogen-activated protein kinase (MAPK)/NF-κB pathway, which ultimately results in the prodn. of nitric oxide (NO) and disease-resolving pro-inflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGD6gaty1su7Vg90H21EOLACvtfcHk0lhG8oZjV3GvBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVagtr0%253D&md5=81b80bfa20b79875270ab26460219283</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2013.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2013.68%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DKar%26aufirst%3DS.%26aulast%3DBasu%2BBall%26aufirst%3DW.%26aulast%3DGhosh%26aufirst%3DK.%26aulast%3DDas%26aufirst%3DP.%2BK.%26atitle%3DThe%2520curative%2520effect%2520of%2520fucoidan%2520on%2520visceral%2520leishmaniasis%2520is%2520mediated%2520by%2520activation%2520of%2520map%2520kinases%2520through%2520specific%2520protein%2520kinase%2520c%2520isoforms%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2014%26volume%3D11%26spage%3D263%26epage%3D274%26doi%3D10.1038%2Fcmi.2013.68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kyriazis, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koutsoni, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aligiannis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karampetsou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotsika, E.</span></span> <span> </span><span class="NLM_article-title">The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">441</span>, <span class="refDoi"> DOI: 10.1186/s13071-016-1701-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1186%2Fs13071-016-1701-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27501956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCgtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=441&author=I.+D.+Kyriazisauthor=O.+S.+Koutsoniauthor=N.+Aligiannisauthor=K.+Karampetsouauthor=A.-L.+Skaltsounisauthor=E.+Dotsika&title=The+leishmanicidal+activity+of+oleuropein+is+selectively+regulated+through+inflammation-+and+oxidative+stress-related+genes&doi=10.1186%2Fs13071-016-1701-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes</span></div><div class="casAuthors">Kyriazis, Ioannis D.; Koutsoni, Olga S.; Aligiannis, Nektarios; Karampetsou, Kalliopi; Skaltsounis, Alexios-Leandros; Dotsika, Eleni</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">441/1-441/16</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Much research effort has been focused on investigating new compds. derived from low-cost sources, such as natural products, for treating leishmaniasis.  Oleuropein derived from numerous plants, particularly from the olive tree, Olea europaea L. (Oleaceae), is a biophenol with many biol. activities.  Our previous findings showed that oleuropein exhibits leishmanicidal effects against three Leishmania spp. in vitro, and minimizes the parasite burden in L. donovani-infected BALB/c mice.  The aim of the present study is to investigate the possible mechanism(s) that mediate this leishmanicidal activity.  Methods: We detd. the efficacy of oleuropein in elevating ROS and NO prodn. in L. donovani-infected J774A.1 macrophages and in explanted splenocytes and hepatocytes obtained from L. donovani-infected BALB/c mice.  We also assessed the expression of genes that are related to inflammation, T-cell polarization and antioxidant defense, in splenocytes.  Finally, we detd. the ratios of specific IgG2a/IgG1 antibodies and DTH reactions in L. donovani-infected BALB/c mice treated with oleuropein.  Results: Oleuropein was able to elevate ROS prodn. in both in vitro and in vivo models of visceral leishmaniasis and raised NO prodn. in ex vivo cultures of splenocytes and hepatocytes.  The extensive oxidative stress found in oleuropein-treated mice was obviated by the upregulation of the host's antioxidant enzyme (mGCLC) and the simultaneous downregulation of the corresponding enzyme of the parasite (LdGCLC).  Moreover, oleuropein was able to mount a significant Th1 polarization characterized by the expression of immune genes (IL-12β, IL-10, TGF-β1, IFN-γ) and transcription factors (Tbx21 and GATA3).  Moreover, this immunomodulatory effect was also correlated with an inhibitory effect on IL-1β gene expression, rather than with the expression of IL-1α, IL-1rn and TNF-α.  Furthermore, oleuropein-treated BALB/c mice mounted a delayed-type hypersensitivity (DTH) response and an elevated Leishmania-specific IgG2a/IgG1 ratio that clearly demonstrated an in vivo protective mechanism.  Conclusion: The ability of Oleuropein to promote a Th1 type immune response in L. donovani-infected BALB/c mice points towards the candidacy of this bioactive compd. as an immunomodulatory agent that may complement therapeutic approaches to leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHO7yEyaWFDbVg90H21EOLACvtfcHk0lhG8oZjV3GvBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCgtr7F&md5=426d80dc8caaacbd0a9aec5331fa2d87</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2Fs13071-016-1701-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13071-016-1701-4%26sid%3Dliteratum%253Aachs%26aulast%3DKyriazis%26aufirst%3DI.%2BD.%26aulast%3DKoutsoni%26aufirst%3DO.%2BS.%26aulast%3DAligiannis%26aufirst%3DN.%26aulast%3DKarampetsou%26aufirst%3DK.%26aulast%3DSkaltsounis%26aufirst%3DA.-L.%26aulast%3DDotsika%26aufirst%3DE.%26atitle%3DThe%2520leishmanicidal%2520activity%2520of%2520oleuropein%2520is%2520selectively%2520regulated%2520through%2520inflammation-%2520and%2520oxidative%2520stress-related%2520genes%26jtitle%3DParasites%2520Vectors%26date%3D2016%26volume%3D9%26spage%3D441%26doi%3D10.1186%2Fs13071-016-1701-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, C. S.</span></span> <span> </span><span class="NLM_article-title">Miltefosine induces apoptosis in arsenite-resistant <i>Leishmania donovani</i> promastigotes through mitochondrial dysfunction</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2006.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.exppara.2006.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=17161839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFGrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=1-13&author=N.+K.+Vermaauthor=G.+Singhauthor=C.+S.+Dey&title=Miltefosine+induces+apoptosis+in+arsenite-resistant+Leishmania+donovani+promastigotes+through+mitochondrial+dysfunction&doi=10.1016%2Fj.exppara.2006.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction</span></div><div class="casAuthors">Verma, Navin K.; Singh, Gaganmeet; Dey, Chinmoy S.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The control of leishmaniasis in absence of vaccine solely depends on the choice of chemotherapy.  The major hurdle in successful leishmanial chemotherapy is emergence of drug resistance.  Miltefosine, the first orally administrable anti-leishmanial drug, has shown the potential against drug-resistant strains of Leishmania.  However, there are discrepancies regarding the involvement of P-glycoprotein (Pgp) and sensitivity of miltefosine in multiple drug-resistant (MDR) cell lines that overexpress Pgp in Leishmania.  To address this, the effect of miltefosine in arsenite-resistant Leishmania donovani (Ld-As20) promastigotes displaying an MDR phenotype and overexpressing Pgp-like protein was investigated in the current study.  Results indicate that Ld-As20 is sensitive to miltefosine.  Miltefosine induces process of programmed cell death in Ld-As20 in a time-dependent manner as detd. by cell shrinkage, externalization of phosphatidylserine and DNA fragmentation.  Miltefosine treatment leads to loss of mitochondrial membrane potential and the release of cytochrome C with consequent activation of cellular proteases.  Activation of cellular proteases resulted in activation of DNase that damaged kinetoplast DNA and induced dyskinetoplasty.  These data indicate that miltefosine causes apoptosis-like death in arsenite-resistant L. donovani.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3qjJzeojqeLVg90H21EOLACvtfcHk0ljmAcTLVGBlvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFGrs7Y%253D&md5=86c1d3ff42b4595cfbf2685c95f102b1</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2006.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2006.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DN.%2BK.%26aulast%3DSingh%26aufirst%3DG.%26aulast%3DDey%26aufirst%3DC.%2BS.%26atitle%3DMiltefosine%2520induces%2520apoptosis%2520in%2520arsenite-resistant%2520Leishmania%2520donovani%2520promastigotes%2520through%2520mitochondrial%2520dysfunction%26jtitle%3DExp.%2520Parasitol.%26date%3D2007%26volume%3D116%26spage%3D1%26epage%3D13%26doi%3D10.1016%2Fj.exppara.2006.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shadab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deepthi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, N.</span></span> <span> </span><span class="NLM_article-title">Apoptosis-like cell death in <i>Leishmania donovani</i> treated with kalsometm10, a new liposomal amphotericin b</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0171306</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0171306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1371%2Fjournal.pone.0171306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=28170432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpvFykurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0171306&author=M.+Shadabauthor=B.+Jhaauthor=M.+Asadauthor=M.+Deepthiauthor=M.+Kamranauthor=N.+Ali&title=Apoptosis-like+cell+death+in+Leishmania+donovani+treated+with+kalsometm10%2C+a+new+liposomal+amphotericin+b&doi=10.1371%2Fjournal.pone.0171306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B</span></div><div class="casAuthors">Shadab, Md.; Jha, Baijayanti; Asad, Mohammad; Deepthi, Makaraju; Kamran, Mohd.; Ali, Nahid</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0171306/1-e0171306/31</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Objective: The present study aimed to elucidate the cell death mechanism in Leishmania donovani upon treatment with KalsomeTM10, a new liposomal amphotericin B.  Methodol./Principal findings: We studied morphol. alterations in promastigotes through phase contrast and SEM.  Phosphatidylserine (PS) exposure, loss of mitochondrial membrane potential and disruption of mitochondrial integrity was detd. by flow cytometry using annexinV-FITC, JC-1 and mitotraker, resp.  For analyzing oxidative stress, generation of H2O2 (bioluminescence kit) and mitochondrial superoxide O2- (mitosox) were measured.  DNA fragmentation was evaluated using terminal deoxyribonucleotidyl transferase mediated dUTP nick-end labeling (TUNEL) and DNA laddering assay.  We found that KalsomeTM10 is more effective then Ambisome against the promastigote as well as intracellular amastigote forms.  The mechanistic study showed that KalsomeTM10 induced several morphol. alterations in promastigotes typical of apoptosis.  KalsomeTM10 treatment showed a dose- and time-dependent exposure of PS in promastigotes.  Further, study on mitochondrial pathway revealed loss of mitochondrial membrane potential as well as disruption in mitochondrial integrity with depletion of intracellular pool of ATP.  KalsomeTM10 treated promastigotes showed increased ROS prodn., diminished GSH levels and increased caspase-like activity.  DNA fragmentation and cell cycle arrest was obsd. in KalsomeTM10 treated promastigotes.  Apoptotic DNA fragmentation was also obsd. in KalsomeTM10 treated intracellular amastigotes.  KalsomeTM10 induced generation of ROS and nitric oxide leads to the killing of the intracellular parasites.  Moreover, endocytosis is indispensable for KalsomeTM10 mediated anti-leishmanial effect in host macrophage.  Conclusions: KalsomeTM10 induces apoptotic-like cell death in L. donovani parasites to exhibit its anti-leishmanial function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wZxw3BVGqLVg90H21EOLACvtfcHk0ljmAcTLVGBlvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpvFykurs%253D&md5=a07c4d1ce833e18bf6267abf45c5c86b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0171306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0171306%26sid%3Dliteratum%253Aachs%26aulast%3DShadab%26aufirst%3DM.%26aulast%3DJha%26aufirst%3DB.%26aulast%3DAsad%26aufirst%3DM.%26aulast%3DDeepthi%26aufirst%3DM.%26aulast%3DKamran%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DN.%26atitle%3DApoptosis-like%2520cell%2520death%2520in%2520Leishmania%2520donovani%2520treated%2520with%2520kalsometm10%252C%2520a%2520new%2520liposomal%2520amphotericin%2520b%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0171306%26doi%3D10.1371%2Fjournal.pone.0171306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Félix, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Souza, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lima, M. d. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frade, D. K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafim, V. d. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, K. A. d. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Néris, P. L. d. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotti, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Aquino, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, M. R.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial activity of new thiophene-indole hybrids: Design, synthesis, biological and cytotoxic evaluation, and chemometric studies</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3972</span>– <span class="NLM_lpage">3977</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.bmc.2016.04.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27515718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWjurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3972-3977&author=M.+B.+F%C3%A9lixauthor=E.+R.+de+Souzaauthor=M.+d.+C.+A.+de+Limaauthor=D.+K.+G.+Fradeauthor=V.+d.+L.+Serafimauthor=K.+A.+d.+F.+Rodriguesauthor=P.+L.+d.+N.+N%C3%A9risauthor=F.+F.+Ribeiroauthor=L.+Scottiauthor=M.+T.+Scottiauthor=T.+M.+de+Aquinoauthor=M.+R.+de+Oliveiraauthor=M.+R.+de+Oliveira&title=Antileishmanial+activity+of+new+thiophene-indole+hybrids%3A+Design%2C+synthesis%2C+biological+and+cytotoxic+evaluation%2C+and+chemometric+studies&doi=10.1016%2Fj.bmc.2016.04.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Antileishmanial activity of new thiophene-indole hybrids: Design, synthesis, biological and cytotoxic evaluation, and chemometric studies</span></div><div class="casAuthors">Felix, Mayara B.; de Souza, Edson R.; de Lima, Maria do C. A.; Frade, Daiana Karla G.; Serafim, Vanessa de L.; Rodrigues, Klinger Antonio da F.; Neris, Patricia Lima do N.; Ribeiro, Frederico F.; Scotti, Luciana; Scotti, Marcus T.; de Aquino, Thiago M.; Junior, Francisco Jaime B., Jr.; de Oliveira, Marcia R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3972-3977</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present work, thirty-two hybrid compds. contg. cycloalka[b]thiophene and indole moieties (TN5, TN5 1-7, TN6, TN6 1-7, TN7, TN7 1-7, TN8, TN8 1-7) were designed, synthesized and evaluated for their cytotoxic and antileishmanial activity against Leishmania amazonensis promastigotes.  More than half of the compds. (18 compds.) exhibited significant antileishmanial activity (IC50 lower than 10.0 μg/L), showing better performance than the ref. drugs (tri- and penta-valent antimonials).  The most active compds. were TN8-7, TN6-1 and TN7 with resp. IC50 values of 2.1, 2.3 and 3.2 μg/mL.  Demonstrating that all of the compds. were less toxic than the ref. drugs, even at the highest evaluated concn. (400 μg/mL), no compd. tested presented human erythrocyte cytotoxicity.  Compd. TN8-7's effectiveness against a trivalent antimony-resistant culture was demonstrated.  It was obsd. that TN8-7's antileishmanial activity is assocd. with DNA fragmentation of L. amazonensis promastigotes.  Chemometric studies (CPCA, PCA, and PLS) highlight intrinsic soly./lipophilicity, and compd. size and shape as closely related to activity.  The authors' results suggest that hybrid cycloalka[b]thiophene-indole derivs. may be considered as lead compds. for further development of new drugs for the treatment of leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRAys2INiLLVg90H21EOLACvtfcHk0ljmAcTLVGBlvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWjurjF&md5=8b3ff076393116fef2c9e0ccdf7c687e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.057%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25A9lix%26aufirst%3DM.%2BB.%26aulast%3Dde%2BSouza%26aufirst%3DE.%2BR.%26aulast%3Dde%2BLima%26aufirst%3DM.%2Bd.%2BC.%2BA.%26aulast%3DFrade%26aufirst%3DD.%2BK.%2BG.%26aulast%3DSerafim%26aufirst%3DV.%2Bd.%2BL.%26aulast%3DRodrigues%26aufirst%3DK.%2BA.%2Bd.%2BF.%26aulast%3DN%25C3%25A9ris%26aufirst%3DP.%2BL.%2Bd.%2BN.%26aulast%3DRibeiro%26aufirst%3DF.%2BF.%26aulast%3DScotti%26aufirst%3DL.%26aulast%3DScotti%26aufirst%3DM.%2BT.%26aulast%3Dde%2BAquino%26aufirst%3DT.%2BM.%26aulast%3Dde%2BOliveira%26aufirst%3DM.%2BR.%26aulast%3Dde%2BOliveira%26aufirst%3DM.%2BR.%26atitle%3DAntileishmanial%2520activity%2520of%2520new%2520thiophene-indole%2520hybrids%253A%2520Design%252C%2520synthesis%252C%2520biological%2520and%2520cytotoxic%2520evaluation%252C%2520and%2520chemometric%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3972%26epage%3D3977%26doi%3D10.1016%2Fj.bmc.2016.04.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayana, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keerthana, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span> <span> </span><span class="NLM_article-title">Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2016.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.bcp.2016.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=28017772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGns7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=26-42&author=D.+Ramuauthor=S.+Gargauthor=R.+Ayanaauthor=A.+K.+Keerthanaauthor=V.+Sharmaauthor=C.+P.+Sainiauthor=S.+Senauthor=S.+Patiauthor=S.+Singh&title=Novel+%CE%B2-carboline-quinazolinone+hybrids+disrupt+Leishmania+donovani+redox+homeostasis+and+show+promising+antileishmanial+activity&doi=10.1016%2Fj.bcp.2016.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity</span></div><div class="casAuthors">Ramu, Dandugudumula; Garg, Swati; Ayana, R.; Keerthana, A. K.; Sharma, Vijeta; Saini, C. P.; Sen, Subhabrata; Pati, Soumya; Singh, Shailja</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-42</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Visceral Leishmaniasis is a deadly parasitic disease caused by Leishmania donovani.  Paucity exists in the discovery of novel chemotherapeutics against Leishmaniasis.  In this study, the authors synthesized a natural product inspired Diversity Oriented Synthesis library of L. donovani Trypanothione reductase (LdTR) inhibitor β-carboline-quinazolinone hybrids, which are different in stereochem. architecture and diverse in the bioactive chem. space.  It is noteworthy that chirality affects drug-to-protein binding affinity since proteins in any living system are present only in one of the chiral forms.  Upon evaluation of the hybrids, one of the chiral forms i.e.  I showed profound cytotoxic effect in micromolar range as compared to its other chiral form.  In-silico docking studies confirmed high binding efficiency of I with the catalytic pocket of LdTR.  Treatment of L. donovani parasites with I inhibits LdTR activity, induces imbalance in redox homeostasis by enhancing ROS, disrupts the mitochondrial membrane potential, modifies actin polymn. and alters the surface topol. and architecture.  All these cellular modifications eventually led to apoptosis-like death of promastigotes.  Furthermore, the authors synthesized the analogs of I and found that these compds. show profound antileishmanial activity in the nanomolar range both in promastigotes and intracellular amastigotes.  The enhanced inhibitory potential of these compds. was further supported by in-silico anal. of protein-ligand interactions which revealed high binding efficiency towards the catalytic pocket of LdTR.  Taken together, this study reports the serendipitous discovery of β-carboline-quinazolinone hybrids with enhanced antileishmanial activity along with the in-depth structure-activity relationships and mechanism of action of these analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo10izoNensZbVg90H21EOLACvtfcHk0lgNAavSZ7aotg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGns7jL&md5=31ad28094bd32986a59b0f76d074dcf9</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2016.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2016.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DRamu%26aufirst%3DD.%26aulast%3DGarg%26aufirst%3DS.%26aulast%3DAyana%26aufirst%3DR.%26aulast%3DKeerthana%26aufirst%3DA.%2BK.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DSaini%26aufirst%3DC.%2BP.%26aulast%3DSen%26aufirst%3DS.%26aulast%3DPati%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DS.%26atitle%3DNovel%2520%25CE%25B2-carboline-quinazolinone%2520hybrids%2520disrupt%2520Leishmania%2520donovani%2520redox%2520homeostasis%2520and%2520show%2520promising%2520antileishmanial%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D129%26spage%3D26%26epage%3D42%26doi%3D10.1016%2Fj.bcp.2016.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baréa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidóia, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Paula, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanello, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarragiotto, M. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2018.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=29549842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslaiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=579-590&author=P.+Bar%C3%A9aauthor=V.+A.+Barbosaauthor=D.+L.+Bid%C3%B3iaauthor=J.+C.+de+Paulaauthor=T.+F.+Stefanelloauthor=W.+F.+da+Costaauthor=C.+V.+Nakamuraauthor=M.+H.+Sarragiotto&title=Synthesis%2C+antileishmanial+activity+and+mechanism+of+action+studies+of+novel+%CE%B2-carboline-1%2C3%2C5-triazine+hybrids&doi=10.1016%2Fj.ejmech.2018.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids</span></div><div class="casAuthors">Barea, Paula; Barbosa, Valeria Aquilino; Bidoia, Danielle Lazarin; Carreira de Paula, Jessica; Stefanello, Talitha Fernandes; Ferreira da Costa, Willian; Nakamura, Celso Vataru; Sarragiotto, Maria Helena</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel β-carboline-1,3,5-triazine hybrids were synthesized and evaluated for their in vitro antileishmanial activity against promastigote and amastigote forms of Leishmania amazonensis.  Among the compds. tested, the hybrids 9d, 9e, 16a and 16b (I - IV, resp.) showed potent activity against the promastigote forms with IC50 values less than 8 μM.  Compds. 9e and 16b were also active against amastigote forms, displaying IC50 values of 1.0 ± 0.1 μM and 1.2 ± 0.5 μM, resp.  Besides that, the hybrid 16b bearing the 4-methoxyphenyl group at C-1 of β-carboline and isopropylamino group at 1,3,5-triazine, showed low toxicity, being 23.5 and 121.4 times more toxic for promastigotes and axenic amastigotes, resp., than for macrophage J774-A1 cell lines.  Investigation of action mechanism in promastigotes showed that compd. 16b caused alterations in cell division cycle and an increase of lipid-storage bodies, leading the cells to death through various factors.  The accumulation of lipid bodies may be assocd. with apoptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZcHiTqbTrxbVg90H21EOLACvtfcHk0lgNAavSZ7aotg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslaiuro%253D&md5=40cc58bd7ea18346feb0e319cb323f7e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DBar%25C3%25A9a%26aufirst%3DP.%26aulast%3DBarbosa%26aufirst%3DV.%2BA.%26aulast%3DBid%25C3%25B3ia%26aufirst%3DD.%2BL.%26aulast%3Dde%2BPaula%26aufirst%3DJ.%2BC.%26aulast%3DStefanello%26aufirst%3DT.%2BF.%26aulast%3Dda%2BCosta%26aufirst%3DW.%2BF.%26aulast%3DNakamura%26aufirst%3DC.%2BV.%26aulast%3DSarragiotto%26aufirst%3DM.%2BH.%26atitle%3DSynthesis%252C%2520antileishmanial%2520activity%2520and%2520mechanism%2520of%2520action%2520studies%2520of%2520novel%2520%25CE%25B2-carboline-1%252C3%252C5-triazine%2520hybrids%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D150%26spage%3D579%26epage%3D590%26doi%3D10.1016%2Fj.ejmech.2018.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashutosh</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, N.</span></span> <span> </span><span class="NLM_article-title">Use of <i>Leishmania donovani</i> field isolates expressing the luciferase reporter gene in in vitro drug screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3776</span>– <span class="NLM_lpage">3783</span>, <span class="refDoi"> DOI: 10.1128/aac.49.9.3776-3783.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.49.9.3776-3783.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16131481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFKltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=3776-3783&author=+Ashutoshauthor=S.+Guptaauthor=+Rameshauthor=S.+Sundarauthor=N.+Goyal&title=Use+of+Leishmania+donovani+field+isolates+expressing+the+luciferase+reporter+gene+in+in+vitro+drug+screening&doi=10.1128%2Faac.49.9.3776-3783.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening</span></div><div class="casAuthors">Ashutosh; Gupta, Suman; Ramesh; Sundar, Shyam; Goyal, Neena</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3776-3783</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Currently available primary screens for the selection of candidate antileishmanial compds. are not ideal.  These techniques are time-consuming, laborious, and difficult to scale and require macrophages, which limit their use for high-throughput screening.  We have developed Leishmania donovani field isolates that constitutively express the firefly luciferase reporter gene (luc) as a part of an episomal vector.  An excellent correlation between parasite no. and luciferase activity was obsd.  Luc expression was stable, even in the absence of drug selection, for 4 wk.  The transfectants were infective to macrophages, and intracellular amastigotes exhibited luciferase activity.  The suitability of these recombinant field isolates for in vitro screening of antileishmanial drugs was established.  The luciferase-expressing sodium stibogluconate-resistant cell lines offer a model for the screening of compds. for resistance.  The system is in routine use at the Central Drug Research Institute, Lucknow, India, for high-throughput screening of newly synthesized compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdEOITLsx4YLVg90H21EOLACvtfcHk0lgNAavSZ7aotg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFKltbc%253D&md5=037e281233753a528e79236807b013da</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2Faac.49.9.3776-3783.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.49.9.3776-3783.2005%26sid%3Dliteratum%253Aachs%26aulast%3DAshutosh%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DRamesh%26aulast%3DSundar%26aufirst%3DS.%26aulast%3DGoyal%26aufirst%3DN.%26atitle%3DUse%2520of%2520Leishmania%2520donovani%2520field%2520isolates%2520expressing%2520the%2520luciferase%2520reporter%2520gene%2520in%2520in%2520vitro%2520drug%2520screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D3776%26epage%3D3783%26doi%3D10.1128%2Faac.49.9.3776-3783.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, O. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurya, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raju, K. S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taneja, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahajuddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. P.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial activity of pyrazolopyridine derivatives and their potential as an adjunct therapy with miltefosine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1059</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms12lsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1041-1059&author=D.+Anandauthor=P.+K.+Yadavauthor=O.+P.+S.+Patelauthor=N.+Parmarauthor=R.+K.+Mauryaauthor=P.+Vishwakarmaauthor=K.+S.+R.+Rajuauthor=I.+Tanejaauthor=M.+Wahajuddinauthor=S.+Karauthor=P.+P.+Yadav&title=Antileishmanial+activity+of+pyrazolopyridine+derivatives+and+their+potential+as+an+adjunct+therapy+with+miltefosine&doi=10.1021%2Facs.jmedchem.6b01447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with Miltefosine</span></div><div class="casAuthors">Anand, Devireddy; Yadav, Pawan Kumar; Patel, Om P. S.; Parmar, Naveen; Maurya, Rahul K.; Vishwakarma, Preeti; Raju, Kanumuri S. R.; Taneja, Isha; Wahajuddin, M.; Kar, Susanta; Yadav, Prem P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1041-1059</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of pyrazolo(dihydro)pyridines was synthesized and evaluated for antileishmanial efficacy against exptl. visceral leishmaniasis (VL).  Among all compds., I and II exhibited better activity than miltefosine against intracellular amastigotes.  Compd. II (50 mg/kg/day) was further studied against Leishmania donovani/BALB/c mice via the i.p. route for 5 days and displayed >91 and >93% clearance of splenic and liver parasitic burden, resp.  Combination treatment of II with a subcurative dose of miltefosine (5 mg/kg) in BALB/c mice almost completely ameliorated the disease (>97% inhibition) by augmenting nitric oxide generation and shifting the immune response toward Th1.  Furthermore, investigating the effect of II on Leishmania promastigotes revealed that it induced mol. events, such as a loss in mitochondrial membrane potential, externalization of phosphatidylserine, and DNA fragmentation, that ultimately resulted in the programmed cell death of the parasite.  These results along with pharmacokinetic studies suggest that II could be a promising lead for treating VL as an adjunct therapy with miltefosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4j0TmZlIPp7Vg90H21EOLACvtfcHk0liFyvTnc12s7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms12lsw%253D%253D&md5=d9d7aa8b3418f99f72ba498659eeaa5d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01447%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DD.%26aulast%3DYadav%26aufirst%3DP.%2BK.%26aulast%3DPatel%26aufirst%3DO.%2BP.%2BS.%26aulast%3DParmar%26aufirst%3DN.%26aulast%3DMaurya%26aufirst%3DR.%2BK.%26aulast%3DVishwakarma%26aufirst%3DP.%26aulast%3DRaju%26aufirst%3DK.%2BS.%2BR.%26aulast%3DTaneja%26aufirst%3DI.%26aulast%3DWahajuddin%26aufirst%3DM.%26aulast%3DKar%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BP.%26atitle%3DAntileishmanial%2520activity%2520of%2520pyrazolopyridine%2520derivatives%2520and%2520their%2520potential%2520as%2520an%2520adjunct%2520therapy%2520with%2520miltefosine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1041%26epage%3D1059%26doi%3D10.1021%2Facs.jmedchem.6b01447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumder, H. K.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in <i>Leishmania donovani</i></span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1007/s10495-008-0224-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1007%2Fs10495-008-0224-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=18506627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVWhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=867-882&author=R.+Dasauthor=A.+Royauthor=N.+Duttaauthor=H.+K.+Majumder&title=Reactive+oxygen+species+and+imbalance+of+calcium+homeostasis+contributes+to+curcumin+induced+programmed+cell+death+in+Leishmania+donovani&doi=10.1007%2Fs10495-008-0224-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani</span></div><div class="casAuthors">Das, Rakhee; Roy, Amit; Dutta, Neeta; Majumder, Hemanta K.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">867-882</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Curcumin, a polyphenol compd., has been recognized as a promising anti-cancer drug.  The purpose of the present study was to investigate the cytotoxicity of curcumin to Leishmania donovani, the causative agent for visceral leishmaniasis.  Flow cytometric anal. revealed that curcumin induced cell cycle arrest at G2/M phase.  Incubation of Leishmania promastigotes with curcumin caused exposure of phosphatidylserine to the outer leaflet of plasma membrane.  This event is preceded by curcumin-induced formation of reactive oxygen species (ROS) and elevation of cytosolic calcium through the release of calcium ions from intracellular stores as well as by influx of extracellular calcium.  Elevation of cytosolic calcium is responsible for depolarization of mitochondrial membrane potential (ΔΨm), release of Cytochrome c into the cytosol and concomitant nuclear alterations that included deoxynucleotidyltransferase-mediated dUTP end labeling (TUNEL) and DNA fragmentation.  Taken together, these data indicate that curcumin has promising antileishmanial activity that is mediated by programmed cell death and, accordingly, merits further investigation as a therapeutic option for the treatment of leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOjHhuvT6_rVg90H21EOLACvtfcHk0liFyvTnc12s7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVWhs74%253D&md5=4de27ff8ab20b055c13fbe3666068f40</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs10495-008-0224-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-008-0224-7%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DR.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DDutta%26aufirst%3DN.%26aulast%3DMajumder%26aufirst%3DH.%2BK.%26atitle%3DReactive%2520oxygen%2520species%2520and%2520imbalance%2520of%2520calcium%2520homeostasis%2520contributes%2520to%2520curcumin%2520induced%2520programmed%2520cell%2520death%2520in%2520Leishmania%2520donovani%26jtitle%3DApoptosis%26date%3D2008%26volume%3D13%26spage%3D867%26epage%3D882%26doi%3D10.1007%2Fs10495-008-0224-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrakar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, S.</span></span> <span> </span><span class="NLM_article-title">15d-prostaglandin j2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis</span>. <i>J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1007/s00109-016-1384-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1007%2Fs00109-016-1384-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=26830627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2nsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2016&pages=695-710&author=P.+Vishwakarmaauthor=N.+Parmarauthor=P.+K.+Yadavauthor=P.+Chandrakarauthor=S.+Kar&title=15d-prostaglandin+j2+induced+reactive+oxygen+species-mediated+apoptosis+during+experimental+visceral+leishmaniasis&doi=10.1007%2Fs00109-016-1384-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis</span></div><div class="casAuthors">Vishwakarma, Preeti; Parmar, Naveen; Yadav, Pawan Kumar; Chandrakar, Pragya; Kar, Susanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">695-710</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: 15-Deoxy-delta (12,14)-prostaglandin J2 (15d-PgJ2) is a potent bioactive lipid mediator, known to possess several roles in cell regulation and differentiation along with antimicrobial efficacy against different bacterial and viral infections.  In the present study, we investigated the therapeutic efficacy and mechanism of action of 15d-PgJ2 in vitro in Leishmania donovani promastigotes and infected J774 macrophages, and in vivo in Balb/c mice/golden hamster model of exptl. visceral leishmaniasis.  15D-PgJ2 effectively killed L. donovani promastigotes and amastigotes in vitro with IC50 of 104.6 and 80.09 nM, resp.  At 2 mg/kg (mice) and 4 mg/kg (hamster) doses, 15d-PgJ2 decreased >90 % spleen and liver parasite burden.  It significantly reduced interleukin (IL)-10 and transforming growth factor (TGF)-β synthesis in infected macrophages and splenocytes.  15D-PgJ2 induced reactive oxygen species (ROS)-dependent apoptosis of promastigotes by triggering phosphatidyl serine externalization, mitochondrial membrane damage and inducing caspase-like activity.  In vitro drug interaction studies revealed an indifference to the synergistic assocn. of 15d-PgJ2 with Miltefosine and Amphotericin-B (Amp-B).  Moreover, when combined with sub-curative doses of Miltefosine and Amphotericin-B, 15d-PgJ2 resulted in >95 % parasite removal.  Our results suggested that 15d-PgJ2 induces mitochondria-dependent apoptosis of L. donovani and is a good therapeutic candidate for adjunct therapy against exptl. visceral leishmaniasis.  Key message: 15d-PgJ2 effectively eliminated both promastigotes and amastigotes form of L. donovani.  15D-PgJ2 decreased parasite burden from infected mice and hamsters with reduced Th2 cytokines.  15D-PgJ2 induced ROS-mediated mitochondrial apoptosis of L. donovani promastigotes.  15D-PgJ2 is a good therapeutic candidate for adjunct therapy with Miltefosine and Amp-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNFuNTl43KHLVg90H21EOLACvtfcHk0liFyvTnc12s7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2nsb8%253D&md5=c6f146a82e0e28d9cba80cd46c404188</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2Fs00109-016-1384-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-016-1384-5%26sid%3Dliteratum%253Aachs%26aulast%3DVishwakarma%26aufirst%3DP.%26aulast%3DParmar%26aufirst%3DN.%26aulast%3DYadav%26aufirst%3DP.%2BK.%26aulast%3DChandrakar%26aufirst%3DP.%26aulast%3DKar%26aufirst%3DS.%26atitle%3D15d-prostaglandin%2520j2%2520induced%2520reactive%2520oxygen%2520species-mediated%2520apoptosis%2520during%2520experimental%2520visceral%2520leishmaniasis%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2016%26volume%3D94%26spage%3D695%26epage%3D710%26doi%3D10.1007%2Fs00109-016-1384-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koella, J. C.</span></span> <span> </span><span class="NLM_article-title">A comparison of three methods of estimating ec50 in studies of drug resistance of malaria parasites</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/0001-706x(93)90083-n</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2F0001-706x%2893%2990083-n" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=8147282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1993&pages=257-261&author=W.+Huberauthor=J.+C.+Koella&title=A+comparison+of+three+methods+of+estimating+ec50+in+studies+of+drug+resistance+of+malaria+parasites&doi=10.1016%2F0001-706x%2893%2990083-n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites</span></div><div class="casAuthors">Huber W; Koella J C</div><div class="citationInfo"><span class="NLM_cas:title">Acta tropica</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-61</span>
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCnHrDefzn2skU0YCbOU3EfW6udTcc2eYyKZsS7BD0cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D&md5=4d08dce20a9b83bc996d3ab05dab73e4</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0001-706x%2893%2990083-n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0001-706x%252893%252990083-n%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKoella%26aufirst%3DJ.%2BC.%26atitle%3DA%2520comparison%2520of%2520three%2520methods%2520of%2520estimating%2520ec50%2520in%2520studies%2520of%2520drug%2520resistance%2520of%2520malaria%2520parasites%26jtitle%3DActa%2520Trop.%26date%3D1993%26volume%3D55%26spage%3D257%26epage%3D261%26doi%3D10.1016%2F0001-706x%2893%2990083-n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMaster, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamysz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGwire, B. S.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial Peptide-induced Apoptotic Death ofLeishmaniaResults from Calcium-de pend ent, Caspase-independent Mitochondrial Toxicity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">15496</span>– <span class="NLM_lpage">15504</span>, <span class="refDoi"> DOI: 10.1074/jbc.m809079200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1074%2Fjbc.m809079200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=19357081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFyqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=15496-15504&author=M.+M.+Kulkarniauthor=W.+R.+McMasterauthor=W.+Kamyszauthor=B.+S.+McGwire&title=Antimicrobial+Peptide-induced+Apoptotic+Death+ofLeishmaniaResults+from+Calcium-de+pend+ent%2C+Caspase-independent+Mitochondrial+Toxicity&doi=10.1074%2Fjbc.m809079200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial peptide-induced apoptotic death of Leishmania results from calcium-dependent, caspase-independent mitochondrial toxicity</span></div><div class="casAuthors">Kulkarni, Manjusha M.; McMaster, W. Robert; Kamysz, Wojciech; McGwire, Bradford S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">15496-15504</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">α- And θ-defensin-, magainin-, and cathelicidin-type antimicrobial peptides (AMPs) can kill the pathogenic protozoan Leishmania.  Comparative studies of a panel of AMPs have defined two distinct groups: those that induce nonapoptotic (Class I) and apoptotic (Class II) parasite killing based on their differential ability to induce phosphatidyl serine exposure, loss of mitochondrial membrane potential and decreased ATP prodn., induction of caspase-3/7 and -12 activity, and DNA degrdn.  Class II AMPs cause rapid influx of the vital stain SYTOX and an increase in intracellular Ca2+, whereas Class I AMPs cause a slow accumulation of SYTOX and do not affect intracellular Ca2+ levels.  Inhibitors of cysteine or caspase proteases diminished fast influx of SYTOX through the surface membrane and DNA degrdn. but do not ablate the annexin V staining or the induction of apoptosis by Class II AMPs.  This suggests that the changes in surface permeability in AMP-mediated apoptosis are related to the downstream events of intracellular cysteine/caspase activation or the loss of ATP.  The activation of caspase-12-like activity was Ca2+-dependent, and inhibitors of voltage-gated and nonspecific Ca2+ channels diminished this activity.  Flufenamic acid, a nonspecific Ca2+ inhibitor, completely ablated AMP-induced mitochondrial dysfunction and cell death, indicating the importance of dysregulation of Ca2+ in antimicrobial peptide-induced apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNdgTp2LsZVbVg90H21EOLACvtfcHk0lgVxExOVC-nAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFyqt7o%253D&md5=6ac05269ad13cbbd6407faf355a943ca</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m809079200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m809079200%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DM.%2BM.%26aulast%3DMcMaster%26aufirst%3DW.%2BR.%26aulast%3DKamysz%26aufirst%3DW.%26aulast%3DMcGwire%26aufirst%3DB.%2BS.%26atitle%3DAntimicrobial%2520Peptide-induced%2520Apoptotic%2520Death%2520ofLeishmaniaResults%2520from%2520Calcium-de%2520pend%2520ent%252C%2520Caspase-independent%2520Mitochondrial%2520Toxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D15496%26epage%3D15504%26doi%3D10.1074%2Fjbc.m809079200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrakar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kathuria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnihotri, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqi, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, S.</span></span> <span> </span><span class="NLM_article-title">Ammonium trichloro [1,2-ethanediolato-O,O′]-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1007/s00018-017-2653-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1007%2Fs00018-017-2653-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=28900667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOrtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2018&pages=563-588&author=P.+Vishwakarmaauthor=N.+Parmarauthor=P.+Chandrakarauthor=T.+Sharmaauthor=M.+Kathuriaauthor=P.+K.+Agnihotriauthor=M.+I.+Siddiqiauthor=K.+Mitraauthor=S.+Kar&title=Ammonium+trichloro+%5B1%2C2-ethanediolato-O%2CO%E2%80%B2%5D-tellurate+cures+experimental+visceral+leishmaniasis+by+redox+modulation+of+Leishmania+donovani+trypanothione+reductase+and+inhibiting+host+integrin+linked+PI3K%2FAkt+pathway&doi=10.1007%2Fs00018-017-2653-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Ammonium trichloro [1,2-ethanediolato-O,O']-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway</span></div><div class="casAuthors">Vishwakarma, Preeti; Parmar, Naveen; Chandrakar, Pragya; Sharma, Tanuj; Kathuria, Manoj; Agnihotri, Pramod K.; Siddiqi, Mohammad Imran; Mitra, Kalyan; Kar, Susanta</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">563-588</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">In an endeavor to search for affordable and safer therapeutics against debilitating visceral leishmaniasis, we examd. antileishmanial potential of ammonium trichloro [1,2-ethanediolato-O,O']-tellurate (AS101); a tellurium based non toxic immunomodulator.  AS101 showed significant in vitro efficacy against both Leishmania donovani promastigotes and amastigotes at sub-micromolar concns.  AS101 could also completely eliminate organ parasite load from L. donovani infected Balb/c mice along with significant efficacy against infected hamsters ( 93% inhibition).  Analyzing mechanistic details revealed that the double edged AS101 could directly induce apoptosis in promastigotes along with indirectly activating host by reversing T-cell anergy to protective Th1 mode, increased ROS generation and anti-leishmanial IgG prodn.  AS101 could inhibit IL-10/STAT3 pathway in L. donovani infected macrophages via blocking α4β7 integrin dependent PI3K/Akt signaling and activate host MAPKs and NF-κB for Th1 response.  In silico docking and biochem. assays revealed AS101's affinity to form thiol bond with cysteine residues of trypanothione reductase in Leishmania promastigotes leading to its inactivation and inducing ROS-mediated apoptosis of the parasite via increased Ca2+ level, loss of ATP and mitochondrial membrane potential along with metacaspase activation.  Our findings provide the first evidence for the mechanism of action of AS101 with excellent safety profile and suggest its promising therapeutic potential against exptl. visceral leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3sa59qiz_iLVg90H21EOLACvtfcHk0lgVxExOVC-nAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOrtb7J&md5=bef1e5c188b49e25587ad7ac5760c0ca</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2Fs00018-017-2653-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-017-2653-3%26sid%3Dliteratum%253Aachs%26aulast%3DVishwakarma%26aufirst%3DP.%26aulast%3DParmar%26aufirst%3DN.%26aulast%3DChandrakar%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DT.%26aulast%3DKathuria%26aufirst%3DM.%26aulast%3DAgnihotri%26aufirst%3DP.%2BK.%26aulast%3DSiddiqi%26aufirst%3DM.%2BI.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DKar%26aufirst%3DS.%26atitle%3DAmmonium%2520trichloro%2520%255B1%252C2-ethanediolato-O%252CO%25E2%2580%25B2%255D-tellurate%2520cures%2520experimental%2520visceral%2520leishmaniasis%2520by%2520redox%2520modulation%2520of%2520Leishmania%2520donovani%2520trypanothione%2520reductase%2520and%2520inhibiting%2520host%2520integrin%2520linked%2520PI3K%252FAkt%2520pathway%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2018%26volume%3D75%26spage%3D563%26epage%3D588%26doi%3D10.1007%2Fs00018-017-2653-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kathuria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sashidhara, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span> <span> </span><span class="NLM_article-title">Induction of mitochondrial dysfunction and oxidative stress in <i>Leishmania donovani</i> by orally active clerodane diterpene</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5916</span>– <span class="NLM_lpage">5928</span>, <span class="refDoi"> DOI: 10.1128/aac.02459-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.02459-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25070112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslShsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5916-5928&author=M.+Kathuriaauthor=A.+Bhattacharjeeauthor=K.+V.+Sashidharaauthor=S.+P.+Singhauthor=K.+Mitra&title=Induction+of+mitochondrial+dysfunction+and+oxidative+stress+in+Leishmania+donovani+by+orally+active+clerodane+diterpene&doi=10.1128%2Faac.02459-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of mitochondrial dysfunction and oxidative stress in Leishmania donovani by orally active clerodane diterpene</span></div><div class="casAuthors">Kathuria, Manoj; Bhattacharjee, Arindam; Sashidhara, Koneni V.; Singh, Suriya Pratap; Mitra, Kalyan</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5916-5928, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">This study was performed to investigate the mechanistic aspects of cell death induced by a clerodane diterpene (K-09) in Leishmania donovani promastigotes that was previously demonstrated to be safe and orally active against visceral leishmaniasis (VL).  K-09 caused depolarization of the mitochondrion and the generation of reactive oxygen species, triggering an apoptotic response in L. donovani promastigotes.  Mitochondrial dysfunction subsequently resulted in the release of cytochrome c into the cytosol, impairing ATP prodn.  Oxidative stress caused the depletion of reduced glutathione, while pretreatment with antioxidant N-acetyl cysteine (NAC) was able to abrogate oxidative stress.  However, NAC failed to restore the mitochondrial membrane potential or intracellular calcium homeostasis after K-09 treatment, suggesting that the generation of oxidative stress is a downstream event relative to the other events.  Caspase-3/-7-like protease activity and genomic DNA fragmentation were obsd.  Electron microscopy studies revealed gross morphol. alterations typical of apoptosis, including severe mitochondrial damage, pyknosis of the nucleus, structural disruption of the mitochondrion-kinetoplast complex, flagellar pocket alterations, and the displacement of organelles.  Moreover, an increased no. of lipid droplets was detected after K-09 treatment, which is suggestive of altered lipid metab.  Our results indicate that K-09 induces mitochondrial dysfunction and oxidative stress-mediated apoptotic cell death in L. donovani promastigotes, sharing many features with metazoan apoptosis.  These mechanistic insights provide a basis for further investigation toward the development of K-09 as a potential drug candidate for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj1t4sZJZPzrVg90H21EOLACvtfcHk0lgVxExOVC-nAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslShsrbI&md5=c51fa163b8ae548fe9408ab6276c913a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1128%2Faac.02459-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.02459-14%26sid%3Dliteratum%253Aachs%26aulast%3DKathuria%26aufirst%3DM.%26aulast%3DBhattacharjee%26aufirst%3DA.%26aulast%3DSashidhara%26aufirst%3DK.%2BV.%26aulast%3DSingh%26aufirst%3DS.%2BP.%26aulast%3DMitra%26aufirst%3DK.%26atitle%3DInduction%2520of%2520mitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%2520in%2520Leishmania%2520donovani%2520by%2520orally%2520active%2520clerodane%2520diterpene%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5916%26epage%3D5928%26doi%3D10.1128%2Faac.02459-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">XXIV, U. P.</span> <i>The United State of Pharmacopoeia Convention</i>, <span class="NLM_publisher-loc">Rockville, Maryland</span>, <span class="NLM_year">2000</span>; p  <span class="NLM_fpage">185</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=185&author=XXIV%2C+U.+P.&title=The+United+State+of+Pharmacopoeia+Convention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DThe%2520United%2520State%2520of%2520Pharmacopoeia%2520Convention%26date%3D2000%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chhonker, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleightholm, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murry, D. J.</span></span> <span> </span><span class="NLM_article-title">Bioanalytical method development and validation of moxidectin in plasma by LC-MS/MS: Application to in vitro metabolism</span>. <i>Biomed. Chromatogr.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">e4389</span>, <span class="refDoi"> DOI: 10.1002/bmc.4389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1002%2Fbmc.4389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=30238696" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=e4389&author=Y.+S.+Chhonkerauthor=R.+L.+Sleightholmauthor=D.+J.+Murry&title=Bioanalytical+method+development+and+validation+of+moxidectin+in+plasma+by+LC-MS%2FMS%3A+Application+to+in+vitro+metabolism&doi=10.1002%2Fbmc.4389"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fbmc.4389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbmc.4389%26sid%3Dliteratum%253Aachs%26aulast%3DChhonker%26aufirst%3DY.%2BS.%26aulast%3DSleightholm%26aufirst%3DR.%2BL.%26aulast%3DMurry%26aufirst%3DD.%2BJ.%26atitle%3DBioanalytical%2520method%2520development%2520and%2520validation%2520of%2520moxidectin%2520in%2520plasma%2520by%2520LC-MS%252FMS%253A%2520Application%2520to%2520in%2520vitro%2520metabolism%26jtitle%3DBiomed.%2520Chromatogr.%26date%3D2019%26volume%3D33%26spage%3De4389%26doi%3D10.1002%2Fbmc.4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Characterization of preclinical in vitro and in vivo pharmacokinetics properties for kbp-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4319</span>– <span class="NLM_lpage">4328</span>, <span class="refDoi"> DOI: 10.2147/dddt.s83055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.2147%2Fdddt.s83055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=26273193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVOitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=4319-4328&author=H.+Liuauthor=Z.+Huangauthor=H.+Liauthor=Q.+Zhangauthor=X.+Tanauthor=F.+Luauthor=S.+Li&title=Characterization+of+preclinical+in+vitro+and+in+vivo+pharmacokinetics+properties+for+kbp-7018%2C+a+new+tyrosine+kinase+inhibitor+candidate+for+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.2147%2Fdddt.s83055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Huang, Zhenhua; Li, Heran; Zhang, Qian; Tan, Xiaojuan; Lu, Fangzheng; Liu, Hongzhuo; Li, Sanming</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4319-4328</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">KBP-7018 is a novel selective tyrosine kinase inhibitor with potential for the treatment of idiopathic pulmonary fibrosis.  The objective of this study was to characterize the preclin. pharmacokinetics of KBP-7018 in vitro and in vivo, and then to assess the likelihood of developing KBP-7018 as a clin. candidate.  The systemic clearance (CL) of KBP-7018 was relatively low in rodents and monkeys with a value of less than 30% of hepatic blood flow, while it was high in dogs.  The steady-state vol. of distribution (Vss) ranged from 1.51 L/kg to 4.65 L/kg across the species tested.  The max. concn. (Cmax) of KBP-7018 occurred at 0.25-6 h after oral dosing, and the bioavailability was moderate (21%-68%).  The human CL (∼20% of hepatic blood flow) and Vss (1.6-5.3 L/kg) were predicted by allometric scaling method and together with the other modeling methods indicated low metab. and acceptable half-time (4.8-19.3 h) in vivo.  Overall, the preclin. data make it amenable to further oral solid dosage from design for the upcoming Phase I trials in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIv5wrbFKCrVg90H21EOLACvtfcHk0lhFGnEl6bSMGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVOitbs%253D&md5=71c3e026e232f685a9c9186707d5720e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.2147%2Fdddt.s83055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Fdddt.s83055%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520preclinical%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacokinetics%2520properties%2520for%2520kbp-7018%252C%2520a%2520new%2520tyrosine%2520kinase%2520inhibitor%2520candidate%2520for%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2015%26volume%3D9%26spage%3D4319%26epage%3D4328%26doi%3D10.2147%2Fdddt.s83055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ahmed Abdelhameed, Mei Feng, April C. Joice, Emilia M. Zywot, Yiru Jin, Chris La Rosa, Xiaoping Liao, Heidi L. Meeds, Yena Kim, Junan Li, Craig A. McElroy, Michael Zhuo Wang, <span class="NLM_string-name hlFld-ContribAuthor">Karl A. Werbovetz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antileishmanial Evaluation of Arylimidamide–Azole Hybrids Containing a Phenoxyalkyl Linker. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (7)
                                     , 1901-1922. <a href="https://doi.org/10.1021/acsinfecdis.0c00855" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00855</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00855%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DSynthesis%252Band%252BAntileishmanial%252BEvaluation%252Bof%252BArylimidamide%2525E2%252580%252593Azole%252BHybrids%252BContaining%252Ba%252BPhenoxyalkyl%252BLinker%26aulast%3DAbdelhameed%26aufirst%3DAhmed%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05122020%26date%3D04022021%26volume%3D7%26issue%3D7%26spage%3D1901%26epage%3D1922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shushu Hao, Jiazhi Yang, Peng Liu, Jing Xu, Chenchen Yang, <span class="NLM_string-name hlFld-ContribAuthor">Feng Li</span>. </span><span class="cited-content_cbyCitation_article-title">Linear-Organic-Polymer-Supported Iridium Complex as a Recyclable Auto-Tandem Catalyst for the Synthesis of Quinazolinones via Selective Hydration/Acceptorless Dehydrogenative Coupling from o-Aminobenzonitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (7)
                                     , 2553-2558. <a href="https://doi.org/10.1021/acs.orglett.1c00475" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00475%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DLinear-Organic-Polymer-Supported%252BIridium%252BComplex%252Bas%252Ba%252BRecyclable%252BAuto-Tandem%252BCatalyst%252Bfor%252Bthe%252BSynthesis%252Bof%252BQuinazolinones%252Bvia%252BSelective%252BHydration%25252FAcceptorless%252BDehydrogenative%252BCoupling%252Bfrom%252Bo-Aminobenzonitriles%26aulast%3DHao%26aufirst%3DShushu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08022021%26date%3D17032021%26volume%3D23%26issue%3D7%26spage%3D2553%26epage%3D2558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Margherita Ortalli, Stefania Varani, Giorgia Cimato, Ruben Veronesi, Arianna Quintavalla, Marco Lombardo, Magda Monari, <span class="NLM_string-name hlFld-ContribAuthor">Claudio Trombini</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the Pharmacophoric Role of the O–O Bond in Synthetic Antileishmanial Compounds: Comparison between 1,2-Dioxanes and Tetrahydropyrans. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 13140-13158. <a href="https://doi.org/10.1021/acs.jmedchem.0c01589" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01589%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvaluation%252Bof%252Bthe%252BPharmacophoric%252BRole%252Bof%252Bthe%252BO%2525E2%252580%252593O%252BBond%252Bin%252BSynthetic%252BAntileishmanial%252BCompounds%25253A%252BComparison%252Bbetween%252B1%25252C2-Dioxanes%252Band%252BTetrahydropyrans%26aulast%3DOrtalli%26aufirst%3DMargherita%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10092020%26date%3D22102020%26volume%3D63%26issue%3D21%26spage%3D13140%26epage%3D13158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rajnikanth Sunke, Adula Kalyani, <span class="NLM_string-name hlFld-ContribAuthor">K. C. Kumara Swamy</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(I)-Catalyzed Ligand-Free Tandem One-Pot or Sequential Annulation via Knoevenagel Intermediates: An Entry into Multifunctional Naphthalenes, Phenanthrenes, Quinolines, and Benzo[b]carbazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (2)
                                     , 1073-1086. <a href="https://doi.org/10.1021/acs.joc.9b02991" title="DOI URL">https://doi.org/10.1021/acs.joc.9b02991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b02991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b02991%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCu%252528I%252529-Catalyzed%252BLigand-Free%252BTandem%252BOne-Pot%252Bor%252BSequential%252BAnnulation%252Bvia%252BKnoevenagel%252BIntermediates%25253A%252BAn%252BEntry%252Binto%252BMultifunctional%252BNaphthalenes%25252C%252BPhenanthrenes%25252C%252BQuinolines%25252C%252Band%252BBenzo%25255Bb%25255Dcarbazoles%26aulast%3DSunke%26aufirst%3DRajnikanth%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D05112019%26date%3D26122019%26date%3D11122019%26volume%3D85%26issue%3D2%26spage%3D1073%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shachi  Mishra</span>, <span class="hlFld-ContribAuthor ">Naveen  Parmar</span>, <span class="hlFld-ContribAuthor ">Pragya  Chandrakar</span>, <span class="hlFld-ContribAuthor ">Chandra Prakash  Sharma</span>, <span class="hlFld-ContribAuthor ">Sajiya  Parveen</span>, <span class="hlFld-ContribAuthor ">Ravi P.  Vats</span>, <span class="hlFld-ContribAuthor ">Anuradha  Seth</span>, <span class="hlFld-ContribAuthor ">Atul  Goel</span>, <span class="hlFld-ContribAuthor ">Susanta  Kar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in vitro and in vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113516. <a href="https://doi.org/10.1016/j.ejmech.2021.113516" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113516%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bbiological%252Bevaluation%252Bof%252Bpyranone-piperazine%252Banalogs%252Bas%252Bpotent%252Bantileishmanial%252Bagents%26aulast%3DMishra%26aufirst%3DShachi%26date%3D2021%26volume%3D221%26spage%3D113516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iratxe  Barbolla</span>, <span class="hlFld-ContribAuthor ">Leidi  Hernández-Suárez</span>, <span class="hlFld-ContribAuthor ">Viviana  Quevedo-Tumailli</span>, <span class="hlFld-ContribAuthor ">Deyani  Nocedo-Mena</span>, <span class="hlFld-ContribAuthor ">Sonia  Arrasate</span>, <span class="hlFld-ContribAuthor ">María Auxiliadora  Dea-Ayuela</span>, <span class="hlFld-ContribAuthor ">Humberto  González-Díaz</span>, <span class="hlFld-ContribAuthor ">Nuria  Sotomayor</span>, <span class="hlFld-ContribAuthor ">Esther  Lete</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-mediated synthesis and biological evaluation of C-10b substituted Dihydropyrrolo[1,2-b]isoquinolines as antileishmanial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113458. <a href="https://doi.org/10.1016/j.ejmech.2021.113458" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113458%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPalladium-mediated%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BC-10b%252Bsubstituted%252BDihydropyrrolo%25255B1%25252C2-b%25255Disoquinolines%252Bas%252Bantileishmanial%252Bagents%26aulast%3DBarbolla%26aufirst%3DIratxe%26date%3D2021%26volume%3D220%26spage%3D113458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atukuri  Dorababu</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoline: A Promising Scaffold in Recent Antiprotozoal Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (9)
                                     , 2164-2177. <a href="https://doi.org/10.1002/slct.202100115" title="DOI URL">https://doi.org/10.1002/slct.202100115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100115%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DQuinoline%25253A%252BA%252BPromising%252BScaffold%252Bin%252BRecent%252BAntiprotozoal%252BDrug%252BDiscovery%26aulast%3DDorababu%26aufirst%3DAtukuri%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D9%26spage%3D2164%26epage%3D2177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allison M.  Rice</span>, <span class="hlFld-ContribAuthor ">Yueming  Long</span>, <span class="hlFld-ContribAuthor ">S. Bruce  King</span>. </span><span class="cited-content_cbyCitation_article-title">Nitroaromatic Antibiotics as Nitrogen Oxide Sources. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 267. <a href="https://doi.org/10.3390/biom11020267" title="DOI URL">https://doi.org/10.3390/biom11020267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11020267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11020267%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DNitroaromatic%252BAntibiotics%252Bas%252BNitrogen%252BOxide%252BSources%26aulast%3DRice%26aufirst%3DAllison%2BM.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neena  Goyal</span>, <span class="hlFld-ContribAuthor ">Manveer  Patel</span>, <span class="hlFld-ContribAuthor ">Sanjay  Batra</span>. </span><span class="cited-content_cbyCitation_article-title">Modern Drug Discovery and Development in the Area of Leishmaniasis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 123-158. <a href="https://doi.org/10.1007/978-981-15-8002-4_5" title="DOI URL">https://doi.org/10.1007/978-981-15-8002-4_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-8002-4_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-8002-4_5%26sid%3Dliteratum%253Aachs%26atitle%3DModern%252BDrug%252BDiscovery%252Band%252BDevelopment%252Bin%252Bthe%252BArea%252Bof%252BLeishmaniasis%26aulast%3DGoyal%26aufirst%3DNeena%26date%3D2021%26date%3D2021%26spage%3D123%26epage%3D158%26pub%3DSpringer%2520Singapore%26atitle%3DDrug%252BDiscovery%252Band%252BDrug%252BDevelopment%26aulast%3DDikshit%26aufirst%3DMadhu%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Om P.S.  Patel</span>, <span class="hlFld-ContribAuthor ">Omobolanle Janet  Jesumoroti</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Richard M.  Beteck</span>. </span><span class="cited-content_cbyCitation_article-title">Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112994. <a href="https://doi.org/10.1016/j.ejmech.2020.112994" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112994</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112994%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetronidazole-conjugates%25253A%252BA%252Bcomprehensive%252Breview%252Bof%252Brecent%252Bdevelopments%252Btowards%252Bsynthesis%252Band%252Bmedicinal%252Bperspective%26aulast%3DPatel%26aufirst%3DOm%2BP.S.%26date%3D2021%26volume%3D210%26spage%3D112994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atteneri  López-Arencibia</span>, <span class="hlFld-ContribAuthor ">Carlos J.  Bethencourt-Estrella</span>, <span class="hlFld-ContribAuthor ">Mónica B.  Freijo</span>, <span class="hlFld-ContribAuthor ">María  Reyes-Batlle</span>, <span class="hlFld-ContribAuthor ">Ines  Sifaoui</span>, <span class="hlFld-ContribAuthor ">Desirée San  Nicolás-Hernández</span>, <span class="hlFld-ContribAuthor ">Grant  McNaughton-Smith</span>, <span class="hlFld-ContribAuthor ">Jacob  Lorenzo-Morales</span>, <span class="hlFld-ContribAuthor ">Teresa  Abad-Grillo</span>, <span class="hlFld-ContribAuthor ">José E.  Piñero</span>. </span><span class="cited-content_cbyCitation_article-title">New phenalenone analogues with improved activity against Leishmania species. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2020,</strong> <em>132 </em>, 110814. <a href="https://doi.org/10.1016/j.biopha.2020.110814" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.110814</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.110814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.110814%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DNew%252Bphenalenone%252Banalogues%252Bwith%252Bimproved%252Bactivity%252Bagainst%252BLeishmania%252Bspecies%26aulast%3DL%25C3%25B3pez-Arencibia%26aufirst%3DAtteneri%26date%3D2020%26volume%3D132%26spage%3D110814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atukuri  Dorababu</span>. </span><span class="cited-content_cbyCitation_article-title">Report on Recently (2017–20) Designed Quinoline‐Based Human Cancer Cell Growth Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (44)
                                     , 13902-13915. <a href="https://doi.org/10.1002/slct.202003888" title="DOI URL">https://doi.org/10.1002/slct.202003888</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202003888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202003888%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DReport%252Bon%252BRecently%252B%2525282017%2525E2%252580%25259320%252529%252BDesigned%252BQuinoline%2525E2%252580%252590Based%252BHuman%252BCancer%252BCell%252BGrowth%252BInhibitors%26aulast%3DDorababu%26aufirst%3DAtukuri%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D44%26spage%3D13902%26epage%3D13915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonaly L.  Albino</span>, <span class="hlFld-ContribAuthor ">Jamire M.  da Silva</span>, <span class="hlFld-ContribAuthor ">Michelangela S.  de C. Nobre</span>, <span class="hlFld-ContribAuthor ">Yvnni M. S.  de M. e Silva</span>, <span class="hlFld-ContribAuthor ">Mirelly B.  Santos</span>, <span class="hlFld-ContribAuthor ">Rodrigo S. A.  de Araújo</span>, <span class="hlFld-ContribAuthor ">Maria  do C. A. de Lima</span>, <span class="hlFld-ContribAuthor ">Martine  Schmitt</span>, <span class="hlFld-ContribAuthor ">Ricardo O.  de Moura</span>. </span><span class="cited-content_cbyCitation_article-title">Bioprospecting of Nitrogenous Heterocyclic Scaffolds with Potential Action for Neglected Parasitosis: A Review. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2020,</strong> <em>26 </em>
                                    (33)
                                     , 4112-4150. <a href="https://doi.org/10.2174/1381612826666200701160904" title="DOI URL">https://doi.org/10.2174/1381612826666200701160904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612826666200701160904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612826666200701160904%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DBioprospecting%252Bof%252BNitrogenous%252BHeterocyclic%252BScaffolds%252Bwith%252BPotential%252BAction%252Bfor%252BNeglected%252BParasitosis%25253A%252BA%252BReview%26aulast%3DAlbino%26aufirst%3DSonaly%2BL.%26date%3D2020%26volume%3D26%26issue%3D33%26spage%3D4112%26epage%3D4150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dibyendu  Paik</span>, <span class="hlFld-ContribAuthor ">Pijush Kanti  Pramanik</span>, <span class="hlFld-ContribAuthor ">Tapati  Chakraborti</span>. </span><span class="cited-content_cbyCitation_article-title">Curative efficacy of purified serine protease inhibitor PTF3 from potato tuber in experimental visceral leishmaniasis. </span><span class="cited-content_cbyCitation_journal-name">International Immunopharmacology</span><span> <strong>2020,</strong> <em>85 </em>, 106623. <a href="https://doi.org/10.1016/j.intimp.2020.106623" title="DOI URL">https://doi.org/10.1016/j.intimp.2020.106623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.intimp.2020.106623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.intimp.2020.106623%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Immunopharmacology%26atitle%3DCurative%252Befficacy%252Bof%252Bpurified%252Bserine%252Bprotease%252Binhibitor%252BPTF3%252Bfrom%252Bpotato%252Btuber%252Bin%252Bexperimental%252Bvisceral%252Bleishmaniasis%26aulast%3DPaik%26aufirst%3DDibyendu%26date%3D2020%26volume%3D85%26spage%3D106623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lagudu  Devi</span>, <span class="hlFld-ContribAuthor ">Alice R.  Robert</span>, <span class="hlFld-ContribAuthor ">Himavathi  Ganja</span>, <span class="hlFld-ContribAuthor ">Suresh  Maddila</span>, <span class="hlFld-ContribAuthor ">Sreekantha B.  Jonnalagadda</span>. </span><span class="cited-content_cbyCitation_article-title">A rapid, sustainable and environmental friendly protocol for the catalyst-free synthesis of 2-methyl-5-oxo-hexahydroquinoline-3-carboxylate via ultrasonic irradiation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Data Collections</span><span> <strong>2020,</strong> <em>28 </em>, 100432. <a href="https://doi.org/10.1016/j.cdc.2020.100432" title="DOI URL">https://doi.org/10.1016/j.cdc.2020.100432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cdc.2020.100432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cdc.2020.100432%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Data%2520Collections%26atitle%3DA%252Brapid%25252C%252Bsustainable%252Band%252Benvironmental%252Bfriendly%252Bprotocol%252Bfor%252Bthe%252Bcatalyst-free%252Bsynthesis%252Bof%252B2-methyl-5-oxo-hexahydroquinoline-3-carboxylate%252Bvia%252Bultrasonic%252Birradiation%26aulast%3DDevi%26aufirst%3DLagudu%26date%3D2020%26volume%3D28%26spage%3D100432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Strategy for designing of quinoline–nitroimidazole hybrids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Quinoline–Metronidazole Conjugates (<b>15a–15m</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Et<sub>3</sub>N, DCM, 0 °C, 5 h. (ii) K<sub>2</sub>CO<sub>3</sub>, DMF, 35–40 °C, 24 h (iii) TFA, 120 °C, 3 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Antileishmanial activity of <b>15b</b> and <b>15i</b> in in vitro. (A) Percentage inhibition of parasites was assessed by luciferase assay after treatment with <b>15b</b> and <b>15i</b> at different concentrations for 24 and 48 h. (B) Percent viability/survival of promastigotes was evaluated by MTT assay after treatment with varying concentrations of <b>15b</b> and <b>15i</b> for 48 h. (C,D) Macrophages were infected with a 1:8 (cell: promastigote) ratio, followed by treatment with different doses of compounds <b>15b</b> and <b>15i</b> for 48 h, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The percentage of amastigote inhibition was determined by luciferase assay (C) and the number of intra-macrophagic amastigotes was evaluated by Giemsa staining (D) as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (E,F) Vero cells and J774 macrophages were incubated at varying concentrations of <b>15b</b> and <b>15i</b> for 48 h and cell viability was checked by the MTT method. Data are represented as means ±SD of individual experiments (<i>n</i> = 3), which were done in replicate. Significance levels are represented as untreated vs <b>15b</b>, <b>15i-</b>treated groups with 25 and 50 μM doses, **<i>p</i> < 0.005, ***<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pictorial representation of SAR of quinoline–metronidazole hybrid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vitro stability of compounds <b>15b</b> and <b>15i</b> in simulated gastric (A) and intestinal (B) fluids up to 2 h. In vitro stability of compounds <b>15b</b> and <b>15i</b> in rat plasma (C) and in RLMs (D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>15b</b> and <b>15i</b> treatment in controlling in vivo infection: 15 day-infected BALB/c mice were treated with different doses of <b>15b</b> and <b>15i</b> as indicated. Mice of different experimental groups (<i>n</i> = 5 mice per group), were killed for the determination of hepatic (A) and splenic (B) parasite burden by the stamp-smear method and represented as Leishman Donovan units (LDU). The in vivo safety index of <b>15b</b> and <b>15i</b> was determined by assessment of serological markers. (C,D) 15 day-infected BALB/c mice were treated with 50 mg/kg of quinoline, metronidazole, <b>15b</b>, <b>15i</b> and 25 mg/kg of miltefosine for 5 consecutive days. Mice of different experimental groups (<i>n</i> = 5 mice per group), were sacrificed at day 7 post-treatment for the determination of hepatic (C) and splenic (D) parasite burden by the stamp-smear method and represented as LDU. (E) AST and (F) ALT at various time points in infected and treated BALB/c mice. Data represent mean ± SD (<i>n</i> = 5 mice per group), representative of three independent experiments were performed in replicate. Significance is indicated for untreated vs <b>15b</b>, <b>15i-</b>treated groups with 50 mg/kg dose; *<i>p</i> < 0.05, **<i>p</i> < 0.005, ***p < 0.0006, ns = nonsignificant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>15i-</b>treated <i>L. donovani</i> promastigotes underwent apoptosis: J774 macrophages infected with <i>L. donovani</i> promastigotes (24 h) were further incubated with 50 μM of <b>15i</b> for 48 h. (A) Th1 and (B) Th2 cytokines levels in cultured supernatant were evaluated by ELISA. (C) <i>L. donovani</i> parasites were incubated with 50 μM of <b>15i</b> for different time points and analyzed for membrane permeabilization using the SYTOX dye. Results were represented in percentages to the maximum normalized fluorescence as obtained with 0.1% Triton X-100 used for maximal promastigote permeabilization. (D) Exponential phase <i>L. donovani</i> parasite (1 × 10<sup>6</sup>) was incubated at maximum parasite inhibitory concentration of <b>15i</b> (50 μM) for 12, 24, and 48 h. Parasites incubated with 0.1% DMSO for 48 h were taken as the vehicle control. After incubation, promastigotes were stained with Annexin-V Alexa Fluor 488 and PI and analyzed by flow cytometry. (E) DNA fragmentation of parasites was analyzed by TUNEL assay. Log phase promastigotes were incubated with either vehicle (48 h) or <b>15i</b> (50 μM) for 48 h. TUNEL assay was carried out as mentioned in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Tunnel-stained parasites were then visualized by both phase contrast, as well as fluorescent microscopy. (F) Fluorogenic substrate BOC-GRR-AMC (<i>t</i>-butyloxycarbonyl-Gly-Arg-Arg-AMC) was used to determine metacaspase activity. Log phase promastigotes were treated with DMSO (0.1%), 15i (50 μM) either alone or in parasites pretreated with antipain (1 μM) or zVAD-fmk (100 μM) for 1 h. Activity is expressed as relative fluorescence unit and normalized to mg of protein obtained leishmanial cell lysates. The significance level is determined for the untreated vs treated groups, ns = nonsignificant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Determination of MMP loss, Cyt <i>c</i> release, ATP, ROS, and NO generation in 15i-treated promastigotes. (A) Exponential phase promastigotes were incubated with <b>15i</b> (50 μM) for 6–48 h or vehicle (0.1% DMSO). Parasites were also incubated with CCCP (50 μM), as the positive control. Changes in MMP were observed after the addition of the JC-1 dye in flow cytometry. (B) Immunoblot study to check the level of cytochrome <i>c</i> in mitochondrial (upper panel) and cytoplasmic (lower panel) fractions isolated from vehicle (0.1% DMSO, 48 h) or 15i-treated parasites (50 μM, 6–48 h). COX-IV and β-tubulin were used as the endogenous controls for mitochondrial and cytosolic fractions, respectively. (C) <i>L. donovani</i> parasites were incubated with either 0.1% DMSO or 50 μM of <b>15i</b> for 6–48 h. ATP content in the cytosol was determined as mentioned in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (D) Parasites were untreated, vehicle-treated or treated with <b>15i</b> compound at (50 μM) for different time periods and probed with H<sub>2</sub>DCFDA (20 μM). ROS generation was measured by flow cytometry as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (E) Log phase <i>L. donovani</i> promastigotes were incubated with <b>15i</b> (50 μM) for the respective time period followed by labeling with DAF-2DA (40 μM); fluorescence was measured as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Data are expressed as mean of at least 3 independent experiments done in duplicate. The significance level is determined for the untreated vs treated groups, **<i>p</i> < 0.005, ***<i>p</i> < 0.0004, ns = nonsignificant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/medium/jm-2019-006283_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Mean plasma concentrations vs time profile of compound <b>15i</b> in BALB/c mice at 50 mg/kg dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-11/acs.jmedchem.9b00628/20190607/images/large/jm-2019-006283_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00628&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chappuis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghalib, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peeling, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelaert, M.</span></span> <span> </span><span class="NLM_article-title">Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">873</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1038/nrmicro1748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1038%2Fnrmicro1748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=17938629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKltbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=873-882&author=F.+Chappuisauthor=S.+Sundarauthor=A.+Hailuauthor=H.+Ghalibauthor=S.+Rijalauthor=R.+W.+Peelingauthor=J.+Alvarauthor=M.+Boelaert&title=Visceral+leishmaniasis%3A+What+are+the+needs+for+diagnosis%2C+treatment+and+control%3F&doi=10.1038%2Fnrmicro1748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?</span></div><div class="casAuthors">Chappuis, Francois; Sundar, Shyam; Hailu, Asrat; Ghalib, Hashim; Rijal, Suman; Peeling, Rosanna W.; Alvar, Jorge; Boelaert, Marleen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">873-882</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Visceral leishmaniasis (VL) is a systemic protozoan disease that is transmitted by phlebotomine sandflies.  Poor and neglected populations in East Africa and the Indian sub-continent are particularly affected.  Early and accurate diagnosis and treatment remain key components of VL control.  In addn. to improved diagnostic tests, accurate and simple tests are needed to identify treatment failures.  Miltefosine, paromomycin and liposomal amphotericin B are gradually replacing pentavalent antimonials and conventional amphotericin B as the preferred treatments in some regions, but in other areas these drugs are still being evaluated in both mono- and combination therapies.  New diagnostic tools and new treatment strategies will only have an impact if they are made widely available to patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra_fthzaSpxrVg90H21EOLACvtfcHk0ljIn46jHWqsgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKltbzJ&md5=b7e8a768d6c6cb32a310515cff4da9f7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1748%26sid%3Dliteratum%253Aachs%26aulast%3DChappuis%26aufirst%3DF.%26aulast%3DSundar%26aufirst%3DS.%26aulast%3DHailu%26aufirst%3DA.%26aulast%3DGhalib%26aufirst%3DH.%26aulast%3DRijal%26aufirst%3DS.%26aulast%3DPeeling%26aufirst%3DR.%2BW.%26aulast%3DAlvar%26aufirst%3DJ.%26aulast%3DBoelaert%26aufirst%3DM.%26atitle%3DVisceral%2520leishmaniasis%253A%2520What%2520are%2520the%2520needs%2520for%2520diagnosis%252C%2520treatment%2520and%2520control%253F%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2007%26volume%3D5%26spage%3D873%26epage%3D882%26doi%3D10.1038%2Fnrmicro1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murray, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravia, N. G.</span></span> <span> </span><span class="NLM_article-title">Advances in leishmaniasis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">1561</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(05)67629-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2FS0140-6736%2805%2967629-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16257344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2005&pages=1561-1577&author=H.+W.+Murrayauthor=J.+D.+Bermanauthor=C.+R.+Daviesauthor=N.+G.+Saravia&title=Advances+in+leishmaniasis&doi=10.1016%2Fs0140-6736%2805%2967629-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in leishmaniasis</span></div><div class="casAuthors">Murray, Henry W.; Berman, Jonathan D.; Davies, Clive R.; Saravia, Nancy G.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">9496</span>),
    <span class="NLM_cas:pages">1561-1577</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Governed by parasite and host factors and immunoinflammatory responses, the clin. spectrum of leishmaniasis encompasses subclin. (inapparent), localized (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral).  Symptomatic disease is subacute or chronic and diverse in presentation and outcome.  Clin. characteristics vary further by endemic region.  Despite T-cell-dependent immune responses, which produce asymptomatic and self-healing infection, or appropriate treatment, intracellular infection is probably life-long since targeted cells (tissue macrophages) allow residual parasites to persist.  There is an epidemic of cutaneous leishmaniasis in Afghanistan and Pakistan and of visceral infection in India and Sudan.  Diagnosis relies on visualising parasites in tissue or serol.; culture and detection of parasite DNA are useful in the lab.  Pentavalent antimony is the conventional treatment; however, resistance of visceral infection in India has spawned new treatment approaches-amphotericin B and its lipid formulations, injectable paromomycin, and oral miltefosine.  Despite tangible advances in diagnosis, treatment, and basic scientific research, leishmaniasis is embedded in poverty and neglected.  Current obstacles to realistic prevention and proper management include inadequate vector (sandfly) control, no vaccine, and insufficient access to or impetus for developing affordable new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokA_8nOIgmnLVg90H21EOLACvtfcHk0ljIn46jHWqsgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsbfK&md5=1534e930a9753fe2584d1c32451b549a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2967629-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252967629-5%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DH.%2BW.%26aulast%3DBerman%26aufirst%3DJ.%2BD.%26aulast%3DDavies%26aufirst%3DC.%2BR.%26aulast%3DSaravia%26aufirst%3DN.%2BG.%26atitle%3DAdvances%2520in%2520leishmaniasis%26jtitle%3DLancet%26date%3D2005%26volume%3D366%26spage%3D1561%26epage%3D1577%26doi%3D10.1016%2Fs0140-6736%2805%2967629-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desjeux, P.</span></span> <span> </span><span class="NLM_article-title">Leishmaniasis: Current situation and new perspectives</span>. <i>Comp. Immunol. Microbiol. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/j.cimid.2004.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.cimid.2004.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=15225981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD2czitl2qtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=305-318&author=P.+Desjeux&title=Leishmaniasis%3A+Current+situation+and+new+perspectives&doi=10.1016%2Fj.cimid.2004.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Leishmaniasis: current situation and new perspectives</span></div><div class="casAuthors">Desjeux P</div><div class="citationInfo"><span class="NLM_cas:title">Comparative immunology, microbiology and infectious diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">305-18</span>
        ISSN:<span class="NLM_cas:issn">0147-9571</span>.
    </div><div class="casAbstract">Leishmaniasis represents a complex of diseases with an important clinical and epidemiological diversity.  Visceral leishmaniasis (VL) is of higher priority than cutaneous leishmaniasis (CL) as it is a fatal disease in the absence of treatment.  Anthroponotic VL foci are of special concern as they are at the origin of frequent and deathly epidemics (e.g.  Sudan).  Leishmaniasis burden remains important: 88 countries, 350 million people at risk, 500,000 new cases of VL per year, 1-1.5 million for CL and DALYs: 2.4 millions.  Most of the burden is concentrated on few countries which allows clear geographic priorities.  Leishmaniasis is still an important public health problem due to not only environmental risk factors such as massive migrations, urbanisation, deforestation, new irrigation schemes, but also to individual risk factors: HIV, malnutrition, genetic, etc em leader Leishmaniasis is part of those diseases which still requires improved control tools.  Consequently WHO/TDR research for leishmaniasis has been more and more focusing on the development of new tools such as diagnostic tests, drugs and vaccines.  The ongoing effort has already produced significant results.  The newly available control tools should allow a scaling up of control activities in priority areas.  In anthroponotic foci, the feasibility of getting a strong impact on mortality, morbidity and transmission, is high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSI9DJyGjvUp-kdrW1FkXG-fW6udTcc2eZ8bMX5qbxkr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czitl2qtA%253D%253D&md5=5720ef59954ab0a8062fe83d127d1768</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cimid.2004.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cimid.2004.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DDesjeux%26aufirst%3DP.%26atitle%3DLeishmaniasis%253A%2520Current%2520situation%2520and%2520new%2520perspectives%26jtitle%3DComp.%2520Immunol.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2004%26volume%3D27%26spage%3D305%26epage%3D318%26doi%3D10.1016%2Fj.cimid.2004.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbwang, J.</span></span> <span> </span><span class="NLM_article-title">Childhood visceral leishmaniasis</span>. <i>Indian J. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16778316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD28zmtl2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2006&pages=353-356&author=S.+K.+Bhattacharyaauthor=D.+Surauthor=J.+Karbwang&title=Childhood+visceral+leishmaniasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Childhood visceral leishmaniasis</span></div><div class="casAuthors">Bhattacharya S K; Sur Dipika; Karbwang Juntra</div><div class="citationInfo"><span class="NLM_cas:title">The Indian journal of medical research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-6</span>
        ISSN:<span class="NLM_cas:issn">0971-5916</span>.
    </div><div class="casAbstract">Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani and transmitted by the bite of infected sandfly Phlebotomus argentipes.  Nearly half of the VL cases occur in children (childhood or paediatric VL).  The clinical manifestations of childhood VL are more or less same as in the adults.  Prolonged fever with anorexia and loss of appetite are the major presenting features.  Marked enlargement of the spleen and liver (spleen larger than liver) with moderate to severe anaemia and changes in hair take place.  Bacterial infection is a common coinfection and intestinal parasitic infestations are very common in children with VL.  Liver function tests, blood, urine and stool may show abnormalities.  Confirmation of diagnosis is made by demonstration of parasite by microscopic examination and culture of materials obtained by bone marrow aspiration or splenic puncture.  Sodium antimony gluconate (stibogluconate) has been the drug of choice for over past 50 yr.  Pentamidine isothionate, though effective is relatively toxic.  Amphotericin B is the most effective drug for the treatment of VL.  Miltefosine is the first-ever oral drug, is highly effective.  Post kala-azar dermal leishmaniasis (PKDL) in children poses a therapeutic challenge.  In the absence of an ideal vaccine for VL, control measures would essentially include prevention of transmission through vector control and community awareness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdd__WUPJVrw5nADWVYHg1fW6udTcc2eZ8bMX5qbxkr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zmtl2gtw%253D%253D&md5=71b08f78608d9311ab6930cb6490595c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DSur%26aufirst%3DD.%26aulast%3DKarbwang%26aufirst%3DJ.%26atitle%3DChildhood%2520visceral%2520leishmaniasis%26jtitle%3DIndian%2520J.%2520Med.%2520Res.%26date%3D2006%26volume%3D123%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span> <span> </span><span class="NLM_article-title">Drug resistance in indian visceral leishmaniasis</span>. <i>Trop. Med. Int. Health</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.1046/j.1365-3156.2001.00778.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1046%2Fj.1365-3156.2001.00778.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11703838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD3MnltFOqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=849-854&author=S.+Sundar&title=Drug+resistance+in+indian+visceral+leishmaniasis&doi=10.1046%2Fj.1365-3156.2001.00778.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance in Indian visceral leishmaniasis</span></div><div class="casAuthors">Sundar S</div><div class="citationInfo"><span class="NLM_cas:title">Tropical medicine & international health : TM & IH</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">849-54</span>
        ISSN:<span class="NLM_cas:issn">1360-2276</span>.
    </div><div class="casAbstract">Throughout the world, pentavalent antimonial compounds (Sb(v)) have been the mainstay of antileishmanial therapy for more than 50 years.  Sb(v) has been highly effective in the treatment of Indian visceral leishmaniasis (VL: kala-azar) at a low dose (10 mg/kg) for short durations (6-10 days).  But in the early 1980s reports of its ineffectiveness emerged, and the dose of Sb(v) was eventually raised to 20 mg/kg for 30-40 days.  This regimen cures most patients with VL except in India, where the proportion of patients unresponsive to Sb(v) has steadily increased.  In hyperendemic districts of north Bihar, 50-65% patients fail treatment with Sb(v).  Important reasons are rampant use of subtherapeutic doses, incomplete duration of treatment and substandard drugs.  In vitro experiments have established emergence of Sb(v) resistant strains of Leishmania donovani, as isolates from unresponsive patients require 3-5 times more Sb(v) to reach similarly effectiveness against the parasite as in Sb(v) responders.  Anthroponotic transmission in India has been an important factor in rapid increase in the Sb(v) refractoriness.  Pentamidine was the first drug to be used and cured 99% of these refractory patients, but over time even with double the amount of initial doses, it cures only 69-78% patients now and its use has largely been abandoned in India.  Despite several disadvantages, amphotericin B is the only drug available for use in these areas and should be used as first-line drug instead of Sb(v).  The new oral antileishmanial drug miltefosine is likely to be the first-line drug in future.  Unfortunately, development of newer antileishmanial drugs is rare; two promising drugs, aminosidine and sitamaquine, may be developed for use in the treatment of VL.  Lipid associated amphotericin B has an excellent safety and efficacy profile, but remains out of reach for most patients because of its high cost.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNUjLeVs7MGevW160gIxP_fW6udTcc2eZ8bMX5qbxkr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnltFOqsQ%253D%253D&md5=5a51e3af86ed330f99315841ec1d44ec</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-3156.2001.00778.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-3156.2001.00778.x%26sid%3Dliteratum%253Aachs%26aulast%3DSundar%26aufirst%3DS.%26atitle%3DDrug%2520resistance%2520in%2520indian%2520visceral%2520leishmaniasis%26jtitle%3DTrop.%2520Med.%2520Int.%2520Health%26date%3D2001%26volume%3D6%26spage%3D849%26epage%3D854%26doi%3D10.1046%2Fj.1365-3156.2001.00778.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freitas-Junior, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira-Neto, J. L.</span></span> <span> </span><span class="NLM_article-title">Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?</span>. <i>Int. J. Parasitol.: Drugs Drug Resist.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.ijpddr.2012.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ijpddr.2012.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24533267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1KmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=11-19&author=L.+H.+Freitas-Juniorauthor=E.+Chatelainauthor=H.+A.+Kimauthor=J.+L.+Siqueira-Neto&title=Visceral+leishmaniasis+treatment%3A+What+do+we+have%2C+what+do+we+need+and+how+to+deliver+it%3F&doi=10.1016%2Fj.ijpddr.2012.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?</span></div><div class="casAuthors">Freitas-Junior, Lucio H.; Chatelain, Eric; Kim, Helena Andrade; Siqueira-Neto, Jair L.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Parasitology: Drugs and Drug Resistance</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-19</span>CODEN:
                <span class="NLM_cas:coden">IJPDAX</span>;
        ISSN:<span class="NLM_cas:issn">2211-3207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Leishmaniasis is one of the most neglected tropical disease in terms of drug discovery and development.  Most antileishmanial drugs are highly toxic, present resistance issues or require hospitalization, being therefore not adequate to the field.  Recently improvements have been achieved by combination therapy, reducing the time and cost of treatment.  Nonetheless, new drugs are still urgently needed.  In this review, we describe the current visceral leishmaniasis (VL) treatments and their limitations.  We also discuss the new strategies in the drug discovery field including the development and implementation of high-throughput screening (HTS) assays and the joint efforts of international teams to deliver clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsxC-9pemCbVg90H21EOLACvtfcHk0ljvAXGSO6HEdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1KmtLY%253D&md5=bc79e6a916e0dac45ec0879ecdc27e03</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpddr.2012.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpddr.2012.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DH.%2BA.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26atitle%3DVisceral%2520leishmaniasis%2520treatment%253A%2520What%2520do%2520we%2520have%252C%2520what%2520do%2520we%2520need%2520and%2520how%2520to%2520deliver%2520it%253F%26jtitle%3DInt.%2520J.%2520Parasitol.%253A%2520Drugs%2520Drug%2520Resist.%26date%3D2012%26volume%3D2%26spage%3D11%26epage%3D19%26doi%3D10.1016%2Fj.ijpddr.2012.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jha, T. K.</span></span> <span> </span><span class="NLM_article-title">Drug unresponsiveness & combination therapy for kala-azar</span>. <i>Indian J. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16778318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslShsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2006&pages=389-398&author=T.+K.+Jha&title=Drug+unresponsiveness+%26+combination+therapy+for+kala-azar"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Drug unresponsiveness & combination therapy for kala-azar</span></div><div class="casAuthors">Jha, T. K.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Medical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">389-398</span>CODEN:
                <span class="NLM_cas:coden">IMIREV</span>;
        ISSN:<span class="NLM_cas:issn">0971-5916</span>.
    
            (<span class="NLM_cas:orgname">Indian Council of Medical Research</span>)
        </div><div class="casAbstract">A review.  Pentavalent antimonials (Sbv) have been successfully used for treatment of kala-azar since last six decades.  Since 1970s its conventional dosages have failed to achieve with 60 per cent unresponsiveness reported with WHO regimen in Bihar (India).  Pentamidine initially used as a second line of drug, acquired resistance (25%) even with prolonged dosage.  Newer oral drug miltefosine is a potent antileishmanial drug with longer half-life, a property likely to acquire resistance.  Paromomycin has undergone extensive clin. trials in Indian kala-azar patients.  Being an aminoglycoside, acquired resistance is likely to occur when used as a monotherapy.  To encounter the problem of treatment failure in kala-azar and to reduce length of therapy, combination of at least two effective antileishmanial agents is a desirable option.  In India sodium stibogluconate (SSG) in std. dose has been combined with other antileishmanial agents including paromomycin without encouraging result.  Infection with Leishmania donovani depresses cell-mediated immunity.  Immunol. balance is tilted in favor of Th2 suppressive cytokines over Th1 producing protective cytokines.  Interferon gamma (IFN-γ) has been used in combination with Sbv in Indian kala-azar patients with unexpectedly discouraging results.  Combination of two most potent leishmanicidal drugs amphotericin B and miltefosine which are not dependent on host immune system, may shorten the course of therapy besides encountering unresponsiveness.  A combination therapy should be preferred when treating kala-azar assocd. with HIV/AIDS.  Immunotherapy with exogenous Th1 stimulating cytokines or use of antileishmanial vaccine in combination with a potent chemotherapeutic agent is a future option.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-54SmIfUxDrVg90H21EOLACvtfcHk0ljvAXGSO6HEdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslShsLk%253D&md5=680b3b0388d8d302f54258407d3ababa</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJha%26aufirst%3DT.%2BK.%26atitle%3DDrug%2520unresponsiveness%2520%2526%2520combination%2520therapy%2520for%2520kala-azar%26jtitle%3DIndian%2520J.%2520Med.%2520Res.%26date%3D2006%26volume%3D123%26spage%3D389%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">More, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makharia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, H. W.</span></span> <span> </span><span class="NLM_article-title">Failure of pentavalent antimony in visceral leishmaniasis in india: Report from the center of the indian epidemic</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1104</span>– <span class="NLM_lpage">1107</span>, <span class="refDoi"> DOI: 10.1086/318121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1086%2F318121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11049798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD3M7htVagug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2000&pages=1104-1107&author=S.+Sundarauthor=D.+K.+Moreauthor=M.+K.+Singhauthor=V.+P.+Singhauthor=S.+Sharmaauthor=A.+Makhariaauthor=P.+C.+K.+Kumarauthor=H.+W.+Murray&title=Failure+of+pentavalent+antimony+in+visceral+leishmaniasis+in+india%3A+Report+from+the+center+of+the+indian+epidemic&doi=10.1086%2F318121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic</span></div><div class="casAuthors">Sundar S; More D K; Singh M K; Singh V P; Sharma S; Makharia A; Kumar P C; Murray H W</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1104-7</span>
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    </div><div class="casAbstract">In India, 320 patients with visceral leishmaniasis (209 in the state of Bihar and 11 in the neighboring state of Uttar Pradesh) received identical pentavalent antimony (Sb) treatment.  Sb induced long-term cure in 35% (95% confidence interval [CI], 28%-42%) of those in Bihar versus 86% (95% CI, 79%-93%) of those in Uttar Pradesh.  In Bihar, the center of the Indian epidemic, traditional Sb treatment should be abandoned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSgpGjHbUAdr9yzdcP07UmufW6udTcc2ea-FwMxwEBCO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7htVagug%253D%253D&md5=96fce619cd1c5006ec9c168b2c01bb2d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1086%2F318121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F318121%26sid%3Dliteratum%253Aachs%26aulast%3DSundar%26aufirst%3DS.%26aulast%3DMore%26aufirst%3DD.%2BK.%26aulast%3DSingh%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DV.%2BP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DMakharia%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DP.%2BC.%2BK.%26aulast%3DMurray%26aufirst%3DH.%2BW.%26atitle%3DFailure%2520of%2520pentavalent%2520antimony%2520in%2520visceral%2520leishmaniasis%2520in%2520india%253A%2520Report%2520from%2520the%2520center%2520of%2520the%2520indian%2520epidemic%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2000%26volume%3D31%26spage%3D1104%26epage%3D1107%26doi%3D10.1086%2F318121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, Z.</span></span> <span> </span><span class="NLM_article-title">Miltefosine: First oral drug for treatment of visceral leishmaniasis</span>. <i>Med. J. Armed Forces India</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">66</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/s0377-1237(06)80162-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fs0377-1237%2806%2980162-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27407849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BC2s7pvFamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=66-67&author=V.+Agrawalauthor=Z.+Singh&title=Miltefosine%3A+First+oral+drug+for+treatment+of+visceral+leishmaniasis&doi=10.1016%2Fs0377-1237%2806%2980162-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Miltefosine: First Oral Drug for Treatment of Visceral Leishmaniasis</span></div><div class="casAuthors">Agrawal V K; Singh Zile</div><div class="citationInfo"><span class="NLM_cas:title">Medical journal, Armed Forces India</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-7</span>
        ISSN:<span class="NLM_cas:issn">0377-1237</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTDxnorIE-IzTMsgLhIoICsfW6udTcc2ea-FwMxwEBCO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7pvFamtg%253D%253D&md5=364eb5067ac60232accb95dca2d0dee3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fs0377-1237%2806%2980162-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0377-1237%252806%252980162-0%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DV.%26aulast%3DSingh%26aufirst%3DZ.%26atitle%3DMiltefosine%253A%2520First%2520oral%2520drug%2520for%2520treatment%2520of%2520visceral%2520leishmaniasis%26jtitle%3DMed.%2520J.%2520Armed%2520Forces%2520India%26date%3D2006%26volume%3D62%26spage%3D66%26epage%3D67%26doi%3D10.1016%2Fs0377-1237%2806%2980162-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, J.</span></span> <span> </span><span class="NLM_article-title">Treatment of american cutaneous leishmaniasis with miltefosine, an oral agent</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">E57</span>– <span class="NLM_lpage">E61</span>, <span class="refDoi"> DOI: 10.1086/322689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1086%2F322689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11528586" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=E57-E61&author=J.+Sotoauthor=J.+Toledoauthor=P.+Gutierrezauthor=R.+S.+Nichollsauthor=J.+Padillaauthor=J.+Engelauthor=C.+Fischerauthor=A.+Vossauthor=J.+Berman&title=Treatment+of+american+cutaneous+leishmaniasis+with+miltefosine%2C+an+oral+agent&doi=10.1086%2F322689"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1086%2F322689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F322689%26sid%3Dliteratum%253Aachs%26aulast%3DSoto%26aufirst%3DJ.%26aulast%3DToledo%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DP.%26aulast%3DNicholls%26aufirst%3DR.%2BS.%26aulast%3DPadilla%26aufirst%3DJ.%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DVoss%26aufirst%3DA.%26aulast%3DBerman%26aufirst%3DJ.%26atitle%3DTreatment%2520of%2520american%2520cutaneous%2520leishmaniasis%2520with%2520miltefosine%252C%2520an%2520oral%2520agent%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2001%26volume%3D33%26spage%3DE57%26epage%3DE61%26doi%3D10.1086%2F322689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monge-Maillo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Vélez, R.</span></span> <span> </span><span class="NLM_article-title">Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.1093/cid/civ004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1093%2Fcid%2Fciv004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25601455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvns1ektg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=1398-1404&author=B.+Monge-Mailloauthor=R.+L%C3%B3pez-V%C3%A9lez&title=Miltefosine+for+visceral+and+cutaneous+leishmaniasis%3A+drug+characteristics+and+evidence-based+treatment+recommendations&doi=10.1093%2Fcid%2Fciv004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations</span></div><div class="casAuthors">Monge-Maillo Begona; Lopez-Velez Rogelio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1398-404</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Miltefosine is the only recognized oral agent with potential to treat leishmaniasis.  Miltefosine had demonstrated very good cure rates for visceral leishmaniasis (VL) in India, Nepal, and Bangladesh, but high rates of clinical failures have been recently reported.  Moderate efficacy has been observed for VL in East Africa, whereas data from Mediterranean countries and Latin America are scarce.  Results have not been very promising for patients coinfected with VL and human immunodeficiency virus.  However, miltefosine's long half-life and its oral administration could make it a good option for maintenance prophylaxis.  Good evidence of efficacy has been documented in Old World cutaneous leishmaniasis (CL), and different cure rates among New World CL have been obtained depending on the geographical areas and species involved.  Appropriate regimens for New World mucocutaneous leishmaniasis need to be established, although longer treatment duration seems to confer better results.  Strategies to prevent the development and spread of miltefosine resistance are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoSEc0tthPZDMsgLhIoICsfW6udTcc2ea-FwMxwEBCO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvns1ektg%253D%253D&md5=8acd6993f6d425cf6d381a3f6cacadd8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fcid%2Fciv004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcid%252Fciv004%26sid%3Dliteratum%253Aachs%26aulast%3DMonge-Maillo%26aufirst%3DB.%26aulast%3DL%25C3%25B3pez-V%25C3%25A9lez%26aufirst%3DR.%26atitle%3DMiltefosine%2520for%2520visceral%2520and%2520cutaneous%2520leishmaniasis%253A%2520drug%2520characteristics%2520and%2520evidence-based%2520treatment%2520recommendations%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D60%26spage%3D1398%26epage%3D1404%26doi%3D10.1093%2Fcid%2Fciv004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">TheREnantiomer of the Antitubercular Drug PA-824 as a Potential Oral Treatment for Visceral Leishmaniasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4699</span>– <span class="NLM_lpage">4706</span>, <span class="refDoi"> DOI: 10.1128/aac.00722-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.00722-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=23856774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVygtb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=4699-4706&author=S.+Pattersonauthor=S.+Wyllieauthor=L.+Stojanovskiauthor=M.+R.+Perryauthor=F.+R.+C.+Simeonsauthor=S.+Norvalauthor=M.+Osuna-Cabelloauthor=M.+De+Ryckerauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=TheREnantiomer+of+the+Antitubercular+Drug+PA-824+as+a+Potential+Oral+Treatment+for+Visceral+Leishmaniasis&doi=10.1128%2Faac.00722-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral leishmaniasis</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan; Stojanovski, Laste; Perry, Meghan R.; Simeons, Frederick R. C.; Norval, Suzanne; Osuna-Cabello, Maria; De Rycker, Manu; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4699-4706</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The novel nitroimidazopyran agent (S)-PA-824 has potent antibacterial activity against Mycobacterium tuberculosis in vitro and in vivo and is currently in phase II clin. trials for tuberculosis (TB).  In contrast to M. tuberculosis, where (R)-PA-824 is inactive, we report here that both enantiomers of PA-824 show potent parasiticidal activity against Leishmania donovani, the causative agent of visceral leishmaniasis (VL).  In leishmania-infected macrophages, (R)-PA-824 is 6-fold more active than (S)-PA-824.  Both des-nitro analogs are inactive, underlining the importance of the nitro group in the mechanism of action.  Although the in vitro and in vivo pharmacol. profiles of the two enantiomers are similar, (R)-PA-824 is more efficacious in the murine model of VL, with >99% suppression of parasite burden when administered orally at 100 mg kg of body wt.-1, twice daily for 5 days.  In M. tuberculosis, (S)-PA-824 is a prodrug that is activated by a deazaflavin-dependent nitroreductase (Ddn), an enzyme which is absent in Leishmania spp.  Unlike the case with nifurtimox and fexinidazole, transgenic parasites overexpressing the leishmania nitroreductase are not hypersensitive to either (R)-PA-824 or (S)-PA-824, indicating that this enzyme is not the primary target of these compds.  Drug combination studies in vitro indicate that fexinidazole and (R)-PA-824 are additive whereas (S)-PA-824 and (R)-PA-824 show mild antagonistic behavior.  Thus, (R)-PA-824 is a promising candidate for late lead optimization for VL and may have potential for future use in combination therapy with fexinidazole, currently in phase II clin. trials against VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1xswg68vjdLVg90H21EOLACvtfcHk0ljkqzJhCCWm6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVygtb7I&md5=401760844c66c37003791c9dcf83392b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2Faac.00722-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.00722-13%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPerry%26aufirst%3DM.%2BR.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DTheREnantiomer%2520of%2520the%2520Antitubercular%2520Drug%2520PA-824%2520as%2520a%2520Potential%2520Oral%2520Treatment%2520for%2520Visceral%2520Leishmaniasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D4699%26epage%3D4706%26doi%3D10.1128%2Faac.00722-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e09744</span>, <span class="refDoi"> DOI: 10.7554/elife.09744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.7554%2Felife.09744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27215734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsFamtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e09744&author=S.+Pattersonauthor=S.+Wyllieauthor=S.+Norvalauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=J.+L.+Auerauthor=M.+Osuna-Cabelloauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=The+anti-tubercular+drug+delamanid+as+a+potential+oral+treatment+for+visceral+leishmaniasis&doi=10.7554%2Felife.09744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis</span></div><div class="casAuthors">Patterson, Stephen; Wyllie, Susan; Norval, Suzanne; Stojanovski, Laste; Simeons, Frederick R. C.; Auer, Jennifer L.; Osuna-Cabello, Maria; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e09744/1-e09744/21</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">There is an urgent requirement for safe, oral and cost-effective drugs for the treatment of visceral leishmaniasis (VL).  We report that delamanid (OPC-67683), an approved drug for multi-drug resistant tuberculosis, is a potent inhibitor of Leishmaniadonovani both in vitro and in vivo.  Twice-daily oral dosing of delamanid at 30 mg kg-1 for 5 days resulted in sterile cures in a mouse model of VL.  Treatment with lower doses revealed a U-shaped (hormetic) dose-response curve with greater parasite suppression at 1 mg kg-1 than at 3 mg kg-1 (5 or 10 day dosing).  Dosing delamanid for 10 days confirmed the hormetic dose-response and improved the efficacy at all doses investigated.  Mechanistic studies reveal that delamanid is rapidly metabolised by parasites via an enzyme, distinct from the nitroreductase that activates fexinidazole.  Delamanid has the potential to be repurposed as a much-needed oral therapy for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqepWvGUGZ0cbVg90H21EOLACvtfcHk0ljkqzJhCCWm6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsFamtLw%253D&md5=1a704d1acb52b08cae5f73cf625f293a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.7554%2Felife.09744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252Felife.09744%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DAuer%26aufirst%3DJ.%2BL.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DThe%2520anti-tubercular%2520drug%2520delamanid%2520as%2520a%2520potential%2520oral%2520treatment%2520for%2520visceral%2520leishmaniasis%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De09744%26doi%3D10.7554%2Felife.09744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">119re1</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3003326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1126%2Fscitranslmed.3003326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=22301556" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=119re1&author=S.+Wyllieauthor=S.+Pattersonauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=S.+Norvalauthor=R.+Kimeauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=The+anti-trypanosome+drug+fexinidazole+shows+potential+for+treating+visceral+leishmaniasis&doi=10.1126%2Fscitranslmed.3003326"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003326%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DKime%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DThe%2520anti-trypanosome%2520drug%2520fexinidazole%2520shows%2520potential%2520for%2520treating%2520visceral%2520leishmaniasis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D119re1%26doi%3D10.1126%2Fscitranslmed.3003326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukkavilli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinjari, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengottuvelan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadekar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pothuri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrashekar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koiram, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harisudhan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moinuddin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vachharajani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D.</span></span> <span> </span><span class="NLM_article-title">In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of dndi-vl-2098, a potential oral treatment for visceral leishmaniasis</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejps.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25261338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Gms73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2014&pages=147-155&author=R.+Mukkavilliauthor=J.+Pinjariauthor=B.+Patelauthor=S.+Sengottuvelanauthor=S.+Mondalauthor=A.+Gadekarauthor=M.+Vermaauthor=J.+Patelauthor=L.+Pothuriauthor=G.+Chandrashekarauthor=P.+Koiramauthor=T.+Harisudhanauthor=A.+Moinuddinauthor=D.+Launayauthor=N.+Vachharajaniauthor=V.+Ramanathanauthor=D.+Martin&title=In+vitro+metabolism%2C+disposition%2C+preclinical+pharmacokinetics+and+prediction+of+human+pharmacokinetics+of+dndi-vl-2098%2C+a+potential+oral+treatment+for+visceral+leishmaniasis&doi=10.1016%2Fj.ejps.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis</span></div><div class="casAuthors">Mukkavilli, Rao; Pinjari, Jakir; Patel, Bhavesh; Sengottuvelan, Shankar; Mondal, Subodh; Gadekar, Ajit; Verma, Manas; Patel, Jignesh; Pothuri, Lavanya; Chandrashekar, Gopu; Koiram, Prabhakar; Harisudhan, Tanukrishnan; Moinuddin, Ansari; Launay, Delphine; Vachharajani, Nimish; Ramanathan, Vikram; Martin, Denis</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">147-155</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The in vitro metab. and in vivo pharmacokinetic (PK) properties of DNDI-VL-2098, a potential oral agent for Visceral Leishmaniasis (VL) were studied and used to predict its human pharmacokinetics.  DNDI-VL-2098 showed a low soly. (10 μM) and was highly permeable (>200 nm/s) in the Caco-2 model.  It was stable in vitro in liver microsomes and hepatocytes and no metabolite was detectable in circulating plasma from dosed animals suggesting very slow, if any, metab. of the compd.  DNDI-VL-2098 was moderate to highly bound to plasma proteins across the species tested (94-98%).  DNDI-VL-2098 showed satisfactory PK properties in mouse, hamster, rat and dog with a low blood clearance (<15% of hepatic blood flow except hamster), a vol. of distribution of about 3 times total body water, acceptable half-life (1-6 h across the species) and good oral bioavailability (37-100%).  Allometric scaling of the preclin. PK data to human gave a blood half-life of approx. 20 h suggesting that the compd. could be a once-a-day drug.  Based on the above assumptions, the min. efficacious dose predicted for a 50 kg human was 150 mg and 300 mg, using efficacy results in the mouse and hamster, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg5azRMLSQ37Vg90H21EOLACvtfcHk0lj_fPbjM6J6GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Gms73N&md5=9d351c194ceba25f2dc23be54bb1ba33</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DMukkavilli%26aufirst%3DR.%26aulast%3DPinjari%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DB.%26aulast%3DSengottuvelan%26aufirst%3DS.%26aulast%3DMondal%26aufirst%3DS.%26aulast%3DGadekar%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DPothuri%26aufirst%3DL.%26aulast%3DChandrashekar%26aufirst%3DG.%26aulast%3DKoiram%26aufirst%3DP.%26aulast%3DHarisudhan%26aufirst%3DT.%26aulast%3DMoinuddin%26aufirst%3DA.%26aulast%3DLaunay%26aufirst%3DD.%26aulast%3DVachharajani%26aufirst%3DN.%26aulast%3DRamanathan%26aufirst%3DV.%26aulast%3DMartin%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520metabolism%252C%2520disposition%252C%2520preclinical%2520pharmacokinetics%2520and%2520prediction%2520of%2520human%2520pharmacokinetics%2520of%2520dndi-vl-2098%252C%2520a%2520potential%2520oral%2520treatment%2520for%2520visceral%2520leishmaniasis%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D65%26spage%3D147%26epage%3D155%26doi%3D10.1016%2Fj.ejps.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foth, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Activation of bicyclic nitro-drugs by a novel nitroreductase (ntr2) in leishmania</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e1005971</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1005971</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1371%2Fjournal.ppat.1005971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27812217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitV2mt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=e1005971&author=S.+Wyllieauthor=A.+J.+Robertsauthor=S.+Norvalauthor=S.+Pattersonauthor=B.+J.+Fothauthor=M.+Berrimanauthor=K.+D.+Readauthor=A.+H.+Fairlamb&title=Activation+of+bicyclic+nitro-drugs+by+a+novel+nitroreductase+%28ntr2%29+in+leishmania&doi=10.1371%2Fjournal.ppat.1005971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of bicyclic nitro-drugs by a novel nitroreductase (NTR2) in Leishmania</span></div><div class="casAuthors">Wyllie, Susan; Roberts, Adam J.; Norval, Suzanne; Patterson, Stephen; Foth, Bernardo J.; Berriman, Matthew; Read, Kevin D.; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1005971/1-e1005971/22</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Drug discovery pipelines for the "neglected diseases" are now heavily populated with nitroheterocyclic compds.  Recently, the bicyclic nitro-compds. (R)-PA-824, DNDI-VL-2098 and delamanid have been identified as potential candidates for the treatment of visceral leishmaniasis.  Using a combination of quant. proteomics and whole genome sequencing of susceptible and drug-resistant parasites we identified a putative NAD(P)H oxidase as the activating nitroreductase (NTR2).  Whole genome sequencing revealed that deletion of a single cytosine in the gene for NTR2 that is likely to result in the expression of a non-functional truncated protein.  Susceptibility of leishmania was restored by reintroduction of the wild-type gene into the resistant line, which was accompanied by the ability to metabolise these compds.  Overexpression of NTR2 in wild-type parasites rendered cells hyper-sensitive to bicyclic nitro-compds., but only marginally to the monocyclic nitro-drugs, nifurtimox and fexinidazole sulfone, known to be activated by a mitochondrial oxygen-insensitive nitroreductase (NTR1).  Conversely, a double knockout NTR2 null cell line was completely resistant to bicyclic nitro-compds. and only marginally resistant to nifurtimox.  Sensitivity was fully restored on expression of NTR2 in the null background.  Thus, NTR2 is necessary and sufficient for activation of these bicyclic nitro-drugs.  Recombinant NTR2 was capable of reducing bicyclic nitro-compds. in the same rank order as drug sensitivity in vitro.  These findings may aid the future development of better, novel anti-leishmanial drugs.  Moreover, the discovery of anti-leishmanial nitro-drugs with independent modes of activation and independent mechanisms of resistance alleviates many of the concerns over the continued development of these compd. series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnnO9nEnuzw7Vg90H21EOLACvtfcHk0lj_fPbjM6J6GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitV2mt7g%253D&md5=0506a45a0a29a613f96c1b874af54b96</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1005971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1005971%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DFoth%26aufirst%3DB.%2BJ.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DActivation%2520of%2520bicyclic%2520nitro-drugs%2520by%2520a%2520novel%2520nitroreductase%2520%2528ntr2%2529%2520in%2520leishmania%26jtitle%3DPLoS%2520Pathog.%26date%3D2016%26volume%3D12%26spage%3De1005971%26doi%3D10.1371%2Fjournal.ppat.1005971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bongarzone, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">The concept of privileged structures in rational drug design: Focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1517/17460441.2011.550914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1517%2F17460441.2011.550914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=22647203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlehsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=251-268&author=S.+Bongarzoneauthor=M.+L.+Bolognesi&title=The+concept+of+privileged+structures+in+rational+drug+design%3A+Focus+on+acridine+and+quinoline+scaffolds+in+neurodegenerative+and+protozoan+diseases&doi=10.1517%2F17460441.2011.550914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases</span></div><div class="casAuthors">Bongarzone, Salvatore; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-268</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  For nearly 20 years, privileged structures have offered an optimal source of core scaffolds and capping fragments for the design of combinatorial libraries directed at a broad spectrum of targets.  From describing structures promiscuous within a given target family, the concept has evolved to include frameworks that can modulate proteins lacking a strict target class relation.  Based on a literature search from 2000 to 2010, we discuss how two privileged motifs, quinolines and acridines, are particularly recurrent in compds. active against two quite different pathologies, neurodegenerative and protozoan diseases.  As privileged structures, quinolines and acridines could improve the productivity of drug discovery projects in the field of neurodegenerative and protozoan diseases.  They could be particularly relevant for protozoan diseases because of the importance of cost-effective strategies and less stringent intellectual property concerns.  Furthermore, because of their inherent affinity for various targets, privileged structures could offer a viable starting point in the search for novel multi-target ligands.  Finally, from a broader perspective, they can serve as effective probes for investigating unknown but interrelated mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH8GsG8UoG17Vg90H21EOLACvtfcHk0lgmcbbLMmESlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlehsr8%253D&md5=a06cb7c7bdd8561ee6138bf8453082c9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.550914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.550914%26sid%3Dliteratum%253Aachs%26aulast%3DBongarzone%26aufirst%3DS.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DThe%2520concept%2520of%2520privileged%2520structures%2520in%2520rational%2520drug%2520design%253A%2520Focus%2520on%2520acridine%2520and%2520quinoline%2520scaffolds%2520in%2520neurodegenerative%2520and%2520protozoan%2520diseases%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D251%26epage%3D268%26doi%3D10.1517%2F17460441.2011.550914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keri, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S. A.</span></span> <span> </span><span class="NLM_article-title">Quinoline: A promising antitubercular target</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2014.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.biopha.2014.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25458785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGisbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2014&pages=1161-1175&author=R.+S.+Keriauthor=S.+A.+Patil&title=Quinoline%3A+A+promising+antitubercular+target&doi=10.1016%2Fj.biopha.2014.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline: A promising antitubercular target</span></div><div class="casAuthors">Keri, Rangappa S.; Patil, Siddappa A.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1161-1175</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Tuberculosis (TB) remains a global public health problem in recent years.  TB originated mainly from various strains of Mycobacterium tuberculosis, is a highly infectious and chronic disease with high infection rate since ancient times.  Since the last 50 years, the same long-duration, multidrug treatment plan is being followed for the treatment of tuberculosis.  Due to the development of resistance to conventional antibiotics there is a need for new therapeutic strategies to combat M. tuberculosis.  Subsequently, there is an urgent need for the development of new drug mols. with newer targets and with an alternative mechanism of action.  Among hetrocyclic compds., quinoline compds. are important privileged structure in medicinal chem., are widely used as "parental" compds. to synthesize mols. with medical benefits, esp. with anti-malarial and anti-microbial activities.  Certain, quinoline-based compds., also show effective anti-TB activity.  This broad spectrum of biol. and biochem. activities has been further facilitated by the synthetic versatility of quinoline, which allows the generation of a large no. of structurally diverse derivs.  To pave the way for future research, there is a need to collect the latest information in this promising area.  In the present review, we have collated published reports on this versatile core to provide an insight so that its full therapeutic potential can be utilized for the treatment tuberculosis.  It is hoped that, this review will be helpful for new thoughts in the quest for rational designs of more active and less toxic quinoline-based anti-TB drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLb6nFd3vm9bVg90H21EOLACvtfcHk0lgmcbbLMmESlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGisbvL&md5=21f7da91946ed726e9d2931e31784ea7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2014.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DKeri%26aufirst%3DR.%2BS.%26aulast%3DPatil%26aufirst%3DS.%2BA.%26atitle%3DQuinoline%253A%2520A%2520promising%2520antitubercular%2520target%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2014%26volume%3D68%26spage%3D1161%26epage%3D1175%26doi%3D10.1016%2Fj.biopha.2014.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span> <span> </span><span class="NLM_article-title">Quinoline as a privileged scaffold in cancer drug discovery</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1508</span>, <span class="refDoi"> DOI: 10.2174/092986711795328382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.2174%2F092986711795328382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21428893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslOit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1488-1508&author=V.+R.+Solomonauthor=H.+Lee&title=Quinoline+as+a+privileged+scaffold+in+cancer+drug+discovery&doi=10.2174%2F092986711795328382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline as a privileged scaffold in cancer drug discovery</span></div><div class="casAuthors">Solomon, V. R.; Lee, H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1488-1508</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Quinoline (1-azanaphthalene) is a heterocyclic arom. nitrogen compd. characterized by a double-ring structure that contains a benzene ring fused to pyridine at two adjacent carbon atoms.  Quinoline compds. are widely used as "parental" compds. to synthesize mols. with medical benefits, esp. with anti-malarial and anti-microbial activities.  Certain quinoline-based compds. also show effective anticancer activity.  This broad spectrum of biol. and biochem. activities has been further facilitated by the synthetic versatility of quinoline, which allows the generation of a large no. of structurally diverse derivs.  This includes numerous analogs derived from substitution of the quinoline ring system, and derivatization of quinoline ring structure.  Quinoline and its analogs have recently been examd. for their modes of function in the inhibition of tyrosine kinases, proteasome, tubulin polymn. and DNA repair.  In this review, we have summarized our knowledge on quinoline compds. with respect to their anticancer activities, mechanisms of action, structure-activity relationship (SAR), and selective and specific activity against various cancer drug targets.  In particular, we focus our review on in vitro and in vivo anticancer activities of quinoline and its analogs in the context of cancer drug development and refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwaNwDSFVcrLVg90H21EOLACvtfcHk0lh-kQiaO-ABlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslOit70%253D&md5=9c8cb8b477523b99bbe6d8b08eca00de</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F092986711795328382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795328382%26sid%3Dliteratum%253Aachs%26aulast%3DSolomon%26aufirst%3DV.%2BR.%26aulast%3DLee%26aufirst%3DH.%26atitle%3DQuinoline%2520as%2520a%2520privileged%2520scaffold%2520in%2520cancer%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1488%26epage%3D1508%26doi%3D10.2174%2F092986711795328382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vlahopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critselis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voutsas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschovi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxevanis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrousos, G.</span></span> <span> </span><span class="NLM_article-title">New use for old drugs? Prospective targets of chloroquines in cancer therapy</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.2174/1389450115666140714121514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.2174%2F1389450115666140714121514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25023646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGisrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=843-851&author=S.+Vlahopoulosauthor=E.+Critselisauthor=I.+Voutsasauthor=S.+Perezauthor=M.+Moschoviauthor=C.+Baxevanisauthor=G.+Chrousos&title=New+use+for+old+drugs%3F+Prospective+targets+of+chloroquines+in+cancer+therapy&doi=10.2174%2F1389450115666140714121514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy</span></div><div class="casAuthors">Vlahopoulos, Spiros; Critselis, Elena; Voutsas, Ioannis F.; Perez, Sonia A.; Moschovi, Maria; Baxevanis, Constantin N.; Chrousos, George P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">843-851</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  During the last decade research is gradually repositioning the antimalarial drug chloroquine, and certain related quinoline derivs., as anticancer agents.  Chloroquine and hydroxychloroquine, in particular, have relatively wellcharacterized toxicity profiles due to several decades of use for treatment of malaria.  Previously published review articles provide an excellent overview of the diversity of chloroquine effects on cancer cells, both in the cell culture as well as on human tumors grafted into mice; and an account of the increasing pace of incorporation of hydroxychloroquine in combination treatment schemes for clin. studies.  In this review we present some features that are common between cancers that are sensitive to quinoline derivs., in particular features that are amenable to pharmaceutical intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKPhn3gaHU8bVg90H21EOLACvtfcHk0lh-kQiaO-ABlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGisrvJ&md5=5a40a706c855bf76ed9ca3345d887e34</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1389450115666140714121514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450115666140714121514%26sid%3Dliteratum%253Aachs%26aulast%3DVlahopoulos%26aufirst%3DS.%26aulast%3DCritselis%26aufirst%3DE.%26aulast%3DVoutsas%26aufirst%3DI.%26aulast%3DPerez%26aufirst%3DS.%26aulast%3DMoschovi%26aufirst%3DM.%26aulast%3DBaxevanis%26aufirst%3DC.%26aulast%3DChrousos%26aufirst%3DG.%26atitle%3DNew%2520use%2520for%2520old%2520drugs%253F%2520Prospective%2520targets%2520of%2520chloroquines%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2014%26volume%3D15%26spage%3D843%26epage%3D851%26doi%3D10.2174%2F1389450115666140714121514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loiseau, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cojean, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrével, J.</span></span> <span> </span><span class="NLM_article-title">Sitamaquine as a putative antileishmanial drug candidate: From the mechanism of action to the risk of drug resistance</span>. <i>Parasite</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1051/parasite/2011182115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1051%2Fparasite%2F2011182115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21678786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnht12hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=115-119&author=P.+M.+Loiseauauthor=S.+Cojeanauthor=J.+Schr%C3%A9vel&title=Sitamaquine+as+a+putative+antileishmanial+drug+candidate%3A+From+the+mechanism+of+action+to+the+risk+of+drug+resistance&doi=10.1051%2Fparasite%2F2011182115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance</span></div><div class="casAuthors">Loiseau P M; Cojean S; Schrevel J</div><div class="citationInfo"><span class="NLM_cas:title">Parasite (Paris, France)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-9</span>
        ISSN:<span class="NLM_cas:issn">1252-607X</span>.
    </div><div class="casAbstract">Sitamaquine is a 8-aminoquinoline in development for the treatment of visceral leishmaniasis by oral route, no activity being observed on the experimental cutaneous leishmaniasis experimental models.  Recent data explain how sitamaquine accumulate in Leishmania parasites, however its molecular targets remain to be identified.  An advantage of sitamaquine is its short elimination half-life, preventing a rapid resistance emergence.  The antileishmanial action of its metabolites is not known.  The selection of a sitamaquine-resistant clone of L. donovani in laboratory and the phase II clinical trials pointing out some adverse effects such as methemoglobinemia and nephrotoxicity are considered for a further development decision.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXINeSec3k29K0qsdY6Nc1fW6udTcc2eagI-lA-8gvPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnht12hsg%253D%253D&md5=97ea4b0043ef7d33a16fd9b332d2a5fa</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1051%2Fparasite%2F2011182115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fparasite%252F2011182115%26sid%3Dliteratum%253Aachs%26aulast%3DLoiseau%26aufirst%3DP.%2BM.%26aulast%3DCojean%26aufirst%3DS.%26aulast%3DSchr%25C3%25A9vel%26aufirst%3DJ.%26atitle%3DSitamaquine%2520as%2520a%2520putative%2520antileishmanial%2520drug%2520candidate%253A%2520From%2520the%2520mechanism%2520of%2520action%2520to%2520the%2520risk%2520of%2520drug%2520resistance%26jtitle%3DParasite%26date%3D2011%26volume%3D18%26spage%3D115%26epage%3D119%26doi%3D10.1051%2Fparasite%2F2011182115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque-Ortega, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanys, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamarro, F.</span></span> <span> </span><span class="NLM_article-title">Tafenoquine, an antiplasmodial 8-aminoquinoline, targets leishmania respiratory complex iii and induces apoptosis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5344</span>– <span class="NLM_lpage">5351</span>, <span class="refDoi"> DOI: 10.1128/aac.00790-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.00790-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=20837758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2msr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=5344-5351&author=L.+Carvalhoauthor=J.+R.+Luque-Ortegaauthor=J.+I.+Manzanoauthor=S.+Castanysauthor=L.+Rivasauthor=F.+Gamarro&title=Tafenoquine%2C+an+antiplasmodial+8-aminoquinoline%2C+targets+leishmania+respiratory+complex+iii+and+induces+apoptosis&doi=10.1128%2Faac.00790-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tafenoquine, an antiplasmodial 8-aminoquinoline, targets Leishmania respiratory complex III and induces apoptosis</span></div><div class="casAuthors">Carvalho, Luis; Luque-Ortega, Juan Roman; Manzano, Jose Ignacio; Castanys, Santiago; Rivas, Luis; Gamarro, Francisco</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5344-5351</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tafenoquine (TFQ), an 8-aminoquinoline analog of primaquine, which is under clin. trial (phase IIb/III) for the treatment and prevention of malaria, may represent an alternative treatment for leishmaniasis.  Here, the authors have studied the mechanism of action of TFQ against Leishmania parasites.  TFQ impaired the overall bioenergetic metab. of Leishmania promastigotes, causing a rapid drop in intracellular ATP levels without affecting plasma membrane permeability.  TFQ induced mitochondrial dysfunction through the inhibition of cytochrome c reductase (respiratory complex III) with a decrease in the oxygen consumption rate and depolarization of mitochondrial membrane potential.  This was accompanied by ROS prodn., elevation of intracellular Ca2+ levels and concomitant nuclear DNA fragmentation.  It is concluded that TFQ targets Leishmania mitochondria, leading to an apoptosis-like death process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqub4UUn4WPo7Vg90H21EOLACvtfcHk0lg4XmtFbYO4Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2msr%252FO&md5=966bb6693b6e5cf4a16482a642b5e9e4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2Faac.00790-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.00790-10%26sid%3Dliteratum%253Aachs%26aulast%3DCarvalho%26aufirst%3DL.%26aulast%3DLuque-Ortega%26aufirst%3DJ.%2BR.%26aulast%3DManzano%26aufirst%3DJ.%2BI.%26aulast%3DCastanys%26aufirst%3DS.%26aulast%3DRivas%26aufirst%3DL.%26aulast%3DGamarro%26aufirst%3DF.%26atitle%3DTafenoquine%252C%2520an%2520antiplasmodial%25208-aminoquinoline%252C%2520targets%2520leishmania%2520respiratory%2520complex%2520iii%2520and%2520induces%2520apoptosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D5344%26epage%3D5351%26doi%3D10.1128%2Faac.00790-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antinarelli, L. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, R. M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, I. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lima, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coimbra, E. S.</span></span> <span> </span><span class="NLM_article-title">4-aminoquinoline derivatives as potential antileishmanial agents</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">714</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1111%2Fcbdd.12540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25682728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKnsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2015&pages=704-714&author=L.+M.+R.+Antinarelliauthor=R.+M.+P.+Diasauthor=I.+O.+Souzaauthor=W.+P.+Limaauthor=J.+Gameiroauthor=A.+D.+da+Silvaauthor=E.+S.+Coimbra&title=4-aminoquinoline+derivatives+as+potential+antileishmanial+agents&doi=10.1111%2Fcbdd.12540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">4-Aminoquinoline Derivatives as Potential Antileishmanial Agents</span></div><div class="casAuthors">Antinarelli, Luciana M. R.; Dias, Rafael M. P.; Souza, Isabela O.; Lima, Wallace P.; Gameiro, Jacy; da Silva, Adilson D.; Coimbra, Elaine S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">704-714</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The leishmanicidal activity of a series of 4-aminoquinoline (AMQ) derivs. was assayed against Leishmania amazonensis.  This activity against the intracellular parasite was found stronger than for L. amazonensis promastigotes.  Neither compd. was cytotoxic against macrophages.  The compd. AMQ-j, which exhibited a strong activity against promastigotes and amastigotes of L. amazonensis (IC50 values of 5.9 and 2.4 μg/mL, resp.) and similar leishmanicidal activity to ref. drugs, was chosen for studies regarding its possible mechanism of action toward parasite death.  The results showed that the compd. AMQ-j induced depolarization of the mitochondrial membrane potential in promastigotes and in L. amazonensis-infected macrophages, but not in uninfected macrophages.  Furthermore, the depolarization of the mitochondrial membrane potential was dose dependent in infected macrophages.  The authors have established that promastigotes and L. amazonensis-infected macrophages treated with AMQ-j were submitted to oxidative stress.  This is in line with the increase in the level of reactive oxygen species (ROS).  Leishmania amazonensis-infected macrophages treated with AMQ-j did not show a significant increase in the prodn. of nitric oxide.  The authors' results indicate the effective and selective action of AMQ-j against L. amazonensis, and its mechanism of action appears to be mediated by mitochondrial dysfunction assocd. with ROS prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_9QP5g9WmbVg90H21EOLACvtfcHk0lg4XmtFbYO4Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKnsLrO&md5=0088fe4550916838d190d4d406e87d1c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12540%26sid%3Dliteratum%253Aachs%26aulast%3DAntinarelli%26aufirst%3DL.%2BM.%2BR.%26aulast%3DDias%26aufirst%3DR.%2BM.%2BP.%26aulast%3DSouza%26aufirst%3DI.%2BO.%26aulast%3DLima%26aufirst%3DW.%2BP.%26aulast%3DGameiro%26aufirst%3DJ.%26aulast%3Dda%2BSilva%26aufirst%3DA.%2BD.%26aulast%3DCoimbra%26aufirst%3DE.%2BS.%26atitle%3D4-aminoquinoline%2520derivatives%2520as%2520potential%2520antileishmanial%2520agents%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2015%26volume%3D86%26spage%3D704%26epage%3D714%26doi%3D10.1111%2Fcbdd.12540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coimbra, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antinarelli, L. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, I. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinel, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, R. P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva, A. D.</span></span> <span> </span><span class="NLM_article-title">Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>260</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2016.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.cbi.2016.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27789199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOqsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=260&publication_year=2016&pages=50-57&author=E.+S.+Coimbraauthor=L.+M.+R.+Antinarelliauthor=N.+P.+Silvaauthor=I.+O.+Souzaauthor=R.+S.+Meinelauthor=M.+N.+Rochaauthor=R.+P.+P.+Soaresauthor=A.+D.+da+Silva&title=Quinoline+derivatives%3A+Synthesis%2C+leishmanicidal+activity+and+involvement+of+mitochondrial+oxidative+stress+as+mechanism+of+action&doi=10.1016%2Fj.cbi.2016.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action</span></div><div class="casAuthors">Coimbra, Elaine S.; Antinarelli, Luciana M. R.; Silva, Natalia P.; Souza, Isabela O.; Meinel, Raissa S.; Rocha, Marcele N.; Soares, Rodrigo P. P.; da Silva, Adilson D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">260</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-57</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Leishmaniasis comprise a spectrum of diseases caused by protozoa parasites from the genus Leishmania, affecting millions of people worldwide, mainly in subtropical countries.  Most antileishmanial drugs are highly toxic, present resistance issues or require long-term treatment.  Consequently, new drugs are urgently needed.  Quinoline-contg. compds. have displayed an impressive array of biol. properties over the years, including antileishmanial activity.  In the present study, we report the synthesis and evaluation of novel quinoline derivs. (QuinDer) against Leishmania species and cytotoxic effect on mammalian cells.  The ROS prodn. and mitochondrial membrane potential analyses were also studied.  The compd. QuinDer1 showed activity on L. amazonensis and L. braziliensis promastigotes and this compd. exhibited a strong inhibition of the proliferation of L. amazonensis amastigotes at nM concn. (IC50 of 0.0911 μM), being 139 times more active than miltefosine (IC50 of 12.7 μM), used as ref. drug.  This compd. presents low cytotoxicity toward murine macrophages and human erythrocytes.  In addn., promastigotes of L. amazonensis treated with the compd. QuinDer1 present high generation of ROS levels with low alterations in mitochondrial membrane potential and maintenance of parasite membrane integrity.  No substantial NO prodn. in infected-macrophages treated with this compd. was detected.  These results suggest that the compd. QuinDer 1 is a potent and selective antileishmanial agent by mitochondrial oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZvTzyH_xDcLVg90H21EOLACvtfcHk0ljgxwRQWa7sQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOqsLjE&md5=8a388b91fca68966948242c8035552ea</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DCoimbra%26aufirst%3DE.%2BS.%26aulast%3DAntinarelli%26aufirst%3DL.%2BM.%2BR.%26aulast%3DSilva%26aufirst%3DN.%2BP.%26aulast%3DSouza%26aufirst%3DI.%2BO.%26aulast%3DMeinel%26aufirst%3DR.%2BS.%26aulast%3DRocha%26aufirst%3DM.%2BN.%26aulast%3DSoares%26aufirst%3DR.%2BP.%2BP.%26aulast%3Dda%2BSilva%26aufirst%3DA.%2BD.%26atitle%3DQuinoline%2520derivatives%253A%2520Synthesis%252C%2520leishmanicidal%2520activity%2520and%2520involvement%2520of%2520mitochondrial%2520oxidative%2520stress%2520as%2520mechanism%2520of%2520action%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2016%26volume%3D260%26spage%3D50%26epage%3D57%26doi%3D10.1016%2Fj.cbi.2016.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.-L.</span></span> <span> </span><span class="NLM_article-title">Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent helicobacter pylori urease inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">7531</span>– <span class="NLM_lpage">7536</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2009.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.bmc.2009.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=19804978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ylurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7531-7536&author=W.-J.+Maoauthor=P.-C.+Lvauthor=L.+Shiauthor=H.-Q.+Liauthor=H.-L.+Zhu&title=Synthesis%2C+molecular+docking+and+biological+evaluation+of+metronidazole+derivatives+as+potent+helicobacter+pylori+urease+inhibitors&doi=10.1016%2Fj.bmc.2009.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors</span></div><div class="casAuthors">Mao, Wen-Jun; Lv, Peng-Cheng; Shi, Lei; Li, Huan-Qiu; Zhu, Hai-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7531-7536</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fourteen metronidazole derivs. (compds. 3a-f and 4b-h) have been synthesized by coupling of metronidazole and salicylic acid derivs.  All of them are reported for the first time.  Their chem. structures are characterized by 1H NMR, MS, and elemental anal.  The inhibitory activities against Helicobacter pylori urease have been investigated in vitro and many compds. have showed promising potential inhibitory activities of H. pylori urease.  The effect of compds. 4b (IC50 = 26 μM) and 4g (I) (IC50 = 12 μM) was comparable with that of acetohydroxamic acid, a well known H. pylori urease inhibitor used as a pos. control.  The exptl. values of IC50 showed that inhibitor was potent urease inhibitor.  A docking anal. using the 4.0 program could explain the inhibitory activities of compd. 4g against H. pylori urease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg_ZR_XnNdNLVg90H21EOLACvtfcHk0ljgxwRQWa7sQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ylurzO&md5=4d0b0072bd2983c3a905f18e152ad5e8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2009.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2009.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DW.-J.%26aulast%3DLv%26aufirst%3DP.-C.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DZhu%26aufirst%3DH.-L.%26atitle%3DSynthesis%252C%2520molecular%2520docking%2520and%2520biological%2520evaluation%2520of%2520metronidazole%2520derivatives%2520as%2520potent%2520helicobacter%2520pylori%2520urease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D7531%26epage%3D7536%26doi%3D10.1016%2Fj.bmc.2009.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anthwal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajesh, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawat, M. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushwaha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maikhuri, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawat, D. S.</span></span> <span> </span><span class="NLM_article-title">Novel metronidazole-chalcone conjugates with potential to counter drug resistance in trichomonas vaginalis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.03.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2014.03.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24727243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsFWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=89-94&author=A.+Anthwalauthor=U.+C.+Rajeshauthor=M.+S.+M.+Rawatauthor=B.+Kushwahaauthor=J.+P.+Maikhuriauthor=V.+L.+Sharmaauthor=G.+Guptaauthor=D.+S.+Rawat&title=Novel+metronidazole-chalcone+conjugates+with+potential+to+counter+drug+resistance+in+trichomonas+vaginalis&doi=10.1016%2Fj.ejmech.2014.03.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis</span></div><div class="casAuthors">Anthwal, Amit; Rajesh, U. Chinna; Rawat, M. S. M.; Kushwaha, Bhavana; Maikhuri, Jagdamba P.; Sharma, Vishnu L.; Gupta, Gopal; Rawat, Diwan S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-94</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Trichomoniasis is the most prevalent, curable sexually transmitted disease (STD), which increases risk of viral STDs and HIV.  However, drug resistance has been developed by some strains of Trichomonas vaginalis against Metronidazole (MTZ), the FDA approved drug against trichomoniasis.  In the present study twenty two chalcone hybrids of metronidazole have been synthesized in a quest to get new mols. with higher potential against metronidazole-resistant T. vaginalis.  All new hybrid mols. were found active against T. vaginalis with varying levels of activity against MTZ-susceptible and resistant strains.  Eight compds. (4a, 4c, 4d, 4e, 4f, 4h, 4q and 4s) were found as active as the std. drug with an MIC of 1.56 μg/mL against MTZ-susceptible strain.  However, compds. 4e, 4h and 4m were 4-times more active than MTZ against drug-resistant T. vaginalis, amongst which 4e and 4h were most promising against both susceptible and resistant strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoksCW6pBl6oLVg90H21EOLACvtfcHk0ljgxwRQWa7sQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsFWnt74%253D&md5=1fe0abb810d598fc18bc90ad9e5bc219</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.03.076%26sid%3Dliteratum%253Aachs%26aulast%3DAnthwal%26aufirst%3DA.%26aulast%3DRajesh%26aufirst%3DU.%2BC.%26aulast%3DRawat%26aufirst%3DM.%2BS.%2BM.%26aulast%3DKushwaha%26aufirst%3DB.%26aulast%3DMaikhuri%26aufirst%3DJ.%2BP.%26aulast%3DSharma%26aufirst%3DV.%2BL.%26aulast%3DGupta%26aufirst%3DG.%26aulast%3DRawat%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520metronidazole-chalcone%2520conjugates%2520with%2520potential%2520to%2520counter%2520drug%2520resistance%2520in%2520trichomonas%2520vaginalis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D89%26epage%3D94%26doi%3D10.1016%2Fj.ejmech.2014.03.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Mayoral, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">do Carmo Carreiras, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soriano, E.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Friedländer Reaction</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">2652</span>– <span class="NLM_lpage">2671</span>, <span class="refDoi"> DOI: 10.1021/cr800482c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr800482c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2652-2671&author=J.+Marco-Contellesauthor=E.+P%C3%A9rez-Mayoralauthor=A.+Samadiauthor=M.+do+Carmo+Carreirasauthor=E.+Soriano&title=Recent+Advances+in+the+Friedl%C3%A4nder+Reaction&doi=10.1021%2Fcr800482c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Friedlander Reaction</span></div><div class="casAuthors">Marco-Contelles, Jose; Perez-Mayoral, Elena; Samadi, Abdelouahid; Carreiras, Maria do Carmo; Soriano, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2652-2671</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review is an update of the Friedlander reaction from the most significant literature from 1981 to the present.  A particular emphasis is on the development of novel catalysts, exptl. conditions as well as an application toward natural products synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8jFyV0XzFYLVg90H21EOLACvtfcHk0lgntH0fhj-LJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVSltrY%253D&md5=247618f98000f1a747a443a1648854bc</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcr800482c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr800482c%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez-Mayoral%26aufirst%3DE.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3Ddo%2BCarmo%2BCarreiras%26aufirst%3DM.%26aulast%3DSoriano%26aufirst%3DE.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Friedl%25C3%25A4nder%2520Reaction%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2652%26epage%3D2671%26doi%3D10.1021%2Fcr800482c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaabani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soleimani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badri, Z.</span></span> <span> </span><span class="NLM_article-title">Triflouroacetic acid as an efficient catalyst for the synthesis of quinoline</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">635</span>, <span class="refDoi"> DOI: 10.1080/00397910601055230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1080%2F00397910601055230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlSqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=629-635&author=A.+Shaabaniauthor=E.+Soleimaniauthor=Z.+Badri&title=Triflouroacetic+acid+as+an+efficient+catalyst+for+the+synthesis+of+quinoline&doi=10.1080%2F00397910601055230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroacetic acid as an efficient catalyst for the synthesis of quinoline</span></div><div class="casAuthors">Shaabani, Ahmad; Soleimani, Ebrahim; Badri, Zahra</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">629-635</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Trifluoroacetic acid efficiently catalyzed the Friedlander synthesis of quinolines through a condensation reaction of an 2-aminoaryl ketone with an activated α-CH acid such as cyclic or acyclic β-dicarbonyl or cyclic ketone compds. under solvent-free conditions with high yields within several minutes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVzMAFyqorIrVg90H21EOLACvtfcHk0lgntH0fhj-LJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlSqtrg%253D&md5=c774b59c1cbc2013dedd25de377e9639</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F00397910601055230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910601055230%26sid%3Dliteratum%253Aachs%26aulast%3DShaabani%26aufirst%3DA.%26aulast%3DSoleimani%26aufirst%3DE.%26aulast%3DBadri%26aufirst%3DZ.%26atitle%3DTriflouroacetic%2520acid%2520as%2520an%2520efficient%2520catalyst%2520for%2520the%2520synthesis%2520of%2520quinoline%26jtitle%3DSynth.%2520Commun.%26date%3D2007%26volume%3D37%26spage%3D629%26epage%3D635%26doi%3D10.1080%2F00397910601055230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zalila, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Fadili, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desponds, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaff, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasel, N.</span></span> <span> </span><span class="NLM_article-title">Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in <i>Leishmania major</i></span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2010.07443.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1111%2Fj.1365-2958.2010.07443.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21166905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=222-239&author=H.+Zalilaauthor=I.+J.+Gonz%C3%A1lezauthor=A.+K.+El-Fadiliauthor=M.+B.+Delgadoauthor=C.+Despondsauthor=C.+Schaffauthor=N.+Fasel&title=Processing+of+metacaspase+into+a+cytoplasmic+catalytic+domain+mediating+cell+death+in+Leishmania+major&doi=10.1111%2Fj.1365-2958.2010.07443.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of metacaspase into a cytoplasmic catalytic domain mediating cell death in Leishmania major</span></div><div class="casAuthors">Zalila, Habib; Gonzalez, Iveth J.; El-Fadili, Amal Kuendig; Delgado, Maria Belen; Desponds, Chantal; Schaff, Cedric; Fasel, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">222-239</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Metacaspases are cysteine peptidases that could play a role similar to caspases in the cell death program of plants, fungi and protozoa.  The human protozoan parasite Leishmania major expresses a single metacaspase (LmjMCA) harboring a central domain with the catalytic dyad histidine and cysteine as found in caspases.  In this study, we investigated the processing sites important for the maturation of LmjMCA catalytic domain, the cellular localization of LmjMCA polypeptides, and the functional role of the catalytic domain in the cell death pathway of Leishmania parasites.  Although LmjMCA polypeptide precursor form harbors a functional mitochondrial localization signal (MLS), we detd. that LmjMCA polypeptides are mainly localized in the cytoplasm.  In stress conditions, LmjMCA precursor forms were extensively processed into sol. forms contg. the catalytic domain.  This domain was sufficient to enhance sensitivity of parasites to hydrogen peroxide by impairing the mitochondrion.  These data provide exptl. evidences of the importance of LmjMCA processing into an active catalytic domain and of its role in disrupting mitochondria, which could be relevant in the design of new drugs to fight leishmaniasis and likely other protozoan parasitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOQrLYvT3z27Vg90H21EOLACvtfcHk0lgntH0fhj-LJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGrurs%253D&md5=043857c6d1cd7e5d794b8fb7d48389e7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2010.07443.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2010.07443.x%26sid%3Dliteratum%253Aachs%26aulast%3DZalila%26aufirst%3DH.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DI.%2BJ.%26aulast%3DEl-Fadili%26aufirst%3DA.%2BK.%26aulast%3DDelgado%26aufirst%3DM.%2BB.%26aulast%3DDesponds%26aufirst%3DC.%26aulast%3DSchaff%26aufirst%3DC.%26aulast%3DFasel%26aufirst%3DN.%26atitle%3DProcessing%2520of%2520metacaspase%2520into%2520a%2520cytoplasmic%2520catalytic%2520domain%2520mediating%2520cell%2520death%2520in%2520Leishmania%2520major%26jtitle%3DMol.%2520Microbiol.%26date%3D2011%26volume%3D79%26spage%3D222%26epage%3D239%26doi%3D10.1111%2Fj.1365-2958.2010.07443.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaisankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumder, H. K.</span></span> <span> </span><span class="NLM_article-title">Disuccinyl betulin triggers metacaspase-dependent endonuclease g-mediated cell death in unicellular protozoan parasite <i>Leishmania donovani</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2186</span>– <span class="NLM_lpage">2201</span>, <span class="refDoi"> DOI: 10.1128/aac.02193-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.02193-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24468787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVSls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=2186-2201&author=S.+Chowdhuryauthor=T.+Mukherjeeauthor=S.+R.+Chowdhuryauthor=S.+Senguptaauthor=S.+Mukhopadhyayauthor=P.+Jaisankarauthor=H.+K.+Majumder&title=Disuccinyl+betulin+triggers+metacaspase-dependent+endonuclease+g-mediated+cell+death+in+unicellular+protozoan+parasite+Leishmania+donovani&doi=10.1128%2Faac.02193-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Disuccinyl betulin triggers metacaspase-dependent endonuclease G-mediated cell death in unicellular protozoan parasite Leishmania donovani</span></div><div class="casAuthors">Chowdhury, Sayan; Mukherjee, Tulika; Chowdhury, Somenath Roy; Sengupta, Souvik; Mukhopadhyay, Sibabrata; Jaisankar, Parasuraman; Majumder, Hemanta K.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2186-2201, 17 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The unicellular organism Leishmania undergoes apoptosis-like cell death in response to external stress or exposure to antileishmanial agents.  Here, we showed that 3-O,28-O-disuccinyl betulin (DiSB), a potent topoisomerase type IB inhibitor, induced parasitic cell death by generating oxidative stress.  The characteristic feature of the death process resembled the programmed cell death (PCD) seen in higher eukaryotes.  In the current study, the generation of reactive oxygen species (ROS), followed by the depolarization of mitochondrial membrane potential (ΔΨm), caused a loss in ATP prodn. in Leishmania parasites.  This further gave pos. feedback to produce a large amt. of ROS, which in turn caused oxidative DNA lesions and genomic DNA fragmentation.  The treatment of promastigotes with DiSB induced high expression levels of metacaspase protein that led to cell death in this unicellular organism.  The PCD was insensitive to benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD-fmk), suggesting that the death process was not assocd. with the activation of caspases.  DiSB treatment translocated Leishmania donovani endonuclease G (LdEndoG) from mitochondria to the nucleus, which was responsible for the DNA degrdn. process.  Conditional antisense knockdown of L. donovani metacaspase (LdMC), as well as EndoG, -subverted death of the parasite and rescued cell cycle arrest in G1 phase.  The present study on the effector mols. assocd. with the PCD pathway of the parasite should help to manifest the mechanisms of PCD and also might be exploited in antileishmanial chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruBDSKpSSWNbVg90H21EOLACvtfcHk0lgZJ6ATmzRPSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVSls7c%253D&md5=94babff29a54bce89b74c94f2f1202df</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2Faac.02193-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.02193-13%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DMukherjee%26aufirst%3DT.%26aulast%3DChowdhury%26aufirst%3DS.%2BR.%26aulast%3DSengupta%26aufirst%3DS.%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DJaisankar%26aufirst%3DP.%26aulast%3DMajumder%26aufirst%3DH.%2BK.%26atitle%3DDisuccinyl%2520betulin%2520triggers%2520metacaspase-dependent%2520endonuclease%2520g-mediated%2520cell%2520death%2520in%2520unicellular%2520protozoan%2520parasite%2520Leishmania%2520donovani%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D2186%26epage%3D2201%26doi%3D10.1128%2Faac.02193-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gannavaram, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvapandiyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debrabant, A.</span></span> <span> </span><span class="NLM_article-title">Characterization of Metacaspases with Trypsin-Like Activity and Their Putative Role in Programmed Cell Death in the Protozoan ParasiteLeishmania</span>. <i>Eukaryotic Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1745</span>– <span class="NLM_lpage">1757</span>, <span class="refDoi"> DOI: 10.1128/ec.00123-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Fec.00123-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=17715367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Smu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1745-1757&author=N.+Leeauthor=S.+Gannavaramauthor=A.+Selvapandiyanauthor=A.+Debrabant&title=Characterization+of+Metacaspases+with+Trypsin-Like+Activity+and+Their+Putative+Role+in+Programmed+Cell+Death+in+the+Protozoan+ParasiteLeishmania&doi=10.1128%2Fec.00123-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of metacaspases with trypsin-like activity and their putative role in programmed cell death in the protozoan parasite Leishmania</span></div><div class="casAuthors">Lee, Nancy; Gannavaram, Sreenivas; Selvapandiyan, Angamuthu; Debrabant, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Eukaryotic Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1745-1757</span>CODEN:
                <span class="NLM_cas:coden">ECUEA2</span>;
        ISSN:<span class="NLM_cas:issn">1535-9778</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In this report, we have characterized two metacaspases of Leishmania donovani, L. donovani metacaspase-1 (LdMC1) and LdMC2.  These two proteins show 98% homol. with each other, and both contain a characteristic C-terminal proline-rich domain.  Both genes are transcribed in promastigotes and axenic amastigotes of L. donovani; however, LdMC1 shows increased mRNA levels in axenic amastigotes.  An anti-LdMC antibody was obtained and showed reactivity with a single ∼42-kDa protein band in both promastigote and axenic amastigote parasite whole-cell lysates by Western blotting.  Pulse-chase expts. suggest that LdMCs are not synthesized as proenzymes, and immunofluorescence studies show that LdMCs are assocd. with the acidocalcisome compartments of L. donovani.  Enzymic assays of immunopptd. LdMCs show that native LdMCs efficiently cleave trypsin substrates and are unable to cleave caspase-specific substrates.  Consistently, LdMC activity is insensitive to caspase inhibitors and is efficiently inhibited by trypsin inhibitors, such as leupeptin, antipain, and Nα-tosyl-L-lysine-chloromethyl ketone (TLCK).  In addn., our results show that LdMC activity was induced in parasites treated with hydrogen peroxide, a known trigger of programmed cell death (PCD) in Leishmania and that parasites overexpressing metacaspases are more sensitive to hydrogen peroxide-induced PCD.  These findings suggest that Leishmania metacaspases are not responsible for the caspase-like activities reported in this organism and suggest a possible role for LdMCs as effector mols. in Leishmania PCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMY4mcGuffRrVg90H21EOLACvtfcHk0lgZJ6ATmzRPSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Smu73E&md5=adc971bcf7476d69c8a5fc8cb738e3ea</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2Fec.00123-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fec.00123-07%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DN.%26aulast%3DGannavaram%26aufirst%3DS.%26aulast%3DSelvapandiyan%26aufirst%3DA.%26aulast%3DDebrabant%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520Metacaspases%2520with%2520Trypsin-Like%2520Activity%2520and%2520Their%2520Putative%2520Role%2520in%2520Programmed%2520Cell%2520Death%2520in%2520the%2520Protozoan%2520ParasiteLeishmania%26jtitle%3DEukaryotic%2520Cell%26date%3D2007%26volume%3D6%26spage%3D1745%26epage%3D1757%26doi%3D10.1128%2Fec.00123-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adak, S.</span></span> <span> </span><span class="NLM_article-title">Endoplasmic reticulum stress-induced apoptosis in leishmania through Ca<sup>2+</sup>-dependent and caspase-independent mechanism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">13638</span>– <span class="NLM_lpage">13646</span>, <span class="refDoi"> DOI: 10.1074/jbc.m110.201889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1074%2Fjbc.m110.201889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21330370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVKmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=13638-13646&author=S.+Dolaiauthor=S.+Palauthor=R.+K.+Yadavauthor=S.+Adak&title=Endoplasmic+reticulum+stress-induced+apoptosis+in+leishmania+through+Ca2%2B-dependent+and+caspase-independent+mechanism&doi=10.1074%2Fjbc.m110.201889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Endoplasmic Reticulum Stress-induced Apoptosis in Leishmania through Ca2+-dependent and Caspase-independent Mechanism</span></div><div class="casAuthors">Dolai, Subhankar; Pal, Swati; Yadav, Rajesh K.; Adak, Subrata</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">13638-13646</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Numerous reports have shown that mitochondrial dysfunctions play a major role in apoptosis of Leishmania parasites, but the endoplasmic reticulum (ER) stress-induced apoptosis in Leishmania remains largely unknown.  In this study, we investigate ER stress-induced apoptotic pathways in Leishmania major using tunicamycin as an ER stress inducer.  ER stress activates the expression of ER-localized chaperone protein BIP/GRP78 (binding protein/identical to the 78-kDa glucose-regulated protein) with concomitant generation of intracellular reactive oxygen species.  Upon exposure to ER stress, the elevation of cytosolic Ca2+ level is obsd. due to release of Ca2+ from internal stores.  Increase in cytosolic Ca2+ causes mitochondrial membrane potential depolarization and ATP loss as ablation of Ca2+ by blocking voltage-gated cation channels with verapamil preserves mitochondrial membrane potential and cellular ATP content.  Furthermore, ER stress-induced reactive oxygen species (ROS)-dependent release of cytochrome c and endonuclease G from mitochondria to cytosol and subsequent translocation of endonuclease G to nucleus are obsd.  Inhibition of caspase-like proteases with the caspase inhibitor benzyloxycarbonyl-VAD-fluoromethyl ketone or metacaspase inhibitor antipain does not prevent nuclear DNA fragmentation and phosphatidylserine exposure.  Conversely, significant protection in tunicamycin-induced DNA degrdn. and phosphatidylserine exposure was achieved by either pretreatment of antioxidants (N-acetyl-L-cysteine, GSH, and L-cysteine), chem. chaperone (4-phenylbutyric acid), or addn. of Ca2+ chelator (1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid-acetoxymethyl ester).  Taken together, these data strongly demonstrate that ER stress-induced apoptosis in L. major is dependent on ROS and Ca2+-induced mitochondrial toxicity but independent of caspase-like proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-5MjZA1-pC7Vg90H21EOLACvtfcHk0lja5xGCxeZfxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVKmu7g%253D&md5=26ec203a8463227be3674197282b8972</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m110.201889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m110.201889%26sid%3Dliteratum%253Aachs%26aulast%3DDolai%26aufirst%3DS.%26aulast%3DPal%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DR.%2BK.%26aulast%3DAdak%26aufirst%3DS.%26atitle%3DEndoplasmic%2520reticulum%2520stress-induced%2520apoptosis%2520in%2520leishmania%2520through%2520Ca2%252B-dependent%2520and%2520caspase-independent%2520mechanism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D13638%26epage%3D13646%26doi%3D10.1074%2Fjbc.m110.201889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reimão, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniwaki, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinconi, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama-Yasunaka, J. K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uliana, S. R. B.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial activity of the estrogen receptor modulator raloxifene</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e2842</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0002842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1371%2Fjournal.pntd.0002842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24810565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SjtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e2842&author=J.+Q.+Reim%C3%A3oauthor=D.+C.+Miguelauthor=N.+N.+Taniwakiauthor=C.+T.+Trinconiauthor=J.+K.+U.+Yokoyama-Yasunakaauthor=S.+R.+B.+Uliana&title=Antileishmanial+activity+of+the+estrogen+receptor+modulator+raloxifene&doi=10.1371%2Fjournal.pntd.0002842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antileishmanial activity of the estrogen receptor modulator raloxifene</span></div><div class="casAuthors">Reimao, Juliana Q.; Miguel, Danilo C.; Taniwaki, Noemi N.; Trinconi, Cristiana T.; Yokoyama-Yasunaka, Jenicer K. U.; Uliana, Silvia R. B.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2842/1-e2842/11, 11</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The treatment of leishmaniasis relies mostly on parenteral drugs with potentially serious adverse effects.  Addnl., parasite resistance in the treatment of leishmaniasis was demonstrated for the majority of drugs available, making the search for more effective and less toxic drugs and treatment regimens a priority for the control of leishmaniasis.  The aims of this study were to evaluate the antileishmanial activity of raloxifene in vitro and in vivo and to investigate its mechanism of action against Leishmania amazonensis.  Raloxifene was shown to possess antileishmanial activity in vitro against several species with EC50 values ranging from 30.2 to 38.0 mM against promastigotes and from 8.8 to 16.2 μM against intracellular amastigotes.  Raloxifene's mechanism of action was investigated through transmission electron microscopy and labeling with propidium iodide, DiSBAC2(3), rhodamine 123, and monodansylcadaverine.  Microscopic examns. showed that raloxifene treated parasites displayed autophagosomes and mitochondrial damage while the plasma membrane remained continuous.  Nonetheless, plasma membrane potential was rapidly altered upon raloxifene treatment with initial hyperpolarization followed by depolarization.  Loss of mitochondrial membrane potential was also verified.  Treatment of L. amazonensis - infected BALB/c mice with raloxifene led to significant decrease in lesion size and parasite burden.  The results of this work extend the investigation of selective estrogen receptor modulators as potential candidates for leishmaniasis treatment.  The antileishmanial activity of raloxifene was demonstrated in vitro and in vivo.  Raloxifene produces functional disorder on the plasma membrane of L. amazonensis promastigotes and leads to functional and morphol. disruption of mitochondria, which culminate in cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBJXO7S2QB-rVg90H21EOLACvtfcHk0lja5xGCxeZfxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SjtLbL&md5=0a795c1239e6fb1fc80f2d4b10a72883</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0002842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0002842%26sid%3Dliteratum%253Aachs%26aulast%3DReim%25C3%25A3o%26aufirst%3DJ.%2BQ.%26aulast%3DMiguel%26aufirst%3DD.%2BC.%26aulast%3DTaniwaki%26aufirst%3DN.%2BN.%26aulast%3DTrinconi%26aufirst%3DC.%2BT.%26aulast%3DYokoyama-Yasunaka%26aufirst%3DJ.%2BK.%2BU.%26aulast%3DUliana%26aufirst%3DS.%2BR.%2BB.%26atitle%3DAntileishmanial%2520activity%2520of%2520the%2520estrogen%2520receptor%2520modulator%2520raloxifene%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De2842%26doi%3D10.1371%2Fjournal.pntd.0002842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca-Silva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inacio, J. D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canto-Cavalheiro, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almeida-Amaral, E. E.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in <i>Leishmania amazonensis</i></span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e14666</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0014666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1371%2Fjournal.pone.0014666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=21346801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitlOqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e14666&author=F.+Fonseca-Silvaauthor=J.+D.+F.+Inacioauthor=M.+M.+Canto-Cavalheiroauthor=E.+E.+Almeida-Amaral&title=Reactive+oxygen+species+production+and+mitochondrial+dysfunction+contribute+to+quercetin+induced+death+in+Leishmania+amazonensis&doi=10.1371%2Fjournal.pone.0014666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis</span></div><div class="casAuthors">Fonseca-Silva, Fernanda; Inacio, Job D. F.; Canto-Cavalheiro, Marilene M.; Almeida-Amaral, Elmo Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e14666</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Leishmaniasis, a parasitic disease caused by protozoa of the genus Leishmania, affects more than 12 million people worldwide.  Quercetin has generated considerable interest as a pharmaceutical compd. with a wide range of therapeutic activities.  One such activity is exhibited against the bloodstream parasite Trypanosoma brucei and amastigotes of Leishmania donovani.  However, the mechanism of protozoan action of quercetin has not been studied.  Methodol./Principal Findings: In the present study, we report here the mechanism for the antileishmanial activity of quercetin against Leishmania amazonensis promastigotes.  Quercetin inhibited L. amazonensis promastigote growth in a dose- and time- dependent manner beginning at 48 h of treatment and with max. growth inhibition obsd. at 96 h.  The IC50 for quercetin at 48 h was 31.4 μM.  Quercetin increased ROS generation in a dose-dependent manner after 48 h of treatment.  The antioxidant GSH and NAC each significantly reduced quercetin-induced cell death.  In addn., quercetin caused mitochondrial dysfunction due to collapse of mitochondrial membrane potential.  Conclusions/Significance: The effects of several drugs that interfere directly with mitochondrial physiol. in parasites such as Leishmania have been described.  The unique mitochondrial features of Leishmania make this organelle an ideal drug target while minimizing toxicity.  Quercetin has been described as a pro-oxidant, generating ROS which are responsible for cell death in some cancer cells.  Mitochondrial membrane potential loss can be brought about by ROS added directly in vitro or induced by chem. agents.  Taken together, our results demonstrate that quercetin eventually exerts its antileishmanial effect on L. amazonensis promastigotes due to the generation of ROS and disrupted parasite mitochondrial function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovyf7ofWnI67Vg90H21EOLACvtfcHk0lja5xGCxeZfxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitlOqsrk%253D&md5=2409cab097fcbf3fec0ea81831a4a0c2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0014666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0014666%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca-Silva%26aufirst%3DF.%26aulast%3DInacio%26aufirst%3DJ.%2BD.%2BF.%26aulast%3DCanto-Cavalheiro%26aufirst%3DM.%2BM.%26aulast%3DAlmeida-Amaral%26aufirst%3DE.%2BE.%26atitle%3DReactive%2520oxygen%2520species%2520production%2520and%2520mitochondrial%2520dysfunction%2520contribute%2520to%2520quercetin%2520induced%2520death%2520in%2520Leishmania%2520amazonensis%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De14666%26doi%3D10.1371%2Fjournal.pone.0014666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonchoroff, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perl, A.</span></span> <span> </span><span class="NLM_article-title">Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling</span>. <i>J. Immunol</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">1466</span>– <span class="NLM_lpage">1479</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=9973403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADyaK1MXhtVSmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=1999&pages=1466-1479&author=K.+Bankiauthor=E.+Hutterauthor=N.+J.+Gonchoroffauthor=A.+Perl&title=Elevation+of+mitochondrial+transmembrane+potential+and+reactive+oxygen+intermediate+levels+are+early+events+and+occur+independently+from+activation+of+caspases+in+Fas+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling</span></div><div class="casAuthors">Banki, Katalin; Hutter, Eliza; Gonchoroff, Nick J.; Perl, Andras</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1466-1479</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Stimulation of the CD95/Fas/Apo-1 receptor leads to apoptosis through activation of the caspase family of cysteine proteases and disruption of the mitochondrial transmembrane potential (Δψm).  We show that, in Jurkat human T cells and peripheral blood lymphocytes, Fas-induced apoptosis is preceded by 1) an increase in reactive oxygen intermediates (ROI) and 2) an elevation of Δψm.  These events are followed by externalization of phosphatidylserine (PS), disruption of Δψm, and cell death.  The caspase inhibitor peptides, DEVD-CHO, Z-VAD.fmk, and Boc-Asp.fmk, blocked Fas-induced PS externalization, disruption of Δψm, and cell death, suggesting that these events are sequelae of caspase activation.  By contrast, in the presence of caspase inhibitors, ROI levels and Δψm of Fas-stimulated cells remained elevated.  Because ROI levels and Δψm are regulated by the supply of reducing equiv. from the pentose phosphate pathway (PPP), we studied the impact of transaldolase (TAL), a key enzyme of the PPP, on Fas signaling.  Overexpression of TAL accelerated Fas-induced mitochondrial ROI prodn., Δψm elevation, activation of caspase-8 and caspase-3, proteolysis of poly(A)DP-ribose polymerase, and PS externalization.  Addnl., suppression of TAL diminished these activities.  Therefore, by controlling the balance between mitochondrial ROI prodn. and metabolic supply of reducing equiv. through the PPP, TAL regulates susceptibility to Fas-induced apoptosis.  Early increases in ROI levels and Δψm as well as the dominant effect of TAL expression on activation of caspase-8/Fas-assocd. death domain-like IL-1β-converting enzyme, the most upstream member of the caspase cascade, suggest a pivotal role for redox signaling at the initiation of Fas-mediated apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg2oR-I5qcr7Vg90H21EOLACvtfcHk0lhkG8BnqsZulA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtVSmt78%253D&md5=9acd91942c4bcea2a8b479adebf876f5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanki%26aufirst%3DK.%26aulast%3DHutter%26aufirst%3DE.%26aulast%3DGonchoroff%26aufirst%3DN.%2BJ.%26aulast%3DPerl%26aufirst%3DA.%26atitle%3DElevation%2520of%2520mitochondrial%2520transmembrane%2520potential%2520and%2520reactive%2520oxygen%2520intermediate%2520levels%2520are%2520early%2520events%2520and%2520occur%2520independently%2520from%2520activation%2520of%2520caspases%2520in%2520Fas%2520signaling%26jtitle%3DJ.%2520Immunol%26date%3D1999%26volume%3D162%26spage%3D1466%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akaike, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide and virus infection</span>. <i>Immunology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2567.2000.00142.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1046%2Fj.1365-2567.2000.00142.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11106932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2000&pages=300-308&author=T.+Akaikeauthor=H.+Maeda&title=Nitric+oxide+and+virus+infection&doi=10.1046%2Fj.1365-2567.2000.00142.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide and virus infection</span></div><div class="casAuthors">Akaike, T.; Maeda, H.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">IMMUAM</span>;
        ISSN:<span class="NLM_cas:issn">0019-2805</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 100 refs.  Nitric oxide (NO) has complex and diverse functions in physiol. and pathophysiol. phenomena.  The mechanisms of many events induced by NO are now well defined, so that a fundamental understanding of NO biol. is almost established.  Accumulated evidence suggests that NO and oxygen radicals such as superoxide are key mols. in the pathogenesis of various infectious diseases.  NO biosynthesis, particularly through expression of an inducible NO synthase (iNOS), occurs in a variety of microbial infections.  Although antimicrobial activity of NO is appreciated for bacteria and protozoa, NO has opposing effects in virus infections such as influenza virus pneumonia and certain other neurotropic virus infections.  INOS produces an excessive amt. of NO for long periods, which allows generation of a highly reactive nitrogen oxide species, peroxynitrite, via a radical coupling reaction of NO with superoxide.  Thus, peroxynitrite causes oxidative tissue injury through potent oxidn. and nitration reactions of various biomols.  NO also appears to affect a host's immune response, with immunopathol. consequences.  For example, overprodn. of NO in virus infections in mice is reported to suppress type 1 helper T-cell-dependent immune responses, leading to type 2 helper T-cell-biased immunol. host responses.  Thus, NO may be a host response modulator rather than a simple antiviral agent.  The unique biol. properties of NO are further illustrated by the authors' recent data suggesting that viral mutation and evolution may be accelerated by NO-induced oxidative stress.  Here, the authors discuss these multiple roles of NO in pathogenesis of virus infections as related to both non-specific inflammatory responses and immunol. host reactions modulated by NO during infections in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsp4S51nRXz7Vg90H21EOLACvtfcHk0lhkG8BnqsZulA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslWnurs%253D&md5=0cbd4bb6eba7ab491372b7db76b03722</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2567.2000.00142.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2567.2000.00142.x%26sid%3Dliteratum%253Aachs%26aulast%3DAkaike%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DNitric%2520oxide%2520and%2520virus%2520infection%26jtitle%3DImmunology%26date%3D2000%26volume%3D101%26spage%3D300%26epage%3D308%26doi%3D10.1046%2Fj.1365-2567.2000.00142.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloh, M. U.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">8841</span>– <span class="NLM_lpage">8848</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.16.8841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1073%2Fpnas.97.16.8841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10922044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls12ltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=8841-8848&author=C.+Nathanauthor=M.+U.+Shiloh&title=Reactive+oxygen+and+nitrogen+intermediates+in+the+relationship+between+mammalian+hosts+and+microbial+pathogens&doi=10.1073%2Fpnas.97.16.8841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens</span></div><div class="casAuthors">Nathan, Carl; Shiloh, Michael U.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8841-8848</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review with 108 refs.  This review summarizes recent evidence from knock-out mice on the role of reactive oxygen intermediates and reactive nitrogen intermediates (RNI) in mammalian immunity.  Reflections on redundancy in immunity help explain an apparent paradox: the phagocyte oxidase and inducible nitric oxide synthase are each nonredundant, and yet also mutually redundant, in host defense.  In combination, the contribution of these two enzymes appears to be greater than previously appreciated.  The remainder of this review focuses on a relatively new field, the basis of microbial resistance to RNI.  Exptl. tuberculosis provides an important example of an extended, dynamic balance between host and pathogen in which RNI play a major role.  In diseases such as tuberculosis, a mol. understanding of host-pathogen interactions requires characterization of the defenses used by microbes against RNI, analogous to our understanding of defenses against reactive oxygen intermediates.  Genetic and biochem. approaches have identified candidates for RNI-resistance genes in Mycobacterium tuberculosis and other pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgw49tYRs8cbVg90H21EOLACvtfcHk0lhkG8BnqsZulA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls12ltLo%253D&md5=5e6589928a67892c82daa76a107c328b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.16.8841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.16.8841%26sid%3Dliteratum%253Aachs%26aulast%3DNathan%26aufirst%3DC.%26aulast%3DShiloh%26aufirst%3DM.%2BU.%26atitle%3DReactive%2520oxygen%2520and%2520nitrogen%2520intermediates%2520in%2520the%2520relationship%2520between%2520mammalian%2520hosts%2520and%2520microbial%2520pathogens%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D8841%26epage%3D8848%26doi%3D10.1073%2Fpnas.97.16.8841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunet, L. R.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide in parasitic infections</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1457</span>– <span class="NLM_lpage">1467</span>, <span class="refDoi"> DOI: 10.1016/s1567-5769(01)00090-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fs1567-5769%2801%2900090-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=11515811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFSmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=1457-1467&author=L.+R.+Brunet&title=Nitric+oxide+in+parasitic+infections&doi=10.1016%2Fs1567-5769%2801%2900090-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide in parasitic infections</span></div><div class="casAuthors">Brunet, Laura Rosa</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1457-1467</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with refs.  Nitric oxide (NO) is implicated as an integral component of the host armament against invading parasites.  Strongest evidence has come from lab. models of protozoan infections.  During malaria, toxoplasmosis and leishmaniasis, to name just a few, the preferential prodn. of pro-inflammatory cytokines predisposes to the increased synthesis of NO, which mediates host protection through either direct parasite killing or by limiting parasite growth.  More recently, evidence has been put forward for a beneficial role of NO during helminthic infections.  In the case of Schistosomiasis mansoni, for example, NO plays a role in regulation of egg-induced inflammation, preventing hepatocyte death and widespread tissue damage.  In spite of these findings, rather than being the ultimate panacea, NO prodn. requires tight control to limit cytotoxic damage to the host's own cells.  Unregulated prodn. may lead to a variety of damaging effects including alterations to normal neurol. functions during cerebral malaria and intestinal pathol. during trichinosis.  In this review, I will summarize the role of NO during a no. of parasitic infections, drawing on specific examples of disease caused by protozoan and metazoan parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmTB45_qWsbLVg90H21EOLACvtfcHk0lhM-A2rC-a_RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFSmt74%253D&md5=6f3db0441c98b86f696967244230ea17</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fs1567-5769%2801%2900090-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1567-5769%252801%252900090-x%26sid%3Dliteratum%253Aachs%26aulast%3DBrunet%26aufirst%3DL.%2BR.%26atitle%3DNitric%2520oxide%2520in%2520parasitic%2520infections%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2001%26volume%3D1%26spage%3D1457%26epage%3D1467%26doi%3D10.1016%2Fs1567-5769%2801%2900090-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockett, K. A.</span></span> <span> </span><span class="NLM_article-title">Nitric oxide and parasitic disease</span>. <i>Adv. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/s0065-308x(08)60218-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fs0065-308x%2808%2960218-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=8881597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADyaK2s%252FjsF2nuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=1-56&author=I.+A.+Clarkauthor=K.+A.+Rockett&title=Nitric+oxide+and+parasitic+disease&doi=10.1016%2Fs0065-308x%2808%2960218-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide and parasitic disease</span></div><div class="casAuthors">Clark I A; Rockett K A</div><div class="citationInfo"><span class="NLM_cas:title">Advances in parasitology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-56</span>
        ISSN:<span class="NLM_cas:issn">0065-308X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjBJbJGv_aUiCEBeYuoi7AfW6udTcc2eY2bH0u1m2yNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FjsF2nuw%253D%253D&md5=a724770d14a2ed6b58f44ef94fc5fec2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fs0065-308x%2808%2960218-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0065-308x%252808%252960218-3%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DI.%2BA.%26aulast%3DRockett%26aufirst%3DK.%2BA.%26atitle%3DNitric%2520oxide%2520and%2520parasitic%2520disease%26jtitle%3DAdv.%2520Parasitol.%26date%3D1996%26volume%3D37%26spage%3D1%26epage%3D56%26doi%3D10.1016%2Fs0065-308x%2808%2960218-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span> <span> </span><span class="NLM_article-title">Assessing the essentiality of <i>Leishmania donovani</i> nitroreductase and its role in nitro drug activation</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1128/aac.01788-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.01788-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=23208716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVCrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=901-906&author=S.+Wyllieauthor=S.+Pattersonauthor=A.+H.+Fairlamb&title=Assessing+the+essentiality+of+Leishmania+donovani+nitroreductase+and+its+role+in+nitro+drug+activation&doi=10.1128%2Faac.01788-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activation</span></div><div class="casAuthors">Wyllie, Susan; Patterson, Stephen; Fairlamb, Alan H.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">901-906</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The nitroimidazole fexinidazole has potential as a safe and effective oral drug therapy for the treatment of visceral leishmaniasis.  To date, nitroheterocyclics have not been used in the treatment of leishmaniasis, and relatively little is known about their mechanism of action.  In African trypanosomes, nitro drugs are reductively activated by a type I nitroreductase (NTR), absent in mammalian cells.  Modulation of nitroreductase levels in Trypanosoma brucei directly affected sensitivity to nitro compds., with reduced concns. of the enzyme leading to moderate nitro drug resistance.  In view of the progression of fexinidazole into clin. development for visceral leishmaniasis, here the authors assess the essentiality of the nitroreductase in Leishmania donovani and the effect of modulating nitroreductase levels on susceptibility to fexinidazole.  The failure to directly replace both endogenous copies of the NTR gene, except in the presence of an ectopic copy of the gene, suggests that the NTR gene is essential for the growth and survival of L. donovani promastigotes.  Loss of a single chromosomal copy of the L. donovani NTR gene resulted in parasites that were mildly resistant (<2-fold) to the predominant in vivo metabolite of fexinidazole, while parasites overexpressing NTR were 18-fold more susceptible.  Leishmania NTR plays a pivotal role in fexinidazole activation.  Reliance on a single enzyme for prodrug activation may leave fexinidazole vulnerable to the emergence of drug resistance.  However, the essentiality of the NTR in L. donovani promastigotes, combined with the limited resistance shown by NTR single knockout cells, suggests that the potential for the spread of NTR-based resistance to fexinidazole may be limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg4Xp29BI2LVg90H21EOLACvtfcHk0lhM-A2rC-a_RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVCrur8%253D&md5=36c765efc47253bfabbadf48c2b9a9f7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2Faac.01788-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.01788-12%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26atitle%3DAssessing%2520the%2520essentiality%2520of%2520Leishmania%2520donovani%2520nitroreductase%2520and%2520its%2520role%2520in%2520nitro%2520drug%2520activation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D901%26epage%3D906%26doi%3D10.1128%2Faac.01788-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kucuksayan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozben, T.</span></span> <span> </span><span class="NLM_article-title">Hybrid compounds as multitarget directed anticancer agents</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">907</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160927155515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.2174%2F1568026616666160927155515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27697050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFems74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=907-918&author=E.+Kucuksayanauthor=T.+Ozben&title=Hybrid+compounds+as+multitarget+directed+anticancer+agents&doi=10.2174%2F1568026616666160927155515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Hybrid Compounds as Multitarget Directed Anticancer Agents</span></div><div class="casAuthors">Kucuksayan, Ertan; Ozben, Tomris</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">907-918</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Cancer is a multifactorial disease including interactions of complex genetic and environmental factors.  Clin. efficacy of anticancer chemotherapies is hampered by various factors including multidrug resistance (MDR).  There is a strong need to discover more potent novel cancer drugs to kill cancer cells selectively.  The recent new strategy for cancer treatment involves the design and synthesis of hybrid compds. as multitargeted anticancer agents.  In this review, we focus on studies using hybrid compds. which were designed and synthesized from two or more different bioactive moieties conjugating them into a single hybrid drug.  Hybrid compds. having more than a single target have been considered as more efficient and potent anticancer agents, since it is almost impossible to destroy cancer cells with a single target.  Hybrid compds. overcome many disadvantages of single cancer drugs such as low soly., adverse effects, and multi drug resistance.  We have compiled the data of recent studies using the new hybrid anticancer drugs in cancer treatment.  Thus, the design, synthesis and clin. trials of new hybrid compds. should be continued and supported in future.  Results of recent studies have proved that they have a great potential to be used as novel anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJOJ7wNU8XJLVg90H21EOLACvtfcHk0lhM-A2rC-a_RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFems74%253D&md5=9018c95a6277fc3fdafa47514587efff</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160927155515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160927155515%26sid%3Dliteratum%253Aachs%26aulast%3DKucuksayan%26aufirst%3DE.%26aulast%3DOzben%26aufirst%3DT.%26atitle%3DHybrid%2520compounds%2520as%2520multitarget%2520directed%2520anticancer%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D907%26epage%3D918%26doi%3D10.2174%2F1568026616666160927155515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannecouque, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span> <span> </span><span class="NLM_article-title">Anti-hiv drug discovery and development: Current innovations and future trends</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2849</span>– <span class="NLM_lpage">2878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00497</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00497" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCjur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2849-2878&author=P.+Zhanauthor=C.+Pannecouqueauthor=E.+De+Clercqauthor=X.+Liu&title=Anti-hiv+drug+discovery+and+development%3A+Current+innovations+and+future+trends&doi=10.1021%2Facs.jmedchem.5b00497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends</span></div><div class="casAuthors">Zhan, Peng; Pannecouque, Christophe; De Clercq, Erik; Liu, Xinyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2849-2878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains, poor bioavailability, and cumulative toxicities, and so there is a need for alternative strategies of antiretroviral drug discovery and addnl. therapeutic agents with novel action modes or targets.  From this perspective, we first review current strategies of antiretroviral drug discovery and optimization, with the aid of selected examples from the recent literature.  We highlight the development of phosphate ester-based prodrugs as a means to improve the aq. soly. of HIV inhibitors, and the introduction of the substrate envelope hypothesis as a new approach for overcoming HIV drug resistance.  Finally, we discuss future directions for research, including opportunities for exploitation of novel antiretroviral targets, and the strategy of activation of latent HIV reservoirs as a means to eradicate the virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3sWUJPJgQN7Vg90H21EOLACvtfcHk0ljEP4HhP9z0SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCjur3E&md5=de3f5aee273b0dd6f7e84e20410d06d7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00497%26sid%3Dliteratum%253Aachs%26aulast%3DZhan%26aufirst%3DP.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DAnti-hiv%2520drug%2520discovery%2520and%2520development%253A%2520Current%2520innovations%2520and%2520future%2520trends%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2849%26epage%3D2878%26doi%3D10.1021%2Facs.jmedchem.5b00497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yepes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agut, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vélez, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardona, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robledo, S. M.</span></span> <span> </span><span class="NLM_article-title">Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2017.09.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=29028533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=73-83&author=E.+Oteroauthor=E.+Garc%C3%ADaauthor=G.+Palaciosauthor=L.+M.+Yepesauthor=M.+Cardaauthor=R.+Agutauthor=I.+D.+V%C3%A9lezauthor=W.+I.+Cardonaauthor=S.+M.+Robledo&title=Triclosan-caffeic+acid+hybrids%3A+Synthesis%2C+leishmanicidal%2C+trypanocidal+and+cytotoxic+activities&doi=10.1016%2Fj.ejmech.2017.09.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities</span></div><div class="casAuthors">Otero, Elver; Garcia, Elisa; Palacios, Genesis; Yepes, Lina M.; Carda, Miguel; Agut, Raul; Velez, Ivan D.; Cardona, Wilson I.; Robledo, Sara M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73-83</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis, cytotoxicity, anti-leishmanial and anti-trypanosomal activities of twelve triclosan-caffeic acid hybrids are described herein.  The structure of the synthesized products was elucidated by a combination of spectrometric analyses.  The synthesized compds. were evaluated against amastigotes forms of L. (V) panamensis, which is the most prevalent Leishmania species in Colombia, and against Trypanosoma cruzi, which is the pathogenic species to humans.  Cytotoxicity was evaluated against human U-937 macrophages.  Eight compds. were active against L.(V) panamensis and eight of them against T. cruzi with EC50 values <40 μM.  Most of the compds. showed antiprotozoal activity and with exception of 3-(5-Chloro-2-(2,4-dichlorophenoxy)phenoxy)propyl (E)-3(3,4-dihydroxyphenyl)prop-2-enoate, 3-(5-Chloro-2-(2,4-dichlorophenoxy)phenoxy)propyl (E)-3(3,4-dimethoxyphenyl)prop-2-enoate and 7-(5-Chloro-2-(2,4-dichlorophenoxy)phenoxy)heptyl (E)-3(3,4-dimethoxyphenyl)prop-2-enoate, the remaining compds. were toxic for mammalian cells, yet they have potential to be considered as candidates for anti-trypanosomal and anti-leishmanial drug development.  The activity is dependent on the length of the alkyl linker with compd. 4-(5-Chloro-2-(2,4-dichlorophenoxy)phenoxy)butyl(E)-3(3,4-dihydroxyphenyl)prop-2-enoate, bearing a four-carbon alkyl chain, the most performing hybrid.  In general, hydroxyl groups increase both activity and cytotoxicity and the presence of the double bond in the side chain is not decisive for cytotoxicity and antiprotozoal activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrts5tpwO8g7rVg90H21EOLACvtfcHk0ljEP4HhP9z0SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1GmurvN&md5=26c3cb38fd18d986d78cdc536a2d27ac</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.064%26sid%3Dliteratum%253Aachs%26aulast%3DOtero%26aufirst%3DE.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DE.%26aulast%3DPalacios%26aufirst%3DG.%26aulast%3DYepes%26aufirst%3DL.%2BM.%26aulast%3DCarda%26aufirst%3DM.%26aulast%3DAgut%26aufirst%3DR.%26aulast%3DV%25C3%25A9lez%26aufirst%3DI.%2BD.%26aulast%3DCardona%26aufirst%3DW.%2BI.%26aulast%3DRobledo%26aufirst%3DS.%2BM.%26atitle%3DTriclosan-caffeic%2520acid%2520hybrids%253A%2520Synthesis%252C%2520leishmanicidal%252C%2520trypanocidal%2520and%2520cytotoxic%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D141%26spage%3D73%26epage%3D83%26doi%3D10.1016%2Fj.ejmech.2017.09.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baquedano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espuelas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguewa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Font, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Ruiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palop, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanmartín, C.</span></span> <span> </span><span class="NLM_article-title">Novel hybrid selenosulfonamides as potent antileishmanial agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.12.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2013.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24448421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlyitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=116-123&author=Y.+Baquedanoauthor=E.+Morenoauthor=S.+Espuelasauthor=P.+Nguewaauthor=M.+Fontauthor=K.+J.+Gutierrezauthor=A.+Jim%C3%A9nez-Ruizauthor=J.+A.+Palopauthor=C.+Sanmart%C3%ADn&title=Novel+hybrid+selenosulfonamides+as+potent+antileishmanial+agents&doi=10.1016%2Fj.ejmech.2013.12.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Novel hybrid selenosulfonamides as potent antileishmanial agents</span></div><div class="casAuthors">Baquedano, Ylenia; Moreno, Esther; Espuelas, Socorro; Nguewa, Paul; Font, Maria; Gutierrez, Kilian Jesus; Jimenez-Ruiz, Antonio; Palop, Juan Antonio; Sanmartin, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">116-123</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Diselenide and sulfonamide derivs. have recently attracted considerable interest as leishmanicidal agents in drug discovery.  In this study, a novel series of sixteen hybrid selenosulfonamides has been synthesized and screened for their in vitro activity against Leishmania infantum intracellular amastigotes and THP-1 cells.  These assays revealed that most of the compds. exhibited antileishmanial activity in the low micromolar range and led us to identify three lead compds. with IC50 values ranging from 0.83-1.47 μM and selectivity indexes (SI) over 17, much higher than those obsd. for the ref. drugs miltefosine and edelfosine.  When evaluated against intracellular amastigotes, the most active compd. (IC50 = 2.8 μM), showed higher activity and much less toxicity against THP-1 cells than edelfosine.  These compds. could potentially serve as templates for future drug-optimization and drug-development efforts for their use as therapeutic agents in developing countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRo75gUYjPALVg90H21EOLACvtfcHk0ljEP4HhP9z0SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlyitb4%253D&md5=3f59d79b9fe230dc379a791b8b8ff98e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DBaquedano%26aufirst%3DY.%26aulast%3DMoreno%26aufirst%3DE.%26aulast%3DEspuelas%26aufirst%3DS.%26aulast%3DNguewa%26aufirst%3DP.%26aulast%3DFont%26aufirst%3DM.%26aulast%3DGutierrez%26aufirst%3DK.%2BJ.%26aulast%3DJim%25C3%25A9nez-Ruiz%26aufirst%3DA.%26aulast%3DPalop%26aufirst%3DJ.%2BA.%26aulast%3DSanmart%25C3%25ADn%26aufirst%3DC.%26atitle%3DNovel%2520hybrid%2520selenosulfonamides%2520as%2520potent%2520antileishmanial%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D74%26spage%3D116%26epage%3D123%26doi%3D10.1016%2Fj.ejmech.2013.12.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Somaratne, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranawaka, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaruwan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wipuladasa, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Silva, S. H. P.</span></span> <span> </span><span class="NLM_article-title">Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in <i>Leishmania donovani</i> cutaneous leishmaniasis</span>. <i>J. Dermatol. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1080/09546634.2018.1472738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1080%2F09546634.2018.1472738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=29764246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtV2gu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=87-91&author=V.+N.+Somaratneauthor=R.+R.+Ranawakaauthor=H.+M.+Jayaruwanauthor=D.+M.+Wipuladasaauthor=S.+H.+P.+de+Silva&title=Randomized%2C+double-blind+study+on+intralesional+metronidazole+versus+intralesional+sodium+stibogluconate+in+Leishmania+donovani+cutaneous+leishmaniasis&doi=10.1080%2F09546634.2018.1472738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis</span></div><div class="casAuthors">Somaratne, Vijani N.; Ranawaka, Ranthilaka R.; Jayaruwan, H. M.; Wipuladasa, D. M.; de Silva, S. H. Padmal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Treatment</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-91</span>CODEN:
                <span class="NLM_cas:coden">JDTREY</span>;
        ISSN:<span class="NLM_cas:issn">0954-6634</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The aim of our study was to assess the efficacy of intralesional metronidazole on Leishmania donovani cutaneous leishmaniasis (CL).  A total of 188 patients with CL were randomly allocated to intralesional sodium stibogluconate (SSG) and intralesional metronidazole.  Cure was assessed after 1-10 injections.  Cure rates were assessed for statistical significance using chi-square test at p = .05 level (SLCTR/2014/028).  When the treatment cutoff was taken at 100%, the rate of cure for SSG (n = 64, 65.6%) was higher than that of metronidazole (n = 45, 48.9%): statistically significant at p < .05 level (Yates cor. chi-square 5.37, df = 1, p < .5).  When the treatment cutoff was taken at >80%, the rate of cure for SSG (n = 75, 77.1%) was also higher than that of metronidazole (n = 58, 63.0%): statistically significant at p < .05 level (Yates cor. chi-square 4.46, df = 1, p < .5).  Since it is based on a smaller sample, we estd. the statistical power of the test at a cutoff of 100% [above 80%] results identified a risk ratio of 1.4 [1.3], and a statistical power based on normal approxn. at 74.8% [70.0%], resp.  This study showed that intralesional SSG has the best response against CL, while intralesional metronidazole was an effective alternative treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs0EZkmfPH1rVg90H21EOLACvtfcHk0li9WxNAFnKBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtV2gu7zO&md5=57fbb127bc146acdefc1394efa594a1d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F09546634.2018.1472738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09546634.2018.1472738%26sid%3Dliteratum%253Aachs%26aulast%3DSomaratne%26aufirst%3DV.%2BN.%26aulast%3DRanawaka%26aufirst%3DR.%2BR.%26aulast%3DJayaruwan%26aufirst%3DH.%2BM.%26aulast%3DWipuladasa%26aufirst%3DD.%2BM.%26aulast%3Dde%2BSilva%26aufirst%3DS.%2BH.%2BP.%26atitle%3DRandomized%252C%2520double-blind%2520study%2520on%2520intralesional%2520metronidazole%2520versus%2520intralesional%2520sodium%2520stibogluconate%2520in%2520Leishmania%2520donovani%2520cutaneous%2520leishmaniasis%26jtitle%3DJ.%2520Dermatol.%2520Treat.%26date%3D2019%26volume%3D30%26spage%3D87%26epage%3D91%26doi%3D10.1080%2F09546634.2018.1472738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gangneux, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dullin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulahian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garin, Y. J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derouin, F.</span></span> <span> </span><span class="NLM_article-title">Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by <i>Leishmania infantum</i></span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">174</span>, <span class="refDoi"> DOI: 10.1128/aac.43.1.172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.43.1.172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=9869587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADyaK1MXpvFGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1999&pages=172-174&author=J.-P.+Gangneuxauthor=M.+Dullinauthor=A.+Sulahianauthor=Y.+J.-F.+Garinauthor=F.+Derouin&title=Experimental+evaluation+of+second-line+oral+treatments+of+visceral+leishmaniasis+caused+by+Leishmania+infantum&doi=10.1128%2Faac.43.1.172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum</span></div><div class="casAuthors">Gangneux, Jean-Pierre; Dullin, Michael; Sulahian, Annie; Garin, Yves Jean-Francois; Derouin, Francis</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">172-174</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In a murine model of Leishmania infantum visceral leishmaniasis, metronidazole, ketoconazole, fluconazole, itraconazole, and terbinafine were less effective than antimonial agents in reducing hepatic parasite load.  Ketoconazole potentiated the effect of meglumine antimoniate ref. therapy through its marked activity against spleen infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1v0O2D2RmLVg90H21EOLACvtfcHk0li9WxNAFnKBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXpvFGmug%253D%253D&md5=ae65e257ae1e318a080bc43d97eeccce</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1128%2Faac.43.1.172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.43.1.172%26sid%3Dliteratum%253Aachs%26aulast%3DGangneux%26aufirst%3DJ.-P.%26aulast%3DDullin%26aufirst%3DM.%26aulast%3DSulahian%26aufirst%3DA.%26aulast%3DGarin%26aufirst%3DY.%2BJ.-F.%26aulast%3DDerouin%26aufirst%3DF.%26atitle%3DExperimental%2520evaluation%2520of%2520second-line%2520oral%2520treatments%2520of%2520visceral%2520leishmaniasis%2520caused%2520by%2520Leishmania%2520infantum%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1999%26volume%3D43%26spage%3D172%26epage%3D174%26doi%3D10.1128%2Faac.43.1.172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">del
Estal, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moya, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucero, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salgado, R.</span></span> <span> </span><span class="NLM_article-title">Metronidazole therapy for visceral leishmaniasis</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1162</span>, <span class="refDoi"> DOI: 10.1093/clinids/19.6.1161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1093%2Fclinids%2F19.6.1161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=7888556" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=1161-1162&author=P.+L.+del%0AEstalauthor=M.+S.+Moyaauthor=T.+Martinauthor=M.+J.+Luceroauthor=R.+Salgado&title=Metronidazole+therapy+for+visceral+leishmaniasis&doi=10.1093%2Fclinids%2F19.6.1161"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F19.6.1161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F19.6.1161%26sid%3Dliteratum%253Aachs%26aulast%3Ddel%2BEstal%26aufirst%3DP.%2BL.%26aulast%3DMoya%26aufirst%3DM.%2BS.%26aulast%3DMartin%26aufirst%3DT.%26aulast%3DLucero%26aufirst%3DM.%2BJ.%26aulast%3DSalgado%26aufirst%3DR.%26atitle%3DMetronidazole%2520therapy%2520for%2520visceral%2520leishmaniasis%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1994%26volume%3D19%26spage%3D1161%26epage%3D1162%26doi%3D10.1093%2Fclinids%2F19.6.1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianciardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasanella, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foglia Manzillo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliva, G.</span></span> <span> </span><span class="NLM_article-title">The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">492</span>, <span class="refDoi"> DOI: 10.1007/s00436-004-1170-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1007%2Fs00436-004-1170-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=15278443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADC%252BD2cvhtF2gsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=486-492&author=P.+Bianciardiauthor=A.+Fasanellaauthor=V.+Foglia+Manzilloauthor=T.+Trottaauthor=A.+Paganoauthor=S.+Sorinoauthor=L.+Gradoniauthor=G.+Oliva&title=The+efficacy+of+enrofloxacin%2C+alone+or+combined+with+metronidazole%2C+in+the+therapy+of+canine+leishmaniasis&doi=10.1007%2Fs00436-004-1170-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis</span></div><div class="casAuthors">Bianciardi Paolo; Fasanella Antonio; Foglia Manzillo Valentina; Trotta Teresa; Pagano Annalisa; Sorino Simona; Gradoni Luigi; Oliva Gaetano</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">486-92</span>
        ISSN:<span class="NLM_cas:issn">0932-0113</span>.
    </div><div class="casAbstract">We evaluated the efficacy of enrofloxacin, alone or combined with metronidazole, against Leishmania infantum.  The in vitro activity of this fluoroquinolone was assessed using two different methods: a direct test aimed at assessing the drug activity on the parasite, and an indirect test aimed at evaluating the drug effect on macrophage killing, lymphomonocyte activation and nitric oxide production.  An in vivo test was also performed on 36 dogs with leishmaniasis, subdivided into three groups, one treated with enrofloxacin, another with enrofloxacin plus metronidazole, and a control group with meglumine antimoniate.  The direct test did not show any action of enrofloxacin on the parasite, while the indirect testing showed an enhancement of macrophage killing and an increase in nitric oxide production.  These findings show that enrofloxacin does not exert a direct anti-leishmanial activity in vitro.  However, on the basis of the positive immunostimulation results shown in vitro and the clinical improvement, particularly of the cutaneous lesions, obtained in several dogs in the in vivo trial, the use of enrofloxacin in association with a specific anti-leishmanial drug can be proposed in the therapeutic protocol of canine leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtlNK0ZLY7al1C8OJBvdfbfW6udTcc2ea0-I99KKSU97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvhtF2gsg%253D%253D&md5=1901e6faca1668e0f2ad4eeb1256520d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2Fs00436-004-1170-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-004-1170-0%26sid%3Dliteratum%253Aachs%26aulast%3DBianciardi%26aufirst%3DP.%26aulast%3DFasanella%26aufirst%3DA.%26aulast%3DFoglia%2BManzillo%26aufirst%3DV.%26aulast%3DTrotta%26aufirst%3DT.%26aulast%3DPagano%26aufirst%3DA.%26aulast%3DSorino%26aufirst%3DS.%26aulast%3DGradoni%26aufirst%3DL.%26aulast%3DOliva%26aufirst%3DG.%26atitle%3DThe%2520efficacy%2520of%2520enrofloxacin%252C%2520alone%2520or%2520combined%2520with%2520metronidazole%252C%2520in%2520the%2520therapy%2520of%2520canine%2520leishmaniasis%26jtitle%3DParasitol.%2520Res.%26date%3D2004%26volume%3D93%26spage%3D486%26epage%3D492%26doi%3D10.1007%2Fs00436-004-1170-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Löfmark, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlund, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nord, C. E.</span></span> <span> </span><span class="NLM_article-title">Metronidazole is still the drug of choice for treatment of anaerobic infections</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">S16</span>– <span class="NLM_lpage">S23</span>, <span class="refDoi"> DOI: 10.1086/647939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1086%2F647939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=20067388" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=S16-S23&author=S.+L%C3%B6fmarkauthor=C.+Edlundauthor=C.+E.+Nord&title=Metronidazole+is+still+the+drug+of+choice+for+treatment+of+anaerobic+infections&doi=10.1086%2F647939"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1086%2F647939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F647939%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6fmark%26aufirst%3DS.%26aulast%3DEdlund%26aufirst%3DC.%26aulast%3DNord%26aufirst%3DC.%2BE.%26atitle%3DMetronidazole%2520is%2520still%2520the%2520drug%2520of%2520choice%2520for%2520treatment%2520of%2520anaerobic%2520infections%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2010%26volume%3D50%26spage%3DS16%26epage%3DS23%26doi%3D10.1086%2F647939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loiseau, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bories, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres de Ortiz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schinini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas de
Arias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhfakh, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franck, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figadere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocquemiller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournet, A.</span></span> <span> </span><span class="NLM_article-title">Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4950</span>– <span class="NLM_lpage">4956</span>, <span class="refDoi"> DOI: 10.1128/aac.49.12.4950-4956.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.49.12.4950-4956.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16304157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=4950-4956&author=H.+Nakayamaauthor=P.+M.+Loiseauauthor=C.+Boriesauthor=S.+Torres+de+Ortizauthor=A.+Schininiauthor=E.+Sernaauthor=A.+Rojas+de%0AAriasauthor=M.+A.+Fakhfakhauthor=X.+Franckauthor=B.+Figadereauthor=R.+Hocquemillerauthor=A.+Fournet&title=Efficacy+of+orally+administered+2-substituted+quinolines+in+experimental+murine+cutaneous+and+visceral+leishmaniases&doi=10.1128%2Faac.49.12.4950-4956.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases</span></div><div class="casAuthors">Nakayama, Hector; Loiseau, Philippe M.; Bories, Christian; Torres de Ortiz, Susana; Schinini, Alicia; Serna, Elsa; Rojas de Arias, Antonieta; Fakhfakh, Mohamed A.; Franck, Xavier; Figadere, Bruno; Hocquemiller, Reynald; Fournet, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4950-4956</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report in this study the in vivo efficacy of nine 2-substituted quinolines on the Leishmania amazonensis cutaneous infection murine model and on the Leishmania infantum and Leishmania donovani visceral infection murine models.  In the case of the L. amazonensis model, quinolines were administered orally at 25 mg/kg twice daily for 15 days.  Some of quinolines reduced by 80 to 90% the parasite burdens in the lesion, whereas N-methylglucamine antimoniate (Glucantime), administered by s.c. injections at 100 mg [28 mg Sb(V)] per kg of body wt. daily, reduced the parasite burdens by 98%.  In visceral leishmaniasis due to L. infantum, mice treated orally at 25 mg/kg daily for 10 days with various quinolines showed a significant redn. of parasite burdens in the liver and spleen.  These quinolines were significantly more effective than meglumine antimoniate to reduce the parasite burden in both the liver and spleen.  Also, the oral in vivo activity of three quinolines were detd. against L. donovani (LV 9) at 12.5 and 25 mg/kg for 10 days.  Their activity was compared with that of miltefosine at 7.5 mg/kg.  Miltefosine, 2-n-propylquinoline, and another quinoline at 12.5 mg/kg significantly reduced the parasite burdens in the liver by 72, 66, and 61%, resp.  From the present study, one of quinolines (compd. 5) is the most promising compd. against both cutaneous and visceral leishmaniasis.  The double antileishmanial and antiviral activities of these compds. suggest that this series could be a potential treatment for coinfection of Leishmania-human immunodeficiency virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5nMRJk3YOA7Vg90H21EOLACvtfcHk0lgEhxn4K4einQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsr%252FP&md5=45528bab61c8b85282601a2d5198e7d4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2Faac.49.12.4950-4956.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.49.12.4950-4956.2005%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DLoiseau%26aufirst%3DP.%2BM.%26aulast%3DBories%26aufirst%3DC.%26aulast%3DTorres%2Bde%2BOrtiz%26aufirst%3DS.%26aulast%3DSchinini%26aufirst%3DA.%26aulast%3DSerna%26aufirst%3DE.%26aulast%3DRojas%2Bde%2BArias%26aufirst%3DA.%26aulast%3DFakhfakh%26aufirst%3DM.%2BA.%26aulast%3DFranck%26aufirst%3DX.%26aulast%3DFigadere%26aufirst%3DB.%26aulast%3DHocquemiller%26aufirst%3DR.%26aulast%3DFournet%26aufirst%3DA.%26atitle%3DEfficacy%2520of%2520orally%2520administered%25202-substituted%2520quinolines%2520in%2520experimental%2520murine%2520cutaneous%2520and%2520visceral%2520leishmaniases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D4950%26epage%3D4956%26doi%3D10.1128%2Faac.49.12.4950-4956.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yousuf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adhikari, S.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against <i>Leishmania donovani</i></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2016.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27598235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWisL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=468-479&author=M.+Yousufauthor=D.+Mukherjeeauthor=S.+Deyauthor=C.+Palauthor=S.+Adhikari&title=Antileishmanial+ferrocenylquinoline+derivatives%3A+Synthesis+and+biological+evaluation+against+Leishmania+donovani&doi=10.1016%2Fj.ejmech.2016.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani</span></div><div class="casAuthors">Yousuf, Md.; Mukherjee, Debarati; Dey, Somaditya; Pal, Chiranjib; Adhikari, Susanta</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">468-479</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The emergence of resistance against existing antileishmanial drugs necessitates the search for new classes of antileishmanial compds.  Herein a series of structurally diverse ferrocenylquinolines have been synthesized and evaluated for in vitro antileishmanial activity against Leishmania donovani using the MTT assay.  Thirteen (M2-M14) substituted ferrocenylquinoline congeners possessing triazole rings were generated by palladium mediated Suzuki-Miyaura coupling reaction of 5-iodoferrocenylquinolinetriazole and substituted arylboronic acids.  All the synthesized compds. were tested for its antileishmanial activity using both promastigote and amastigote stages of L. donovani.  Among them, three compds. (M4, M7 and M9) exhibited promising anti-promastigote activity, with an IC50 value of 28.7 μM, 22.1 μM and 28 μM, resp., and no cytotoxicity toward host splenocytes.  These three compds. are equally effective against the intracellular amastigote stage of L. donovani showing the IC50 values of 16 μM (M4), 8 μM (M7) and 16 μM (M9), resp., with consistent nitric oxide generation as required for parasite clearance.  From the battery of tests conducted in this study, it appears that these compds. induce parasite death by promoting cell cycle arrest and triggering apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY6jkOM05-S7Vg90H21EOLACvtfcHk0lisCdnxnjf9-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWisL%252FL&md5=18fc8b652426881a980226a25381a981</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DYousuf%26aufirst%3DM.%26aulast%3DMukherjee%26aufirst%3DD.%26aulast%3DDey%26aufirst%3DS.%26aulast%3DPal%26aufirst%3DC.%26aulast%3DAdhikari%26aufirst%3DS.%26atitle%3DAntileishmanial%2520ferrocenylquinoline%2520derivatives%253A%2520Synthesis%2520and%2520biological%2520evaluation%2520against%2520Leishmania%2520donovani%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D468%26epage%3D479%26doi%3D10.1016%2Fj.ejmech.2016.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ukil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, P. K.</span></span> <span> </span><span class="NLM_article-title">18 -Glycyrrhetinic Acid Triggers Curative Th1 Response and Nitric Oxide Up-Regulation in Experimental Visceral Leishmaniasis Associated with the Activation of NF- B</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1169</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.175.2.1161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.4049%2Fjimmunol.175.2.1161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16002718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvV2qu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2005&pages=1161-1169&author=A.+Ukilauthor=A.+Biswasauthor=T.+Dasauthor=P.+K.+Das&title=18+-Glycyrrhetinic+Acid+Triggers+Curative+Th1+Response+and+Nitric+Oxide+Up-Regulation+in+Experimental+Visceral+Leishmaniasis+Associated+with+the+Activation+of+NF-+B&doi=10.4049%2Fjimmunol.175.2.1161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">18β-Glycyrrhetinic Acid Triggers Curative Th1 Response and Nitric Oxide Up-Regulation in Experimental Visceral Leishmaniasis Associated with the Activation of NF-κB</span></div><div class="casAuthors">Ukil, Anindita; Biswas, Aruna; Das, Tapasi; Das, Pijush K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1161-1169</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The efficacy of 18β-glycyrrhetinic acid (GRA), a pentacyclic triterpene belonging to the β-amyrin series of plant origin, was evaluated in exptl. visceral leishmaniasis.  GRA is reported to have antitumor and immunoregulatory activities, which may be attributable in part to the induction of NO.  Indeed, an 11-fold increase in NO prodn. was obsd. with 20 μM GRA in mouse peritoneal macrophages infected with Leishmania donovani promastigotes.  In addn. to having appreciable inhibitory effects on amastigote multiplication within macrophages (IC50, 4.6 μg/mL), complete elimination of liver and spleen parasite burden was achieved by GRA at a dose of 50 mg/kg/day, given three times, 5 days apart, in a 45-day mouse model of visceral leishmaniasis.  GRA treatment resulted in reduced levels of IL-10 and IL-4, but increased levels of IL-12, IFN-γ, TNF-α, and inducible NO synthase, reflecting a switch of CD4+ differentiation from Th2 to Th1.  This treatment is likely to activate immunity, thereby imparting resistance to reinfection.  GRA induced NF-κB migration into the nucleus of parasite-infected cells and caused a diminishing presence of IκB in the cytoplasm.  The lower level of cytoplasmic IκBα in GRA-treated cells resulted from increased phosphorylation of IκBα and higher activity of IκB kinase (IKK).  Addnl. expts. demonstrated that GRA does not directly affect IKK activity.  These results suggest that GRA exerts its effects at some level upstream of IKK in the signaling pathway and induces the prodn. of proinflammatory mediators through a mechanism that, at least in part, involves induction of NF-κB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_7G4pZJbY8LVg90H21EOLACvtfcHk0lisCdnxnjf9-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvV2qu74%253D&md5=b61bb00578133072ad516283f8f2afbf</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.175.2.1161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.175.2.1161%26sid%3Dliteratum%253Aachs%26aulast%3DUkil%26aufirst%3DA.%26aulast%3DBiswas%26aufirst%3DA.%26aulast%3DDas%26aufirst%3DT.%26aulast%3DDas%26aufirst%3DP.%2BK.%26atitle%3D18%2520-Glycyrrhetinic%2520Acid%2520Triggers%2520Curative%2520Th1%2520Response%2520and%2520Nitric%2520Oxide%2520Up-Regulation%2520in%2520Experimental%2520Visceral%2520Leishmaniasis%2520Associated%2520with%2520the%2520Activation%2520of%2520NF-%2520B%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D175%26spage%3D1161%26epage%3D1169%26doi%3D10.4049%2Fjimmunol.175.2.1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu Ball, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, P. K.</span></span> <span> </span><span class="NLM_article-title">The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of map kinases through specific protein kinase c isoforms</span>. <i>Cell. Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">274</span>, <span class="refDoi"> DOI: 10.1038/cmi.2013.68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1038%2Fcmi.2013.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=24561457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVagtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=263-274&author=G.+Sharmaauthor=S.+Karauthor=W.+Basu+Ballauthor=K.+Ghoshauthor=P.+K.+Das&title=The+curative+effect+of+fucoidan+on+visceral+leishmaniasis+is+mediated+by+activation+of+map+kinases+through+specific+protein+kinase+c+isoforms&doi=10.1038%2Fcmi.2013.68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The curative effect of fucoidan on visceral leishmaniasis is mediated by activation of MAP kinases through specific protein kinase C isoforms</span></div><div class="casAuthors">Sharma, Gunjan; Kar, Susanta; Basu Ball, Writoban; Ghosh, Kuntal; Das, Pijush K.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-274</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Fucoidan can cure both antimony-sensitive and antimony-resistant visceral leishmaniasis through immune activation.  However, the signaling events underlying this cellular response remain uncharacterized.  The present study reveals that fucoidan induces activation of p38 and ERK1/2 and NF-κB DNA binding in both normal and Leishmania donovani-infected macrophages, as revealed by western blotting and electrophoretic mobility shift assay (EMSA), resp.  Pharmacol. inhibition of p38, ERK1/2 or the NF-κB pathway markedly attenuated fucoidan-induced pro-inflammatory cytokine synthesis and inducible nitric oxide synthase (iNOS) gene transcription, resulting in a redn. of parasite clearance.  To decipher the underlying mechanism of fucoidan-mediated parasite suppression, the expression and functionality of various protein kinase C (PKC) isoforms were evaluated by immunoblotting and enzyme activity assay.  Fucoidan elicited an increase in expression and activity of PKC-α, -βI and -βII isoforms in infected macrophages.  Functional knockdown of PKC-α and -β resulted in downregulation of p38 and ERK1/2, along with a marked redn. of IL-12 and TNF-α prodn. in fucoidan-treated infected macrophages.  Collectively, these results suggest that the curative effect of fucoidan is mediated by PKC-dependent activation of the mitogen-activated protein kinase (MAPK)/NF-κB pathway, which ultimately results in the prodn. of nitric oxide (NO) and disease-resolving pro-inflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGD6gaty1su7Vg90H21EOLACvtfcHk0lisCdnxnjf9-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVagtr0%253D&md5=81b80bfa20b79875270ab26460219283</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fcmi.2013.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcmi.2013.68%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DKar%26aufirst%3DS.%26aulast%3DBasu%2BBall%26aufirst%3DW.%26aulast%3DGhosh%26aufirst%3DK.%26aulast%3DDas%26aufirst%3DP.%2BK.%26atitle%3DThe%2520curative%2520effect%2520of%2520fucoidan%2520on%2520visceral%2520leishmaniasis%2520is%2520mediated%2520by%2520activation%2520of%2520map%2520kinases%2520through%2520specific%2520protein%2520kinase%2520c%2520isoforms%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2014%26volume%3D11%26spage%3D263%26epage%3D274%26doi%3D10.1038%2Fcmi.2013.68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kyriazis, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koutsoni, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aligiannis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karampetsou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotsika, E.</span></span> <span> </span><span class="NLM_article-title">The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">441</span>, <span class="refDoi"> DOI: 10.1186/s13071-016-1701-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1186%2Fs13071-016-1701-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27501956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCgtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=441&author=I.+D.+Kyriazisauthor=O.+S.+Koutsoniauthor=N.+Aligiannisauthor=K.+Karampetsouauthor=A.-L.+Skaltsounisauthor=E.+Dotsika&title=The+leishmanicidal+activity+of+oleuropein+is+selectively+regulated+through+inflammation-+and+oxidative+stress-related+genes&doi=10.1186%2Fs13071-016-1701-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes</span></div><div class="casAuthors">Kyriazis, Ioannis D.; Koutsoni, Olga S.; Aligiannis, Nektarios; Karampetsou, Kalliopi; Skaltsounis, Alexios-Leandros; Dotsika, Eleni</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">441/1-441/16</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Much research effort has been focused on investigating new compds. derived from low-cost sources, such as natural products, for treating leishmaniasis.  Oleuropein derived from numerous plants, particularly from the olive tree, Olea europaea L. (Oleaceae), is a biophenol with many biol. activities.  Our previous findings showed that oleuropein exhibits leishmanicidal effects against three Leishmania spp. in vitro, and minimizes the parasite burden in L. donovani-infected BALB/c mice.  The aim of the present study is to investigate the possible mechanism(s) that mediate this leishmanicidal activity.  Methods: We detd. the efficacy of oleuropein in elevating ROS and NO prodn. in L. donovani-infected J774A.1 macrophages and in explanted splenocytes and hepatocytes obtained from L. donovani-infected BALB/c mice.  We also assessed the expression of genes that are related to inflammation, T-cell polarization and antioxidant defense, in splenocytes.  Finally, we detd. the ratios of specific IgG2a/IgG1 antibodies and DTH reactions in L. donovani-infected BALB/c mice treated with oleuropein.  Results: Oleuropein was able to elevate ROS prodn. in both in vitro and in vivo models of visceral leishmaniasis and raised NO prodn. in ex vivo cultures of splenocytes and hepatocytes.  The extensive oxidative stress found in oleuropein-treated mice was obviated by the upregulation of the host's antioxidant enzyme (mGCLC) and the simultaneous downregulation of the corresponding enzyme of the parasite (LdGCLC).  Moreover, oleuropein was able to mount a significant Th1 polarization characterized by the expression of immune genes (IL-12β, IL-10, TGF-β1, IFN-γ) and transcription factors (Tbx21 and GATA3).  Moreover, this immunomodulatory effect was also correlated with an inhibitory effect on IL-1β gene expression, rather than with the expression of IL-1α, IL-1rn and TNF-α.  Furthermore, oleuropein-treated BALB/c mice mounted a delayed-type hypersensitivity (DTH) response and an elevated Leishmania-specific IgG2a/IgG1 ratio that clearly demonstrated an in vivo protective mechanism.  Conclusion: The ability of Oleuropein to promote a Th1 type immune response in L. donovani-infected BALB/c mice points towards the candidacy of this bioactive compd. as an immunomodulatory agent that may complement therapeutic approaches to leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHO7yEyaWFDbVg90H21EOLACvtfcHk0lisCdnxnjf9-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCgtr7F&md5=426d80dc8caaacbd0a9aec5331fa2d87</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2Fs13071-016-1701-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13071-016-1701-4%26sid%3Dliteratum%253Aachs%26aulast%3DKyriazis%26aufirst%3DI.%2BD.%26aulast%3DKoutsoni%26aufirst%3DO.%2BS.%26aulast%3DAligiannis%26aufirst%3DN.%26aulast%3DKarampetsou%26aufirst%3DK.%26aulast%3DSkaltsounis%26aufirst%3DA.-L.%26aulast%3DDotsika%26aufirst%3DE.%26atitle%3DThe%2520leishmanicidal%2520activity%2520of%2520oleuropein%2520is%2520selectively%2520regulated%2520through%2520inflammation-%2520and%2520oxidative%2520stress-related%2520genes%26jtitle%3DParasites%2520Vectors%26date%3D2016%26volume%3D9%26spage%3D441%26doi%3D10.1186%2Fs13071-016-1701-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dey, C. S.</span></span> <span> </span><span class="NLM_article-title">Miltefosine induces apoptosis in arsenite-resistant <i>Leishmania donovani</i> promastigotes through mitochondrial dysfunction</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2006.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.exppara.2006.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=17161839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFGrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=1-13&author=N.+K.+Vermaauthor=G.+Singhauthor=C.+S.+Dey&title=Miltefosine+induces+apoptosis+in+arsenite-resistant+Leishmania+donovani+promastigotes+through+mitochondrial+dysfunction&doi=10.1016%2Fj.exppara.2006.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction</span></div><div class="casAuthors">Verma, Navin K.; Singh, Gaganmeet; Dey, Chinmoy S.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The control of leishmaniasis in absence of vaccine solely depends on the choice of chemotherapy.  The major hurdle in successful leishmanial chemotherapy is emergence of drug resistance.  Miltefosine, the first orally administrable anti-leishmanial drug, has shown the potential against drug-resistant strains of Leishmania.  However, there are discrepancies regarding the involvement of P-glycoprotein (Pgp) and sensitivity of miltefosine in multiple drug-resistant (MDR) cell lines that overexpress Pgp in Leishmania.  To address this, the effect of miltefosine in arsenite-resistant Leishmania donovani (Ld-As20) promastigotes displaying an MDR phenotype and overexpressing Pgp-like protein was investigated in the current study.  Results indicate that Ld-As20 is sensitive to miltefosine.  Miltefosine induces process of programmed cell death in Ld-As20 in a time-dependent manner as detd. by cell shrinkage, externalization of phosphatidylserine and DNA fragmentation.  Miltefosine treatment leads to loss of mitochondrial membrane potential and the release of cytochrome C with consequent activation of cellular proteases.  Activation of cellular proteases resulted in activation of DNase that damaged kinetoplast DNA and induced dyskinetoplasty.  These data indicate that miltefosine causes apoptosis-like death in arsenite-resistant L. donovani.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3qjJzeojqeLVg90H21EOLACvtfcHk0ljBwIlLCHDbXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFGrs7Y%253D&md5=86c1d3ff42b4595cfbf2685c95f102b1</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2006.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2006.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DN.%2BK.%26aulast%3DSingh%26aufirst%3DG.%26aulast%3DDey%26aufirst%3DC.%2BS.%26atitle%3DMiltefosine%2520induces%2520apoptosis%2520in%2520arsenite-resistant%2520Leishmania%2520donovani%2520promastigotes%2520through%2520mitochondrial%2520dysfunction%26jtitle%3DExp.%2520Parasitol.%26date%3D2007%26volume%3D116%26spage%3D1%26epage%3D13%26doi%3D10.1016%2Fj.exppara.2006.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shadab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deepthi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, N.</span></span> <span> </span><span class="NLM_article-title">Apoptosis-like cell death in <i>Leishmania donovani</i> treated with kalsometm10, a new liposomal amphotericin b</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0171306</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0171306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1371%2Fjournal.pone.0171306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=28170432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpvFykurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0171306&author=M.+Shadabauthor=B.+Jhaauthor=M.+Asadauthor=M.+Deepthiauthor=M.+Kamranauthor=N.+Ali&title=Apoptosis-like+cell+death+in+Leishmania+donovani+treated+with+kalsometm10%2C+a+new+liposomal+amphotericin+b&doi=10.1371%2Fjournal.pone.0171306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B</span></div><div class="casAuthors">Shadab, Md.; Jha, Baijayanti; Asad, Mohammad; Deepthi, Makaraju; Kamran, Mohd.; Ali, Nahid</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0171306/1-e0171306/31</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Objective: The present study aimed to elucidate the cell death mechanism in Leishmania donovani upon treatment with KalsomeTM10, a new liposomal amphotericin B.  Methodol./Principal findings: We studied morphol. alterations in promastigotes through phase contrast and SEM.  Phosphatidylserine (PS) exposure, loss of mitochondrial membrane potential and disruption of mitochondrial integrity was detd. by flow cytometry using annexinV-FITC, JC-1 and mitotraker, resp.  For analyzing oxidative stress, generation of H2O2 (bioluminescence kit) and mitochondrial superoxide O2- (mitosox) were measured.  DNA fragmentation was evaluated using terminal deoxyribonucleotidyl transferase mediated dUTP nick-end labeling (TUNEL) and DNA laddering assay.  We found that KalsomeTM10 is more effective then Ambisome against the promastigote as well as intracellular amastigote forms.  The mechanistic study showed that KalsomeTM10 induced several morphol. alterations in promastigotes typical of apoptosis.  KalsomeTM10 treatment showed a dose- and time-dependent exposure of PS in promastigotes.  Further, study on mitochondrial pathway revealed loss of mitochondrial membrane potential as well as disruption in mitochondrial integrity with depletion of intracellular pool of ATP.  KalsomeTM10 treated promastigotes showed increased ROS prodn., diminished GSH levels and increased caspase-like activity.  DNA fragmentation and cell cycle arrest was obsd. in KalsomeTM10 treated promastigotes.  Apoptotic DNA fragmentation was also obsd. in KalsomeTM10 treated intracellular amastigotes.  KalsomeTM10 induced generation of ROS and nitric oxide leads to the killing of the intracellular parasites.  Moreover, endocytosis is indispensable for KalsomeTM10 mediated anti-leishmanial effect in host macrophage.  Conclusions: KalsomeTM10 induces apoptotic-like cell death in L. donovani parasites to exhibit its anti-leishmanial function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wZxw3BVGqLVg90H21EOLACvtfcHk0ljBwIlLCHDbXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpvFykurs%253D&md5=a07c4d1ce833e18bf6267abf45c5c86b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0171306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0171306%26sid%3Dliteratum%253Aachs%26aulast%3DShadab%26aufirst%3DM.%26aulast%3DJha%26aufirst%3DB.%26aulast%3DAsad%26aufirst%3DM.%26aulast%3DDeepthi%26aufirst%3DM.%26aulast%3DKamran%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DN.%26atitle%3DApoptosis-like%2520cell%2520death%2520in%2520Leishmania%2520donovani%2520treated%2520with%2520kalsometm10%252C%2520a%2520new%2520liposomal%2520amphotericin%2520b%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0171306%26doi%3D10.1371%2Fjournal.pone.0171306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Félix, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Souza, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lima, M. d. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frade, D. K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafim, V. d. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, K. A. d. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Néris, P. L. d. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scotti, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Aquino, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, M. R.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial activity of new thiophene-indole hybrids: Design, synthesis, biological and cytotoxic evaluation, and chemometric studies</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3972</span>– <span class="NLM_lpage">3977</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.bmc.2016.04.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=27515718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWjurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3972-3977&author=M.+B.+F%C3%A9lixauthor=E.+R.+de+Souzaauthor=M.+d.+C.+A.+de+Limaauthor=D.+K.+G.+Fradeauthor=V.+d.+L.+Serafimauthor=K.+A.+d.+F.+Rodriguesauthor=P.+L.+d.+N.+N%C3%A9risauthor=F.+F.+Ribeiroauthor=L.+Scottiauthor=M.+T.+Scottiauthor=T.+M.+de+Aquinoauthor=M.+R.+de+Oliveiraauthor=M.+R.+de+Oliveira&title=Antileishmanial+activity+of+new+thiophene-indole+hybrids%3A+Design%2C+synthesis%2C+biological+and+cytotoxic+evaluation%2C+and+chemometric+studies&doi=10.1016%2Fj.bmc.2016.04.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Antileishmanial activity of new thiophene-indole hybrids: Design, synthesis, biological and cytotoxic evaluation, and chemometric studies</span></div><div class="casAuthors">Felix, Mayara B.; de Souza, Edson R.; de Lima, Maria do C. A.; Frade, Daiana Karla G.; Serafim, Vanessa de L.; Rodrigues, Klinger Antonio da F.; Neris, Patricia Lima do N.; Ribeiro, Frederico F.; Scotti, Luciana; Scotti, Marcus T.; de Aquino, Thiago M.; Junior, Francisco Jaime B., Jr.; de Oliveira, Marcia R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3972-3977</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present work, thirty-two hybrid compds. contg. cycloalka[b]thiophene and indole moieties (TN5, TN5 1-7, TN6, TN6 1-7, TN7, TN7 1-7, TN8, TN8 1-7) were designed, synthesized and evaluated for their cytotoxic and antileishmanial activity against Leishmania amazonensis promastigotes.  More than half of the compds. (18 compds.) exhibited significant antileishmanial activity (IC50 lower than 10.0 μg/L), showing better performance than the ref. drugs (tri- and penta-valent antimonials).  The most active compds. were TN8-7, TN6-1 and TN7 with resp. IC50 values of 2.1, 2.3 and 3.2 μg/mL.  Demonstrating that all of the compds. were less toxic than the ref. drugs, even at the highest evaluated concn. (400 μg/mL), no compd. tested presented human erythrocyte cytotoxicity.  Compd. TN8-7's effectiveness against a trivalent antimony-resistant culture was demonstrated.  It was obsd. that TN8-7's antileishmanial activity is assocd. with DNA fragmentation of L. amazonensis promastigotes.  Chemometric studies (CPCA, PCA, and PLS) highlight intrinsic soly./lipophilicity, and compd. size and shape as closely related to activity.  The authors' results suggest that hybrid cycloalka[b]thiophene-indole derivs. may be considered as lead compds. for further development of new drugs for the treatment of leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRAys2INiLLVg90H21EOLACvtfcHk0lgKdEjOmALOKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWjurjF&md5=8b3ff076393116fef2c9e0ccdf7c687e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.057%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25A9lix%26aufirst%3DM.%2BB.%26aulast%3Dde%2BSouza%26aufirst%3DE.%2BR.%26aulast%3Dde%2BLima%26aufirst%3DM.%2Bd.%2BC.%2BA.%26aulast%3DFrade%26aufirst%3DD.%2BK.%2BG.%26aulast%3DSerafim%26aufirst%3DV.%2Bd.%2BL.%26aulast%3DRodrigues%26aufirst%3DK.%2BA.%2Bd.%2BF.%26aulast%3DN%25C3%25A9ris%26aufirst%3DP.%2BL.%2Bd.%2BN.%26aulast%3DRibeiro%26aufirst%3DF.%2BF.%26aulast%3DScotti%26aufirst%3DL.%26aulast%3DScotti%26aufirst%3DM.%2BT.%26aulast%3Dde%2BAquino%26aufirst%3DT.%2BM.%26aulast%3Dde%2BOliveira%26aufirst%3DM.%2BR.%26aulast%3Dde%2BOliveira%26aufirst%3DM.%2BR.%26atitle%3DAntileishmanial%2520activity%2520of%2520new%2520thiophene-indole%2520hybrids%253A%2520Design%252C%2520synthesis%252C%2520biological%2520and%2520cytotoxic%2520evaluation%252C%2520and%2520chemometric%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3972%26epage%3D3977%26doi%3D10.1016%2Fj.bmc.2016.04.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayana, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keerthana, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saini, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span> <span> </span><span class="NLM_article-title">Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2016.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.bcp.2016.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=28017772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGns7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=26-42&author=D.+Ramuauthor=S.+Gargauthor=R.+Ayanaauthor=A.+K.+Keerthanaauthor=V.+Sharmaauthor=C.+P.+Sainiauthor=S.+Senauthor=S.+Patiauthor=S.+Singh&title=Novel+%CE%B2-carboline-quinazolinone+hybrids+disrupt+Leishmania+donovani+redox+homeostasis+and+show+promising+antileishmanial+activity&doi=10.1016%2Fj.bcp.2016.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity</span></div><div class="casAuthors">Ramu, Dandugudumula; Garg, Swati; Ayana, R.; Keerthana, A. K.; Sharma, Vijeta; Saini, C. P.; Sen, Subhabrata; Pati, Soumya; Singh, Shailja</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-42</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Visceral Leishmaniasis is a deadly parasitic disease caused by Leishmania donovani.  Paucity exists in the discovery of novel chemotherapeutics against Leishmaniasis.  In this study, the authors synthesized a natural product inspired Diversity Oriented Synthesis library of L. donovani Trypanothione reductase (LdTR) inhibitor β-carboline-quinazolinone hybrids, which are different in stereochem. architecture and diverse in the bioactive chem. space.  It is noteworthy that chirality affects drug-to-protein binding affinity since proteins in any living system are present only in one of the chiral forms.  Upon evaluation of the hybrids, one of the chiral forms i.e.  I showed profound cytotoxic effect in micromolar range as compared to its other chiral form.  In-silico docking studies confirmed high binding efficiency of I with the catalytic pocket of LdTR.  Treatment of L. donovani parasites with I inhibits LdTR activity, induces imbalance in redox homeostasis by enhancing ROS, disrupts the mitochondrial membrane potential, modifies actin polymn. and alters the surface topol. and architecture.  All these cellular modifications eventually led to apoptosis-like death of promastigotes.  Furthermore, the authors synthesized the analogs of I and found that these compds. show profound antileishmanial activity in the nanomolar range both in promastigotes and intracellular amastigotes.  The enhanced inhibitory potential of these compds. was further supported by in-silico anal. of protein-ligand interactions which revealed high binding efficiency towards the catalytic pocket of LdTR.  Taken together, this study reports the serendipitous discovery of β-carboline-quinazolinone hybrids with enhanced antileishmanial activity along with the in-depth structure-activity relationships and mechanism of action of these analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo10izoNensZbVg90H21EOLACvtfcHk0lgKdEjOmALOKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGns7jL&md5=31ad28094bd32986a59b0f76d074dcf9</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2016.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2016.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DRamu%26aufirst%3DD.%26aulast%3DGarg%26aufirst%3DS.%26aulast%3DAyana%26aufirst%3DR.%26aulast%3DKeerthana%26aufirst%3DA.%2BK.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DSaini%26aufirst%3DC.%2BP.%26aulast%3DSen%26aufirst%3DS.%26aulast%3DPati%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DS.%26atitle%3DNovel%2520%25CE%25B2-carboline-quinazolinone%2520hybrids%2520disrupt%2520Leishmania%2520donovani%2520redox%2520homeostasis%2520and%2520show%2520promising%2520antileishmanial%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D129%26spage%3D26%26epage%3D42%26doi%3D10.1016%2Fj.bcp.2016.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baréa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidóia, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Paula, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanello, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarragiotto, M. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2Fj.ejmech.2018.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=29549842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslaiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=579-590&author=P.+Bar%C3%A9aauthor=V.+A.+Barbosaauthor=D.+L.+Bid%C3%B3iaauthor=J.+C.+de+Paulaauthor=T.+F.+Stefanelloauthor=W.+F.+da+Costaauthor=C.+V.+Nakamuraauthor=M.+H.+Sarragiotto&title=Synthesis%2C+antileishmanial+activity+and+mechanism+of+action+studies+of+novel+%CE%B2-carboline-1%2C3%2C5-triazine+hybrids&doi=10.1016%2Fj.ejmech.2018.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids</span></div><div class="casAuthors">Barea, Paula; Barbosa, Valeria Aquilino; Bidoia, Danielle Lazarin; Carreira de Paula, Jessica; Stefanello, Talitha Fernandes; Ferreira da Costa, Willian; Nakamura, Celso Vataru; Sarragiotto, Maria Helena</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">579-590</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel β-carboline-1,3,5-triazine hybrids were synthesized and evaluated for their in vitro antileishmanial activity against promastigote and amastigote forms of Leishmania amazonensis.  Among the compds. tested, the hybrids 9d, 9e, 16a and 16b (I - IV, resp.) showed potent activity against the promastigote forms with IC50 values less than 8 μM.  Compds. 9e and 16b were also active against amastigote forms, displaying IC50 values of 1.0 ± 0.1 μM and 1.2 ± 0.5 μM, resp.  Besides that, the hybrid 16b bearing the 4-methoxyphenyl group at C-1 of β-carboline and isopropylamino group at 1,3,5-triazine, showed low toxicity, being 23.5 and 121.4 times more toxic for promastigotes and axenic amastigotes, resp., than for macrophage J774-A1 cell lines.  Investigation of action mechanism in promastigotes showed that compd. 16b caused alterations in cell division cycle and an increase of lipid-storage bodies, leading the cells to death through various factors.  The accumulation of lipid bodies may be assocd. with apoptotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZcHiTqbTrxbVg90H21EOLACvtfcHk0lgKdEjOmALOKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslaiuro%253D&md5=40cc58bd7ea18346feb0e319cb323f7e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DBar%25C3%25A9a%26aufirst%3DP.%26aulast%3DBarbosa%26aufirst%3DV.%2BA.%26aulast%3DBid%25C3%25B3ia%26aufirst%3DD.%2BL.%26aulast%3Dde%2BPaula%26aufirst%3DJ.%2BC.%26aulast%3DStefanello%26aufirst%3DT.%2BF.%26aulast%3Dda%2BCosta%26aufirst%3DW.%2BF.%26aulast%3DNakamura%26aufirst%3DC.%2BV.%26aulast%3DSarragiotto%26aufirst%3DM.%2BH.%26atitle%3DSynthesis%252C%2520antileishmanial%2520activity%2520and%2520mechanism%2520of%2520action%2520studies%2520of%2520novel%2520%25CE%25B2-carboline-1%252C3%252C5-triazine%2520hybrids%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D150%26spage%3D579%26epage%3D590%26doi%3D10.1016%2Fj.ejmech.2018.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashutosh</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, N.</span></span> <span> </span><span class="NLM_article-title">Use of <i>Leishmania donovani</i> field isolates expressing the luciferase reporter gene in in vitro drug screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3776</span>– <span class="NLM_lpage">3783</span>, <span class="refDoi"> DOI: 10.1128/aac.49.9.3776-3783.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.49.9.3776-3783.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=16131481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFKltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=3776-3783&author=+Ashutoshauthor=S.+Guptaauthor=+Rameshauthor=S.+Sundarauthor=N.+Goyal&title=Use+of+Leishmania+donovani+field+isolates+expressing+the+luciferase+reporter+gene+in+in+vitro+drug+screening&doi=10.1128%2Faac.49.9.3776-3783.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening</span></div><div class="casAuthors">Ashutosh; Gupta, Suman; Ramesh; Sundar, Shyam; Goyal, Neena</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3776-3783</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Currently available primary screens for the selection of candidate antileishmanial compds. are not ideal.  These techniques are time-consuming, laborious, and difficult to scale and require macrophages, which limit their use for high-throughput screening.  We have developed Leishmania donovani field isolates that constitutively express the firefly luciferase reporter gene (luc) as a part of an episomal vector.  An excellent correlation between parasite no. and luciferase activity was obsd.  Luc expression was stable, even in the absence of drug selection, for 4 wk.  The transfectants were infective to macrophages, and intracellular amastigotes exhibited luciferase activity.  The suitability of these recombinant field isolates for in vitro screening of antileishmanial drugs was established.  The luciferase-expressing sodium stibogluconate-resistant cell lines offer a model for the screening of compds. for resistance.  The system is in routine use at the Central Drug Research Institute, Lucknow, India, for high-throughput screening of newly synthesized compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdEOITLsx4YLVg90H21EOLACvtfcHk0lgoszjdMZWTBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFKltbc%253D&md5=037e281233753a528e79236807b013da</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1128%2Faac.49.9.3776-3783.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.49.9.3776-3783.2005%26sid%3Dliteratum%253Aachs%26aulast%3DAshutosh%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DRamesh%26aulast%3DSundar%26aufirst%3DS.%26aulast%3DGoyal%26aufirst%3DN.%26atitle%3DUse%2520of%2520Leishmania%2520donovani%2520field%2520isolates%2520expressing%2520the%2520luciferase%2520reporter%2520gene%2520in%2520in%2520vitro%2520drug%2520screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D3776%26epage%3D3783%26doi%3D10.1128%2Faac.49.9.3776-3783.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, O. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurya, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raju, K. S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taneja, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahajuddin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. P.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial activity of pyrazolopyridine derivatives and their potential as an adjunct therapy with miltefosine</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1059</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms12lsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1041-1059&author=D.+Anandauthor=P.+K.+Yadavauthor=O.+P.+S.+Patelauthor=N.+Parmarauthor=R.+K.+Mauryaauthor=P.+Vishwakarmaauthor=K.+S.+R.+Rajuauthor=I.+Tanejaauthor=M.+Wahajuddinauthor=S.+Karauthor=P.+P.+Yadav&title=Antileishmanial+activity+of+pyrazolopyridine+derivatives+and+their+potential+as+an+adjunct+therapy+with+miltefosine&doi=10.1021%2Facs.jmedchem.6b01447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with Miltefosine</span></div><div class="casAuthors">Anand, Devireddy; Yadav, Pawan Kumar; Patel, Om P. S.; Parmar, Naveen; Maurya, Rahul K.; Vishwakarma, Preeti; Raju, Kanumuri S. R.; Taneja, Isha; Wahajuddin, M.; Kar, Susanta; Yadav, Prem P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1041-1059</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of pyrazolo(dihydro)pyridines was synthesized and evaluated for antileishmanial efficacy against exptl. visceral leishmaniasis (VL).  Among all compds., I and II exhibited better activity than miltefosine against intracellular amastigotes.  Compd. II (50 mg/kg/day) was further studied against Leishmania donovani/BALB/c mice via the i.p. route for 5 days and displayed >91 and >93% clearance of splenic and liver parasitic burden, resp.  Combination treatment of II with a subcurative dose of miltefosine (5 mg/kg) in BALB/c mice almost completely ameliorated the disease (>97% inhibition) by augmenting nitric oxide generation and shifting the immune response toward Th1.  Furthermore, investigating the effect of II on Leishmania promastigotes revealed that it induced mol. events, such as a loss in mitochondrial membrane potential, externalization of phosphatidylserine, and DNA fragmentation, that ultimately resulted in the programmed cell death of the parasite.  These results along with pharmacokinetic studies suggest that II could be a promising lead for treating VL as an adjunct therapy with miltefosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4j0TmZlIPp7Vg90H21EOLACvtfcHk0lgoszjdMZWTBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms12lsw%253D%253D&md5=d9d7aa8b3418f99f72ba498659eeaa5d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01447%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DD.%26aulast%3DYadav%26aufirst%3DP.%2BK.%26aulast%3DPatel%26aufirst%3DO.%2BP.%2BS.%26aulast%3DParmar%26aufirst%3DN.%26aulast%3DMaurya%26aufirst%3DR.%2BK.%26aulast%3DVishwakarma%26aufirst%3DP.%26aulast%3DRaju%26aufirst%3DK.%2BS.%2BR.%26aulast%3DTaneja%26aufirst%3DI.%26aulast%3DWahajuddin%26aufirst%3DM.%26aulast%3DKar%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BP.%26atitle%3DAntileishmanial%2520activity%2520of%2520pyrazolopyridine%2520derivatives%2520and%2520their%2520potential%2520as%2520an%2520adjunct%2520therapy%2520with%2520miltefosine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1041%26epage%3D1059%26doi%3D10.1021%2Facs.jmedchem.6b01447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Das, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumder, H. K.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in <i>Leishmania donovani</i></span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1007/s10495-008-0224-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1007%2Fs10495-008-0224-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=18506627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntVWhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=867-882&author=R.+Dasauthor=A.+Royauthor=N.+Duttaauthor=H.+K.+Majumder&title=Reactive+oxygen+species+and+imbalance+of+calcium+homeostasis+contributes+to+curcumin+induced+programmed+cell+death+in+Leishmania+donovani&doi=10.1007%2Fs10495-008-0224-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani</span></div><div class="casAuthors">Das, Rakhee; Roy, Amit; Dutta, Neeta; Majumder, Hemanta K.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">867-882</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Curcumin, a polyphenol compd., has been recognized as a promising anti-cancer drug.  The purpose of the present study was to investigate the cytotoxicity of curcumin to Leishmania donovani, the causative agent for visceral leishmaniasis.  Flow cytometric anal. revealed that curcumin induced cell cycle arrest at G2/M phase.  Incubation of Leishmania promastigotes with curcumin caused exposure of phosphatidylserine to the outer leaflet of plasma membrane.  This event is preceded by curcumin-induced formation of reactive oxygen species (ROS) and elevation of cytosolic calcium through the release of calcium ions from intracellular stores as well as by influx of extracellular calcium.  Elevation of cytosolic calcium is responsible for depolarization of mitochondrial membrane potential (ΔΨm), release of Cytochrome c into the cytosol and concomitant nuclear alterations that included deoxynucleotidyltransferase-mediated dUTP end labeling (TUNEL) and DNA fragmentation.  Taken together, these data indicate that curcumin has promising antileishmanial activity that is mediated by programmed cell death and, accordingly, merits further investigation as a therapeutic option for the treatment of leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruOjHhuvT6_rVg90H21EOLACvtfcHk0lgoszjdMZWTBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntVWhs74%253D&md5=4de27ff8ab20b055c13fbe3666068f40</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1007%2Fs10495-008-0224-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-008-0224-7%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DR.%26aulast%3DRoy%26aufirst%3DA.%26aulast%3DDutta%26aufirst%3DN.%26aulast%3DMajumder%26aufirst%3DH.%2BK.%26atitle%3DReactive%2520oxygen%2520species%2520and%2520imbalance%2520of%2520calcium%2520homeostasis%2520contributes%2520to%2520curcumin%2520induced%2520programmed%2520cell%2520death%2520in%2520Leishmania%2520donovani%26jtitle%3DApoptosis%26date%3D2008%26volume%3D13%26spage%3D867%26epage%3D882%26doi%3D10.1007%2Fs10495-008-0224-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrakar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, S.</span></span> <span> </span><span class="NLM_article-title">15d-prostaglandin j2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis</span>. <i>J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1007/s00109-016-1384-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1007%2Fs00109-016-1384-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=26830627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2nsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2016&pages=695-710&author=P.+Vishwakarmaauthor=N.+Parmarauthor=P.+K.+Yadavauthor=P.+Chandrakarauthor=S.+Kar&title=15d-prostaglandin+j2+induced+reactive+oxygen+species-mediated+apoptosis+during+experimental+visceral+leishmaniasis&doi=10.1007%2Fs00109-016-1384-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis</span></div><div class="casAuthors">Vishwakarma, Preeti; Parmar, Naveen; Yadav, Pawan Kumar; Chandrakar, Pragya; Kar, Susanta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">695-710</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: 15-Deoxy-delta (12,14)-prostaglandin J2 (15d-PgJ2) is a potent bioactive lipid mediator, known to possess several roles in cell regulation and differentiation along with antimicrobial efficacy against different bacterial and viral infections.  In the present study, we investigated the therapeutic efficacy and mechanism of action of 15d-PgJ2 in vitro in Leishmania donovani promastigotes and infected J774 macrophages, and in vivo in Balb/c mice/golden hamster model of exptl. visceral leishmaniasis.  15D-PgJ2 effectively killed L. donovani promastigotes and amastigotes in vitro with IC50 of 104.6 and 80.09 nM, resp.  At 2 mg/kg (mice) and 4 mg/kg (hamster) doses, 15d-PgJ2 decreased >90 % spleen and liver parasite burden.  It significantly reduced interleukin (IL)-10 and transforming growth factor (TGF)-β synthesis in infected macrophages and splenocytes.  15D-PgJ2 induced reactive oxygen species (ROS)-dependent apoptosis of promastigotes by triggering phosphatidyl serine externalization, mitochondrial membrane damage and inducing caspase-like activity.  In vitro drug interaction studies revealed an indifference to the synergistic assocn. of 15d-PgJ2 with Miltefosine and Amphotericin-B (Amp-B).  Moreover, when combined with sub-curative doses of Miltefosine and Amphotericin-B, 15d-PgJ2 resulted in >95 % parasite removal.  Our results suggested that 15d-PgJ2 induces mitochondria-dependent apoptosis of L. donovani and is a good therapeutic candidate for adjunct therapy against exptl. visceral leishmaniasis.  Key message: 15d-PgJ2 effectively eliminated both promastigotes and amastigotes form of L. donovani.  15D-PgJ2 decreased parasite burden from infected mice and hamsters with reduced Th2 cytokines.  15D-PgJ2 induced ROS-mediated mitochondrial apoptosis of L. donovani promastigotes.  15D-PgJ2 is a good therapeutic candidate for adjunct therapy with Miltefosine and Amp-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNFuNTl43KHLVg90H21EOLACvtfcHk0lgoszjdMZWTBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2nsb8%253D&md5=c6f146a82e0e28d9cba80cd46c404188</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2Fs00109-016-1384-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-016-1384-5%26sid%3Dliteratum%253Aachs%26aulast%3DVishwakarma%26aufirst%3DP.%26aulast%3DParmar%26aufirst%3DN.%26aulast%3DYadav%26aufirst%3DP.%2BK.%26aulast%3DChandrakar%26aufirst%3DP.%26aulast%3DKar%26aufirst%3DS.%26atitle%3D15d-prostaglandin%2520j2%2520induced%2520reactive%2520oxygen%2520species-mediated%2520apoptosis%2520during%2520experimental%2520visceral%2520leishmaniasis%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2016%26volume%3D94%26spage%3D695%26epage%3D710%26doi%3D10.1007%2Fs00109-016-1384-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koella, J. C.</span></span> <span> </span><span class="NLM_article-title">A comparison of three methods of estimating ec50 in studies of drug resistance of malaria parasites</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">257</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/0001-706x(93)90083-n</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1016%2F0001-706x%2893%2990083-n" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=8147282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1993&pages=257-261&author=W.+Huberauthor=J.+C.+Koella&title=A+comparison+of+three+methods+of+estimating+ec50+in+studies+of+drug+resistance+of+malaria+parasites&doi=10.1016%2F0001-706x%2893%2990083-n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites</span></div><div class="casAuthors">Huber W; Koella J C</div><div class="citationInfo"><span class="NLM_cas:title">Acta tropica</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">257-61</span>
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCnHrDefzn2skU0YCbOU3EfW6udTcc2eYVc0Zjiiaawbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7pslSktQ%253D%253D&md5=4d08dce20a9b83bc996d3ab05dab73e4</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0001-706x%2893%2990083-n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0001-706x%252893%252990083-n%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DKoella%26aufirst%3DJ.%2BC.%26atitle%3DA%2520comparison%2520of%2520three%2520methods%2520of%2520estimating%2520ec50%2520in%2520studies%2520of%2520drug%2520resistance%2520of%2520malaria%2520parasites%26jtitle%3DActa%2520Trop.%26date%3D1993%26volume%3D55%26spage%3D257%26epage%3D261%26doi%3D10.1016%2F0001-706x%2893%2990083-n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMaster, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamysz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGwire, B. S.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial Peptide-induced Apoptotic Death ofLeishmaniaResults from Calcium-de pend ent, Caspase-independent Mitochondrial Toxicity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">15496</span>– <span class="NLM_lpage">15504</span>, <span class="refDoi"> DOI: 10.1074/jbc.m809079200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1074%2Fjbc.m809079200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=19357081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFyqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=15496-15504&author=M.+M.+Kulkarniauthor=W.+R.+McMasterauthor=W.+Kamyszauthor=B.+S.+McGwire&title=Antimicrobial+Peptide-induced+Apoptotic+Death+ofLeishmaniaResults+from+Calcium-de+pend+ent%2C+Caspase-independent+Mitochondrial+Toxicity&doi=10.1074%2Fjbc.m809079200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial peptide-induced apoptotic death of Leishmania results from calcium-dependent, caspase-independent mitochondrial toxicity</span></div><div class="casAuthors">Kulkarni, Manjusha M.; McMaster, W. Robert; Kamysz, Wojciech; McGwire, Bradford S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">15496-15504</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">α- And θ-defensin-, magainin-, and cathelicidin-type antimicrobial peptides (AMPs) can kill the pathogenic protozoan Leishmania.  Comparative studies of a panel of AMPs have defined two distinct groups: those that induce nonapoptotic (Class I) and apoptotic (Class II) parasite killing based on their differential ability to induce phosphatidyl serine exposure, loss of mitochondrial membrane potential and decreased ATP prodn., induction of caspase-3/7 and -12 activity, and DNA degrdn.  Class II AMPs cause rapid influx of the vital stain SYTOX and an increase in intracellular Ca2+, whereas Class I AMPs cause a slow accumulation of SYTOX and do not affect intracellular Ca2+ levels.  Inhibitors of cysteine or caspase proteases diminished fast influx of SYTOX through the surface membrane and DNA degrdn. but do not ablate the annexin V staining or the induction of apoptosis by Class II AMPs.  This suggests that the changes in surface permeability in AMP-mediated apoptosis are related to the downstream events of intracellular cysteine/caspase activation or the loss of ATP.  The activation of caspase-12-like activity was Ca2+-dependent, and inhibitors of voltage-gated and nonspecific Ca2+ channels diminished this activity.  Flufenamic acid, a nonspecific Ca2+ inhibitor, completely ablated AMP-induced mitochondrial dysfunction and cell death, indicating the importance of dysregulation of Ca2+ in antimicrobial peptide-induced apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNdgTp2LsZVbVg90H21EOLACvtfcHk0lhMj-YcoE90Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFyqt7o%253D&md5=6ac05269ad13cbbd6407faf355a943ca</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m809079200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m809079200%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DM.%2BM.%26aulast%3DMcMaster%26aufirst%3DW.%2BR.%26aulast%3DKamysz%26aufirst%3DW.%26aulast%3DMcGwire%26aufirst%3DB.%2BS.%26atitle%3DAntimicrobial%2520Peptide-induced%2520Apoptotic%2520Death%2520ofLeishmaniaResults%2520from%2520Calcium-de%2520pend%2520ent%252C%2520Caspase-independent%2520Mitochondrial%2520Toxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D15496%26epage%3D15504%26doi%3D10.1074%2Fjbc.m809079200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrakar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kathuria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnihotri, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqi, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, S.</span></span> <span> </span><span class="NLM_article-title">Ammonium trichloro [1,2-ethanediolato-O,O′]-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1007/s00018-017-2653-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1007%2Fs00018-017-2653-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=28900667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOrtb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2018&pages=563-588&author=P.+Vishwakarmaauthor=N.+Parmarauthor=P.+Chandrakarauthor=T.+Sharmaauthor=M.+Kathuriaauthor=P.+K.+Agnihotriauthor=M.+I.+Siddiqiauthor=K.+Mitraauthor=S.+Kar&title=Ammonium+trichloro+%5B1%2C2-ethanediolato-O%2CO%E2%80%B2%5D-tellurate+cures+experimental+visceral+leishmaniasis+by+redox+modulation+of+Leishmania+donovani+trypanothione+reductase+and+inhibiting+host+integrin+linked+PI3K%2FAkt+pathway&doi=10.1007%2Fs00018-017-2653-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Ammonium trichloro [1,2-ethanediolato-O,O']-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway</span></div><div class="casAuthors">Vishwakarma, Preeti; Parmar, Naveen; Chandrakar, Pragya; Sharma, Tanuj; Kathuria, Manoj; Agnihotri, Pramod K.; Siddiqi, Mohammad Imran; Mitra, Kalyan; Kar, Susanta</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">563-588</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">In an endeavor to search for affordable and safer therapeutics against debilitating visceral leishmaniasis, we examd. antileishmanial potential of ammonium trichloro [1,2-ethanediolato-O,O']-tellurate (AS101); a tellurium based non toxic immunomodulator.  AS101 showed significant in vitro efficacy against both Leishmania donovani promastigotes and amastigotes at sub-micromolar concns.  AS101 could also completely eliminate organ parasite load from L. donovani infected Balb/c mice along with significant efficacy against infected hamsters ( 93% inhibition).  Analyzing mechanistic details revealed that the double edged AS101 could directly induce apoptosis in promastigotes along with indirectly activating host by reversing T-cell anergy to protective Th1 mode, increased ROS generation and anti-leishmanial IgG prodn.  AS101 could inhibit IL-10/STAT3 pathway in L. donovani infected macrophages via blocking α4β7 integrin dependent PI3K/Akt signaling and activate host MAPKs and NF-κB for Th1 response.  In silico docking and biochem. assays revealed AS101's affinity to form thiol bond with cysteine residues of trypanothione reductase in Leishmania promastigotes leading to its inactivation and inducing ROS-mediated apoptosis of the parasite via increased Ca2+ level, loss of ATP and mitochondrial membrane potential along with metacaspase activation.  Our findings provide the first evidence for the mechanism of action of AS101 with excellent safety profile and suggest its promising therapeutic potential against exptl. visceral leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3sa59qiz_iLVg90H21EOLACvtfcHk0lhMj-YcoE90Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOrtb7J&md5=bef1e5c188b49e25587ad7ac5760c0ca</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2Fs00018-017-2653-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-017-2653-3%26sid%3Dliteratum%253Aachs%26aulast%3DVishwakarma%26aufirst%3DP.%26aulast%3DParmar%26aufirst%3DN.%26aulast%3DChandrakar%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DT.%26aulast%3DKathuria%26aufirst%3DM.%26aulast%3DAgnihotri%26aufirst%3DP.%2BK.%26aulast%3DSiddiqi%26aufirst%3DM.%2BI.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DKar%26aufirst%3DS.%26atitle%3DAmmonium%2520trichloro%2520%255B1%252C2-ethanediolato-O%252CO%25E2%2580%25B2%255D-tellurate%2520cures%2520experimental%2520visceral%2520leishmaniasis%2520by%2520redox%2520modulation%2520of%2520Leishmania%2520donovani%2520trypanothione%2520reductase%2520and%2520inhibiting%2520host%2520integrin%2520linked%2520PI3K%252FAkt%2520pathway%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2018%26volume%3D75%26spage%3D563%26epage%3D588%26doi%3D10.1007%2Fs00018-017-2653-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kathuria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sashidhara, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span> <span> </span><span class="NLM_article-title">Induction of mitochondrial dysfunction and oxidative stress in <i>Leishmania donovani</i> by orally active clerodane diterpene</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5916</span>– <span class="NLM_lpage">5928</span>, <span class="refDoi"> DOI: 10.1128/aac.02459-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1128%2Faac.02459-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=25070112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslShsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5916-5928&author=M.+Kathuriaauthor=A.+Bhattacharjeeauthor=K.+V.+Sashidharaauthor=S.+P.+Singhauthor=K.+Mitra&title=Induction+of+mitochondrial+dysfunction+and+oxidative+stress+in+Leishmania+donovani+by+orally+active+clerodane+diterpene&doi=10.1128%2Faac.02459-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of mitochondrial dysfunction and oxidative stress in Leishmania donovani by orally active clerodane diterpene</span></div><div class="casAuthors">Kathuria, Manoj; Bhattacharjee, Arindam; Sashidhara, Koneni V.; Singh, Suriya Pratap; Mitra, Kalyan</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5916-5928, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">This study was performed to investigate the mechanistic aspects of cell death induced by a clerodane diterpene (K-09) in Leishmania donovani promastigotes that was previously demonstrated to be safe and orally active against visceral leishmaniasis (VL).  K-09 caused depolarization of the mitochondrion and the generation of reactive oxygen species, triggering an apoptotic response in L. donovani promastigotes.  Mitochondrial dysfunction subsequently resulted in the release of cytochrome c into the cytosol, impairing ATP prodn.  Oxidative stress caused the depletion of reduced glutathione, while pretreatment with antioxidant N-acetyl cysteine (NAC) was able to abrogate oxidative stress.  However, NAC failed to restore the mitochondrial membrane potential or intracellular calcium homeostasis after K-09 treatment, suggesting that the generation of oxidative stress is a downstream event relative to the other events.  Caspase-3/-7-like protease activity and genomic DNA fragmentation were obsd.  Electron microscopy studies revealed gross morphol. alterations typical of apoptosis, including severe mitochondrial damage, pyknosis of the nucleus, structural disruption of the mitochondrion-kinetoplast complex, flagellar pocket alterations, and the displacement of organelles.  Moreover, an increased no. of lipid droplets was detected after K-09 treatment, which is suggestive of altered lipid metab.  Our results indicate that K-09 induces mitochondrial dysfunction and oxidative stress-mediated apoptotic cell death in L. donovani promastigotes, sharing many features with metazoan apoptosis.  These mechanistic insights provide a basis for further investigation toward the development of K-09 as a potential drug candidate for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj1t4sZJZPzrVg90H21EOLACvtfcHk0ljO3Euh3QaKgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslShsrbI&md5=c51fa163b8ae548fe9408ab6276c913a</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1128%2Faac.02459-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.02459-14%26sid%3Dliteratum%253Aachs%26aulast%3DKathuria%26aufirst%3DM.%26aulast%3DBhattacharjee%26aufirst%3DA.%26aulast%3DSashidhara%26aufirst%3DK.%2BV.%26aulast%3DSingh%26aufirst%3DS.%2BP.%26aulast%3DMitra%26aufirst%3DK.%26atitle%3DInduction%2520of%2520mitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%2520in%2520Leishmania%2520donovani%2520by%2520orally%2520active%2520clerodane%2520diterpene%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5916%26epage%3D5928%26doi%3D10.1128%2Faac.02459-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">XXIV, U. P.</span> <i>The United State of Pharmacopoeia Convention</i>, <span class="NLM_publisher-loc">Rockville, Maryland</span>, <span class="NLM_year">2000</span>; p  <span class="NLM_fpage">185</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=185&author=XXIV%2C+U.+P.&title=The+United+State+of+Pharmacopoeia+Convention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DThe%2520United%2520State%2520of%2520Pharmacopoeia%2520Convention%26date%3D2000%26spage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chhonker, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleightholm, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murry, D. J.</span></span> <span> </span><span class="NLM_article-title">Bioanalytical method development and validation of moxidectin in plasma by LC-MS/MS: Application to in vitro metabolism</span>. <i>Biomed. Chromatogr.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">e4389</span>, <span class="refDoi"> DOI: 10.1002/bmc.4389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.1002%2Fbmc.4389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=30238696" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=e4389&author=Y.+S.+Chhonkerauthor=R.+L.+Sleightholmauthor=D.+J.+Murry&title=Bioanalytical+method+development+and+validation+of+moxidectin+in+plasma+by+LC-MS%2FMS%3A+Application+to+in+vitro+metabolism&doi=10.1002%2Fbmc.4389"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fbmc.4389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbmc.4389%26sid%3Dliteratum%253Aachs%26aulast%3DChhonker%26aufirst%3DY.%2BS.%26aulast%3DSleightholm%26aufirst%3DR.%2BL.%26aulast%3DMurry%26aufirst%3DD.%2BJ.%26atitle%3DBioanalytical%2520method%2520development%2520and%2520validation%2520of%2520moxidectin%2520in%2520plasma%2520by%2520LC-MS%252FMS%253A%2520Application%2520to%2520in%2520vitro%2520metabolism%26jtitle%3DBiomed.%2520Chromatogr.%26date%3D2019%26volume%3D33%26spage%3De4389%26doi%3D10.1002%2Fbmc.4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Characterization of preclinical in vitro and in vivo pharmacokinetics properties for kbp-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4319</span>– <span class="NLM_lpage">4328</span>, <span class="refDoi"> DOI: 10.2147/dddt.s83055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=10.2147%2Fdddt.s83055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=26273193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlsVOitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=4319-4328&author=H.+Liuauthor=Z.+Huangauthor=H.+Liauthor=Q.+Zhangauthor=X.+Tanauthor=F.+Luauthor=S.+Li&title=Characterization+of+preclinical+in+vitro+and+in+vivo+pharmacokinetics+properties+for+kbp-7018%2C+a+new+tyrosine+kinase+inhibitor+candidate+for+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.2147%2Fdddt.s83055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Huang, Zhenhua; Li, Heran; Zhang, Qian; Tan, Xiaojuan; Lu, Fangzheng; Liu, Hongzhuo; Li, Sanming</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4319-4328</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">KBP-7018 is a novel selective tyrosine kinase inhibitor with potential for the treatment of idiopathic pulmonary fibrosis.  The objective of this study was to characterize the preclin. pharmacokinetics of KBP-7018 in vitro and in vivo, and then to assess the likelihood of developing KBP-7018 as a clin. candidate.  The systemic clearance (CL) of KBP-7018 was relatively low in rodents and monkeys with a value of less than 30% of hepatic blood flow, while it was high in dogs.  The steady-state vol. of distribution (Vss) ranged from 1.51 L/kg to 4.65 L/kg across the species tested.  The max. concn. (Cmax) of KBP-7018 occurred at 0.25-6 h after oral dosing, and the bioavailability was moderate (21%-68%).  The human CL (∼20% of hepatic blood flow) and Vss (1.6-5.3 L/kg) were predicted by allometric scaling method and together with the other modeling methods indicated low metab. and acceptable half-time (4.8-19.3 h) in vivo.  Overall, the preclin. data make it amenable to further oral solid dosage from design for the upcoming Phase I trials in human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPIv5wrbFKCrVg90H21EOLACvtfcHk0ljO3Euh3QaKgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlsVOitbs%253D&md5=71c3e026e232f685a9c9186707d5720e</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.2147%2Fdddt.s83055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252Fdddt.s83055%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTan%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520preclinical%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacokinetics%2520properties%2520for%2520kbp-7018%252C%2520a%2520new%2520tyrosine%2520kinase%2520inhibitor%2520candidate%2520for%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2015%26volume%3D9%26spage%3D4319%26epage%3D4328%26doi%3D10.2147%2Fdddt.s83055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i64"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00628">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_68515"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00628">10.1021/acs.jmedchem.9b00628</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00628/suppl_file/jm9b00628_si_001.csv">CSV</a>)</p></li><li><p class="inline"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra of all compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00628/suppl_file/jm9b00628_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00628/suppl_file/jm9b00628_si_001.csv">jm9b00628_si_001.csv (1.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00628/suppl_file/jm9b00628_si_002.pdf">jm9b00628_si_002.pdf (3.94 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00628&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00628%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00628" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac2d4b9bf3bf8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
